PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Shaik, GM; Draberova, L; Cernohouzova, S; Tumova, M; Bugajev, V; Draber, P				Shaik, Gouse M.; Draberova, Lubica; Cernohouzova, Sara; Tumova, Magda; Bugajev, Viktor; Draber, Petr			Pentacyclic triterpenoid ursolic acid interferes with mast cell activation via a lipid-centric mechanism affecting Fc epsilon RI signalosome functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY IGE RECEPTOR; CBL FAMILY PROTEINS; KAPPA-B ACTIVATION; PLASMA-MEMBRANE; OLEANOLIC ACID; TYROSINE PHOSPHORYLATION; NEGATIVE REGULATION; IMMUNOGLOBULIN-E; IN-VIVO; CHOLESTEROL	Pentacyclic triterpenoids, including ursolic acid (UA), are bioactive compounds with multiple biological activities involving anti-inflammatory effects. However, the mode of their action on mast cells, key players in the early stages of allergic inflammation, and underlying molecular mechanisms remain enigmatic. To better understand the effect of UA on mast cell signaling, here we examined the consequences of short-term treatment of mouse bone marrow-derived mast cells with UA. Using IgE-sensitized and antigen-or thapsigargin-activated cells, we found that 15 min exposure to UA inhibited high affinity IgE receptor (FceRI)-mediated degranulation, calcium response, and extracellular calcium uptake. We also found that UA inhibited migration of mouse bone marrow-derived mast cells toward antigen but not toward prostaglandin E2 and stem cell factor. Compared to control antigen-activated cells, UA enhanced the production of tumor necrosis factor-alpha at the mRNA and protein levels. However, secretion of this cytokine was inhibited. Further analysis showed that UA enhanced tyrosine phosphorylation of the SYK kinase and several other proteins involved in the early stages of FceRI signaling, even in the absence of antigen activation, but inhibited or reduced their further phosphorylation at later stages. In addition, we show that UA induced changes in the properties of detergent-resistant plasma membrane micro -domains and reduced antibody-mediated clustering of the FceRI and glycosylphosphatidylinositol-anchored protein Thy -1. Finally, UA inhibited mobility of the FceRI and cholesterol. These combined data suggest that UA exerts its effects, at least in part, via lipid-centric plasma membrane perturbations, hence affecting the functions of the FceRI signalosome.	[Shaik, Gouse M.; Draberova, Lubica; Cernohouzova, Sara; Tumova, Magda; Bugajev, Viktor; Draber, Petr] Czech Acad Sci, Dept Signal Transduct, Inst Mol Genet, Prague, Czech Republic; [Shaik, Gouse M.] King Saud Univ, Coll Sci, Dept Biochem, Riyadh, Saudi Arabia	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; King Saud University	Draber, P (corresponding author), Czech Acad Sci, Dept Signal Transduct, Inst Mol Genet, Prague, Czech Republic.	draberpe@img.cas.cz			Czech Science Foundation [20-16481S]; Ministry of Industry and Trade of the Czech Republic [FV20479]; Technology Agency of the Czech Republic [TP01010060]; Czech Academy of Sciences [RVO 68378050];  [LM2018129];  [CZ.02.1.01/0.0/0.0/18_046/0016045]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Industry and Trade of the Czech Republic; Technology Agency of the Czech Republic; Czech Academy of Sciences(Czech Academy of Sciences); ; 	We thank Daniela Frankova and Romana Budovicova for their technical help, Sarka Takacova and Michal Mrkacek for careful reading of the manuscript, and Jan Valecka and Michaela Blazikova from Service Laboratory of Light Microscopy,<EM><STRONG> </STRONG></EM>Institute of Molecular Genetics of the Czech Academy of Sciences for help with analysis of FceRI, Thy-1.1, and cholesterol mobility. This work was supported by project 20-16481S from the Czech Science Foundation, project FV20479 from the Ministry of Industry and Trade of the Czech Republic, project TP01010060 from the Technology Agency of the Czech Republic, project LM2018129, CZ.02.1.01/0.0/0.0/18_046/0016045 from the of the Czech Republic, and the Institutional project RVO 68378050 from the Czech Academy of Sciences.	Abboud R, 2016, J MEMBRANE BIOL, V249, P327, DOI 10.1007/s00232-016-9871-8; Adewole KE, 2019, J RECEPT SIG TRANSD, V39, P87, DOI 10.1080/10799893.2019.1625062; Alqahtani A, 2013, CURR MED CHEM, V20, P908; Bag N., 2020, BIORXIV, DOI [10.1101/2020.12.26.424347, DOI 10.1101/2020.12.26.424347]; Baumruker T, 2003, INT IMMUNOL, V15, P1207, DOI 10.1093/intimm/dxg120; Bevers EM, 1999, BBA-MOL CELL BIOL L, V1439, P317, DOI 10.1016/S1388-1981(99)00110-9; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Broniatowski M, 2015, BBA-BIOMEMBRANES, V1848, P2154, DOI 10.1016/j.bbamem.2015.05.009; Broniatowski M, 2014, BBA-BIOMEMBRANES, V1838, P2530, DOI 10.1016/j.bbamem.2014.05.027; Bugajev V, 2021, J LIPID RES, V62, DOI 10.1016/j.jlr.2021.100121; Bugajev V, 2010, FEBS LETT, V584, P4949, DOI 10.1016/j.febslet.2010.08.045; Cannon B, 2003, BIOPHYS J, V85, P933, DOI 10.1016/S0006-3495(03)74532-9; CHAPMAN D, 1975, Q REV BIOPHYS, V8, P185, DOI 10.1017/S0033583500001797; Checker R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031318; Chen LH, 2012, CELL SIGNAL, V24, P1565, DOI 10.1016/j.cellsig.2012.03.016; Clarke RJ, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183382; DEITCH AD, 1982, J HISTOCHEM CYTOCHEM, V30, P967, DOI 10.1177/30.9.6182188; Derler I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad7808; Dhakal H, 2021, INT IMMUNOPHARMACOL, V99, DOI 10.1016/j.intimp.2021.107994; Ding HF, 2018, INT J BIOL MACROMOL, V107, P1844, DOI 10.1016/j.ijbiomac.2017.10.040; DRABER P, 1984, SOMAT CELL MOLEC GEN, V10, P435, DOI 10.1007/BF01534848; Draber P, 2016, EUR J PHARMACOL, V778, P11, DOI 10.1016/j.ejphar.2015.02.057; Draber P, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00095; DRABEROVA L, 1991, EUR J IMMUNOL, V21, P1583, DOI 10.1002/eji.1830210703; Draberova L, 2003, J IMMUNOL, V171, P3585, DOI 10.4049/jimmunol.171.7.3585; Draberova L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144596; Draberova L, 2014, MOL CELL BIOL, V34, P4285, DOI 10.1128/MCB.00983-14; EISEMAN E, 1992, NATURE, V355, P78; Fajardo-Sanchez E, 2017, J BIOMOL STRUCT DYN, V35, P2688, DOI 10.1080/07391102.2016.1229219; Flasinski M, 2014, J PHYS CHEM B, V118, P12927, DOI 10.1021/jp508743j; Gasparrini F, 2011, INT ARCH ALLERGY IMM, V156, P16, DOI 10.1159/000322236; Gilfillan AM, 2011, CRIT REV IMMUNOL, V31, P475, DOI 10.1615/CritRevImmunol.v31.i6.30; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gutierrez-Rebolledo GA, 2016, ASIAN PAC J TROP MED, V9, P625, DOI 10.1016/j.apjtm.2016.05.015; Halova I, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aao4354; Halova I, 2018, IMMUNOL REV, V282, P73, DOI 10.1111/imr.12625; Halova I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00119; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Harder KW, 2001, IMMUNITY, V15, P603, DOI 10.1016/S1074-7613(01)00208-4; Harvima IT, 2014, J ALLERGY CLIN IMMUN, V134, P530, DOI 10.1016/j.jaci.2014.03.007; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Horakova H, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-41; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Huranova M, 2010, J CELL BIOL, V191, P75, DOI 10.1083/jcb.201004030; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jayaprakasam B, 2006, J AGR FOOD CHEM, V54, P243, DOI 10.1021/jf0520342; Jin JM, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw399; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Katagiri T, 1999, J IMMUNOL, V163, P1321; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Kim GH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194767; Kim MS, 2008, J IMMUNOL, V180, P4586, DOI 10.4049/jimmunol.180.7.4586; Koshy C, 2015, BBA-GEN SUBJECTS, V1850, P476, DOI 10.1016/j.bbagen.2014.05.010; Kovarova M, 2001, MOL CELL BIOL, V21, P8318, DOI 10.1128/MCB.21.24.8318-8328.2001; Kraft S, 2007, NAT REV IMMUNOL, V7, P365, DOI 10.1038/nri2072; Li LT, 2013, BRAIN RES, V1497, P32, DOI 10.1016/j.brainres.2012.12.032; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Machado DG, 2012, PHARMACOL BIOCHEM BE, V103, P204, DOI 10.1016/j.pbb.2012.08.016; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; MASON DW, 1980, BIOCHEM J, V187, P1; Meyer KH, 1937, T FARADAY SOC, V33, P1062, DOI 10.1039/tf9373301062; Mlala S, 2019, MOLECULES, V24, DOI 10.3390/molecules24152751; Moon PD, 2019, INT J MOL MED, V43, P2252, DOI 10.3892/ijmm.2019.4144; Morris Christopher J, 2003, Methods Mol Biol, V225, P115; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Paulussen JJC, 1999, BIOCHEM PHARMACOL, V57, P503, DOI 10.1016/S0006-2952(98)00317-7; Polakovicova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105539; Pomorski T, 2004, J CELL SCI, V117, P805, DOI 10.1242/jcs.01055; Prades J, 2011, BBA-BIOMEMBRANES, V1808, P752, DOI 10.1016/j.bbamem.2010.12.007; Redei D, 2018, PLANTA MED, V84, P26, DOI 10.1055/s-0043-114424; Rieger AM, 2010, J IMMUNOL METHODS, V358, P81, DOI 10.1016/j.jim.2010.03.019; RIVERA J, 1988, MOL IMMUNOL, V25, P647, DOI 10.1016/0161-5890(88)90100-9; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; RUDOLPH AK, 1981, EUR J IMMUNOL, V11, P527, DOI 10.1002/eji.1830110617; Saravanan R, 2006, LIFE SCI, V78, P713, DOI 10.1016/j.lfs.2005.05.060; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; SCHMITTVERHULST AM, 1978, J EXP MED, V147, P352, DOI 10.1084/jem.147.2.352; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Shishodia S, 2003, CANCER RES, V63, P4375; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Singh J, 2016, INT IMMUNOPHARMACOL, V40, P362, DOI 10.1016/j.intimp.2016.09.019; SIRAGANIAN RP, 1982, FED PROC, V41, P30; Smrz D, 2007, J BIOL CHEM, V282, P10487, DOI 10.1074/jbc.M611090200; Smrz D, 2014, J IMMUNOL, V193, P5924, DOI 10.4049/jimmunol.1303495; Smrz D, 2011, BLOOD, V118, P6803, DOI 10.1182/blood-2011-06-359984; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Surviladze Z, 1998, EUR J IMMUNOL, V28, P1847, DOI 10.1002/(SICI)1521-4141(199806)28:06<1847::AID-IMMU1847>3.0.CO;2-O; Surviladze Z, 2007, J LIPID RES, V48, P1325, DOI 10.1194/jlr.M600485-JLR200; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tolar P, 2001, FOLIA BIOL-PRAGUE, V47, P215; Tolar P, 1997, EUR J IMMUNOL, V27, P3389, DOI 10.1002/eji.1830271238; Volna P, 2004, J EXP MED, V200, P1001, DOI 10.1084/jem.20041213; Waddington KE, 2019, METHODS MOL BIOL, V1951, P209, DOI 10.1007/978-1-4939-9130-3_16; Wang ZX, 1998, MOL CELL BIOL, V18, P590, DOI 10.1128/MCB.18.1.590; Wesseling MC, 2016, CELL PHYSIOL BIOCHEM, V39, P1941, DOI 10.1159/000447891; Xu HL, 2018, BIOMED PHARMACOTHER, V105, P915, DOI 10.1016/j.biopha.2018.06.055; YAMAMURA H, 1994, JPN J PHARMACOL, V66, P377, DOI 10.1254/jjp.66.377; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71; Zhang W, 2006, BBA-GEN SUBJECTS, V1760, P1505, DOI 10.1016/j.bbagen.2006.05.009; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240; Zou JJ, 2019, CURR CANCER DRUG TAR, V19, P245, DOI 10.2174/1568009618666181016145940	108	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102497	10.1016/j.jbc.2022.102497	http://dx.doi.org/10.1016/j.jbc.2022.102497			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36115460	gold, Green Published			2022-12-26	WOS:000886086000009
J	Yu, V; Ronzone, E; Lord, D; Peti, W; Page, R				Yu, Victor; Ronzone, Erik; Lord, Dana; Peti, Wolfgang; Page, Rebecca			MqsR is a noncanonical microbial RNase toxin that is inhibited by antitoxin MqsA via steric blockage of substrate binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; TRANSCRIPTIONAL REPRESSION; CRYSTAL-STRUCTURE; CLEAVAGE; COMPLEX; RELE; MECHANISM; RIBONUCLEASE; DIVERSITY; MAZF	The MqsRA toxin-antitoxin system is a component of the Escherichia coli stress response. Free MqsR, a ribonuclease, cleaves mRNAs containing a 5'-GC-3' sequence causing a global shutdown of translation and the cell to enter a state of dormancy. Despite a general understanding of MqsR function, the molecular mechanism(s) by which MqsR binds and cleaves RNA and how one or more of these activities is inhibited by its cognate antitoxin MqsA is still poorly understood. Here, we used NMR spectroscopy coupled with mRNA cleavage assays to identify the molecular mechanism of MqsR substrate recogni-tion and the MqsR residues that are essential for its catalytic activity. We show that MqsR preferentially binds substrates that contain purines in the -2 and -1 position relative to the MqsR consensus cleavage sequence and that two residues of MqsR, Tyr81, and Lys56 are strictly required for mRNA cleavage. We also show that MqsA inhibits MqsR activity by sterically blocking mRNA substrates from binding while leav-ing the active site fully accessible to mononucleotides. Together, these data identify the residues of MqsR that mediate RNA cleavage and reveal a novel mechanism that regulates MqsR substrate specificity.	[Yu, Victor; Page, Rebecca] Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT 06030 USA; [Ronzone, Erik; Lord, Dana] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI USA; [Peti, Wolfgang] Univ Connecticut, Dept Mol Biol & Biophys, Hlth Ctr, Farmington, CT USA	University of Connecticut; Brown University; University of Connecticut	Page, R (corresponding author), Univ Connecticut, Dept Cell Biol, Hlth Ctr, Farmington, CT 06030 USA.	rpage@uchc.edu		Yu, Victor/0000-0001-8942-0084	NSF;  [MCB-1817621]	NSF(National Science Foundation (NSF)); 	Funding and additional information-This work was supported by grant from the NSF MCB-1817621 to R. P.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; Bertelsen MB, 2021, STRUCTURE, V29, P139, DOI 10.1016/j.str.2020.10.002; Brown BL, 2013, J BIOL CHEM, V288, P1286, DOI 10.1074/jbc.M112.421008; Brown BL, 2011, J BIOL CHEM, V286, P2285, DOI 10.1074/jbc.M110.172643; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; BUCKLE AM, 1994, BIOCHEMISTRY-US, V33, P1644, DOI 10.1021/bi00173a005; Castro-Roa D, 2013, NAT CHEM BIOL, V9, P811, DOI [10.1038/NCHEMBIO.1364, 10.1038/nchembio.1364]; Choi W, 2017, FEBS LETT, V591, P1853, DOI 10.1002/1873-3468.12705; Chowdhury N, 2016, MICROBIOLOGYOPEN, V5, P370, DOI 10.1002/mbo3.335; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Culviner PH, 2021, MBIO, V12, DOI 10.1128/mBio.02012-21; De Bruyn P, 2021, PROTEIN SCI, V30, P1103, DOI 10.1002/pro.4071; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gobl C, 2014, PROG NUCL MAG RES SP, V80, P26, DOI 10.1016/j.pnmrs.2014.05.003; Gottesman S, 2019, J BIOL CHEM, V294, P11685, DOI 10.1074/jbc.REV119.005593; Griffin MA, 2013, BIOCHEMISTRY-US, V52, P8633, DOI 10.1021/bi401325c; Gucinski GC, 2019, STRUCTURE, V27, P1660, DOI 10.1016/j.str.2019.08.010; Han Y, 2020, BMB REP, V53, P611, DOI 10.5483/BMBRep.2020.53.12.203; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; Hurley JM, 2009, J BIOL CHEM, V284, P18605, DOI 10.1074/jbc.M109.008763; Jurenas D, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00262; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Loverix S, 2000, CHEM BIOL, V7, P651, DOI 10.1016/S1074-5521(00)00005-3; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Matzov D, 2019, FEBS J, V286, P3558, DOI 10.1111/febs.14968; Mets T, 2019, BIOCHIMIE, V156, P79, DOI 10.1016/j.biochi.2018.10.004; Moritz CP, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600189; Neubauer C, 2009, CELL, V139, P1084, DOI 10.1016/j.cell.2009.11.015; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pavelich IJ, 2019, NUCLEIC ACIDS RES, V47, P10400, DOI 10.1093/nar/gkz760; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Rivero-Gutierrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; SEVCIK J, 1993, EUR J BIOCHEM, V216, P301, DOI 10.1111/j.1432-1033.1993.tb18145.x; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Zegers I, 1998, NAT STRUCT BIOL, V5, P280, DOI 10.1038/nsb0498-280; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	47	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102535	10.1016/j.jbc.2022.102535	http://dx.doi.org/10.1016/j.jbc.2022.102535			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36162504	Green Published, gold			2022-12-26	WOS:000882627400003
J	Azad, A; Campbell, KR; Zhabyeyev, P; Oudit, GY; Moore, RB; Murray, AG				Azad, Abul K.; Campbell, Kieran R.; Zhabyeyev, Pavel; Oudit, Gavin Y.; Moore, Ronald B.; Murray, Allan G.			Loss of apelin blocks the emergence of sprouting angiogenesis in experimental tumors	FASEB JOURNAL			English	Article						angiogenesis inhibitors; apelin; endothelial cells; gene expression profiling; neoplasm; neovascularization; single-cell analysis; vascular endothelial growth factor receptor-2	ENDOTHELIAL-CELL HETEROGENEITY; CANCER; VEGF; HYPOXIA; PROGRESSION; VESSELS; NORMALIZATION; METASTASIS; INHIBITION; INVASION	Angiogenesis inhibitor drugs targeting vascular endothelial growth factor (VEGF) signaling to the endothelial cell (EC) are used to treat various cancer types. However, primary or secondary resistance to therapy is common. Clinical and pre-clinical studies suggest that alternative pro-angiogenic factors are upregulated after VEGF pathway inhibition. Therefore, identification of alternative pro-angiogenic pathway(s) is critical for the development of more effective anti-angiogenic therapy. Here we study the role of apelin as a pro-angiogenic G-protein-coupled receptor ligand in tumor growth and angiogenesis. We found that loss of apelin in mice delayed the primary tumor growth of Lewis lung carcinoma 1 and B16F10 melanoma when combined with the VEGF receptor tyrosine kinase inhibitor, sunitinib. Targeting apelin in combination with sunitinib markedly reduced the tumor vessel density, and decreased microvessel remodeling. Apelin loss reduced angiogenic sprouting and tip cell marker gene expression in comparison to the sunitinib-alone-treated mice. Single-cell RNA sequencing of tumor EC demonstrated that the loss of apelin prevented EC tip cell differentiation. Thus, apelin is a potent pro-angiogenic cue that supports initiation of tumor neovascularization. Together, our data suggest that targeting apelin may be useful as adjuvant therapy in combination with VEGF signaling inhibition to inhibit the growth of advanced tumors.	[Azad, Abul K.; Zhabyeyev, Pavel; Oudit, Gavin Y.; Murray, Allan G.] Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada; [Campbell, Kieran R.] Univ Toronto, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Campbell, Kieran R.] Univ Toronto, Dept Mol Genet & Stat Sci, Toronto, ON, Canada; [Zhabyeyev, Pavel; Oudit, Gavin Y.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Moore, Ronald B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada	University of Alberta; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Alberta; University of Alberta; University of Alberta	Murray, AG (corresponding author), Univ Alberta, Dept Med, Rm 275 HMRC, Edmonton, AB T6G 2S2, Canada.	allan.murray@ualberta.ca	Moore, Ronald Brian/AET-3015-2022		Canadian Institutes of Health Research [PJT175257]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by an operating award from the Canadian Institutes of Health Research (PJT175257) to Allan G. Murray.	Apte RS, 2019, CELL, V176, P1248, DOI 10.1016/j.cell.2019.01.021; Bennewith KL, 2004, CANCER RES, V64, P6183, DOI 10.1158/0008-5472.CAN-04-0289; Berta J, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85162-0; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Ebos JML, 2011, NAT REV CLIN ONCOL, V8, P210, DOI 10.1038/nrclinonc.2011.21; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Frisch A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114179; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Goveia J, 2020, CANCER CELL, V37, P21, DOI 10.1016/j.ccell.2019.12.001; Harford-Wright E, 2017, BRAIN, V140, P2939, DOI 10.1093/brain/awx253; Hawkins R, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07154-z; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kahn BM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136655; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Kasai A, 2013, ANGIOGENESIS, V16, P723, DOI 10.1007/s10456-013-9349-6; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kerbel RS, 2015, CANCER J, V21, P274, DOI 10.1097/PPO.0000000000000134; Kidoya H, 2012, ONCOGENE, V31, P3254, DOI 10.1038/onc.2011.489; Koh YJ, 2010, CANCER CELL, V18, P171, DOI 10.1016/j.ccr.2010.07.001; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Lugano R, 2020, CELL MOL LIFE SCI, V77, P1745, DOI 10.1007/s00018-019-03351-7; Lun ATL, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0947-7; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Martin JD, 2019, ANNU REV PHYSIOL, V81, P505, DOI 10.1146/annurev-physiol-020518-114700; Mastrella G, 2019, CANCER RES, V79, P2298, DOI 10.1158/0008-5472.CAN-18-0881; McCarthy DJ, 2017, BIOINFORMATICS, V33, P1179, DOI 10.1093/bioinformatics/btw777; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Motzer RJ, 2020, CANCER CELL, V38, P803, DOI 10.1016/j.ccell.2020.10.011; Neelakantan D, 2019, MOL CANCER RES, V17, P1378, DOI 10.1158/1541-7786.MCR-18-0989; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Podgorska M, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101513; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schito L, 2016, TRENDS CANCER, V2, P758, DOI 10.1016/j.trecan.2016.10.016; Sorli SC, 2007, ONCOGENE, V26, P7692, DOI 10.1038/sj.onc.1210573; Stuhler V, 2021, EXPERT OPIN BIOL TH, V21, P1215, DOI 10.1080/14712598.2021.1890713; Tolkach Y, 2019, BRIT J CANCER, V120, P633, DOI 10.1038/s41416-019-0396-7; Uribesalgo I, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809266; Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9; Wu FTH, 2019, BRIT J CANCER, V120, P196, DOI 10.1038/s41416-018-0297-1; Yamagishi A, 2019, INT J BIOL SCI, V15, P1546, DOI 10.7150/ijbs.33423; Zhao H, 2018, CELL REP, V25, P1241, DOI 10.1016/j.celrep.2018.10.015; Zhao Q, 2018, CANCER RES, V78, P2370, DOI 10.1158/0008-5472.CAN-17-2728	52	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22560	10.1096/fj.202200616RR	http://dx.doi.org/10.1096/fj.202200616RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1NF	36165236				2022-12-26	WOS:000859931700001
J	Ishikura, S; Yoshida, K; Tsunoda, T; Shirasawa, S				Ishikura, Shuhei; Yoshida, Kazumasa; Tsunoda, Toshiyuki; Shirasawa, Senji			Death domain-associated protein DAXX regulates noncoding RNA transcription at the centromere through the transcription regulator ZFAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; SUSCEPTIBILITY; ACTIVATION; DISEASE; PROFILE; MITOSIS; HDAXX; LEADS	The centromere is an essential chromosomal structure for faithful chromosome segregation during cell division. No protein-coding genes exist at the centromeres, but centromeric DNA is actively transcribed into noncoding RNA (ncRNA). This centromeric transcription and its ncRNA products play important roles in centromere functions. We previously re-ported that the transcriptional regulator ZFAT (zinc -finger protein with AT hook) plays a pivotal role in ncRNA tran-scription at the centromere; however, it was unclear how ZFAT involvement was regulated. Here, we show that the death domain-associated protein (DAXX) promotes centromeric localization of ZFAT to regulate ncRNA transcription at the centromere. Coimmunoprecipitation analysis of endogenous proteins clearly reveals that DAXX interacts with ZFAT. In addition, we show that ectopic coexpression of ZFAT with DAXX increases the centromeric levels of both ZFAT and ncRNA, compared with ectopic expression of ZFAT alone. On the other hand, we found that siRNA-mediated depletion of DAXX decreases the centromeric levels of both ZFAT and ncRNA in cells ectopically expressing ZFAT. These results suggest that DAXX promotes the centromeric localization of ZFAT and ZFAT-regulated centromeric ncRNA transcription. Furthermore, we demonstrate that depletion of endogenous DAXX protein is sufficient to cause a decrease in the ncRNA levels at the centromeres of chromosomes 17 and X in which ZFAT regulates the transcription, indicating a physiological significance of DAXX in ZFAT-regulated centromeric ncRNA transcription. Taken together, these results demonstrate that DAXX regulates centromeric ncRNA transcription through ZFAT.	[Ishikura, Shuhei; Yoshida, Kazumasa; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka, Japan; [Ishikura, Shuhei; Yoshida, Kazumasa; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Res Inst Adv Mol Med, Fukuoka, Japan	Fukuoka University; Fukuoka University	Shirasawa, S (corresponding author), Fukuoka Univ, Fac Med, Dept Cell Biol, Fukuoka, Japan.; Shirasawa, S (corresponding author), Fukuoka Univ, Res Inst Adv Mol Med, Fukuoka, Japan.	sshirasa@fukuoka-u.ac.jp		Yoshida, Kazumasa/0000-0002-0181-9857; Shirasawa, Senji/0000-0003-3076-3474	Japan Society for the Promotion of Science KAKENHI [20K07317, 22K07221]; Fukuoka University [925, K22009]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fukuoka University	This work was supported by Japan Society for the Promotion of Science KAKENHI grant (grant nos.: 20K07317 [to S. I.] and 22K07221 [to K. Y.]) and by funding from Fukuoka University (Grantgrant nos. 925 and K22009).	Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Catalano C, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00422-6; Chan FL, 2012, P NATL ACAD SCI USA, V109, P1979, DOI 10.1073/pnas.1108705109; Chen YJ, 2022, BIOESSAYS, V44, DOI 10.1002/bies.202100201; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; Erdogan OS, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12221; Eymery A, 2009, NUCLEIC ACIDS RES, V37, P6340, DOI 10.1093/nar/gkp639; Giovinazzi S, 2013, CELL DEATH DIFFER, V20, P721, DOI 10.1038/cdd.2012.169; Giovinazzi S, 2012, ONCOGENE, V31, P13, DOI 10.1038/onc.2011.211; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Gunnarsson R, 2021, LEUKEMIA, V35, P1485, DOI 10.1038/s41375-021-01242-0; Hollenbach AD, 2002, J CELL SCI, V115, P3319; Hoyt SJ, 2022, SCIENCE, V376, P57, DOI 10.1126/science.abk3112; Inoue N, 2012, J CLIN IMMUNOL, V32, P1243, DOI 10.1007/s10875-012-9721-0; Ishikura S, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101213; Ishikura S, 2021, J CELL BIOCHEM, V122, P626, DOI 10.1002/jcb.29890; Ishikura S, 2020, NUCLEIC ACIDS RES, V48, P10848, DOI 10.1093/nar/gkaa815; Ishikura S, 2016, BBA-GENE REGUL MECH, V1859, P1398, DOI 10.1016/j.bbagrm.2016.08.010; Ishikura S, 2016, J BIOL CHEM, V291, P15282, DOI 10.1074/jbc.M116.723734; Ishikura S, 2015, J CELL BIOCHEM, V116, P149, DOI 10.1002/jcb.24954; Iwaihara Y, 2015, ANTICANCER RES, V35, P4419; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Leclerc S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.642732; Lin CW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14502; Liu Q, 2021, GENES GENOM, V43, P217, DOI 10.1007/s13258-021-01041-y; Mahmud I, 2019, NUCLEIC ACIDS RES, V47, P7734, DOI 10.1093/nar/gkz634; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Mihic Pia, 2021, Prog Mol Subcell Biol, V60, P169, DOI 10.1007/978-3-030-74889-0_7; Morozov VM, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0164-y; Morozov VM, 2012, NUCLEUS-AUSTIN, V3, P276, DOI 10.4161/nucl.20180; Nishi K, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0006-7; Ogawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076254; Pan WW, 2013, J BIOL CHEM, V288, P13620, DOI 10.1074/jbc.M112.446369; Pluta AF, 1998, J CELL SCI, V111, P2029; Quenet D., 2014, ELIFE, V3; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Sabatino G, 2013, J BIOL REG HOMEOS AG, V27, P729; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; de Araujo ESS, 2014, EXP MOL PATHOL, V97, P425, DOI 10.1016/j.yexmp.2014.09.009; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tochio Naoya, 2015, Journal of Structural and Functional Genomics, V16, P55, DOI 10.1007/s10969-015-9196-3; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Tsunoda T, 2018, INT J MOL MED, V42, P2595, DOI 10.3892/ijmm.2018.3806; Woo HJ, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0373-7; Zhang FF, 2020, MOL THER, V28, P613, DOI 10.1016/j.ymthe.2019.11.015	48	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102528	10.1016/j.jbc.2022.102528	http://dx.doi.org/10.1016/j.jbc.2022.102528			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36162510	Green Published, gold			2022-12-26	WOS:000881802600011
J	Ng, WY; Atan, R; Yunos, NM; Kamal, AHB; Roslan, MH; Quah, KY; Teh, KX; Zaid, M; Kassim, M; Mariapun, J; Ngim, CF; Dhanoa, A; Yeo, TW				Ng, Wei Yao; Atan, Rafidah; Yunos, Nor'azim Mohd; Kamal, Adam Harrish bin Md; Roslan, Mohd Hariz; Quah, Kai Yuan; Teh, Kai Xuan; Zaid, Masliza; Kassim, Mahazir; Mariapun, Jeevitha; Ngim, Chin Fang; Dhanoa, Amreeta; Yeo, Tsin Wen			A double whammy: The association between comorbidities and severe dengue among adult patients-A matched case-control study	PLOS ONE			English	Article							SERUM LACTATE-DEHYDROGENASE; ACUTE KIDNEY INJURY; HEMORRHAGIC-FEVER; SHOCK SYNDROME; CLASSIFICATION; ENDOTHELIUM; GLYCOCALYX; INFECTION; SYSTEM	Background Dengue infection is the most prevalent mosquito-borne viral infection globally. Concurrently, there has also been an upsurge of non-communicable comorbidities. We aimed to investigate the association between these comorbidities and the development of severe dengue. Methods We performed a retrospective, case-control study involving 117 cases with severe dengue and 351 controls with non-severe dengue; matched according to gender, age (+/- 5 years old), and admission date (+/- 2 weeks). We analyzed the data using conditional odds ratio (cOR) and adjusted conditional odds ratio (AcOR) using univariate and multivariable conditional logistic regression respectively. Results Six main comorbidities namely obesity, diabetes mellitus, hypertension, hyperlipidemia, chronic pulmonary disease, and ischemic heart disease were observed among cases and controls. Multivariable conditional logistic regression model found only hypertension to be independently associated with the development of severe dengue (ACOR 2.46; 95% CI:1.09-5.53). Among symptoms at presentation, lethargy, vomiting, bleeding manifestations, and abdominal pain were associated with increased odds of severe dengue, although the associations were not statistically significant. Headache (ACOR: 0:32; 95% CI: 0.21-0.51) and skin rash (ACOR: 0.42; 95% CI: 0.22-0.81) were associated with significantly lower odds of severe dengue. Severe dengue patients were also found to have significantly higher white cell count, urea, creatinine, alanine aminotransferase, aspartate aminotransferase, creatine kinase, and lactate dehydrogenase on admission, while platelet and albumin were significantly lower compared to non-severe dengue patients. Conclusions Our study found a significant association between hypertension and the development of severe dengue in adult patients. For clinical practice, this finding suggests that dengue patients with underlying hypertension warrant closer clinical monitoring for deterioration. The association between significant derangement in various laboratory parameters and severe dengue as shown in this study is in keeping with previous reports. While further substantiation by larger prospective studies will be desirable, this association may serve to inform the dengue triaging process.	[Ng, Wei Yao; Kamal, Adam Harrish bin Md; Roslan, Mohd Hariz; Quah, Kai Yuan; Teh, Kai Xuan; Mariapun, Jeevitha; Ngim, Chin Fang; Dhanoa, Amreeta] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Selangor, Malaysia; [Ng, Wei Yao; Quah, Kai Yuan] Mackay Hosp & Hlth Serv, Mackay Base Hosp, West Mackay, Qld, Australia; [Atan, Rafidah; Yunos, Nor'azim Mohd] Univ Malaya, Fac Med, Dept Anesthesiol, Kuala Lumpur, Malaysia; [Kamal, Adam Harrish bin Md] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Zaid, Masliza] Hosp Sultanah Aminah, Dept Med, Johor Baharu, Johor, Malaysia; [Kassim, Mahazir] Hosp Sultanah Aminah, Dept Anesthesiol & Intens Care, Johor Baharu, Johor, Malaysia; [Yeo, Tsin Wen] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Yeo, Tsin Wen] Imperial Coll, Singapore, Singapore	Monash University; Monash University Sunway; Universiti Malaya; Universiti Malaya; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kamal, AHB (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Selangor, Malaysia.; Kamal, AHB (corresponding author), Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia.	adamharrish72@gmail.com	Atan, Rafidah/ABH-2367-2021; Yunos, Nor'azim Mohd/U-3994-2017	Atan, Rafidah/0000-0002-3776-7454; Yunos, Nor'azim Mohd/0000-0002-5890-4825; Roslan, Mohd Hariz Bin/0000-0002-3084-4621; Harrish, Adam/0000-0002-4784-3457; Dhanoa, Amreeta/0000-0002-4541-4819; Teh, Kai Xuan/0000-0001-5969-1027; MARIAPUN, JEEVITHA/0000-0003-3421-0527; Quah, Kai Yuan/0000-0002-6439-602X				Academy of Medicine of Malaysia, 2004, CLIN PRACTICE GUIDEL; Alexander N, 2011, TROP MED INT HEALTH, V16, P936, DOI 10.1111/j.1365-3156.2011.02793.x; [Anonymous], SAMPSIZE HOME PAGE; [Anonymous], SOFTW STAT DAT SCI; Basu G, 2011, NEPHROL DIAL TRANSPL, V26, P524, DOI 10.1093/ndt/gfq477; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Chae CU, 2001, HYPERTENSION, V38, P399, DOI 10.1161/01.HYP.38.3.399; Crisis Preparedness & Response Centre, 2013, DENG CAS DEATHS MAL; Erez A, 2014, ISR MED ASSOC J, V16, P439; Figueiredo MAA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000699; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3; Hadinegoro RS, 2012, PAEDIATR INT CHILD H, V32, P33, DOI 10.1179/2046904712Z.00000000052; HALSTEAD SB, 1980, B WORLD HEALTH ORGAN, V58, P1; HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96; Institute for Public Health (IPH), 2015, NAT HLTH MORB SURV 2, VII, DOI DOI 10.1017/CBO9781107415324.004; Krishnamurti C, 2002, AM J TROP MED HYG, V66, P435, DOI 10.4269/ajtmh.2002.66.435; Kumase F, 2010, ACTA MED OKAYAMA, V64, P277; Lam FW, 2015, COMPR PHYSIOL, V5, P1265, DOI 10.1002/cphy.c140074; Lee IK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154772; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Mahmood S, 2013, ISRN TROP MED, V2013; Mehra N, 2012, TROP DOCT, V42, P160, DOI 10.1258/td.2012.120023; MOH, 2015, CLIN PRACTICE GUIDEL; Mourao MPG, 2007, PLATELETS, V18, P605, DOI 10.1080/09537100701426604; Huy NT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002412; Pang JX, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001641; Perveen S, 2016, J RAWALPINDI MED COL, V21, P9; Oliveira JFP, 2015, CLIN KIDNEY J, V8, P681, DOI 10.1093/ckj/sfv106; Pongpan Surangrat, 2013, ISRN Pediatr, V2013, P845876, DOI 10.1155/2013/845876; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125; Sani SSM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2601-8; Schillaci G, 2003, J HYPERTENS, V21, P1841, DOI 10.1097/00004872-200310000-00010; Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Singh MV, 2014, IMMUNOL RES, V59, P243, DOI 10.1007/s12026-014-8548-6; Sirikutt Pugpen, 2014, Journal of the Medical Association of Thailand, V97, pS220; Sprokholt J, 2018, FUTURE VIROL, V13, P287, DOI 10.2217/fvl-2017-0146; Suwarto S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1671-3; Tan VPK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200698; Teixeira MG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003812; Thein TL, 2011, AM J TROP MED HYG, V85, P942, DOI 10.4269/ajtmh.2011.11-0149; Venugopal SK, 2002, CIRCULATION, V106, P1439, DOI 10.1161/01.CIR.0000033116.22237.F9; Villar-Centeno LA, 2008, AM J TROP MED HYG, V78, P370, DOI 10.4269/ajtmh.2008.78.370; WHO, 2009, WHO TECH REP SER, V958, P1; WHO, 1997, DENG HAEM FEV DIAGN; Wong MZ, 2008, ANN ACAD MED SINGAP, V37, P82; Yeung W, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235166; Zein JG, 2004, CHEST, V126, p873S, DOI 10.1378/chest.126.4_MeetingAbstracts.873S; Zeng ZL, 2021, ECLINICALMEDICINE, V32, DOI 10.1016/j.eclinm.2020.100712; Zhang H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/359308; Zulkipli MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006263	54	0	0	16	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2022	17	9							e0273071	10.1371/journal.pone.0273071	http://dx.doi.org/10.1371/journal.pone.0273071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	5C0UJ	36126060	gold, Green Published			2022-12-26	WOS:000863982900001
J	Tan, QL; Liu, ZQ; Gao, XB; Wang, YB; Qiu, XF; Chen, JH; Liang, LC; Guo, HQ; Huang, SS; Wu, DL; Zhou, B; Hu, RG; Li, ZF				Tan, Qilong; Liu, Ziqun; Gao, Xiaobo; Wang, Yibo; Qiu, Xuefeng; Chen, Jiahui; Liang, Liuchun; Guo, Hongqian; Huang, Shengsong; Wu, Denglong; Zhou, Bing; Hu, Ronggui; Li, Zhenfei			Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors	ONCOGENE			English	Article							UBIQUITIN-PROTEIN LIGASE; PROSTATE-CANCER; ANDROGEN-RECEPTOR; E6-ASSOCIATED PROTEIN; E6-AP; ENZALUTAMIDE; RESISTANCE; COACTIVATOR; EXPRESSION; MUTATIONS	Strategies to degrade steroid receptors and their alternative splicing isoforms are critical for disease management. Here we report that celastrol recruited the ubiquitin ligase UBE3A and degraded androgen receptor (AR), AR-v7, and glucocorticoid receptor (GR) to suppress prostate cancer development. UBE3A was not an optimal endogenous AR ubiquitin ligase in mice and patients, but celastrol promoted the interaction between UBE3A and AR. Multiple domains of AR, including the DNA binding domain (DBD), were implicated into the UBE3A-AR interaction. Sharing a conserved DBD, GR, AR-v7, and other steroid receptors were recognized and degraded by UBE3A after celastrol treatment. Thus, celastrol suppressed prostate cancer cell proliferation more potently than enzalutamide. Modifying the carboxyl group of celastrol improved its anti-tumor activity. Together, our findings revealed that celastrol might be a potential molecular glue to enhance the interaction between UBE3A and steroid receptors to degrade multiple steroid receptors and splicing isoforms in prostate cancer, paving a way for further drug optimization and disease treatment.	[Tan, Qilong; Liu, Ziqun; Chen, Jiahui; Li, Zhenfei] Univ Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,Chinese Acad Sc, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Gao, Xiaobo] Fudan Univ, State Key Lab Med Neurobiol, Inst Translat Brain Res, Shanghai 200032, Peoples R China; [Gao, Xiaobo] Fudan Univ, MOE Frontiers Ctr Brain Sci, Shanghai 200032, Peoples R China; [Hu, Ronggui] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Wang, Yibo; Liang, Liuchun; Zhou, Bing] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Wang, Yibo; Zhou, Bing] Univ Chinese Acad Sci, Sch Pharmaceut Sci & Technol, Hangzhou Inst Adv Study, Hangzhou 310024, Peoples R China; [Qiu, Xuefeng; Guo, Hongqian] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Urol, Nanjing 210008, Peoples R China; [Huang, Shengsong; Wu, Denglong] Tongji Univ, Tongji Hosp, Sch Med, Dept Urol, Shanghai 200065, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Nanjing University; Tongji University	Li, ZF (corresponding author), Univ Chinese Acad Sci, State Key Lab Cell Biol, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,Chinese Acad Sc, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Hu, RG (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol,State Key Lab M, 320 Yueyang Rd, Shanghai 200031, Peoples R China.; Zhou, B (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.; Zhou, B (corresponding author), Univ Chinese Acad Sci, Sch Pharmaceut Sci & Technol, Hangzhou Inst Adv Study, Hangzhou 310024, Peoples R China.	zhoubing@simm.ac.cn; coryhu@sibcb.ac.cn; zhenfei.li@sibcb.ac.cn	Li, Zhenfei/AAU-1097-2020	Li, Zhenfei/0000-0001-6520-431X; wang, yibo/0000-0002-6952-2582	National Key R&D Program of China [2018YFA0508200, 2019YFA0802103]; National Natural Science Foundation of China [92157101, 81973166, 91753207, 91853128, 81525019]; Department of Science and Technology of Zhejiang Province [2021C03104]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Zhejiang Province	We thank the staff members (Zhuo Yang, et al) of the chemical biology core facility, the high-performance computing service platform, and the bioinformatics core in Shanghai Institute of Biochemistry and Cell Biology (SIBCB), mass spectrometry staff members of the National Facility for Protein in Shanghai (NFPS), and the Zhangjiang Lab and staff members (Pengyu Wang, et al.) of Bio-Med Big Data Center /Shanghai Institute of Nutrition and Health (SINH) for providing technical support and assistance in data collection and analysis. This work was supported by funding from the National Key R&D Program of China (2018YFA0508200 to ZL; 2019YFA0802103 and 2018YFA0508200 to RH), National Natural Science Foundation of China (92157101 to ZL; 81973166, 91753207 to BZ; 91853128, 81525019 to RH). RH was also supported by funding from Department of Science and Technology of Zhejiang Province (Proj. No. 2021C03104).	Alyamani M, 2017, CELL CHEM BIOL, V24, P825, DOI 10.1016/j.chembiol.2017.05.020; [Anonymous], 2020, Cancer Discov, V10, P1084, DOI 10.1158/2159-8290.CD-NB2020-054; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Birch SE, 2014, ANN ONCOL, V25, P2392, DOI 10.1093/annonc/mdu454; Chadli A, 2010, J BIOL CHEM, V285, P4224, DOI 10.1074/jbc.M109.081018; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Dehm SM, 2008, CANCER RES, V68, P5469, DOI 10.1158/0008-5472.CAN-08-0594; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Fang MM, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.681295; Furr BJA, 1996, EUR UROL, V29, P83; Gao XH, 2005, ENDOCRINOLOGY, V146, P1707, DOI 10.1210/en.2004-1198; Groner AC, 2017, J CLIN INVEST, V127, P1126, DOI 10.1172/JCI88885; Han X, 2019, J MED CHEM, V62, P941, DOI 10.1021/acs.jmedchem.8b01631; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hou ZM, 2022, CELL REP MED, V3, DOI 10.1016/j.xcrm.2022.100561; Hou ZM, 2021, CANCER LETT, V516, P1, DOI 10.1016/j.canlet.2021.04.010; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jones JO, 2009, ACS CHEM BIOL, V4, P199, DOI 10.1021/cb900024z; Khan OY, 2006, MOL ENDOCRINOL, V20, P544, DOI 10.1210/me.2005-0110; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kregel S, 2020, NEOPLASIA, V22, P111, DOI 10.1016/j.neo.2019.12.003; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Li HF, 2014, J MED CHEM, V57, P6458, DOI 10.1021/jm500802j; Li JN, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abe8226; Lim HY, 2021, CANCER LETT, V521, P252, DOI 10.1016/j.canlet.2021.08.030; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mei ZJ, 2022, CELL REP MED, V3, DOI 10.1016/j.xcrm.2022.100608; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Park JH, 2002, AM J PATHOL, V161, P727, DOI 10.1016/S0002-9440(10)64228-9; Ponnusamy S, 2019, CLIN CANCER RES, V25, P6764, DOI 10.1158/1078-0432.CCR-19-1458; Ramamoorthy Sivapriya, 2008, Nucl Recept Signal, V6, pe006, DOI 10.1621/nrs.06006; Salminen A, 2010, BIOCHEM BIOPH RES CO, V394, P439, DOI 10.1016/j.bbrc.2010.03.050; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schneekloth AR, 2008, BIOORG MED CHEM LETT, V18, P5904, DOI 10.1016/j.bmcl.2008.07.114; Seo HR, 2011, CHEM-BIOL INTERACT, V193, P34, DOI 10.1016/j.cbi.2011.04.009; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shi JF, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.558741; Smith CL, 2002, MOL CELL BIOL, V22, P525, DOI 10.1128/MCB.22.2.525-535.2002; Takwale AD, 2020, EUR J MED CHEM, V208, DOI 10.1016/j.ejmech.2020.112769; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Toure M, 2016, ANGEW CHEM INT EDIT, V55, P1966, DOI 10.1002/anie.201507978; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Xu XX, 2018, CELL RES, V28, P48, DOI 10.1038/cr.2017.132; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yang ZM, 2007, NAT MED, V13, P348, DOI 10.1038/nm1547; Zhao LJ, 2020, NEOPLASIA, V22, P522, DOI 10.1016/j.neo.2020.07.002; Zhou YQ, 2017, MOL BIOSYST, V13, P83, DOI 10.1039/c6mb00691d	51	0	0	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 14	2022	41	42					4754	4767		10.1038/s41388-022-02467-8	http://dx.doi.org/10.1038/s41388-022-02467-8		SEP 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5I4GP	36109631				2022-12-26	WOS:000854052300001
J	Miyata, Y; Yamada, K; Nagata, S; Segawa, K				Miyata, Yugo; Yamada, Kyoko; Nagata, Shigekazu; Segawa, Katsumori			Two types of type IV P-type ATPases independently re-establish the asymmetrical distribution of phosphatidylserine in plasma membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPID FLIPPASES; AMINOPHOSPHOLIPID TRANSLOCASE; TRANSPORT; EXPRESSION; EXPOSURE; SCRAMBLASE; P4-ATPASE; CASPASE; COMPLEX; LIPIDS	Phospholipids are asymmetrically distributed between the lipid bilayer of plasma membranes in which phosphatidylserine (PtdSer) is confined to the inner leaflet. ATP11A and ATP11C, type IV P-Type ATPases in plasma membranes, flip PtdSer from the outer to the inner leaflet, but involvement of other P4-ATPases is unclear. We herein demonstrated that once PtdSer was exposed on the cell surface of ATP11A(-/-)ATP11C(-/-) mouse T cell line (W3), its internalization to the inner leaflet of plasma membranes was negligible at 15 degrees C. However, ATP11A(-/-)ATP11C(-/-) cells internalized the exposed PtdSer at 37 degrees C, a temperature at which trafficking of intracellular membranes was active. In addition to ATP11A and 11C, W3 cells expressed ATP8A1, 8B2, 8B4, 9A, 9B, and 11B, with ATP8A1 and ATP11B being present at recycling endosomes. Cells deficient in four P4-ATPases (ATP8A1, 11A, 11B, and 11C) (QKO) did not constitutively expose PtdSer on the cell surface but lost the ability to re-establish PtdSer asymmetry within 1 hour, even at 37 degrees C. The expression of ATP11A or ATP11C conferred QKO cells with the ability to rapidly re-establish PtdSer asymmetry at 15 degrees C and 37 degrees C, while cells expressing ATP8A1 or ATP11B required a temperature of 37 degrees C to achieve this function, and a dynamin inhibitor blocked this process. These results revealed that mammalian cells are equipped with two independent mechanisms to re-establish its asymmetry: the first is a rapid process involving plasma membrane flippases, ATP11A and ATP11C, while the other is mediated by ATP8A1 and ATP11B, which require an endocytosis process.	[Miyata, Yugo; Segawa, Katsumori] Tokyo Med & Dent Univ, Med Res Inst, Dept Med Chem, Bunkyo Ku, Tokyo, Japan; [Yamada, Kyoko; Nagata, Shigekazu; Segawa, Katsumori] Osaka Univ, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka, Japan	Tokyo Medical & Dental University (TMDU); Osaka University	Segawa, K (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Med Chem, Bunkyo Ku, Tokyo, Japan.; Nagata, S; Segawa, K (corresponding author), Osaka Univ, World Premier Int Res Ctr, Immunol Frontier Res Ctr, Lab Biochem & Immunol, Suita, Osaka, Japan.	segawa.mche@tmd.ac.jp; snagata@ifrec.osaka-u.ac.jp	Nagata, Shigekazu/AAG-3203-2019	Nagata, Shigekazu/0000-0001-9758-8426; Segawa, Katsumori/0000-0003-2408-7668; Miyata, Yugo/0000-0002-3245-4600	Japan Society for the Promotion of Science [21H02682, 15H05785, 21H04770, 18H02615]; Ichiro Kanehara foundation; Kobayashi Foundation; SENSHIN Medical Research Foundation; Daiichi Sankyo Foundation of Life Science; Toray Science Foundation; Chugai Foundation for Innovative Drug Discovery Science; Nanken-Kyoten TMDU; Ohsumi Frontier Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ichiro Kanehara foundation; Kobayashi Foundation; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Daiichi Sankyo Foundation of Life Science; Toray Science Foundation(Toray Industries, Inc.); Chugai Foundation for Innovative Drug Discovery Science; Nanken-Kyoten TMDU; Ohsumi Frontier Science Foundation	This work was supported in part by Grants -in -Aid from the Japan Society for the Promotion of Science (18H02615 and 21H02682 to K. S., 15H05785 and 21H04770 to S. N.) , Ichiro Kanehara foundation (K. S.) , Kobayashi Foundation (K. S.) , SENSHIN Medical Research Foundation (K. S.) , Ohsumi Frontier Science Foundation (K. S.) , Daiichi Sankyo Foundation of Life Science (K. S.) , Toray Science Foundation (K. S.) , Chugai Foundation for Innovative Drug Discovery Science (K. S.) , and Nanken-Kyoten TMDU (2021-2-01, to K. S. and S. N.) .	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Andersen JP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00275; Arashiki N, 2019, BIOCHEM BIOPH RES CO, V516, P705, DOI 10.1016/j.bbrc.2019.06.092; Atilla-Gokcumen GE, 2014, CELL, V156, P428, DOI 10.1016/j.cell.2013.12.015; Bevers EM, 2016, PHYSIOL REV, V96, P605, DOI 10.1152/physrev.00020.2015; BEVERS EM, 1989, BIOCHEMISTRY-US, V28, P2382, DOI 10.1021/bi00432a007; Cheng MT, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2118656119; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; Dieudonne T, 2022, ELIFE, V11, DOI 10.7554/eLife.75272; Gadella BM, 2002, BIOL REPROD, V67, P340, DOI 10.1095/biolreprod67.1.340; GHOSH RN, 1994, J CELL SCI, V107, P2177; Grifell-Junyent M, 2022, J CELL SCI, V135, DOI 10.1242/jcs.258649; Harayama T, 2018, NAT REV MOL CELL BIO, V19, P281, DOI 10.1038/nrm.2017.138; Hiraizumi M, 2019, SCIENCE, V365, P1149, DOI 10.1126/science.aay3353; Hsu VW, 2012, NAT REV MOL CELL BIO, V13, P1, DOI 10.1038/nrm3332; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KUISMANEN E, 1989, METHOD CELL BIOL, V32, P257; Lee S, 2015, EMBO J, V34, P669, DOI 10.15252/embj.201489703; Lenoir G, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.737907; M.Ishiyama, 2020, bioRxiv, DOI 10.1101/2020.11.16.379206; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McCusker D, 2012, CURR OPIN CELL BIOL, V24, P845, DOI 10.1016/j.ceb.2012.10.008; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Montigny C, 2016, BBA-MOL CELL BIOL L, V1861, P767, DOI 10.1016/j.bbalip.2015.12.020; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Nagata S, 2021, CURR OPIN IMMUNOL, V68, P1, DOI 10.1016/j.coi.2020.07.007; Nagata S, 2020, CURR OPIN IMMUNOL, V62, P31, DOI 10.1016/j.coi.2019.11.009; Nakanishi H, 2020, J BIOL CHEM, V295, P10180, DOI 10.1074/jbc.RA120.014144; Ochiai Y, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2200582119; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Okamoto S, 2020, MOL BIOL CELL, V31, P2115, DOI 10.1091/mbc.E20-04-0225; Park J, 2021, EMBO J, V40, DOI 10.15252/embj.2020107121; Raymond C, 2011, METHODS, V55, P44, DOI 10.1016/j.ymeth.2011.04.002; Ryoden Y, 2020, J IMMUNOL, V204, P559, DOI 10.4049/jimmunol.1900448; Sartorel E, 2018, MOL BIOL CELL, V29, P1299, DOI 10.1091/mbc.E18-01-0051; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Segawa K, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI148005; Segawa K, 2018, P NATL ACAD SCI USA, V115, P12212, DOI 10.1073/pnas.1814323115; Segawa K, 2018, J BIOL CHEM, V293, P2172, DOI 10.1074/jbc.RA117.000289; Segawa K, 2016, J BIOL CHEM, V291, P762, DOI 10.1074/jbc.M115.690727; Segawa K, 2015, TRENDS CELL BIOL, V25, P639, DOI 10.1016/j.tcb.2015.08.003; Segawa K, 2014, SCIENCE, V344, P1164, DOI 10.1126/science.1252809; Siggs OM, 2011, P NATL ACAD SCI USA, V108, P7890, DOI 10.1073/pnas.1104631108; Siggs OM, 2011, NAT IMMUNOL, V12, P434, DOI 10.1038/ni.2012; Stevens HC, 2008, J BIOL CHEM, V283, P35060, DOI 10.1074/jbc.M802379200; SULLIVAN PC, 1987, J CELL PHYSIOL, V131, P58, DOI 10.1002/jcp.1041310110; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Suzuki J, 2013, SCIENCE, V341, P403, DOI 10.1126/science.1236758; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Takatsu H, 2014, J BIOL CHEM, V289, P33543, DOI 10.1074/jbc.M114.593012; Takatsu H, 2011, J BIOL CHEM, V286, P38159, DOI 10.1074/jbc.M111.281006; Tanaka K, 2011, J BIOCHEM, V149, P131, DOI 10.1093/jb/mvq140; Tsuchiya M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04436-w; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Vance JE, 2015, TRAFFIC, V16, P1, DOI 10.1111/tra.12230; Wang J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29108-z; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Zhou Y, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101439	61	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11								10.1016/j.jbc.2022.102527	http://dx.doi.org/10.1016/j.jbc.2022.102527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36162506	Green Published, gold			2022-12-26	WOS:000882627400012
J	Ogden, S; Carys, K; Ahmed, I; Bruce, J; Sharrocks, AD				Ogden, Samuel; Carys, Kashmala; Ahmed, Ibrahim; Bruce, Jason; Sharrocks, Andrew D.			Regulatory chromatin rewiring promotes metabolic switching during adaptation to oncogenic receptor tyrosine kinase inhibition	ONCOGENE			English	Article							CANCER-CELLS; ESOPHAGEAL; TRASTUZUMAB; DRIVES; COMBINATION; PLASTICITY; LAPATINIB; GENES; ALPHA; WOMEN	Oesophageal adenocarcinoma (OAC) patients show poor survival rates and there are few targeted molecular therapies available. However, components of the receptor tyrosine kinase (RTK) driven pathways are commonly mutated in OAC, typified by high frequency amplifications of the RTK ERBB2. ERBB2 can be therapeutically targeted, but this has limited clinical benefit due to the acquisition of drug resistance. Here we examined how OAC cells adapt to ERBB2 inhibition as they transition to a drug resistant state. ERBB2 inhibition triggers widespread remodelling of the accessible chromatin landscape and the underlying gene regulatory networks. The transcriptional regulators HNF4A and PPARGC1A play a key role in this network rewiring. Initially, inhibition of cell cycle associated gene expression programmes is observed, with compensatory increases in the programmes driving changes in metabolic activity. Both PPARGC1A and HNF4A are required for the acquisition of resistance to ERBB2 inhibition and PPARGC1A is instrumental in promoting a switch to dependency on oxidative phosphorylation. Our work therefore reveals the molecular pathways that support the acquisition of a resistant state and points to potential new therapeutic strategies to combat cellular adaptation and ensuing drug resistance.	[Ogden, Samuel; Carys, Kashmala; Ahmed, Ibrahim; Bruce, Jason; Sharrocks, Andrew D.] Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England	University of Manchester	Sharrocks, AD (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Sch Biol Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	andrew.d.sharrocks@manchester.ac.uk		Bruce, Jason/0000-0002-4503-1981	Wellcome Trust [103857/Z/14/Z, 102171/Z/13/Z]	Wellcome Trust(Wellcome Trust)	We thank Guanhua Yan for excellent technical assistance, Connor Rogerson for advice and help with RNA-seq data processing and staff in the Bioinformatics, Genomic Technologies and Flow cytometry core facilities. Rebecca Fitzgerald for providing the OAC organoid. We also thank Nicoletta Bobola, Tim Somervaille and Shen-Hsi Yang for critical appraisal of the manuscript. This work was funded by grants from the Wellcome Trust (103857/Z/14/Z and 102171/Z/13/Z).	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bang YJ, 2010, LANCET, V376, P1302; Bell CC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10652-9; Bi MJ, 2020, NAT CELL BIOL, V22, P701, DOI 10.1038/s41556-020-0514-z; Blackwell KL, 2010, J CLIN ONCOL, V28, P1124, DOI 10.1200/JCO.2008.21.4437; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boumahdi S, 2020, NAT REV DRUG DISCOV, V19, P39, DOI 10.1038/s41573-019-0044-1; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Britton E, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006879; Brunton H, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107625; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Charos AE, 2012, GENOME RES, V22, P1668, DOI 10.1101/gr.127761.111; Chen L, 2020, GUT, V69, P630, DOI 10.1136/gutjnl-2019-318325; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Coleman HG, 2018, GASTROENTEROLOGY, V154, P390, DOI 10.1053/j.gastro.2017.07.046; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; De Vitto H, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0081-6; Deblois G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12156; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Flavahan WA, 2019, NATURE, V575, P229, DOI 10.1038/s41586-019-1668-3; Frankell AM, 2019, NAT GENET, V51, P506, DOI 10.1038/s41588-018-0331-5; Hammerlindl H, 2018, J CELL COMMUN SIGNAL, V12, P133, DOI 10.1007/s12079-017-0435-1; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Hecht JR, 2016, J CLIN ONCOL, V34, P443, DOI 10.1200/JCO.2015.62.6598; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Janjigian YY, 2018, CANCER DISCOV, V8, P49, DOI 10.1158/2159-8290.CD-17-0787; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Keld R, 2011, BRIT J CANCER, V105, P124, DOI 10.1038/bjc.2011.187; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Kim J, 2014, J CLIN INVEST, V124, P5145, DOI 10.1172/JCI75200; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05190-9; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liau BB, 2017, CELL STEM CELL, V20, P233, DOI 10.1016/j.stem.2016.11.003; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Ma S, 2021, CANCER RES, V81, P1216, DOI 10.1158/0008-5472.CAN-20-0652; Maag JLV, 2017, MOL CANCER RES, V15, P1558, DOI 10.1158/1541-7786.MCR-17-0332; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Pan J, 2020, CANCER RES, V80, P2722, DOI 10.1158/0008-5472.CAN-20-0390; Peters Y, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0086-z; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ramirez M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10690; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rogerson C, 2020, ELIFE, V9, DOI 10.7554/eLife.57189; Rogerson C, 2019, GENOME RES, V29, P723, DOI 10.1101/gr.243345.118; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shen SS, 2020, CELL, V183, P860, DOI 10.1016/j.cell.2020.10.027; Somerville TDD, 2018, CELL REP, V25, P1741, DOI 10.1016/j.celrep.2018.10.051; Stachler MD, 2018, GASTROENTEROLOGY, V155, P156, DOI 10.1053/j.gastro.2018.03.047; Stein EM, 2017, BLOOD, V130, P722, DOI 10.1182/blood-2017-04-779405; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang DS, 2019, GUT, V68, P1152, DOI 10.1136/gutjnl-2018-316522; Weaver JMJ, 2014, NAT GENET, V46, P837, DOI 10.1038/ng.3013; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xia WL, 2002, ONCOGENE, V21, P6255, DOI 10.1038/sj.onc.1205794; Yen K, 2017, CANCER DISCOV, V7, P478, DOI 10.1158/2159-8290.CD-16-1034; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zeng Y, 2018, PHARM BIOL, V56, P393, DOI 10.1080/13880209.2018.1493610; Zhang YR, 2020, CANCER RES, V80, P30, DOI 10.1158/0008-5472.CAN-19-1389; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZHOU YY, 2019, NAT COMMUN, V10, DOI [DOI 10.1038/S41467-019-09234-6, 10.1038/S41467-019-09234-6, DOI 10.1038/s41587-020-0546-8]	72	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 21	2022	41	43					4808	4822		10.1038/s41388-022-02465-w	http://dx.doi.org/10.1038/s41388-022-02465-w		SEP 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5M4RI	36153371	hybrid, Green Published			2022-12-26	WOS:000857812100001
J	Cario, A; Wickramasinghe, SP; Rhoades, E; Berger, CL				Cario, Alisa; Wickramasinghe, Sanjula P.; Rhoades, Elizabeth; Berger, Christopher L.			The N-terminal disease-associated R5L Tau mutation increases microtubule shrinkage rate due to disruption of microtubule-bound Tau patches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENT; DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; DIFFERENTIAL REGULATION; FTDP-17 MUTATIONS; ALPHA-SYNUCLEIN; PROTEIN-TAU; TUBULIN; KINESIN; DOMAINS	Regulation of the neuronal microtubule cytoskeleton is achieved through the coordination of microtubule-associated proteins (MAPs). MAP-Tau, the most abundant MAP in the axon, functions to modulate motor motility, participate in signaling cascades, as well as directly mediate microtubule dynamics. Tau misregulation is associated with a class of neurodegenerative diseases, known as tauopathies, including progressive supranuclear palsy, Pick's disease, and Alzheimer's disease. Many disease-associated mutations in Tau are found in the C-terminal microtubule-binding domain. These mutations decrease microtubule-binding affinity and are proposed to reduce microtubule stability, leading to disease. N-terminal disease-associated mutations also exist, but the mechanistic details of their downstream effects are not as clear. Here, we investigate the effect of the progressive supranuclear palsy- associated N-terminal R5L mutation on Tau-mediated microtubule dynamics using an in vitro reconstituted system. We show that the R5L mutation does not alter Tau interactions with tubulin by fluorescence correlation spectroscopy. Using total internal reflection fluorescence microscopy, we determined that the R5L mutation has no effect on microtubule growth rate, catastrophe frequency, or rescue frequency. Rather, the R5L mutation increases microtubule shrinkage rate. We determine this is due to disruption of Tau patches, larger order Tau complexes known to form on the GDP-microtubule lattice. Altogether, these results provide insight into the role of Tau patches in mediating microtubule dynamics and suggesting a novel mechanism by which mutations in the N-terminal projection domain reduce microtubule stability.	[Cario, Alisa; Berger, Christopher L.] Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA; [Wickramasinghe, Sanjula P.; Rhoades, Elizabeth] Univ Penn, Perelman Sch Med, Biochem & Mol Biophys Grad Grp, Philadelphia, PA USA; [Rhoades, Elizabeth] Univ Penn, Dept Chem, Philadelphia, PA USA	University of Vermont; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Berger, CL (corresponding author), Univ Vermont, Dept Mol Physiol & Biophys, Burlington, VT 05405 USA.	cberger@uvm.edu			National Institute of General Medical Sciences/National Institutes of Health [R01 GM132646]; National Institute on Aging/National Institutes of Health [RF1 RAG053951]	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute of General Medical Sciences/National Institutes of Health funding to C. L. B. (grant no.: R01 GM132646)and the National Institute on Aging/National Institutes of Health funding to E. R. (grant no.: RF1 RAG053951). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r; BERGEN LG, 1980, J CELL BIOL, V84, P141, DOI 10.1083/jcb.84.1.141; Borroni B, 2008, ACTA NEUROL SCAND, V117, P359, DOI 10.1111/j.1600-0404.2007.00955.x; Borroni B, 2008, NEUROLOGY, V71, P1796, DOI 10.1212/01.wnl.0000335941.68602.39; BRANDT R, 1995, J CELL BIOL, V131, P1327, DOI 10.1083/jcb.131.5.1327; Bunker JM, 2006, J BIOL CHEM, V281, P11856, DOI 10.1074/jbc.M509420200; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Cario A, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2114215119; CARLIER MF, 1987, BIOCHEMISTRY-US, V26, P4428, DOI 10.1021/bi00388a036; Castle BT, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101782; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Chaudhary AR, 2018, TRAFFIC, V19, P111, DOI 10.1111/tra.12537; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; Lessard DV, 2021, bioRxiv, DOI 10.1101/2021.08.11.455914; Deshpande A, 2008, FASEB J, V22, P2357, DOI 10.1096/fj.07-096909; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Duan AR, 2017, J MOL BIOL, V429, P1424, DOI 10.1016/j.jmb.2017.03.018; Farmer V, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012144; Gardner MK, 2011, CELL, V147, P1092, DOI 10.1016/j.cell.2011.10.037; Goedert M, 2005, MOVEMENT DISORD, V20, pS45, DOI 10.1002/mds.20539; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; Goode BL, 2000, J BIOL CHEM, V275, P38182, DOI 10.1074/jbc.M007489200; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Gyparaki MT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021461118; Hendrix J, 2013, METHOD ENZYMOL, V518, P205, DOI 10.1016/B978-0-12-388422-0.00009-1; Hinrichs MH, 2012, J BIOL CHEM, V287, P38559, DOI 10.1074/jbc.M112.369785; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543; Kadavath H, 2015, ANGEW CHEM INT EDIT, V54, P10347, DOI 10.1002/anie.201501714; Kadavath H, 2015, P NATL ACAD SCI USA, V112, P7501, DOI 10.1073/pnas.1504081112; Kanaan NM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.006; Kanaan NM, 2011, J NEUROSCI, V31, P9858, DOI 10.1523/JNEUROSCI.0560-11.2011; Kapanidis Achillefs, 2015, Cold Spring Harb Protoc, V2015, P979, DOI 10.1101/pdb.top086405; Kellogg EH, 2018, SCIENCE, V360, P1242, DOI 10.1126/science.aat1780; KIRSCHNER M, 1986, CELL, V45, P329, DOI 10.1016/0092-8674(86)90318-1; Kutter S, 2016, J MOL BIOL, V428, P1742, DOI 10.1016/j.jmb.2016.03.010; Leboeuf AC, 2008, J BIOL CHEM, V283, P36406, DOI 10.1074/jbc.M803519200; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; McKibben KM, 2019, J BIOL CHEM, V294, P19381, DOI 10.1074/jbc.RA119.010172; McVicker DP, 2014, CYTOSKELETON, V71, P184, DOI 10.1002/cm.21163; McVicker DP, 2011, J BIOL CHEM, V286, P42873, DOI 10.1074/jbc.M111.292987; Melo AM, 2016, P NATL ACAD SCI USA, V113, P14336, DOI 10.1073/pnas.1610137113; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; MURPHY DB, 1977, J MOL BIOL, V117, P33, DOI 10.1016/0022-2836(77)90021-3; Mutreja Y, 2019, BIOCHEMISTRY-US, V58, P742, DOI 10.1021/acs.biochem.8b01039; ODDE DJ, 1995, BIOPHYS J, V69, P796, DOI 10.1016/S0006-3495(95)79953-2; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Panda D, 2003, P NATL ACAD SCI USA, V100, P9548, DOI 10.1073/pnas.1633508100; Poorkaj P, 2002, ANN NEUROL, V52, P511, DOI 10.1002/ana.10340; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Schwalbe M, 2014, STRUCTURE, V22, P238, DOI 10.1016/j.str.2013.10.020; Siahaan V., 2021, BIORXIV, DOI [10.1101/2021.11.08.467404, DOI 10.1101/2021.11.08.467404]; Siahaan V, 2019, NAT CELL BIOL, V21, P1086, DOI 10.1038/s41556-019-0374-6; Stern JL, 2017, MOL BIOL CELL, V28, P1079, DOI 10.1091/mbc.E16-10-0728; Strang KH, 2019, LAB INVEST, V99, P912, DOI 10.1038/s41374-019-0197-x; Tan R, 2019, NAT CELL BIOL, V21, P1078, DOI 10.1038/s41556-019-0375-5; Trexler AJ, 2009, BIOCHEMISTRY-US, V48, P2304, DOI 10.1021/bi900114z; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; Tropini C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030103; Venkatramani A, 2019, INT J BIOL MACROMOL, V133, P473, DOI 10.1016/j.ijbiomac.2019.04.120; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wickramasinghe SP, 2019, BIOPHYS J, V117, P717, DOI 10.1016/j.bpj.2019.07.028; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506	74	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102526	10.1016/j.jbc.2022.102526	http://dx.doi.org/10.1016/j.jbc.2022.102526			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36162501	gold, Green Published			2022-12-26	WOS:000882199400001
J	Wei, W; Tang, XF; Jiang, N; Ni, C; He, H; Sun, SF; Yu, M; Yu, CY; Qiu, MD; Yan, D; Zhou, ZC; Song, YL; Liu, HM; Zhao, B; Lin, XH				Wei, Wei; Tang, Xiaofang; Jiang, Ning; Ni, Chao; He, Hua; Sun, Shenfei; Yu, Meng; Yu, Chuyue; Qiu, Mengdi; Yan, Dong; Zhou, Zhaocai; Song, Yuanlin; Liu, Hanmin; Zhao, Bing; Lin, Xinhua			Chromatin remodeler Znhit1 controls bone morphogenetic protein signaling in embryonic lung tissue branching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE ROLES; REGENERATION; ENDODERM; DIFFERENTIATION; ANTIGEN; TOPHAT; CELLS; GENE; SOX2	Branching morphogenesis is a key process essential for lung and other organ development in which cellular and tissue ar-chitecture branch out to maximize surface area. While this process is known to be regulated by differential gene expres-sion of ligands and receptors, how chromatin remodeling regulates this process remains unclear. Znhit1 (zinc finger HIT type containing 1), acting as a chromatin remodeler, has pre-viously been shown to control the deposition of the histone variant H2A.Z. Here, we demonstrate that Znhit1 also plays an important role in regulating lung branching. Using Znhit1 conditional KO mice, we show that Znhit1 deficiency in the embryonic lung epithelium leads to failure of branching morphogenesis and neonatal lethality, which is accompanied by reduced cell proliferation and increased cell apoptosis of the epithelium. The results from the transcriptome and the chro-matin immunoprecipitation assay reveal that this is partially regulated by the derepression of Bmp4, encoding bone morphogenetic protein (BMP) 4, which is a direct target of H2A.Z. Furthermore, we show that inhibition of BMP signaling by the protein inhibitor Noggin rescues the lung branching defects of Znhit1 mutants ex vivo. Taken together, our study identifies the critical role of Znhit1/H2A.Z in embryonic lung morphogenesis via the regulation of BMP signaling.	[Wei, Wei; Tang, Xiaofang; Jiang, Ning; Ni, Chao; Sun, Shenfei; Yu, Meng; Yu, Chuyue; Qiu, Mengdi; Yan, Dong; Zhou, Zhaocai; Zhao, Bing; Lin, Xinhua] Fudan Univ, Zhongshan Hosp, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci,State Key Lab Genet Engn, Shanghai, Peoples R China; [Wei, Wei; He, Hua; Liu, Hanmin; Lin, Xinhua] Sichuan Univ, West China Second Univ Hosp, Joint Lab Lung Dev & Related Dis, Chengdu, Peoples R China; [Wei, Wei; He, Hua; Liu, Hanmin; Lin, Xinhua] Fudan Univ, Sch Life Sci, Chengdu, Peoples R China; [Song, Yuanlin] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai, Peoples R China; [Lin, Xinhua] Shanghai Key Lab Lung Inflammat & Injury, Shanghai, Peoples R China	Fudan University; Sichuan University; Fudan University; Fudan University	Zhao, B; Lin, XH (corresponding author), Fudan Univ, Zhongshan Hosp, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci,State Key Lab Genet Engn, Shanghai, Peoples R China.; Liu, HM; Lin, XH (corresponding author), Sichuan Univ, West China Second Univ Hosp, Joint Lab Lung Dev & Related Dis, Chengdu, Peoples R China.; Liu, HM; Lin, XH (corresponding author), Fudan Univ, Sch Life Sci, Chengdu, Peoples R China.; Lin, XH (corresponding author), Shanghai Key Lab Lung Inflammat & Injury, Shanghai, Peoples R China.	xlin@fudan.edu.cn; bingzhao@fudan.edu.cn; liuhm@scu.edu.cn	yu, chuyue/HHC-2890-2022; Sun, Shenfei/GQZ-0154-2022	Qiu, Mengdi/0000-0002-3225-2128	National Natural Science Foundation of China; National KeyResearch and Development Program of China; Science and Technology Commission of Shanghai Municipality;  [31730044];  [32192403];  [32022022];  [31900581];  [2018YFC1003500];  [20DZ2261200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National KeyResearch and Development Program of China; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); ; ; ; ; ; 	Acknowledgments-This work was supported by grants from the National Natural Science Foundation of China (grant nos.: 31730044, 32192403, 32022022, and 31900581) , the National KeyResearch and Development Program of China (grant no.: 2018YFC1003500) , and the Science and Technology Commission of Shanghai Municipality (grant no.: 20DZ2261200) .	BURRI PH, 1984, ANNU REV PHYSIOL, V46, P617, DOI 10.1146/annurev.ph.46.030184.003153; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; GERDES J, 1984, J IMMUNOL, V133, P1710; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; He H, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006992; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hogan BLM, 1998, CURR OPIN GENET DEV, V8, P481, DOI 10.1016/S0959-437X(98)80121-4; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hu GQ, 2013, CELL STEM CELL, V12, P180, DOI 10.1016/j.stem.2012.11.003; Labaki WW, 2020, ANN INTERN MED, V173, pITC17, DOI 10.7326/AITC202008040; Lafarga V, 2007, CELL CYCLE, V6, P2319, DOI 10.4161/cc.6.19.4741; Li QL, 2018, J CELL SCI, V131, DOI 10.1242/jcs.217406; MCCORMICK D, 1993, HISTOPATHOLOGY, V22, P355, DOI 10.1111/j.1365-2559.1993.tb00135.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Perl AKT, 2005, GENESIS, V41, P23, DOI 10.1002/gene.20093; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Subramanian V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003725; Sun SF, 2022, DEV CELL, V57, P901, DOI 10.1016/j.devcel.2022.03.006; Sun SF, 2020, LEUKEMIA, V34, P3348, DOI 10.1038/s41375-020-0988-5; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2013, DEV CELL, V24, P345, DOI 10.1016/j.devcel.2013.01.012; Weaver M, 2000, DEVELOPMENT, V127, P2695; Weaver M, 1999, DEVELOPMENT, V126, P4005; Weber CM, 2014, GENE DEV, V28, P672, DOI 10.1101/gad.238873.114; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Xu MJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.199026; Yang ZM, 2009, BIOCHEM BIOPH RES CO, V386, P146, DOI 10.1016/j.bbrc.2009.05.139; Yao CF, 2017, DEVELOPMENT, V144, P2618, DOI 10.1242/dev.149708; Zhao B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09060-w; Zuo WL, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.02553-2017	35	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102490	10.1016/j.jbc.2022.102490	http://dx.doi.org/10.1016/j.jbc.2022.102490			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36115458	gold, Green Published			2022-12-26	WOS:000875415100006
J	Komatsu, M; Ichikawa, H; Chiwaki, F; Sakamoto, H; Komatsuzaki, R; Asaumi, M; Tsunoyama, K; Fukagawa, T; Matsushita, H; Boku, N; Matsusaki, K; Takeshita, F; Yoshida, T; Sasaki, H				Komatsu, Masayuki; Ichikawa, Hitoshi; Chiwaki, Fumiko; Sakamoto, Hiromi; Komatsuzaki, Rie; Asaumi, Makoto; Tsunoyama, Kazuhisa; Fukagawa, Takeo; Matsushita, Hiromichi; Boku, Narikazu; Matsusaki, Keisuke; Takeshita, Fumitaka; Yoshida, Teruhiko; Sasaki, Hiroki			ARHGAP-RhoA signaling provokes homotypic adhesion-triggered cell death of metastasized diffuse-type gastric cancer	ONCOGENE			English	Article							LIQUID-CHROMATOGRAPHY; STEM-CELLS; PROTEOMICS; MUTATIONS; CARCINOMA; SURVIVAL; ENTOSIS; ROLES; GAIN	Genetic alteration of Rho GTPase-activating proteins (ARHGAP) and GTPase RhoA is a hallmark of diffuse-type gastric cancer and elucidating its biological significance is critical to comprehensively understanding this malignancy. Here, we report that gene fusions of ARHGAP6/ARHGAP26 are frequent genetic events in peritoneally-metastasized gastric and pancreatic cancer. From the malignant ascites of patients, we established gastric cancer cell lines that spontaneously gain hotspot RHOA mutations or four different ARHGAP6/ARHGAP26 fusions. These alterations critically downregulate RhoA-ROCK-MLC2 signaling, which elicits cell death. Omics and functional analyses revealed that the downstream signaling initiates actin stress fibers and reinforces intercellular junctions via several types of catenin. E-cadherin-centered homotypic adhesion followed by lysosomal membrane permeabilization is a pivotal mechanism in cell death. These findings support the tumor-suppressive nature of ARHGAP-RhoA signaling and might indicate a new avenue of drug discovery against this refractory cancer.	[Komatsu, Masayuki; Chiwaki, Fumiko; Takeshita, Fumitaka; Sasaki, Hiroki] Natl Canc Ctr, Dept Translat Oncol, Res Inst, Tokyo, Japan; [Ichikawa, Hitoshi; Sakamoto, Hiromi] Natl Canc Ctr, Dept Clin Genom, Tokyo, Japan; [Komatsuzaki, Rie] Natl Canc Ctr, Div Canc Therapeut, Tokyo, Japan; [Asaumi, Makoto; Tsunoyama, Kazuhisa] Astellas Pharma Inc, Adv Informat & Analyt, Ibaraki, Japan; [Fukagawa, Takeo] Teikyo Univ, Dept Surg, Sch Med, Tokyo, Japan; [Matsushita, Hiromichi] Natl Canc Ctr, Dept Lab Med, Tokyo, Japan; [Boku, Narikazu] Natl Canc Ctr, Div Gastrointestinal Med Oncol, Tokyo, Japan; [Matsusaki, Keisuke] Kanamecho Hosp, Ascites Treatment Ctr, Tokyo, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Genet Med & Serv, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Astellas Pharmaceuticals; Teikyo University; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan	Komatsu, M; Sasaki, H (corresponding author), Natl Canc Ctr, Dept Translat Oncol, Res Inst, Tokyo, Japan.	makomats@ncc.go.jp; hksasaki@ncc.go.jp		Komatsu, Masayuki/0000-0003-1180-1746; Chiwaki, Fumiko/0000-0002-0914-9157; Ichikawa, Hitoshi/0000-0003-0142-2240; Boku, Narikazu/0000-0002-1438-707X	National Institute of Biomedical Innovation [ID10-41]; National Cancer Center Research and Development Fund [28-A-11, 29-A-2, 2020-J-2]; AMED (Japan Agency for Medical Research and Development) [JP20ck0106519]; Astellas Pharma, Inc [CH27066]	National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); National Cancer Center Research and Development Fund(National Cancer Center - Japan); AMED (Japan Agency for Medical Research and Development)(Japan Agency for Medical Research and Development (AMED)); Astellas Pharma, Inc(Astellas Pharmaceuticals)	This research was supported by the National Institute of Biomedical Innovation (Program ID10-41), by the National Cancer Center Research and Development Fund (28-A-11, 29-A-2, and 2020-J-2), by AMED (Japan Agency for Medical Research and Development, JP20ck0106519), and by Astellas Pharma, Inc (CH27066). We thank H. Nikki March, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.	Abe Y, 2020, THERANOSTICS, V10, P2115, DOI 10.7150/thno.37623; Alduaij W, 2011, BLOOD, V117, P4519, DOI 10.1182/blood-2010-07-296913; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bros M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070733; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chiba H, 2008, BBA-BIOMEMBRANES, V1778, P588, DOI 10.1016/j.bbamem.2007.08.017; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; DUARTE I, 1981, HUM PATHOL, V12, P237, DOI 10.1016/S0046-8177(81)80124-4; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fukagawa T, 2010, WORLD J SURG, V34, P563, DOI 10.1007/s00268-009-0355-1; Hamann JC, 2017, CELL REP, V20, P201, DOI 10.1016/j.celrep.2017.06.037; Han MKL, 2017, NAT CELL BIOL, V19, P14, DOI 10.1038/ncb3457; Hodge RG, 2020, CRIT REV BIOCHEM MOL, V55, P386, DOI 10.1080/10409238.2020.1810622; Ivanov A, 2009, J CLIN INVEST, V119, P2143, DOI 10.1172/JCI37884; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Kakiuchi M, 2014, NAT GENET, V46, P583, DOI 10.1038/ng.2984; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kumeta M, 2018, GENES CELLS, V23, P715, DOI 10.1111/gtc.12603; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Leverrier Y, 2001, NAT CELL BIOL, V3, pE91, DOI 10.1038/35070151; Loh CY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101118; Lu M, 2014, MOL CELL, V54, P987, DOI 10.1016/j.molcel.2014.04.029; Ma Z, 2007, J CELL BIOL, V179, P23, DOI 10.1083/jcb.200706097; MacDonald Justin A., 2018, Cardiovascular & Hematological Disorders - Drug Targets, V18, P4, DOI 10.2174/1871529X18666180326120638; Maeda M, 2016, GASTRIC CANCER, V19, P326, DOI 10.1007/s10120-015-0525-9; Mendonsa AM, 2018, ONCOGENE, V37, P4769, DOI 10.1038/s41388-018-0304-2; Mimori K, 2008, CLIN CANCER RES, V14, P2609, DOI 10.1158/1078-0432.CCR-07-4354; Nakayama I, 2019, CANCER SCI, V110, P1352, DOI 10.1111/cas.13967; Negishi A, 2009, CANCER SCI, V100, P514, DOI 10.1111/j.1349-7006.2008.01055.x; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Petrova YI, 2016, MOL BIOL CELL, V27, P3233, DOI 10.1091/mbc.E16-01-0058; Polkowski W, 1999, ANN SURG ONCOL, V6, P290, DOI 10.1007/s10434-999-0290-2; Qiu MZ, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-58; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; Shim HJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66637-y; Shu Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04907-0; Song HN, 2016, J THORAC ONCOL, V11, pE45, DOI 10.1016/j.jtho.2015.12.093; Sun Q, 2014, CELL RES, V24, P1288, DOI 10.1038/cr.2014.137; Svensmark JH, 2019, ONCOGENE, V38, P7447, DOI 10.1038/s41388-019-0963-7; Tanaka Atsushi, 2018, Oncotarget, V9, P29336, DOI 10.18632/oncotarget.25464; Tanaka Y, 2021, NAT CANCER, V2, P962, DOI 10.1038/s43018-021-00240-6; Tcherkezian J, 2007, BIOL CELL, V99, P67, DOI 10.1042/BC20060086; Tomita H, 2016, ONCOTARGET, V7, P11018, DOI 10.18632/oncotarget.6920; Ushiku T, 2016, GASTRIC CANCER, V19, P403, DOI 10.1007/s10120-015-0493-0; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu XF, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0847-5; Yang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06747-4; Yang HHN, 2018, CELL STEM CELL, V23, P882, DOI 10.1016/j.stem.2018.09.016; Yao F, 2015, CELL REP, V12, P272, DOI 10.1016/j.celrep.2015.06.020; Zhang HS, 2020, CANCER DISCOV, V10, P288, DOI 10.1158/2159-8290.CD-19-0811; Zhang WH, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01214; Zheng HC, 2008, VIRCHOWS ARCH, V452, P525, DOI 10.1007/s00428-007-0572-7	58	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 21	2022	41	43					4779	4794		10.1038/s41388-022-02469-6	http://dx.doi.org/10.1038/s41388-022-02469-6		SEP 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5M4RI	36127398				2022-12-26	WOS:000855639800002
J	Shen, XJ; Kong, S; Ma, S; Shen, L; Zheng, M; Qin, SY; Qi, J; Wang, QH; Cui, XP; Ju, SQ				Shen, Xianjuan; Kong, Shan; Ma, Shuo; Shen, Lei; Zheng, Ming; Qin, Shiyi; Qi, Jing; Wang, Qiuhong; Cui, Xiaopeng; Ju, Shaoqing			Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis	ONCOGENE			English	Article							SRSF3 REPRESSES; CIRCULAR RNA; BIOMARKER; PROTEIN; CELLS	Cellular communication between gastric cancer (GC) cells with different metastatic potentials and microenvironments and resultant cancer progression is not fully understood. Circular RNAs (circRNAs) and exosomal circRNAs are known to play extremely important regulatory roles in GC occurrence and progression. Here, we revealed significant differences in coronin-like actin-binding protein 1C (CORO1C) derived circRNA hsa_circ_0000437 between GC and para-cancer tissues. Hsa_circ_0000437 regulated GC cell proliferation, invasion, migration and apoptosis by targeting Ser/Arg-rich splicing factor 3 (SRSF3) and inhibiting programmed cell death 4 (PDCD4). The ectopic expression of hsa_circ_0000437 dramatically promoted tumor growth in nude mice in vivo. Furthermore, both gain-of-function and loss-of-function experiments demonstrated that hsa_circ_0000437 promoted human lymphatic endothelial cells (HLECs) invasion, migration, and tube formation in vitro and also promoted lymphangiogenesis and lymph node metastasis (LNM) in popliteal LNM model in vivo, when it was enriched in GC-secreted exosomes and transferred into HLECs. Mechanistically, exosomal hsa_circ_0000437 induced LNM via HSPA2-ERK signaling pathway independent of VEGF-C. Clinical data showed that exosomal hsa_circ_0000437 was enriched in the serum of GC patients, which was associated with LNM. In summary, these findings highlight the potential role of hsa_circ_0000437 as an outcome biomarker in GC patients with LNM, which may provide a novel target for GC therapy.	[Shen, Xianjuan; Kong, Shan; Ma, Shuo; Shen, Lei; Zheng, Ming; Qin, Shiyi; Ju, Shaoqing] Nantong Univ, Lab Med Ctr, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China; [Shen, Xianjuan; Qi, Jing] Nantong Univ, Res Ctr Clin Med, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China; [Wang, Qiuhong] Nantong Univ, Dept Clin Lab, Nantong Maternal & Child Hlth Care Hosp, Nantong 226018, Jiangsu, Peoples R China; [Cui, Xiaopeng] Nantong Univ, Dept Gen Surg, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Ju, SQ (corresponding author), Nantong Univ, Lab Med Ctr, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China.; Cui, XP (corresponding author), Nantong Univ, Dept Gen Surg, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China.	cuixiaopeng2000@163.com; jsq814@hotmail.com			National Natural Science Foundation of China [81871720, 82072363]; Nantong Science and Technology Project [MS12021002]; Nantong Commission of Health [MB2021061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nantong Science and Technology Project; Nantong Commission of Health	This work was supported by the National Natural Science Foundation of China (Nos. 81871720, 82072363), Nantong Science and Technology Project (MS12021002). The project of Nantong Commission of Health (MB2021061).	Cao LX, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.16; Cao YZ, 2021, GENE, V767, DOI 10.1016/j.gene.2020.145182; Chai PW, 2018, NUCLEIC ACIDS RES, V46, P6041, DOI 10.1093/nar/gky366; Chen LL, 2020, NAT REV MOL CELL BIO, V21, P475, DOI 10.1038/s41580-020-0243-y; Cheng X, 2019, FEBS OPEN BIO, V9, P1097, DOI 10.1002/2211-5463.12639; Deng Y, 2015, ARTERIOSCL THROM VAS, V35, P421, DOI 10.1161/ATVBAHA.114.304881; Feng W, 2019, CLIN CHIM ACTA, V496, P125, DOI 10.1016/j.cca.2019.07.003; Guo X, 2021, CLIN TRANSL ONCOL, V23, P1020, DOI 10.1007/s12094-020-02485-6; Huang AQ, 2020, THERANOSTICS, V10, P3503, DOI 10.7150/thno.42174; Huang XX, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0969-3; Ishii M, 2019, MOL CELL BIOCHEM, V455, P185, DOI 10.1007/s11010-018-3481-y; Jung HY, 2015, CLIN CANCER RES, V21, P962, DOI 10.1158/1078-0432.CCR-13-3173; Ke H, 2018, P NATL ACAD SCI USA, V115, pE3426, DOI 10.1073/pnas.1714573115; Kim J, 2014, CELL DEATH DIFFER, V21, P481, DOI 10.1038/cdd.2013.171; Kok VC, 2020, INT J NANOMED, V15, P8019, DOI 10.2147/IJN.S272378; Kristensen LS, 2019, NAT REV GENET, V20, P675, DOI 10.1038/s41576-019-0158-7; Kuranaga Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103012; Lei B, 2019, INT J MED SCI, V16, P292, DOI 10.7150/ijms.28047; Lei M, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1135-7; Liang YK, 2021, MOL THER-NUCL ACIDS, V23, P355, DOI 10.1016/j.omtn.2020.11.012; Lim JP, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3187-7; Liu LP, 2015, GUT, V64, P26, DOI 10.1136/gutjnl-2013-306388; Liu Y, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01358-w; Ma S, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04158-w; Ma S, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-020-01701-1; Maeng YS, 2016, ONCOGENE, V35, P196, DOI 10.1038/onc.2015.73; Mu GC, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1098-6; Park SK, 2016, BIOCHEM BIOPH RES CO, V470, P431, DOI 10.1016/j.bbrc.2016.01.019; Rong DW, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0958-6; Schwager S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00308; Shi XF, 2020, MOL THER-NUCL ACIDS, V19, P384, DOI 10.1016/j.omtn.2019.11.023; Smyth EC, 2020, LANCET, V396, P635, DOI 10.1016/S0140-6736(20)31288-5; Song X, 2019, CANCER RES, V79, P5288, DOI 10.1158/0008-5472.CAN-19-1504; Wang G, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01964-2; Wang M, 2020, MOL THER-NUCL ACIDS, V21, P367, DOI 10.1016/j.omtn.2020.06.008; Wang ZX, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.682594; Wu P, 2021, HISTOL HISTOPATHOL, V36, P447, DOI 10.14670/HH-18-305; Wu YY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01215-4; Xu LF, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/9612425; Zang JK, 2020, J NEUROSCI RES, V98, P87, DOI 10.1002/jnr.24356; Zhang J, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1015-1; Zhang QG, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1125-9; Zhu YJ, 2019, THERANOSTICS, V9, P3526, DOI 10.7150/thno.32796; Zhu YX, 2020, ONCOGENE, V39, P6071, DOI 10.1038/s41388-020-01421-w	44	0	0	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 14	2022	41	42					4724	4735		10.1038/s41388-022-02449-w	http://dx.doi.org/10.1038/s41388-022-02449-w		SEP 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5I4GP	36109630				2022-12-26	WOS:000854052400002
J	Kotani, N; Nakano, T; Kuwahara, R				Kotani, Norihiro; Nakano, Takanari; Kuwahara, Ryusuke			Host cell membrane proteins located near SARS-CoV-2 spike protein attachment sites are identified using proximity labeling and proteomic analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME-MEDIATED ACTIVATION; FUNCTIONAL RECEPTOR; RADICAL SOURCES; VIRUS ENTRY; CORONAVIRUS; SURFACE; PROLIFERATION; MOLECULES; INFECTION; ADHESION	Coronavirus disease represents a real threat to the global population, and understanding the biological features of the causative virus, that is, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is imperative for mitigating this threat. Analyses of proteins such as primary receptors and coreceptors (cofactors), which are involved in the entry of SARS-CoV-2 into host cells, will provide important clues to help control the virus. Here, we identified host cell membrane protein candidates present in proximity to the attachment sites of SARS-CoV-2 spike proteins, using proximity labeling and proteomic analysis. The identified proteins represent key candidate factors that may be required for viral entry. We found SARS-CoV-2 host protein DPP4, cell adhesion protein Cadherin 17, and glycoprotein CD133 colocalized with cell membrane-bound SARS-CoV-2 spike proteins in Caco-2 cells and thus showed potential as candidate factors. Additionally, our analysis of the experimental infection of HEK293T cells with a SARS-CoV-2 pseudovirus indicated a 2-fold enhanced infectivity in the CD133-ACE2-coexpressing HEK293T cells compared to that in HEK293T cells expressing ACE-2 alone. The information and resources regarding these coreceptor labeling and analysis techniques could be utilized for the development of antiviral agents against SARS-CoV-2 and other emerging viruses.	[Kotani, Norihiro] Saitama Med Univ, Med Res Ctr, Moroyama Machi, Moroyama, Saitama, Japan; [Kotani, Norihiro; Nakano, Takanari] Saitama Med Univ, Dept Biochem, Moroyama Machi, Moroyama, Saitama, Japan; [Kuwahara, Ryusuke] Okinawa Inst Sci & Technol Grad Univ, Quantum Wave Microscopy Unit, Onna, Okinawa, Japan	Saitama Medical University; Saitama Medical University; Okinawa Institute of Science & Technology Graduate University	Kotani, N (corresponding author), Saitama Med Univ, Med Res Ctr, Moroyama Machi, Moroyama, Saitama, Japan.; Kotani, N (corresponding author), Saitama Med Univ, Dept Biochem, Moroyama Machi, Moroyama, Saitama, Japan.	kotani@saitama-med.ac.jp			JSPS KAKENHI;  [JP18K06663]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported by grant-in-aid for scientific research JSPS KAKENHI Grant Number JP18K06663 (to N. K.) .	ArenzanaSeisdedos F, 1996, NATURE, V383, P400, DOI 10.1038/383400a0; Bandres JC, 1998, J VIROL, V72, P2500, DOI 10.1128/JVI.72.3.2500-2504.1998; Bar DZ, 2018, NAT METHODS, V15, P749, DOI 10.1038/s41592-018-0073-4; Bar DZ, 2018, NAT METHODS, V15, P127, DOI 10.1038/nmeth.4533; Bartolome RA, 2014, ONCOGENE, V33, P1658, DOI 10.1038/onc.2013.117; Bojkova D, 2020, NATURE, V583, P469, DOI 10.1038/s41586-020-2332-7; Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003; Chu H, 2020, LANCET MICROBE, V1, pE14, DOI 10.1016/S2666-5247(20)30004-5; Capcha JMC, 2021, FRONT CARDIOVASC MED, V7, DOI 10.3389/fcvm.2020.618651; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hashimoto N, 2012, PROTEOMICS, V12, P3154, DOI 10.1002/pmic.201200279; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hottz ED, 2020, BLOOD, V136, P1330, DOI 10.1182/blood.2020007252; Ishiura Y, 2010, BIOCHEM BIOPH RES CO, V396, P329, DOI 10.1016/j.bbrc.2010.04.092; Iwamaru Y, 2016, J NEUROCHEM, V136, P1204, DOI 10.1111/jnc.13488; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kaneko K, 2016, J BIOL CHEM, V291, P16630, DOI 10.1074/jbc.M115.708834; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Kotani N, 2008, P NATL ACAD SCI USA, V105, P7405, DOI 10.1073/pnas.0710346105; Kotani N, 2019, CANCER SCI, V110, P2607, DOI 10.1111/cas.14108; Kotani N, 2018, NEUROCHEM INT, V119, P140, DOI 10.1016/j.neuint.2017.08.012; Kotani N, 2012, J BIOL CHEM, V287, P37109, DOI 10.1074/jbc.M112.404178; Krueger DK, 2001, J VIROL, V75, P2792, DOI 10.1128/JVI.75.6.2792-2802.2001; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Lamers MM, 2020, SCIENCE, V369, P50, DOI 10.1126/science.abc1669; Lapierre LA, 1999, J CELL SCI, V112, P3723; Li QX, 1997, J VIROL, V71, P4657, DOI 10.1128/JVI.71.6.4657-4662.1997; Li WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110911; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101160; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Matsuyama S, 2020, P NATL ACAD SCI USA, V117, P7001, DOI 10.1073/pnas.2002589117; MISUMI Y, 1992, BIOCHIM BIOPHYS ACTA, V1131, P333, DOI 10.1016/0167-4781(92)90036-Y; Miyagawa-Yamaguchi A, 2015, GLYCOCONJUGATE J, V32, P531, DOI 10.1007/s10719-015-9595-5; Nunnari G, 2020, EXP CELL RES, V395, DOI 10.1016/j.yexcr.2020.112204; Ohkawa Y, 2015, J BIOL CHEM, V290, P16043, DOI 10.1074/jbc.M114.635755; Ohnishi K, 2005, EUR J IMMUNOL, V35, P957, DOI 10.1002/eji.200425853; Qi FR, 2020, BIOCHEM BIOPH RES CO, V526, P135, DOI 10.1016/j.bbrc.2020.03.044; Qiu HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056959; Rajan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28255-7; Rees JS, 2015, MOL CELL PROTEOMICS, V14, P2848, DOI 10.1074/mcp.R115.052902; Sato S, 2018, CHEM COMMUN, V54, P5871, DOI 10.1039/c8cc02891e; Shimoda Y, 2009, CELL ADHES MIGR, V3, P64, DOI 10.4161/cam.3.1.7764; SPRING FA, 1988, IMMUNOLOGY, V64, P37; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Tresoldi I, 2020, J MED VIROL, V92, P1741, DOI 10.1002/jmv.25831; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Varga Z, 2020, LANCET, V395, P1417, DOI 10.1016/S0140-6736(20)30937-5; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Wills ZP, 2012, NEURON, V73, P466, DOI 10.1016/j.neuron.2011.11.029; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Xia P, 2020, FEBS J, V287, P3677, DOI 10.1111/febs.15499; Yamashita R, 2011, J BIOCHEM, V149, P347, DOI 10.1093/jb/mvq148; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	60	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102500	10.1016/j.jbc.2022.102500	http://dx.doi.org/10.1016/j.jbc.2022.102500			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36152751	gold, Green Published			2022-12-26	WOS:000884698500006
J	Dhakal, S; Robang, AS; Bhatt, N; Puangmalai, N; Fung, L; Kayed, R; Paravastu, AK; Rangachari, V				Dhakal, Shailendra; Robang, Alicia S.; Bhatt, Nemil; Puangmalai, Nicha; Fung, Leiana; Kayed, Rakez; Paravastu, Anant K.; Rangachari, Vijayaraghavan			Distinct neurotoxic TDP-43 fibril polymorphs are generated by heterotypic interactions with alpha-Synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYLOID-BETA; A-BETA; TAU; STRAINS; DEMENTIA; AGGREGATION; INTERFACE; ALZHEIMER; SYNAPSES	Amyloid aggregates of specific proteins constitute important pathological hallmarks in many neurodegenerative diseases, defining neuronal degeneration and disease onset. Recently, increasing numbers of patients show comorbidities and overlaps between multiple neurodegenerative diseases, presenting distinct phenotypes. Such overlaps are often accompanied by colocalizations of more than one amyloid protein, prompting the question of whether direct interactions between different amyloid proteins could generate heterotypic amyloids. To answer this question, we investigated the effect of alpha-synuclein (alpha S) on the DNA-binding protein TDP-43 aggregation inspired by their coexistence in pathologies such as Lewy body dementia and limbic predominant age-related TDP-43 encephalopathy. We previously showed alpha S and prion-like C-terminal domain (PrLD) of TDP-43 synergistically interact to generate toxic heterotypic aggregates. Here, we extend these studies to inves-tigate whether alpha S induces structurally and functionally distinct polymorphs of PrLD aggregates. Using alpha S-PrLD heterotypic aggregates generated in two different stoichiometric pro-portions, we show alpha S can affect PrLD fibril forms. PrLD fibrils show distinctive residue level signatures determined by solid state NMR, dye-binding capability, proteinase K (PK) stability, and thermal stability toward SDS denaturation. Furthremore, by gold nanoparticle labeling and transmission electron micro-scopy, we show the presence of both alpha S and PrLD proteins within the same fibrils, confirming the existence of heterotypic amyloid fibrils. We also observe alpha S and PrLD colocalize in the cytosol of neuroblastoma cells and show that the heterotypic PrLD fibrils selectively induce synaptic dysfunction in primary neurons. These findings establish the existence of heterotypic amyloid and provide a molecular basis for the observed overlap between synucleinopathies and TDP-43 proteinopathies.	[Dhakal, Shailendra; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Dept Chem & Biochem, Sch Math & Nat Sci, Hattiesburg, MA 39406 USA; [Dhakal, Shailendra; Rangachari, Vijayaraghavan] Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA; [Robang, Alicia S.; Paravastu, Anant K.] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA; [Bhatt, Nemil; Puangmalai, Nicha; Fung, Leiana; Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Disorders, Galveston, TX USA	University of Southern Mississippi; University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Medical Branch Galveston	Rangachari, V (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Sch Math & Nat Sci, Hattiesburg, MA 39406 USA.; Rangachari, V (corresponding author), Univ Southern Mississippi, Ctr Mol & Cellular Biosci, Hattiesburg, MS 39406 USA.; Paravastu, AK (corresponding author), Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.	anant.paravastu@chbe.gatech.edu; vijay.rangachari@usm.edu		dhakal, shailendra/0000-0003-0019-803X; Fung, Leiana/0000-0002-0874-1597; Robang, Alicia/0000-0003-3857-9559	National Institute of Aging, United States [1R56AG062292-01, AG054025, RF1AG077484, RF1AG073434-01A1]; National Institute on Minority Health and Health Disparities, United States [RF1AG073434-01A1]; National Science Foundation, United States [NSF CBET 1802793]; National Center for Research Resources from the National Institutes of Health [5P20RR01647-11]; National Institute of General Medical Sciences from the National Institutes of Health [8 P20 GM103476-11]; National Science Foundation [NSF MRI 2019023]	National Institute of Aging, United States; National Institute on Minority Health and Health Disparities, United States; National Science Foundation, United States(National Science Foundation (NSF)); National Center for Research Resources from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); National Science Foundation(National Science Foundation (NSF))	The authors would like to thank the following agencies for financial support: National Institute of Aging, United States (1R56AG062292-01 (to V. R.); AG054025, RF1AG077484 (to R. K.) and RF1AG073434-01A1 (to A. K. P.), the National Institute on Minority Health and Health Disparities, United States (RF1AG073434-01A1; to A. K. P.), and the National Science Foundation, United States (NSF CBET 1802793) to V. R.. The authors also thank the National Center for Research Resources (5P20RR01647-11) and the National Institute of General Medical Sciences (8 P20 GM103476-11) from the National Institutes of Health for funding through INBRE for the use of their core facilities, and the National Science Foundation (NSF MRI 2019023) for STED confocal microscope facility. The content is solely the responsibility of the authors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Ahmed RM, 2016, J NEUROL NEUROSUR PS, V87, P1234, DOI 10.1136/jnnp-2014-308350; Armstrong RA, 2005, NEUROPATHOLOGY, V25, P111, DOI 10.1111/j.1440-1789.2005.00605.x; Armstrong RA, 2008, NEUROPATHOLOGY, V28, P351, DOI 10.1111/j.1440-1789.2008.00916.x; Arseni D, 2022, NATURE, V601, P139, DOI 10.1038/s41586-021-04199-3; Ausdenmoore BD, 2011, J NEUROSCI METH, V200, P129, DOI 10.1016/j.jneumeth.2011.06.021; Berning BA, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00335; Bhopatkar AA, 2022, BIOPHYS J, V121, P2107, DOI 10.1016/j.bpj.2022.04.034; Birsa N, 2020, SEMIN CELL DEV BIOL, V99, P193, DOI 10.1016/j.semcdb.2019.05.023; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Candreva J, 2020, BIOCHEMISTRY-US, V59, P425, DOI 10.1021/acs.biochem.9b00655; Cao Q, 2019, NAT STRUCT MOL BIOL, V26, P619, DOI 10.1038/s41594-019-0248-4; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; Chornenkyy Y, 2019, LAB INVEST, V99, P993, DOI 10.1038/s41374-019-0196-y; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Crews L, 2009, NEUROTOX RES, V16, P306, DOI 10.1007/s12640-009-9073-6; Dammer EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038658; Das S, 2020, J CLIN NEUROSCI, V78, P30, DOI 10.1016/j.jocn.2020.04.088; Dasari AKR, 2019, BIOCHEMISTRY-US, V58, P2814, DOI 10.1021/acs.biochem.9b00215; Davis AA, 2018, ANNU REV CELL DEV BI, V34, P545, DOI 10.1146/annurev-cellbio-100617-062636; de Boer EMJ, 2021, J NEUROL NEUROSUR PS, V92, P86, DOI 10.1136/jnnp-2020-322983; Dhakal S, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166953; Dickson D, 2011, J MOL NEUROSCI, V45, P384, DOI 10.1007/s12031-011-9589-0; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Dupiereux Ingrid, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P2; Fandrich M, 2018, J INTERN MED, V283, P218, DOI 10.1111/joim.12732; Fagerquist CK, 2012, J AM SOC MASS SPECTR, V23, P2102, DOI 10.1007/s13361-012-0490-z; Feneberg E, 2021, BRAIN PATHOL, V31, DOI 10.1111/bpa.12923; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fritzsching KJ, 2013, J BIOMOL NMR, V56, P155, DOI 10.1007/s10858-013-9732-z; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gao J, 2018, J NEUROCHEM, V146, P7, DOI 10.1111/jnc.14327; Goedert M, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0495-z; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hojjatian A, 2021, BIOCHEM BIOPH RES CO, V554, P145, DOI 10.1016/j.bbrc.2021.03.091; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Huang DT, 2018, METHODS MOL BIOL, V1777, P23, DOI 10.1007/978-1-4939-7811-3_2; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Ivanova MI, 2021, BIOPHYS CHEM, V269, DOI 10.1016/j.bpc.2020.106507; Jia CY, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01124; Karanth S, 2020, JAMA NEUROL, V77, P1299, DOI 10.1001/jamaneurol.2020.1741; Kawakami I, 2019, ACTA NEUROPATHOL, V138, P751, DOI 10.1007/s00401-019-02077-x; Koppen J, 2020, MOLECULES, V25, DOI 10.3390/molecules25030580; Kovacs GG, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020189; Kremer JJ, 2000, BIOCHEMISTRY-US, V39, P10309, DOI 10.1021/bi0001980; Kushnirov VV, 2020, PRION, V14, P11, DOI 10.1080/19336896.2019.1704612; Lau A, 2020, NAT NEUROSCI, V23, P21, DOI 10.1038/s41593-019-0541-x; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Li QY, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21912-y; Lo Cascio F, 2020, J BIOL CHEM, V295, P14807, DOI 10.1074/jbc.RA120.014630; Louros N, 2022, CURR OPIN STRUC BIOL, V72, P176, DOI 10.1016/j.sbi.2021.11.007; Lu JX, 2020, J BIOL CHEM, V295, P7470, DOI 10.1074/jbc.RA119.012284; Ma BY, 2012, J MOL BIOL, V421, P172, DOI 10.1016/j.jmb.2011.11.023; Mehra S, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11101419; Mompean M, 2018, CELL, V173, P1244, DOI 10.1016/j.cell.2018.03.032; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Nonaka T, 2018, NEUROPATHOLOGY, V38, P64, DOI 10.1111/neup.12427; Obi K, 2008, EXP NEUROL, V210, P409, DOI 10.1016/j.expneurol.2007.11.019; Porta S, 2021, NEUROPATH APPL NEURO, V47, P1033, DOI 10.1111/nan.12732; Puangmalai N, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101766; Puangmalai N, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2503-3; Ramamoorthy, 2005, NMR SPECTROSCOPY BIO; Rao PPN, 2015, CHEM BIOL DRUG DES, V86, P813, DOI 10.1111/cbdd.12552; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Ruz C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165646; Saha J, 2021, FASEB J, V35, DOI 10.1096/fj.202002025RR; Schatzle P, 2012, J NEUROSCI METH, V204, P144, DOI 10.1016/j.jneumeth.2011.11.010; Seeman P, 2011, SYNAPSE, V65, P1289, DOI 10.1002/syn.20957; Sengupta U, 2020, MOL NEUROBIOL, V57, P2741, DOI 10.1007/s12035-020-01913-6; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Shen LJ, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165876; Sidhu A, 2016, ACS CHEM NEUROSCI, V7, P719, DOI 10.1021/acschemneuro.5b00322; Suk TR, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00397-1; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tian TA, 2011, INT J BIOL SCI, V7, P234, DOI 10.7150/ijbs.7.234; Uemura MT, 2022, ACTA NEUROPATHOL, V143, P15, DOI 10.1007/s00401-021-02383-3; Visanji NP, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0172-x; Walker LC, 2016, ANNU REV GENET, V50, P329, DOI 10.1146/annurev-genet-120215-034943; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; Williams T., 2020, BRAIN COMMUN, V2; Wong KM, 2021, J PHYS CHEM B, V125, P13599, DOI 10.1021/acs.jpcb.1c04873; Wong KM, 2021, J PHYS CHEM B, V125, P4004, DOI 10.1021/acs.jpcb.0c11645; Xiao XQ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf7668; Yokota O, 2010, ACTA NEUROPATHOL, V120, P789, DOI 10.1007/s00401-010-0731-9; Zhang MZ, 2015, PHYS CHEM CHEM PHYS, V17, P23245, DOI 10.1039/c5cp03329b; Zhang YX, 2021, CHINESE J CHEM ENG, V30, P225, DOI 10.1016/j.cjche.2020.09.033; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106	94	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102498	10.1016/j.jbc.2022.102498	http://dx.doi.org/10.1016/j.jbc.2022.102498			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36116552	gold, Green Published			2022-12-26	WOS:000882199400003
J	Iwahori, S; Umana, AC; Kalejta, RF; Murata, T				Iwahori, Satoko; Umana, Angie C.; Kalejta, Robert F.; Murata, Takayuki			Serine 13 of the human cytomegalovirus viral cyclin-dependent kinase UL97 is required for regulatory protein 14-3-3 binding and UL97 stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; RETINOBLASTOMA PROTEIN; SUBCELLULAR-LOCALIZATION; PHOSPHORYLATION; PUL97; REPLICATION; DAMAGE; IDENTIFICATION; DETERMINANTS; PROTEOLYSIS	The human cytomegalovirus (HCMV) UL97 protein is a conserved herpesvirus protein kinase (CHPK) and a viral cyclin-dependent kinase (v-CDK). However, mechanisms regulating its activity in the context of infection are unknown. Here, we identified several cellular regulatory 14-3-3 proteins as UL97-interacting partners that promote UL97 stability. Humans are known to encode seven isoforms of 14-3-3 pro-teins (11, e, q, y, sigma, 0, and () that bind phosphoserines or phosphothreonines to impact protein structure, stability, activity, and localization. Our proteomic analysis of UL97 identified 49 interacting partners, including 14-3-3 isoforms 11, q, and y. Furthermore, coimmunoprecipitation with Western blotting assays demonstrated that UL97 interaction with 14-3-3 isoforms 11, e, q, y, and 0 occurs in a kinase activity-dependent manner. Using mutational analysis, we determined the serine residue at amino acid 13 of UL97 is crucial for 14-3-3 inter-action. We demonstrate UL97 S13A (serine to alanine substi-tution at residue 13) retains kinase activity but the mutant protein accumulated at lower levels than WT UL97. Finally, we show both laboratory (AD169) and clinical (TB40/E) strains of HCMV encoding UL97 S13A replicated with WT kinetics in fibroblasts but showed decreased UL97 accumulation. Taken together, we conclude that 14-3-3 proteins interact with and stabilize UL97 during HCMV infection.	[Iwahori, Satoko; Murata, Takayuki] Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan; [Iwahori, Satoko; Umana, Angie C.; Kalejta, Robert F.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA; [Iwahori, Satoko; Umana, Angie C.; Kalejta, Robert F.] Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA	Fujita Health University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Murata, T (corresponding author), Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan.; Kalejta, RF (corresponding author), Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA.; Kalejta, RF (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	rfkalejta@wisc.edu; tmurata@fujita-hu.ac.jp		Iwahori, Satoko/0000-0002-6881-150X	Japan Herpesvirus Infections Forum (JHIF); University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; National Institutes of Health [T32-GM08349]; JSPS KAKENHI [18H06151, 21K07046]; Takeda Science Foundation; Waksman Foundation of Japan Inc; Ichiro Kanehara Foundation; NIH [AI130089, AI139180]	Japan Herpesvirus Infections Forum (JHIF); University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Waksman Foundation of Japan Inc(Waksman Foundation of Japan Inc.); Ichiro Kanehara Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. I. was supported by a Japan Herpesvirus Infections Forum (JHIF) scholarship award in herpes-virus infection research. A. C. U was supported by the University of Wisconsin-Madison Science and Medicine Graduate Research Scholars (SciMed GRS) program and by a National Institutes of Health training grant (T32-GM08349). This work was supported by grants from the JSPS KAKENHI to S. I. (18H06151 and 21K07046), the Takeda Science Foundation, the Waksman Foundation of Japan Inc, the Ichiro Kanehara Foundation, and from the NIH to R. F. K (AI130089 and AI139180). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baek MC, 2002, J VIROL, V76, P11943, DOI 10.1128/JVI.76.23.11943-11952.2002; Biron KK, 2002, ANTIMICROB AGENTS CH, V46, P2365, DOI 10.1128/AAC.46.8.2365-2372.2002; Bogdanow B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18542-1; Businger R, 2019, NAT MICROBIOL, V4, P2260, DOI 10.1038/s41564-019-0557-8; Chung C, 2015, J BIOL CHEM, V290, P23188, DOI 10.1074/jbc.M115.648436; Dar A, 2014, MOL CELL BIOL, V34, P4049, DOI 10.1128/MCB.00838-14; De Meo S, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008855; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Dunaway S, 2005, J CELL SCI, V118, P39, DOI 10.1242/jcs.01570; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Graf L, 2013, VIRUSES-BASEL, V5, P3213, DOI 10.3390/v5123213; Gupta S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00437; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hermeking H, 2006, SEMIN CANCER BIOL, V16, P183, DOI 10.1016/j.semcancer.2006.03.002; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Iwahori S, 2017, J BIOL CHEM, V292, P6583, DOI 10.1074/jbc.M116.773150; Iwahori S, 2015, J BIOL CHEM, V290, P19666, DOI 10.1074/jbc.M115.660043; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kalejta RF, 2003, MOL CELL BIOL, V23, P1885, DOI 10.1128/MCB.23.6.1885-1895.2003; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Kamil JP, 2009, P NATL ACAD SCI USA, V106, P16823, DOI 10.1073/pnas.0901521106; Kang C, 2022, DRUGS, V82, P335, DOI 10.1007/s40265-022-01677-4; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; KATO J, 1993, GENE DEV, V7, P331; Kim ET, 2019, CELL REP, V28, P434, DOI 10.1016/j.celrep.2019.06.027; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Li RF, 2011, CELL HOST MICROBE, V10, P390, DOI 10.1016/j.chom.2011.08.013; LITTLER E, 1992, NATURE, V358, P160, DOI 10.1038/358160a0; Liu JQ, 2021, J CELL MOL MED, V25, P4173, DOI 10.1111/jcmm.16490; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; Madeira F, 2015, BIOINFORMATICS, V31, P2276, DOI 10.1093/bioinformatics/btv133; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Mullard A, 2022, NAT REV DRUG DISCOV, V21, P9, DOI 10.1038/d41573-021-00208-2; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nobre LV, 2019, ELIFE, V8, DOI 10.7554/eLife.49894; Oberstein A, 2015, PROTEOMICS, V15, P2006, DOI 10.1002/pmic.201400607; Obsilova V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228824; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Pennington KL, 2022, MOL CANCER RES, V20, P231, DOI 10.1158/1541-7786.MCR-20-1076; Prichard MN, 1999, J VIROL, V73, P5663, DOI 10.1128/JVI.73.7.5663-5670.1999; Prichard MN, 2005, J VIROL, V79, P15494, DOI 10.1128/JVI.79.24.15494-15502.2005; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028; Sharma M, 2015, J VIROL, V89, P523, DOI 10.1128/JVI.02426-14; SHEW JY, 1990, P NATL ACAD SCI USA, V87, P6, DOI 10.1073/pnas.87.1.6; Sinzger C, 2008, J GEN VIROL, V89, P359, DOI 10.1099/vir.0.83286-0; Sluchanko NN, 2017, FEBS J, V284, P1279, DOI 10.1111/febs.13986; Stegen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053276; Steingruber M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040515; Steingruber M, 2019, J BIOL CHEM, V294, P6188, DOI 10.1074/jbc.RA118.007049; Steingruber M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080219; SULLIVAN V, 1992, NATURE, V358, P162, DOI 10.1038/358162a0; Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657; Tatsumi Y, 2006, J CELL SCI, V119, P3128, DOI 10.1242/jcs.03031; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Tsvetkov P, 2008, PROTEINS, V70, P1357, DOI 10.1002/prot.21614; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wang D, 2013, J VIROL, V87, P6359, DOI 10.1128/JVI.03477-12; Webel R, 2014, J VIROL, V88, P4776, DOI 10.1128/JVI.00192-14; Yu D, 2002, J VIROL, V76, P2316, DOI 10.1128/JVI.76.5.2316-2328.2002; Zhao J, 2011, SEMIN CELL DEV BIOL, V22, P705, DOI 10.1016/j.semcdb.2011.09.012; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005	70	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102513	10.1016/j.jbc.2022.102513	http://dx.doi.org/10.1016/j.jbc.2022.102513			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36150501	Green Published, gold			2022-12-26	WOS:000884698500010
J	Kim, JY; Manna, D; Etscheid, M; Leergaard, TB; Kanse, SM				Kim, Jeong Yeon; Manna, Dipankar; Etscheid, Michael; Leergaard, Trygve B.; Kanse, Sandip M.			Factor VII activating protease (FSAP) inhibits the outcome of ischemic stroke in mouse models	FASEB JOURNAL			English	Article						bleeding; brain; FSAP; HABP2; hemorrhage; ischemic stroke; protease; thrombectomy; thrombolysis; tPA	MARBURG-I POLYMORPHISM; PLASMINOGEN-ACTIVATOR; RECANALIZATION; THROMBOSIS; BLOOD	The outcome of ischemic stroke can be improved by further refinements of thrombolysis and reperfusion strategies. Factor VII activating protease (FSAP) is a circulating serine protease that could be important in this context. Its levels are raised in patients as well as mice after stroke and a single nucleotide polymorphism (SNP) in the coding sequence, which results in an inactive enzyme, is linked to an increased risk of stroke. In vitro, FSAP cleaves fibrinogen to promote fibrinolysis, activates protease-activated receptors, and decreases the cellular cytotoxicity of histones. Based on these facts, we hypothesized that FSAP can be used as a treatment for ischemic stroke. A combination of tissue plasminogen activator (tPA), a thrombolytic drug, and recombinant serine protease domain of FSAP (FSAP-SPD) improved regional cerebral perfusion and neurological outcome and reduced infarct size in a mouse model of thromboembolic stroke. FSAP-SPD also improved stroke outcomes and diminished the negative consequences of co-treatment with tPA in the transient middle cerebral artery occlusion model of stroke without altering cerebral perfusion. The inactive MI-isoform of FSAP had no impact in either model. FSAP enhanced the lysis of blood clots in vitro, but in the tail transection model of hemostasis, FSAP-SPD treatment provoked a faster clotting time indicating that it also has pro-coagulant actions. Thus, apart from enhancing thrombolysis, FSAP has multiple effects on stroke progression and represents a promising novel therapeutic strategy in the treatment of ischemic stroke.	[Kim, Jeong Yeon; Manna, Dipankar; Leergaard, Trygve B.; Kanse, Sandip M.] Univ Oslo, Dept Mol Med, Inst Basic Med Sci, Sognsvannsveien 9, N-0172 Oslo, Norway; [Etscheid, Michael] Paul Ehrlich Inst, Div Hematol Transfus Med, Langen, Germany	University of Oslo; Paul Ehrlich Institute	Kanse, SM (corresponding author), Univ Oslo, Dept Mol Med, Inst Basic Med Sci, Sognsvannsveien 9, N-0172 Oslo, Norway.	sandip.kanse@medisin.uio.no		Kanse, Sandip/0000-0003-0782-9957	Research Council of Norway [251239]; Scientia Fellow/Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Research Council of Norway(Research Council of Norway); Scientia Fellow/Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Research Council of Norway, Grant/ Award Number: 251239; Scientia Fellow/ Maria Sklowdoska Curie Programme; Nasjonalforeningen for Folkehelsen; Stiftelsen Norsk Luftambulanse	Artunc F, 2022, PFLUG ARCH EUR J PHY, V474, P217, DOI 10.1007/s00424-021-02639-7; Berge-Seidl S, 2022, ACS CHEM BIOL, V17, P2631, DOI 10.1021/acschembio.2c00538; Bhatia R, 2010, STROKE, V41, P2254, DOI 10.1161/STROKEAHA.110.592535; Byskov K, 2020, FASEB J, V34, P1079, DOI 10.1096/fj.201801986RR; Campbell BCV, 2020, LANCET, V396, P129, DOI 10.1016/S0140-6736(20)31179-X; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; Cheng YC, 2016, STROKE, V47, P307, DOI 10.1161/STROKEAHA.115.011328; de Lizarrondo SM, 2017, CIRCULATION, V136, P646, DOI 10.1161/CIRCULATIONAHA.117.027290; Desilles JP, 2015, STROKE, V46, P3241, DOI 10.1161/STROKEAHA.115.010721; du Sert NP, 2020, EXP PHYSIOL, V105, P1459, DOI 10.1113/EP088870; de Rueda ME, 2015, STROKE, V46, P2517, DOI 10.1161/STROKEAHA.114.008598; Etscheid M, 2012, THROMB RES, V130, P935, DOI 10.1016/j.thromres.2012.07.023; Etscheid M, 2000, BIOL CHEM, V381, P1223, DOI 10.1515/BC.2000.150; Etscheid M, 2018, BBA-MOL BASIS DIS, V1864, P3397, DOI 10.1016/j.bbadis.2018.07.030; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; Garantziotis S, 2019, MATRIX BIOL, V78-79, P1, DOI 10.1016/j.matbio.2019.02.002; Grasso S, 2018, THROMB RES, V161, P36, DOI 10.1016/j.thromres.2017.11.012; Griffin JH, 2018, BLOOD, V132, P159, DOI 10.1182/blood-2018-02-769026; Griffin JH, 2016, ARTERIOSCL THROM VAS, V36, P2143, DOI 10.1161/ATVBAHA.116.308038; Hanson E, 2012, J THROMB HAEMOST, V10, P848, DOI 10.1111/j.1538-7836.2012.04692.x; Hechler B, 2010, J THROMB HAEMOST, V8, P173, DOI 10.1111/j.1538-7836.2009.03666.x; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Joshi AU, 2015, EUR J NEUROSCI, V41, P963, DOI 10.1111/ejn.12830; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Kanse SM, 2012, ARTERIOSCL THROM VAS, V32, P427, DOI 10.1161/ATVBAHA.111.238394; Kara E, 2017, THROMB HAEMOSTASIS, V117, P1750, DOI 10.1160/TH17-02-0081; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; Laridan E, 2017, ANN NEUROL, V82, P223, DOI 10.1002/ana.24993; Li D, 2020, PHLEBOLOGY, V35, P345, DOI 10.1177/0268355519881604; Mambetsariev N, 2010, ARTERIOSCL THROM VAS, V30, P483, DOI 10.1161/ATVBAHA.109.200451; Maroney SA, 2011, ARTERIOSCL THROM VAS, V31, P821, DOI 10.1161/ATVBAHA.110.220293; Marsman G, 2017, BLOOD ADV, V1, P2491, DOI 10.1182/bloodadvances.2017010959; Mei T, 2019, BIOMATERIALS, V215, DOI 10.1016/j.biomaterials.2019.05.020; Murao A, 2021, APOPTOSIS, V26, P152, DOI 10.1007/s10495-021-01663-3; Nielsen NV, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55531-x; Park JY, 2014, STROKE, V45, P2480, DOI 10.1161/STROKEAHA.114.006297; Ramasubramanian B, 2022, FASEB J, V36, DOI 10.1096/fj.202200303RR; Romisch J, 2002, BIOL CHEM, V383, P1119, DOI 10.1515/BC.2002.121; Rut W, 2019, THROMB RES, V182, P124, DOI 10.1016/j.thromres.2019.08.016; Staessens S, 2021, PLATELETS, V32, P331, DOI 10.1080/09537104.2020.1748586; Stephan F, 2011, CRIT CARE, V15, DOI 10.1186/cc10131; Stoll G, 2019, NAT REV NEUROL, V15, P473, DOI 10.1038/s41582-019-0221-1; Subramaniam S, 2015, THROMB HAEMOSTASIS, V113, P870, DOI 10.1160/TH14-06-0519; Thiebaut AM, 2018, LANCET NEUROL, V17, P1121, DOI 10.1016/S1474-4422(18)30323-5; Tian DS, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-021-00802-1; Trompet S, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/424759; Vivien D, 2017, REV NEUROL-FRANCE, V173, P566, DOI 10.1016/j.neurol.2017.07.003; Wang JA, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1425-0; Waqas M, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2020.105557; Willeit J, 2003, CIRCULATION, V107, P667, DOI 10.1161/01.CIR.0000055189.18831.B1; Wygrecka M, 2007, J BIOL CHEM, V282, P21671, DOI 10.1074/jbc.M610748200; Yamamichi S, 2011, BIOCHEM BIOPH RES CO, V409, P483, DOI 10.1016/j.bbrc.2011.05.030; Zhang J, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.08.08	53	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22564	10.1096/fj.202200828R	http://dx.doi.org/10.1096/fj.202200828R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1ID	36165219	Green Published, Green Submitted			2022-12-26	WOS:000859918300001
J	Nagai-Ito, Y; Xu, LJ; Ito, K; Kajihara, Y; Ito, G; Tomita, T				Nagai-Ito, Yuki; Xu, Lejia; Ito, Kyohei; Kajihara, Yotaro; Ito, Genta; Tomita, Taisuke			The atypical Rab GTPase associated with Parkinson's disease, Rab29, is localized to membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERANYLGERANYL TRANSFERASE; RS1572931 POLYMORPHISM; COMPONENT-A; LRRK2; PROTEIN; GENE; PROMOTER; RISK; MUTATIONS; BINDING	Several genetic studies have shown that the small GTPase Rab29 is involved in the pathogenesis of Parkinson's Disease (PD). It has also been shown that overexpression of Rab29 in-creases the activity of leucine-rich repeat kinase 2, a protein kinase often mutated in familial PD, although the mechanism underlying this activation remains unclear. Here, we employed biochemical analyses to characterize the localization of Rab29 and found that, unlike general Rab proteins, Rab29 is pre-dominantly fractionated into the membrane fraction by ultra -centrifugation. We also found that Rab29 is resistant to extraction from membranes by GDP-dissociation inhibitors (GDIs) in vitro. Furthermore, Rab29 failed to interact with GDIs, and its membrane localization was not affected by the knockout of GDIs in cells. We show that the knockout of Rab geranylgeranyltransferase decreased the hydrophobicity of Rab29, suggesting that Rab29 is geranylgeranylated at its carboxyl terminus as is with typical Rab proteins. Notably, we demonstrated that membrane-bound Rab29 retains some hy-drophilicity, indicating that mechanisms other than ger-anylgeranylation might also be involved in the membrane localization of Rab29. Taken together, these findings uncover the atypical nature of Rab29 among Rab proteins, which will provide important clues for understanding how Rab29 is involved in the molecular pathomechanism of PD.	[Nagai-Ito, Yuki; Xu, Lejia; Ito, Kyohei; Kajihara, Yotaro; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan; [Ito, Genta] Teikyo Univ, Fac Pharm Sci, Dept Biomol Chem, Tokyo, Japan; [Ito, Genta; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Social Cooperat Program Brain & Neurol Disorders, Tokyo, Japan	University of Tokyo; Teikyo University; University of Tokyo	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan.; Ito, G (corresponding author), Teikyo Univ, Fac Pharm Sci, Dept Biomol Chem, Tokyo, Japan.; Ito, G; Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Social Cooperat Program Brain & Neurol Disorders, Tokyo, Japan.	ito.genta.aw@teikyo-u.ac.jp; taisuke@mol.f.u-tokyo.ac.jp	; Tomita, Taisuke/L-5427-2015	Ito, Genta/0000-0001-6370-1099; Tomita, Taisuke/0000-0002-0075-5943	Biogen; Japan Society for the Promotion of Science;  [19H01015];  [21K06558]	Biogen(Biogen); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; 	Funding and additional information-This work was supported part by Biogen; the Grants-in-Aid for Scientific Research (A) [grant number 19H01015 (to T. T.) ] ; the Grants-in-Aid for Scientific Research (C) [grant number 21K06558 (to G. I.) ] from the Japan Society for the Promotion of Science.	ALEXANDROV K, 1994, EMBO J, V13, P5262, DOI 10.1002/j.1460-2075.1994.tb06860.x; ANDRES DA, 1993, CELL, V73, P1091, DOI 10.1016/0092-8674(93)90639-8; Araki M, 2021, HUM MOL GENET, V30, P1618, DOI 10.1093/hmg/ddab146; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Chen TW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10364-0; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Fujimoto T, 2018, BIOCHEM BIOPH RES CO, V495, P1708, DOI 10.1016/j.bbrc.2017.12.024; Gan-Or Z, 2012, ARCH NEUROL-CHICAGO, V69, P105, DOI 10.1001/archneurol.2011.924; GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x; Gomez RC, 2019, J CELL BIOL, V218, P4157, DOI 10.1083/jcb.201902184; Goudarzian M, 2015, NEUROL RES, V37, P1029, DOI 10.1179/1743132815Y.0000000085; Guo XY, 2014, EUR J NEUROL, V21, P1337, DOI 10.1111/ene.12490; Hutt DM, 2000, J BIOL CHEM, V275, P18511, DOI 10.1074/jbc.M909309199; Ito G, 2017, JOVE-J VIS EXP, DOI 10.3791/56688; Khaligh A, 2017, NEUROL RES, V39, P468, DOI 10.1080/01616412.2017.1297558; Kikuchi K, 2021, J NEUROSCI, V41, DOI 10.1523/JNEUROSCI.2595-20.2021; Kuwahara T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29945; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Liu ZY, 2018, HUM MOL GENET, V27, P385, DOI 10.1093/hmg/ddx410; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Madero-Perez J, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00417; OMARY MB, 1981, J BIOL CHEM, V256, P4715; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Purlyte E, 2018, EMBO J, V37, P1, DOI 10.15252/embj.201798099; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; SEABRA MC, 1992, CELL, V70, P1049, DOI 10.1016/0092-8674(92)90253-9; SEABRA MC, 1992, J BIOL CHEM, V267, P14497; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spano S, 2011, P NATL ACAD SCI USA, V108, P18418, DOI 10.1073/pnas.1111959108; Takahashi T, 2019, EMBO REP, V20, DOI 10.15252/embr.201846794; Tan EK, 2010, NEUROLOGY, V75, P508, DOI 10.1212/WNL.0b013e3181eccfcd; Vilarino-Guell C, 2010, NEUROLOGY, V75, P2248, DOI 10.1212/WNL.0b013e318202031f; Wang SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096242; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102499	10.1016/j.jbc.2022.102499	http://dx.doi.org/10.1016/j.jbc.2022.102499			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36116551	Green Published, gold			2022-12-26	WOS:000875415100009
J	Guo, LT; Amikura, K; Jiang, HK; Mukai, T; Fu, X; Wang, YS; O'Donoghue, P; Soll, D; Tharp, JM				Guo, Li -Tao; Amikura, Kazuaki; Jiang, Han -Kai; Mukai, Takahito; Fu, Xian; Wang, Yane-Shih; O'Donoghue, Patrick; Soell, Dieter; Tharp, Jeffery M.			Ancestral archaea expanded the genetic code with pyrrolysine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; TERMINAL DOMAIN; IN-VITRO; AMINOACYLATION; EXPANSION; REVEAL; ENZYME	The pyrrolysyl-tRNA synthetase (PylRS) facilitates the cotranslational installation of the 22nd amino acid pyrrolysine. Owing to its tolerance for diverse amino acid substrates, and its orthogonality in multiple organisms, PylRS has emerged as a major route to install noncanonical amino acids into proteins in living cells. Recently, a novel class of PylRS enzymes was identified in a subset of methanogenic archaea. Enzymes within this class (Delta PylSn) lack the N-terminal tRNA-binding domain that is widely conserved amongst PylRS enzymes, yet remain active and orthogonal in bacteria and eukaryotes. In this study, we use biochemical and in vivo UAG-readthrough assays to characterize the aminoacylation efficiency and substrate spec-trum of a Delta PylSn class PylRS from the archaeon Candidatus Methanomethylophilus alvus. We show that, compared with the full-length enzyme from Methanosarcina mazei, the Ca. M. alvus PylRS displays reduced aminoacylation efficiency but an expanded amino acid substrate spectrum. To gain insight into the evolution of Delta PylSn enzymes, we performed molecular phylogeny using 156 PylRS and 105 pyrrolysine tRNA (tRNAPyl) sequences from diverse archaea and bacteria. This analysis suggests that the PylRS center dot tRNAPyl pair diverged before the evolution of the three domains of life, placing an early limit on the evolution of the Pyl-decoding trait. Furthermore, our results document the coevolutionary history of PylRS and tRNAPyl and reveal the emergence of tRNAPyl sequences with unique A73 and U73 discriminator bases. The orthogonality of these tRNAPyl species with the more common G73-containing tRNAPyl will enable future efforts to engineer PylRS systems for further genetic code expansion.	[Guo, Li -Tao; Amikura, Kazuaki; Soell, Dieter; Tharp, Jeffery M.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Amikura, Kazuaki] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Dept Interdisciplinary Space Sci, Kanagawa, Japan; [Jiang, Han -Kai; Wang, Yane-Shih] Acad Sin, Inst Biol Chem, Taipei, Taiwan; [Jiang, Han -Kai; Wang, Yane-Shih] Acad Sin, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei, Taiwan; [Jiang, Han -Kai] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan; [Mukai, Takahito] Rikkyo Univ, Coll Sci, Dept Life Sci, Tokyo, Japan; [Fu, Xian] BGI Shenzhen, Shenzhen, Peoples R China; [Fu, Xian] Guangdong Prov Key Lab Genome Read & Write, Shenzhen, Peoples R China; [Wang, Yane-Shih] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [O'Donoghue, Patrick] Univ Western Ontario, Dept Biochem, London, ON, Canada; [O'Donoghue, Patrick] Univ Western Ontario, Dept Chem, London, ON, Canada; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT USA; [Tharp, Jeffery M.] Indiana Univ, Dept Biochem & Mol Biol, Sch Med, Indianapolis, IN USA	Yale University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Academia Sinica - Taiwan; National Tsing Hua University; Rikkyo University; Beijing Genomics Institute (BGI); National Taiwan University; Western University (University of Western Ontario); Western University (University of Western Ontario); Yale University; Indiana University System; Indiana University-Purdue University Indianapolis	Tharp, JM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	jemtharp@iu.edu		Jiang, Han-Kai/0000-0001-6884-6318; Tharp, Jeffery/0000-0002-2362-3249; Fu, Xian/0000-0001-9044-8850	Taiwan Academic Talents Overseas Advancement Program of the Ministry of Science and Technology (MOST) [110-2917-I-007-006]; National Institutes of Health Pathway to Independence Award [K99GM141320]; National Institute of General Medical Sciences [R35GM122560]; Department of Energy Office of Basic Energy Sciences [DE-FG02-98ER20311]; National Natural Science Foundation of China [31901029]; Natural Science Foundation of Guangdong Province, China [2021A1515010995]; Academia Sinica; Taiwan Ministry of Science and Technology [MOST 107-2113-M-001-025-MY3, MOST 110-2113-M-001-044]; Natural Sciences and Engineering Research Council of Canada [04282]; Canada Research Chairs [232341]; Canadian Institutes of Health Research [165985]	Taiwan Academic Talents Overseas Advancement Program of the Ministry of Science and Technology (MOST); National Institutes of Health Pathway to Independence Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Academia Sinica(Academia Sinica - Taiwan); Taiwan Ministry of Science and Technology; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	H.-K. J. holds a graduate student fellowship of the Taiwan Academic Talents Overseas Advancement Program of the Ministry of Science and Technology (MOST; grant no.: 110-2917-I-007-006). J. M. T. is a postdoctoral fellow supported by a National Institutes of Health Pathway to Independence Award (grant no.: K99GM141320). This work was supported by grants from the National Institute of General Medical Sciences (grant no.: R35GM122560; to D. S.) and Department of Energy Office of Basic Energy Sciences (grant no.: DE-FG02-98ER20311; to D. S.) ; the National Natural Science Foundation of China (grant no.: 31901029; to X. F.) and the Natural Science Foundation of Guangdong Province, China (grant no.: 2021A1515010995; to X. F.) ; Academia Sinica and the Taiwan Ministry of Science and Technology (MOST 107-2113-M-001-025-MY3 and MOST 110-2113-M-001-044; to Y.-S. W.) ; the Natural Sciences and Engineering Research Council of Canada (grant no.:04282; to P. O.) , Canada Research Chairs (grant no.: 232341; to P. O.), and the Canadian Institutes of Health Research (grant no.: 165985; to P. O.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrogelly A, 2007, P NATL ACAD SCI USA, V104, P3141, DOI 10.1073/pnas.0611634104; Beranek V, 2019, BIOCHEMISTRY-US, V58, P387, DOI 10.1021/acs.biochem.8b00808; Blight SK, 2004, NATURE, V431, P333, DOI 10.1038/nature02895; Borrel G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-679; Borrel G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00453-13; Borrel G, 2014, ARCHAEA, V2014, DOI 10.1155/2014/374146; Brugere JF, 2018, EMERG TOP LIFE SCI, V2, P607, DOI 10.1042/ETLS20180094; Cao Li, 2021, Chembiochem, V22, P2530, DOI 10.1002/cbic.202100218; Chen IMA, 2021, NUCLEIC ACIDS RES, V49, pD751, DOI 10.1093/nar/gkaa939; Cheng L, 2007, INT J SYST EVOL MICR, V57, P2964, DOI 10.1099/ijs.0.65049-0; Cozannet M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010030; Crnkovic A, 2016, CROAT CHEM ACTA, V89, DOI 10.5562/cca2825; Dumas A, 2015, CHEM SCI, V6, P50, DOI 10.1039/c4sc01534g; Dunkelmann DL, 2020, NAT CHEM, V12, P535, DOI 10.1038/s41557-020-0472-x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ellinger T, 1998, BIOTECHNIQUES, V24, P718, DOI 10.2144/98245bm03; Englert M, 2013, FEBS LETT, V587, P3360, DOI 10.1016/j.febslet.2013.08.037; Fournier Greg, 2009, V532, P163, DOI 10.1007/978-1-60327-853-9_9; Gaston MA, 2011, CURR OPIN MICROBIOL, V14, P342, DOI 10.1016/j.mib.2011.04.001; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guan Y, 2017, ENV MICROBIOL REP, V9, P404, DOI 10.1111/1758-2229.12545; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo LT, 2014, P NATL ACAD SCI USA, V111, P16724, DOI 10.1073/pnas.1419737111; Herring S, 2007, FEBS LETT, V581, P3197, DOI 10.1016/j.febslet.2007.06.004; Ibba M, 1996, P NATL ACAD SCI USA, V93, P6953, DOI 10.1073/pnas.93.14.6953; Jiang HK, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00235; Jiang RS, 2012, J BIOL CHEM, V287, P32738, DOI 10.1074/jbc.M112.396754; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kavran JM, 2007, P NATL ACAD SCI USA, V104, P11268, DOI 10.1073/pnas.0704769104; Ko JH, 2013, FEBS LETT, V587, P3243, DOI 10.1016/j.febslet.2013.08.018; Korencic D, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf104; Krahn Natalie, 2020, Enzymes, V48, P351, DOI 10.1016/bs.enz.2020.06.004; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lee I, 2017, INT J SYST EVOL MICR, V67, P2053, DOI 10.1099/ijsem.0.001872; Liu J, 2021, J AM CHEM SOC, V143, P10341, DOI 10.1021/jacs.1c04259; Meineke B, 2018, ACS CHEM BIOL, V13, P3087, DOI 10.1021/acschembio.8b00571; Melnikov SV, 2018, P NATL ACAD SCI USA, V115, pE11505, DOI 10.1073/pnas.1815992115; Melnikov SV, 2018, P NATL ACAD SCI USA, V115, pE6245, DOI 10.1073/pnas.1803208115; Mukai T, 2017, MBIO, V8, DOI 10.1128/mBio.00561-17; Mwirichia R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19181; Nozawa K, 2009, NATURE, V457, P1163, DOI 10.1038/nature07611; Oren A., 2014, PROKARYOTES OTHER MA, P307; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Sayers EW, 2022, NUCLEIC ACIDS RES, V50, pD20, DOI 10.1093/nar/gkab1112; Seki E, 2020, ACS SYNTH BIOL, V9, P718, DOI 10.1021/acssynbio.9b00288; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sollinger A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv149; Sorokin DY, 2018, INT J SYST EVOL MICR, V68, P2199, DOI 10.1099/ijsem.0.002810; Sorokin DY, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.81; Spang A, 2017, SCIENCE, V357, DOI 10.1126/science.aaf3883; Sun J., 2021, ISME COMMUN, V1, P30, DOI DOI 10.1038/S43705-021-00032-0; Suzuki T, 2017, NAT CHEM BIOL, V13, P1261, DOI 10.1038/nchembio.2497; Tharp JM, 2021, ACS CHEM BIOL, V16, P766, DOI 10.1021/acschembio.1c00120; Tharp JM, 2020, CHEMBIOCHEM, V21, P1387, DOI 10.1002/cbic.202000017; Tharp JM, 2020, ANGEW CHEM INT EDIT, V59, P3122, DOI 10.1002/anie.201914671; Tharp JM, 2018, RNA BIOL, V15, P441, DOI 10.1080/15476286.2017.1356561; Vanwonterghem I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.170, 10.1038/nmicrobiol.2016.170]; Wan W, 2014, BBA-PROTEINS PROTEOM, V1844, P1059, DOI 10.1016/j.bbapap.2014.03.002; Wernegreen JJ, 2017, CURR OPIN GENET DEV, V47, P83, DOI 10.1016/j.gde.2017.08.006; Willis JCW, 2018, NAT CHEM, V10, P831, DOI 10.1038/s41557-018-0052-5; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wolfson AD, 1998, RNA, V4, P1019, DOI 10.1017/S1355838298980700; Wong ML, 2012, ORG LETT, V14, P1378, DOI 10.1021/ol300045c; Yamaguchi A, 2018, MOLECULES, V23, DOI 10.3390/molecules23102460; Yanagisawa T, 2008, J MOL BIOL, V378, P634, DOI 10.1016/j.jmb.2008.02.045; Yanagisawa T, 2006, ACTA CRYSTALLOGR F, V62, P1031, DOI 10.1107/S1744309106036700; Yanagisawa T, 2014, CHEMBIOCHEM, V15, P2181, DOI 10.1002/cbic.201402266; Zhang HL, 2022, NUCLEIC ACIDS RES, V50, P4601, DOI 10.1093/nar/gkac271; Zheng YA, 2017, CHEM SCI, V8, P7211, DOI 10.1039/c7sc02560b	72	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102521	10.1016/j.jbc.2022.102521	http://dx.doi.org/10.1016/j.jbc.2022.102521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36152750	gold, Green Published			2022-12-26	WOS:000882627400008
J	Chin, SM; Hatano, T; Sivashanmugam, L; Suchenko, A; Kashina, AS; Balasubramanian, MK; Jansen, S				Chin, Samantha M.; Hatano, Tomoyuki; Sivashanmugam, Lavanya; Suchenko, Andrejus; Kashina, Anna S.; Balasubramanian, Mohan K.; Jansen, Silvia			N-terminal acetylation and arginylation of actin determines the architecture and assembly rate of linear and branched actin networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMICS; PROFILIN	The great diversity in actin network architectures and dy-namics is exploited by cells to drive fundamental biological processes, including cell migration, endocytosis, and cell divi-sion. While it is known that this versatility is the result of the many actin-remodeling activities of actin-binding proteins, such as Arp2/3 and cofilin, recent work also implicates post -translational acetylation or arginylation of the actin N terminus itself as an equally important regulatory mechanism. However, the molecular mechanisms by which acetylation and arginyla-tion alter the properties of actin are not well understood. Here, we directly compare how processing and modification of the N terminus of actin affects its intrinsic polymerization dynamics and its remodeling by actin-binding proteins that are essential for cell migration. We find that in comparison to acetylated actin, arginylated actin reduces intrinsic as well as formin-mediated elongation and Arp2/3-mediated nucleation. By contrast, there are no significant differences in cofilin-mediated severing. Taken together, these results suggest that cells can employ these differently modified actins to regulate actin dynamics. In addition, unprocessed actin with an N -ter-minal methionine residue shows very different effects on formin-mediated elongation, Arp2/3-mediated nucleation, and severing by cofilin. Altogether, this study shows that the nature of the N terminus of actin can promote distinct actin network dynamics, which can be differentially used by cells to locally finetune actin dynamics at distinct cellular locations, such as at the leading edge.	[Chin, Samantha M.; Jansen, Silvia] Washington Univ St Louis, Dept Cell Biol & Physiol, St Louis, MO 63130 USA; [Hatano, Tomoyuki; Sivashanmugam, Lavanya; Suchenko, Andrejus; Balasubramanian, Mohan K.] Univ Warwick, Ctr Mechanochem Cell Biol, Warwick Med Sch, Coventry, England; [Hatano, Tomoyuki; Sivashanmugam, Lavanya; Suchenko, Andrejus; Balasubramanian, Mohan K.] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry, England; [Kashina, Anna S.] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA USA	Washington University (WUSTL); University of Warwick; University of Warwick; University of Pennsylvania	Jansen, S (corresponding author), Washington Univ St Louis, Dept Cell Biol & Physiol, St Louis, MO 63130 USA.	silvia.jansen@wustl.edu		Hatano, Tomoyuki/0000-0002-9092-3989; Kashina, Anna/0000-0002-0243-6866; Suchenko, Andrejus/0000-0002-4832-1642	Wellcome Trust Collaborative Award in Science [671083]; European Research Council Advanced Grant [BB/S003789/1]; BBSRC [R35GM122505]; NIH [R01NS102435];  [203276/Z/16/Z]	Wellcome Trust Collaborative Award in Science(Wellcome Trust); European Research Council Advanced Grant(European Research Council (ERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	The work in the laboratory of M. K. B. was supported by a Wellcome Trust Collaborative Award in Science (203276/Z/16/Z) , a European Research Council Advanced Grant (ERC-2014-ADG No. 671083) , and a collaborative BBSRC award to M. K. B. (BB/S003789/1) . The work in the A. S. K laboratory was supported by NIH grants R35GM122505 and R01NS102435. The content is solely the responsibility of the au- thors and does not necessarily represent the of fi cial views of the National Institutes of Health.	Arnesen T, 2018, CYTOSKELETON, V75, P318, DOI 10.1002/cm.21455; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Boczkowska M, 2008, STRUCTURE, V16, P695, DOI 10.1016/j.str.2008.02.013; Chen L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52848-5; Drazic A, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2021.167397; Drazic A, 2018, P NATL ACAD SCI USA, V115, P4399, DOI 10.1073/pnas.1718336115; Goris M, 2018, P NATL ACAD SCI USA, V115, P4405, DOI 10.1073/pnas.1719251115; Hatano T, 2020, J CELL SCI, V133, DOI 10.1242/jcs.241406; Hatano T, 2018, J CELL SCI, V131, DOI 10.1242/jcs.213827; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Jansen S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8202; Kaksonen M, 2018, NAT REV MOL CELL BIO, V19, P313, DOI 10.1038/nrm.2017.132; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Mu A, 2020, P NATL ACAD SCI USA, V117, P439, DOI 10.1073/pnas.1914072117; Mu A, 2019, NAT CELL BIOL, V21, P592, DOI 10.1038/s41556-019-0307-4; Pavlyk I, 2018, TRAFFIC, V19, P263, DOI 10.1111/tra.12551; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Rebowski G, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8793; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Saha S, 2010, MOL BIOL CELL, V21, P1350, DOI 10.1091/mbc.E09-09-0829; Suarez C, 2015, DEV CELL, V32, P43, DOI 10.1016/j.devcel.2014.10.027; Terman JR, 2013, CURR OPIN CELL BIOL, V25, P30, DOI 10.1016/j.ceb.2012.10.009; Varland S, 2019, TRENDS BIOCHEM SCI, V44, P502, DOI 10.1016/j.tibs.2018.11.010; Vedula P, 2021, ELIFE, V10, DOI 10.7554/eLife.68712; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Zhang FL, 2010, SCIENCE, V329, P1534, DOI 10.1126/science.1191701; Zimmermann D, 2019, CURR OPIN CELL BIOL, V56, P130, DOI 10.1016/j.ceb.2018.12.008	30	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102518	10.1016/j.jbc.2022.102518	http://dx.doi.org/10.1016/j.jbc.2022.102518			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36152749	gold, Green Accepted, Green Published			2022-12-26	WOS:000882199400005
J	Borland, H; Rasmussen, I; Bjerregaard-Andersen, K; Rasmussen, M; Olsen, A; Vilhardt, F				Borland, Helena; Rasmussen, Izabela; Bjerregaard-Andersen, Kaare; Rasmussen, Michel; Olsen, Anders; Vilhardt, Frederik			alpha-synuclein buildup is alleviated via ESCRT-dependent endosomal degradation brought about by p38MAPK inhibition in cells expressing p25 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEWY BODY; AUTOPHAGOSOME MATURATION; LYSOSOMAL DEGRADATION; P38-ALPHA MAPK; PROTEIN; PHOSPHORYLATION; TOXICITY; SER-129; PATHWAY; DISEASE	alpha-synucleinopathy is driven by an imbalance of synthesis and degradation of alpha-synuclein (alpha Syn), causing a build up of alpha Syn aggregates and post-translationally modified species, which not only interfere with normal cellular metabolism but also by their secretion propagates the disease. Therefore, a better under-standing of alpha Syn degradation pathways is needed to address alpha-synucleinopathy. Here, we used the nerve growth factor- differentiated catecholaminergic PC12 neuronal cell line, which was conferred alpha-synucleinopathy by inducible expres-sion of alpha Syn and tubulin polymerization-promoting protein p25 alpha. p25 alpha aggregates alpha Syn, and imposes a partial autophagosome-lysosome block to mimic aspects of lysosomal deficiency common in neurodegenerative disease. Under basal conditions, alpha Syn was degraded by multiple pathways but most prominently by macroautophagy and Nedd4/Ndfip1-mediated degradation. We found that expression of p25 alpha induced strong p38MAPK activity. Remarkably, when opposed by in-hibitor SB203580 or p38MAPK shRNA knockdown, endoly-sosomal localization and degradation of alpha Syn increased, and alpha Syn secretion and cytotoxicity decreased. This effect was specifically dependent on Hsc70 and the endosomal sorting complex required for transport machinery, but different from classical microautophagy, as the alpha Syn Hsc70 binding motif was unnecessary. Furthermore, in a primary neuronal (h)-alpha Syn seeding model, p38MAPK inhibition decreased pathological accumulation of phosphorylated serine-129-alpha Syn and cyto-toxicity. In conclusion, p38MAPK inhibition shifts alpha Syn degradation from various forms of autophagy to an endosomal sorting complex required for transport-dependent uptake mechanism, resulting in increased alpha Syn turnover and cell viability in p25 alpha-expressing cells. More generally, our results suggest that under conditions of autophagolysosomal mal-function, the uninterrupted endosomal pathway offers a pos-sibility to achieve disease-associated protein degradation.	[Borland, Helena; Rasmussen, Izabela; Rasmussen, Michel; Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Borland, Helena; Bjerregaard-Andersen, Kaare] H Lundbeck A S, Dept Cell Biol, Valby, Denmark; [Olsen, Anders] Aalborg Univ, Fac Engn & Sci, Dept Chem & Biosci, Aalborg, Denmark	University of Copenhagen; Lundbeck Corporation; Aalborg University	Vilhardt, F (corresponding author), Univ Copenhagen, Panum Inst, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.	vilhardt@sund.ku.dk			Lundbeck Foundation [R118-A11718]; Danish Parkinson Foundation [R4 -A211]; Niels Ydes Foundation [1195011]; Beckett Foundation; Aage og Johanne Louis-Hansens Foundation; Innovation Fund Denmark [5189-00051B]; Lundbeck A/S; Laege Sofus Carl Emil Friis Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Parkinson Foundation; Niels Ydes Foundation; Beckett Foundation; Aage og Johanne Louis-Hansens Foundation; Innovation Fund Denmark; Lundbeck A/S(Lundbeck Corporation); Laege Sofus Carl Emil Friis Foundation	Funding and additional information - This study was funded by grants to F. V. from the Lundbeck Foundation (grant no.: R118-A11718) , the Danish Parkinson Foundation (grant no.: R4 -A211) , the Niels Ydes Foundation (grant no.: 1195011) , The Beckett Foundation, The Aage og Johanne Louis-Hansens Foundation, and The Laege Sofus Carl Emil Friis Foundation. A grant from Innovation Fund Denmark (grant no.: 5189-00051B) was ob- tained in partnership with Lundbeck A/S.	Alam J, 2016, AUTOPHAGY, V12, P2516, DOI 10.1080/15548627.2016.1238555; Alvarez-Erviti L, 2011, NEUROBIOL DIS, V42, P360, DOI 10.1016/j.nbd.2011.01.029; Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Borland H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010227; Canovas B, 2021, NAT REV MOL CELL BIO, V22, P346, DOI 10.1038/s41580-020-00322-w; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Christensen DP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0519-5; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Davies SE, 2014, NEUROBIOL DIS, V64, P79, DOI 10.1016/j.nbd.2013.12.011; DeBonis S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13242; Ejlerskov P, 2013, J BIOL CHEM, V288, P17313, DOI 10.1074/jbc.M112.401174; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Ganley IG, 2013, ESSAYS BIOCHEM, V55, P65, DOI [10.1042/bse0550065, 10.1042/BSE0550065]; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Ghanem SS, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2109617119; Hori I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02840-8; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kaushik S, 2018, NAT REV MOL CELL BIO, V19, P365, DOI 10.1038/s41580-018-0001-6; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Kragh CL, 2009, J BIOL CHEM, V284, P10211, DOI 10.1074/jbc.M809671200; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Li WM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01609-x; Lindersson E, 2005, J BIOL CHEM, V280, P5703, DOI 10.1074/jbc.M410409200; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Man WK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21027-4; Mbefo MK, 2010, J BIOL CHEM, V285, P2807, DOI 10.1074/jbc.M109.081950; McGlinchey RP, 2015, P NATL ACAD SCI USA, V112, P9322, DOI 10.1073/pnas.1500937112; Menon MB, 2015, AUTOPHAGY, V11, P1425, DOI 10.1080/15548627.2015.1059562; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oku M, 2018, BIOESSAYS, V40, DOI 10.1002/bies.201800008; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Pemberton S, 2011, J BIOL CHEM, V286, P34690, DOI 10.1074/jbc.M111.261321; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Redeker V, 2012, J BIOL CHEM, V287, P32630, DOI 10.1074/jbc.M112.387530; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Sahu R, 2011, DEV CELL, V20, P131, DOI 10.1016/j.devcel.2010.12.003; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Schnoder ML, 2020, FASEB J, V34, P9628, DOI 10.1096/fj.201902731RR; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Svanbergsson A, 2021, NEUROTHERAPEUTICS, V18, P1692, DOI 10.1007/s13311-021-01070-1; Tardiff DF, 2013, SCIENCE, V342, P979, DOI 10.1126/science.1245321; Tarutani A, 2016, J BIOL CHEM, V291, P18675, DOI 10.1074/jbc.M116.734707; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tjelle TE, 1996, J CELL SCI, V109, P2905; Tofaris GK, 2011, P NATL ACAD SCI USA, V108, P17004, DOI 10.1073/pnas.1109356108; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Walker DG, 2013, EXP NEUROL, V240, P190, DOI 10.1016/j.expneurol.2012.11.020; Wang B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4479; Wang RX, 2019, J CELL BIOL, V218, P267, DOI 10.1083/jcb.201804165; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Wei YJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05289; Westerlund M, 2008, MOL CELL NEUROSCI, V39, P586, DOI 10.1016/j.mcn.2008.08.001; Zhou JX, 2011, ACTA NEUROPATHOL, V121, P695, DOI 10.1007/s00401-011-0815-1	73	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102531	10.1016/j.jbc.2022.102531	http://dx.doi.org/10.1016/j.jbc.2022.102531			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36162505	gold, Green Published			2022-12-26	WOS:000886086000003
J	Bru, P; Steen, CJ; Park, S; Amstutz, CL; Sylak-Glassman, EJ; Lam, L; Fekete, A; Mueller, MJ; Longoni, F; Fleming, GR; Niyogi, KK; Malnoe, A				Bru, Pierrick; Steen, Collin J.; Park, Soomin; Amstutz, Cynthia L.; Sylak-Glassman, Emily J.; Lam, Lam; Fekete, Agnes; Mueller, Martin J.; Longoni, Fiamma; Fleming, Graham R.; Niyogi, Krishna K.; Malnoe, Alizee			The major trimeric antenna complexes serve as a site for qH-energy dissipation in plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; A/B-BINDING-PROTEINS; PHOTOSYSTEM-II; CHLOROPHYLL-A; STATE TRANSITIONS; FLUORESCENCE; PHOTOPROTECTION; PHOTOSYNTHESIS; EFFICIENCY; EVOLUTION	Plants and algae are faced with a conundrum: harvesting sufficient light to drive their metabolic needs while dissipating light in excess to prevent photodamage, a process known as nonphotochemical quenching. A slowly relaxing form of energy dissipation, termed qH, is critical for plants' survival under abiotic stress; however, qH location in the photosynthetic membrane is unresolved. Here, we tested whether we could isolate subcomplexes from plants in which qH was induced that would remain in an energy-dissipative state. Interestingly, we found that chlorophyll (Chl) fluorescence lifetimes were decreased by qH in isolated major trimeric antenna complexes, indicating that they serve as a site for qH-energy dissipation and providing a natively quenched complex with physiological relevance to natural conditions. Next, we monitored the changes in thylakoid pigment, protein, and lipid contents of antenna with active or inactive qH but did not detect any evident differences. Finally, we investigated whether specific subunits of the major antenna complexes were required for qH but found that qH was insensitive to trimer composition. Because we previously observed that qH can occur in the absence of specific xanthophylls, and no evident changes in pigments, proteins, or lipids were detected, we tentatively propose that the energy-dissipative state reported here may stem from Chl-Chl excitonic interaction.	[Bru, Pierrick; Malnoe, Alizee] Umea Univ, Umea Plant Sci Ctr UPSC, Dept Plant Physiol, Umea, Sweden; [Steen, Collin J.; Park, Soomin; Sylak-Glassman, Emily J.; Fleming, Graham R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA USA; [Steen, Collin J.; Park, Soomin; Sylak-Glassman, Emily J.; Lam, Lam; Fleming, Graham R.; Niyogi, Krishna K.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Phys Biosci Div, Berkeley, CA USA; [Steen, Collin J.; Park, Soomin; Lam, Lam; Fleming, Graham R.] Kavli Energy Nanosci Inst, Berkeley, CA USA; [Park, Soomin] Korea Univ Technol & Educ, Sch Energy Mat & Chem Engn, Cheonan, Chungnam, South Korea; [Amstutz, Cynthia L.; Niyogi, Krishna K.] Howard Hughes Med Inst, Dept Plant & Microbial Biol, Chevy Chase, MD USA; [Lam, Lam; Fleming, Graham R.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA USA; [Fekete, Agnes; Mueller, Martin J.] Univ Wurzburg, Julius Von Sachs Inst, Bioctr, Pharmaceut Biol, Wurzburg, Germany; [Longoni, Fiamma] Univ Neuchatel, Inst Biol, Neuchatel, Switzerland	Umea University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Korea University of Technology & Education; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Wurzburg; University of Neuchatel	Malnoe, A (corresponding author), Umea Univ, Umea Plant Sci Ctr UPSC, Dept Plant Physiol, Umea, Sweden.	alizee.malnoe@umu.se	; Longoni, Fiamma/O-6577-2017	Bru, Pierrick/0000-0001-5854-0905; Longoni, Fiamma/0000-0003-0587-7621; Steen, Collin/0000-0002-7029-2892; Amstutz, Cynthia/0000-0002-4752-5133	Knut and Alice Wallenberg Foundation [2016.0341, 2016.0352]; Swedish Governmental Agency for Innovation Systems [2016-00504]; Swiss National Science Foundation [31003A_179417]; German Research Foundation Deutsche Forschungsgemeinschaft [179877739]	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Governmental Agency for Innovation Systems(Vinnova); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	K. K. N. is an investigator of the Howard Hughes Medical Institute (HHMI). This article is subject to HHMI's Open Access to Publications policy. HHMI laboratory heads have previously granted a nonexclusive CC BY 4.0 license to the public and a sublicensable license to HHMI in their research articles. Pursuant to those licenses, the author-accepted manuscript of this journal can be made freely available under a CC BY 4.0 license immediately upon publication. The research performed at Umea (P. B. and A. M.) was further supported by grants to UPSC from the Knut and Alice Wallenberg Foundation (grant nos.: 2016.0341 and 2016.0352), and the Swedish Governmental Agency for Innovation Systems (grant no.: 2016-00504). The research performed at Neuchatel was supported by the Swiss National Science Foundation to F.L. (grant no.: 31003A_179417). This work used the Metabolomics Core Unit of the University Wuerzburg, supported by the German Research Foundation Deutsche Forschungsgemeinschaft (project number: 179877739) for lipid profiling.	Amstutz CL, 2020, NAT PLANTS, V6, P154, DOI 10.1038/s41477-020-0591-9; Bailey-Serres J, 2019, NATURE, V575, P109, DOI 10.1038/s41586-019-1679-0; Ballottari M, 2012, BBA-BIOENERGETICS, V1817, P143, DOI 10.1016/j.bbabio.2011.06.005; Bassi R, 2021, ANNU REV PLANT BIOL, V72, P47, DOI 10.1146/annurev-arplant-071720-015522; Bennett DIG, 2018, P NATL ACAD SCI USA, V115, pE9523, DOI 10.1073/pnas.1806597115; Brooks MD, 2013, P NATL ACAD SCI USA, V110, pE2733, DOI 10.1073/pnas.1305443110; Brooks MD, 2011, METHODS MOL BIOL, V775, P299, DOI 10.1007/978-1-61779-237-3_16; Bru P, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9111565; Burgos A, 2011, PLANT J, V66, P656, DOI 10.1111/j.1365-313X.2011.04531.x; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Chukhutsina VU, 2019, PHOTOSYNTH RES, V140, P355, DOI 10.1007/s11120-018-0607-8; Cignoni E, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27526-8; Crepin A, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22062969; Crepin A, 2018, CURR PROTEIN PEPT SC, V19, P699, DOI 10.2174/1389203719666180222101534; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Damkjaer JT, 2009, PLANT CELL, V21, P3245, DOI 10.1105/tpc.108.064006; DemmigAdams B, 2014, ADV PHOTOSYNTH RESP, V40, P1, DOI 10.1007/978-94-017-9032-1; Durr J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22667-1; Gilmore AM, 1998, BIOCHEMISTRY-US, V37, P13582, DOI 10.1021/bi981384x; Giuffra E, 1997, BIOCHEMISTRY-US, V36, P12984, DOI 10.1021/bi9711339; Heigwer F, 2014, NAT METHODS, V11, P122, DOI 10.1038/nmeth.2812; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; Ilioaia C, 2008, J BIOL CHEM, V283, P29505, DOI 10.1074/jbc.M802438200; Iwai M, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.8, 10.1038/NPLANTS.2014.8]; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; KRAUSE GH, 1990, J PLANT PHYSIOL, V136, P472; Kromdijk J, 2016, SCIENCE, V354, P857, DOI 10.1126/science.aai8878; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Levesque-Tremblay G, 2009, PLANT J, V60, P691, DOI 10.1111/j.1365-313X.2009.03991.x; Liguori N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02239-z; Liguori N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15661; Lingvay M, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00849; Malnoe A, 2018, ENVIRON EXP BOT, V154, P123, DOI 10.1016/j.envexpbot.2018.05.005; Malnoe A, 2018, PLANT CELL, V30, P196, DOI 10.1105/tpc.17.00536; Manna P, 2021, BIOPHYS J, V120, P3091, DOI 10.1016/j.bpj.2021.06.010; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Mueller SP, 2015, J EXP BOT, V66, P4517, DOI 10.1093/jxb/erv226; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Murchie EH, 2011, PLANT PHYSIOL, V155, P86, DOI 10.1104/pp.110.168831; Natali A, 2016, J BIOL CHEM, V291, P16730, DOI 10.1074/jbc.M116.730101; Nawrocki WJ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj0055; Nicol L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86975-9; Niyogi KK, 2013, CURR OPIN PLANT BIOL, V16, P307, DOI 10.1016/j.pbi.2013.03.011; Ordon J, 2020, FUNCT INTEGR GENOMIC, V20, P151, DOI 10.1007/s10142-019-00665-4; Ordon J, 2017, PLANT J, V89, P155, DOI 10.1111/tpj.13319; Pietrzykowska M, 2014, PLANT CELL, V26, P3646, DOI 10.1105/tpc.114.127373; Pinnola A, 2018, BIOCHEM SOC T, V46, P467, DOI [10.1042/BST20170307, 10.1042/bst20170307]; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; QUICK WP, 1989, BIOCHIM BIOPHYS ACTA, V977, P287, DOI 10.1016/S0005-2728(89)80082-9; Rantala M, 2018, JOVE-J VIS EXP, DOI 10.3791/58369; Ricci M, 1996, CHEM PHYS LETT, V259, P381, DOI 10.1016/0009-2614(96)00832-9; Ruban AV, 2022, J CHEM PHYS, V156, DOI 10.1063/5.0073825; Saccon F, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101430; Sattari Vayghan H., 2022, FRONT PLANT SCI, V13; Son MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15074-6; Standfuss J, 2004, J BIOL CHEM, V279, P36884, DOI 10.1074/jbc.M402348200; Sylak-Glassman EJ, 2016, PHOTOSYNTH RES, V127, P69, DOI 10.1007/s11120-015-0104-2; Sylak-Glassman EJ, 2014, P NATL ACAD SCI USA, V111, P17498, DOI 10.1073/pnas.1418317111; Takabayashi A, 2011, PLANT CELL PHYSIOL, V52, P2103, DOI 10.1093/pcp/pcr138; Tietz S, 2020, J BIOL CHEM, V295, P1857, DOI 10.1074/jbc.RA119.011707; Valkunas L, 2012, J PHYS CHEM LETT, V3, P2779, DOI 10.1021/jz300983r; van Oort B, 2007, J PHYS CHEM B, V111, P7631, DOI 10.1021/jp070573z; Wang Y, 2020, PLANT J, V101, P874, DOI 10.1111/tpj.14663; Weigel D., 2006, CSH PROTOC, V5; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu PQ, 2020, ELIFE, V9, DOI 10.7554/eLife.58984; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Yu GM, 2022, NAT PLANTS, V8, P840, DOI 10.1038/s41477-022-01177-z; Zhu XG, 2004, J EXP BOT, V55, P1167, DOI 10.1093/jxb/erh141; Zhu XG, 2010, ANNU REV PLANT BIOL, V61, P235, DOI 10.1146/annurev-arplant-042809-112206	72	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102519	10.1016/j.jbc.2022.102519	http://dx.doi.org/10.1016/j.jbc.2022.102519			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36152752	gold, Green Published			2022-12-26	WOS:000882199400010
J	Murach, KA; Liu, ZY; Jude, B; Figueiredo, VC; Wen, Y; Khadgi, S; Lim, S; da Silva, FM; Greene, NP; Lanner, JT; McCarthy, JJ; Vechetti, IJ; von Walden, F				Murach, Kevin A.; Liu, Zhengye; Jude, Baptiste; Figueiredo, Vandre C.; Wen, Yuan; Khadgi, Sabin; Lim, Seongkyun; da Silva, Francielly Morena; Greene, Nicholas P.; Lanner, Johanna T.; McCarthy, John J.; Vechetti, Ivan J.; von Walden, Ferdinand			Multi-transcriptome analysis following an acute skeletal muscle growth stimulus yields tools for discerning global and MYC regulatory networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; RIBOSOME BIOGENESIS; GENE-EXPRESSION; HYPERTROPHIC RESPONSE; MECHANICAL OVERLOAD; CIRCADIAN CLOCK; MESSENGER-RNA; RESISTANCE; STEM; PROTEIN	Myc is a powerful transcription factor implicated in epigenetic reprogramming, cellular plasticity, and rapid growth as well as tumorigenesis. Cancer in skeletal muscle is extremely rare despite marked and sustained Myc induction during loading-induced hypertrophy. Here, we investigated global, actively transcribed, stable, and myonucleus-specific transcriptomes following an acute hypertrophic stimulus in mouse plantaris. With these datasets, we define global and Myc-specific dynamics at the onset of mechanical overload-induced muscle fiber growth. Data collation across analyses reveals an under-appreciated role for the muscle fiber in extracellular matrix remodeling during adaptation, along with the contribution of mRNA stability to epigenetic-related transcript levels in muscle. We also identify Runx1 and Ankrd1 (Marp1) as abundant myonucleus-enriched loading-induced genes. We observed that a strong induction of cell cycle regulators including Myc occurs with mechanical overload in myonuclei. Additionally, in vivo Myc-controlled gene expression in the plantaris was defined using a genetic muscle fiber-specific doxycycline-inducible Myc-overexpression model. We deter-mined Myc is implicated in numerous aspects of gene expression during early-phase muscle fiber growth. Specifically, brief induction of Myc protein in muscle represses Reverb alpha, Reverb beta, and Myh2 while increasing Rpl3, recapitulating gene expression in myonuclei during acute overload. Experimental, comparative, and in silico analyses place Myc at the center of a stable and actively transcribed, loading-responsive, muscle fiber-localized regulatory hub. Collectively, our experiments are a roadmap for understanding global and Myc-mediated transcriptional networks that regulate rapid remodeling in postmitotic cells. We provide open webtools for exploring the five RNA-seq datasets as a resource to the field.	[Murach, Kevin A.; Khadgi, Sabin; Lim, Seongkyun; da Silva, Francielly Morena; Greene, Nicholas P.] Univ Arkansas, Exercise Sci Res Ctr, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA; [Murach, Kevin A.] Univ Arkansas, Cell & Mol Biol Grad Program, Fayetteville, AR 72701 USA; [Liu, Zhengye; Jude, Baptiste] Karolinska Inst, Dept Physiol & Pharmacol, Solna, Sweden; [Jude, Baptiste; von Walden, Ferdinand] Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden; [Figueiredo, Vandre C.; Wen, Yuan; McCarthy, John J.] Univ Kentucky, Ctr Muscle Biol, Lexington, KY USA; [Wen, Yuan] Univ Kentucky, Dept Phys Therapy, Lexington, KY USA; [Lim, Seongkyun; da Silva, Francielly Morena; Greene, Nicholas P.] Univ Arkansas, Cachexia Res Lab, Fayetteville, AR USA; [Figueiredo, Vandre C.; McCarthy, John J.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Vechetti, Ivan J.] Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68588 USA; [Figueiredo, Vandre C.] Oakland Univ, Dept Biol Sci, Rochester, MI USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; Karolinska Institutet; Karolinska Institutet; University of Kentucky; University of Kentucky; University of Arkansas System; University of Arkansas Fayetteville; University of Kentucky; University of Nebraska System; University of Nebraska Lincoln; Oakland University	Murach, KA (corresponding author), Univ Arkansas, Exercise Sci Res Ctr, Dept Hlth Human Performance & Recreat, Fayetteville, AR 72701 USA.; Murach, KA (corresponding author), Univ Arkansas, Cell & Mol Biol Grad Program, Fayetteville, AR 72701 USA.; von Walden, F (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden.; Vechetti, IJ (corresponding author), Univ Nebraska, Dept Nutr & Hlth Sci, Lincoln, NE 68588 USA.	kmurach@uark.edu; ivechetti@unl.edu; ferdinand.von.walden@ki.se		Morena da Silva, Francielly/0000-0001-5019-2125; LIM, SEONGKYUN/0000-0001-7075-5909	NIH [R00 AG063994]; University of Arkansas Vice Chancellor for Research and Innovation; AFM-Telethon [23137]; Swedish Medical Association; Swedish Research Council for Sport Science; Chinese Scholarship Council; SMDF; Oke Wiberg	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas Vice Chancellor for Research and Innovation; AFM-Telethon(Association Francaise contre les Myopathies); Swedish Medical Association; Swedish Research Council for Sport Science; Chinese Scholarship Council(China Scholarship Council); SMDF; Oke Wiberg	This work was supported by NIH R00 AG063994 and startup funds from the University of Arkansas Vice Chancellor for Research and Innovation to K. A. M., support from NIH P20GM104320-07 to I. J. V., and support from AFM-Telethon 23137, SMDF, Oke Wiberg, Swedish Medical Association, and the Swedish Research Council for Sport Science to F. v. W., Z. L. was supported by the Chinese Scholarship Council. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Accornero F, 2014, HUM MOL GENET, V23, P6903, DOI 10.1093/hmg/ddu413; Agrawal P, 2010, CELL CYCLE, V9, P4908, DOI 10.4161/cc.9.24.14199; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Alway SE, 1997, J GERONTOL A-BIOL, V52, pB203, DOI 10.1093/gerona/52A.4.B203; Armstrong DD, 2005, AM J PHYSIOL-CELL PH, V289, pC853, DOI 10.1152/ajpcell.00093.2005; ARMSTRONG RB, 1979, J APPL PHYSIOL, V46, P835, DOI 10.1152/jappl.1979.46.4.835; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Brenner C, 2005, EMBO J, V24, P336, DOI 10.1038/sj.emboj.7600509; Brightwell CR, 2022, AM J PHYSIOL-CELL PH, V323, pC763, DOI 10.1152/ajpcell.00200.2022; Bui Thi V, 2010, Genes Cancer, V1, P568; Cai XW, 2015, CELL STEM CELL, V17, P165, DOI 10.1016/j.stem.2015.06.002; Casanova-Vallve N, 2022, MOL METAB, V61, DOI 10.1016/j.molmet.2022.101504; Chaillou T, 2019, J APPL PHYSIOL, V127, P599, DOI 10.1152/japplphysiol.00946.2018; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Chen YW, 2002, J PHYSIOL-LONDON, V545, P27, DOI 10.1113/jphysiol.2002.021220; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Crist SB, 2022, NAT CELL BIOL, V24, P538, DOI 10.1038/s41556-022-00881-4; Dahiya S, 2011, HUM MOL GENET, V20, P4345, DOI 10.1093/hmg/ddr362; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Das Subhendu K, 2022, Trends Cell Biol, DOI 10.1016/j.tcb.2022.07.006; DEPINHO R, 1987, J CELL BIOCHEM, V33, P257, DOI 10.1002/jcb.240330404; Dungan CM, 2022, FUNCTION, V3, DOI 10.1093/function/zqac027; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Figueiredo VC, 2021, J PHYSIOL-LONDON, V599, P3363, DOI 10.1113/JP281244; Figueiredo VC, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12670; Figueiredo VC, 2019, PHYSIOLOGY, V34, P30, DOI 10.1152/physiol.00034.2018; Fry CS, 2017, CELL STEM CELL, V20, P56, DOI 10.1016/j.stem.2016.09.010; Fry CS, 2014, FASEB J, V28, P1654, DOI 10.1096/fj.13-239426; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Gerst JE, 2018, TRENDS GENET, V34, P832, DOI 10.1016/j.tig.2018.08.004; Gohil K, 2012, AM J PHYSIOL-ENDOC M, V303, pE18, DOI 10.1152/ajpendo.00027.2012; Goodman CA, 2015, FEBS LETT, V589, P1491, DOI 10.1016/j.febslet.2015.04.047; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hurlin PJ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014332; Idol RA, 2007, BLOOD CELL MOL DIS, V39, P35, DOI 10.1016/j.bcmd.2007.02.001; Iwata M, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0181-y; Kalkat M, 2011, CELL CYCLE, V10, P374, DOI 10.4161/cc.10.3.14645; Kamburov A, 2022, NUCLEIC ACIDS RES, V50, pD587, DOI 10.1093/nar/gkab1128; Keckesova Z, 2017, NATURE, V543, P681, DOI 10.1038/nature21408; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Kirby TJ, 2016, METHODS MOL BIOL, V1460, P43, DOI 10.1007/978-1-4939-3810-0_4; Kirby TJ, 2016, MOL BIOL CELL, V27, P788, DOI 10.1091/mbc.E15-08-0585; Kirby TJ, 2015, J APPL PHYSIOL, V119, P321, DOI 10.1152/japplphysiol.00296.2015; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; Li ZG, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14356; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu XH, 2015, BIOCHEM BIOPH RES CO, V464, P208, DOI 10.1016/j.bbrc.2015.06.118; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo W, 2019, CELL DEATH DIFFER, V26, P426, DOI 10.1038/s41418-018-0129-0; Madan B, 2018, J CLIN INVEST, V128, P5620, DOI 10.1172/JCI122383; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Morello LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029174; Mori T, 2021, AM J PHYSIOL-ENDOC M, V321, pE551, DOI 10.1152/ajpendo.00164.2021; Murach KA, 2022, AM J PHYSIOL-CELL PH, V322, pC86, DOI 10.1152/ajpcell.00358.2021; Murach KA, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102372; Murach KA, 2020, FUNCTION, V1, DOI 10.1093/function/zqaa009; Murach KA, 2020, J APPL PHYSIOL, V129, P516, DOI 10.1152/japplphysiol.00319.2020; Nakagawa M, 2010, P NATL ACAD SCI USA, V107, P14152, DOI 10.1073/pnas.1009374107; Newman AM, 2019, NAT BIOTECHNOL, V37, P773, DOI 10.1038/s41587-019-0114-2; Nie ZQ, 2020, ELIFE, V9, DOI 10.7554/eLife.52483; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nishikawa K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113974; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ohsawa I, 2021, FASEB J, V35, DOI 10.1096/fj.202002027RR; Oprescu SN, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100993; Petrany MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20063-w; Petrosino JM, 2019, FASEB J, V33, P2047, DOI 10.1096/fj.201800622RR; Pippa R, 2017, ONCOTARGET, V8, P53989, DOI 10.18632/oncotarget.9840; Player DJ, 2014, BIOTECHNOL LETT, V36, P1113, DOI 10.1007/s10529-014-1464-y; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Qin Q, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1934-6; Rodriguez-Fdez S, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10112984; Rutledge EA, 2020, DEV BIOL, V458, P164, DOI 10.1016/j.ydbio.2019.11.007; Santoro A, 2019, CELL REP, V26, P624, DOI 10.1016/j.celrep.2018.12.071; SEELY S, 1980, MED HYPOTHESES, V6, P133, DOI 10.1016/0306-9877(80)90079-1; Shostak A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11807; Small L, 2020, J PHYSIOL-LONDON, V598, P5739, DOI 10.1113/JP280428; SRIDHAR KS, 1987, CANCER-AM CANCER SOC, V59, P1530, DOI 10.1002/1097-0142(19870415)59:8<1530::AID-CNCR2820590824>3.0.CO;2-H; Stec MJ, 2016, AM J PHYSIOL-ENDOC M, V310, pE652, DOI 10.1152/ajpendo.00486.2015; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Valentino T, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.15137; van der Pijl Robbert J, 2021, Biophys Rev, V13, P653, DOI 10.1007/s12551-021-00836-3; Van der Pijl RJ, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202112925; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Verbrugge SAJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197062; Von Walden F, 2020, EPIGENETICS-US, V15, P1151, DOI 10.1080/15592294.2020.1755581; von Walden F, 2019, J APPL PHYSIOL, V127, P591, DOI 10.1152/japplphysiol.00963.2018; von Walden F, 2012, AM J PHYSIOL-CELL PH, V302, pC1523, DOI 10.1152/ajpcell.00460.2011; Wackerhage H, 2022, SPORTS MED, V52, P2569, DOI 10.1007/s40279-022-01676-1; Wang HA, 2020, FASEB J, V34, P2715, DOI 10.1096/fj.201902623R; Wang XW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01942; Wang XX, 2005, GENE DEV, V19, P1715, DOI 10.1101/gad.1318305; Wen Y, 2021, FUNCTION, V2, DOI 10.1093/function/zqab038; Wen Y, 2016, EXERC SPORT SCI REV, V44, P110, DOI 10.1249/JES.0000000000000082; West DWD, 2016, J PHYSIOL-LONDON, V594, P453, DOI 10.1113/JP271365; WHITELAW PF, 1992, BIOCHEM J, V281, P143, DOI 10.1042/bj2810143; Wolff G, 2012, MED SCI SPORT EXER, V44, P1663, DOI 10.1249/MSS.0b013e318255cf4c; Wu Y, 2013, BIOCHEM BIOPH RES CO, V437, P355, DOI 10.1016/j.bbrc.2013.06.079; ZAK R, 1967, BIOCHEMISTRY-US, V6, P2493, DOI 10.1021/bi00860a028; Zambon AC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r61	106	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102515	10.1016/j.jbc.2022.102515	http://dx.doi.org/10.1016/j.jbc.2022.102515			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36150502	Green Published, gold			2022-12-26	WOS:000881802600001
J	Kaur, D; Verma, P; Singh, M; Sharma, A; Lata, K; Mukhopadhaya, A; Chattopadhyay, K				Kaur, Deepinder; Verma, Pratima; Singh, Mahendra; Sharma, Arpita; Lata, Kusum; Mukhopadhaya, Arunika; Chattopadhyay, Kausik			Pore formation-independent cell death induced by a beta-barrel pore-forming toxin	FASEB JOURNAL			English	Article						apoptosis; mitochondrial damage; mitochondrial membrane permeability transition; mitochondrial ROS; pore-forming toxin; programmed cell death; Vibrio cholerae cytolysin	VIBRIO-CHOLERAE CYTOLYSIN; BIOTYPE EL-TOR; HEMOLYSIN PRODUCTION; CRYSTAL-STRUCTURE; MECHANISMS; APOPTOSIS; TRANSLOCATION; MITOCHONDRIA; ACTIVATION; COMPLEX	Vibrio cholerae cytolysin (VCC) is a beta-barrel pore-forming toxin (beta-PFT). It exhibits potent hemolytic activity against erythrocytes that appears to be a direct outcome of its pore-forming functionality. However, VCC-mediated cell-killing mechanism is more complicated in the case of nucleated mammalian cells. It induces apoptosis in the target nucleated cells, mechanistic details of which are still unclear. Furthermore, it has never been explored whether the ability of VCC to trigger programmed cell death is stringently dependent on its pore-forming activity. Here, we show that VCC can evoke hallmark features of the caspase-dependent apoptotic cell death even in the absence of the pore-forming ability. Our study demonstrates that VCC mutants with abortive pore-forming hemolytic activity can trigger apoptotic cell death responses and cytotoxicity, similar to those elicited by the wild-type toxin. VCC as well as its pore formation-deficient mutants display prominent propensity to translocate to the target cell mitochondria and cause mitochondrial membrane damage. Therefore, our results for the first time reveal that VCC, despite being an archetypical beta-PFT, can kill target nucleated cells independent of its pore-forming functionality. These findings are intriguing for a beta-PFT, whose destination is generally expected to remain limited on the target cell membranes, and whose mode of action is commonly attributed to the membrane-damaging pore-forming ability. Taken together, our study provides critical new insights regarding distinct implications of the two important virulence functionalities of VCC for the V. cholerae pathogenesis process: hemolytic activity for iron acquisition and cytotoxicity for tissue damage by the bacteria.	[Kaur, Deepinder; Verma, Pratima; Singh, Mahendra; Sharma, Arpita; Lata, Kusum; Mukhopadhaya, Arunika; Chattopadhyay, Kausik] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India; [Kaur, Deepinder] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA	Indian Institute of Science Education & Research (IISER) - Mohali; Memorial Sloan Kettering Cancer Center	Mukhopadhaya, A; Chattopadhyay, K (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Sect 81, Mohali 140306, Punjab, India.	arunika@iisermohali.ac.in; kausik@iisermohali.ac.in			Council of Scientific and Industrial Research, India (CSIR); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB) [CRG/2018/001973]; Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)	Council of Scientific and Industrial Research, India (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB); Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)(University Grants Commission, India)	Council of Scientific and Industrial Research, India (CSIR); Department of Biotechnology, Ministry of Science and Technology, India (DBT); DST | Science and Engineering Research Board (SERB), Grant/Award Number: CRG/2018/001973; Indian Institute of Science Education and Research Mohali (IISER Mohali); University Grants Commission (UGC)	Saka HA, 2008, MICROB PATHOGENESIS, V44, P118, DOI 10.1016/j.micpath.2007.08.013; Arcidiacono D, 2008, CELL MICROBIOL, V10, P899, DOI 10.1111/j.1462-5822.2007.01092.x; Babiychuk EB, 2009, CELL DEATH DIFFER, V16, P1126, DOI 10.1038/cdd.2009.30; Bortner CD, 2001, METHOD CELL BIOL, V66, P49; Bouillot S, 2018, TOXINS, V10, DOI 10.3390/toxins10100387; Braun JS, 2007, INFECT IMMUN, V75, P4245, DOI 10.1128/IAI.00031-07; Brito C, 2019, CELL MOL LIFE SCI, V76, P1319, DOI 10.1007/s00018-018-2992-8; Castro-Cordova P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21355-5; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; De Biasi Sara, 2015, Curr Protoc Cytom, V72, DOI 10.1002/0471142956.cy0732s72; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gupta S, 2015, J BIOL CHEM, V290, P31051, DOI 10.1074/jbc.M115.670182; Hajnoczky G, 2003, BIOCHEM BIOPH RES CO, V304, P445, DOI 10.1016/S0006-291X(03)00616-8; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Jiang MX, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00349-0; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kathuria R, 2018, BIOCHEM J, V475, P3039, DOI 10.1042/BCJ20180387; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Marino G, 2013, CELL RES, V23, P1247, DOI 10.1038/cr.2013.115; Menzl K, 1996, EUR J BIOCHEM, V240, P646, DOI 10.1111/j.1432-1033.1996.0646h.x; Mondal AK, 2021, MOL MICROBIOL, V115, P508, DOI 10.1111/mmi.14631; Mondal AK, 2018, ADV EXP MED BIOL, V1112, P281, DOI 10.1007/978-981-13-3065-0_19; Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Paul K, 2014, BIOCHEM BIOPH RES CO, V443, P189, DOI 10.1016/j.bbrc.2013.11.078; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rai AK, 2014, J BIOL CHEM, V289, P16978, DOI 10.1074/jbc.M114.567099; Rai S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17666-8; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; RICHARDSON K, 1986, INFECT IMMUN, V54, P415, DOI 10.1128/IAI.54.2.415-420.1986; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; STOEBNER JA, 1988, INFECT IMMUN, V56, P2891, DOI 10.1128/IAI.56.11.2891-2895.1988; Verma P, 2021, BIOCHEM SOC T, V49, P455, DOI 10.1042/BST20200836; Vogel U, 1998, J CELL SCI, V111, P825; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Waterhouse NJ, 2003, CELL DEATH DIFFER, V10, P853, DOI 10.1038/sj.cdd.4401263; ZAMZAMI N, 2003, METH MOL B, V282, P103; Zhang JH, 2000, CELL RES, V10, P205, DOI 10.1038/sj.cr.7290049; Zhivotovsky B, 2003, ESSAYS BIOCHEM, V39, P25, DOI 10.1042/bse0390025; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; Zitzer A, 1997, INFECT IMMUN, V65, P1293, DOI 10.1128/IAI.65.4.1293-1298.1997	51	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22557	10.1096/fj.202200788R	http://dx.doi.org/10.1096/fj.202200788R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1RX	36125006				2022-12-26	WOS:000857904800001
J	Takami, Y; Wang, C; Nakagami, H; Yamamoto, K; Nozato, Y; Imaizumi, Y; Nagasawa, M; Takeshita, H; Nakajima, T; Takeda, S; Takeya, Y; Kaneda, Y; Rakugi, H				Takami, Yoichi; Wang, Cheng; Nakagami, Hironori; Yamamoto, Koichi; Nozato, Yoichi; Imaizumi, Yuki; Nagasawa, Motonori; Takeshita, Hikari; Nakajima, Tsuneo; Takeda, Shuko; Takeya, Yasushi; Kaneda, Yasufumi; Rakugi, Hiromi			Novel pathophysiological roles of alpha-synuclein in age-related vascular endothelial dysfunction	FASEB JOURNAL			English	Article						aging; endothelial function; eNOS; alpha-synuclein	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ALZHEIMERS-DISEASE; SENESCENCE; EXPRESSION; SIRT1; PRECURSOR; PROTEIN	Although alpha-synuclein (SNCA) is a well-known pathological molecule involved in synucleinopathy in neurons, its physiological roles remain largely unknown. We reported that serum SNCA levels have a close inverse correlation with blood pressure and age, which indicates the involvement of SNCA in age-related endothelial dysfunction. Therefore, this study aimed to elucidate the molecular functions of SNCA in the endothelium. We confirmed that SNCA was expressed in and secreted from endothelial cells (ECs). Exogenous treatment with recombinant SNCA (rSNCA) activated the Akt-eNOS axis and increased nitric oxide production in ECs. Treatment with rSNCA also suppressed TNF-alpha- and palmitic acid-induced NF-kappa B activation, leading to the suppression of VCAM-1 upregulation and restoration of eNOS downregulation in ECs. As for endogenous SNCA expression, replicative senescence resulted in the attenuation of SNCA expression in cultured ECs, similar to the effects of physiological aging on mice aortas. The siRNA-mediated silencing of SNCA consistently resulted in senescent phenotypes, such as eNOS downregulation, increased beta-gal activity, decreased Sirt1 expression, and increased p53 expression, in ECs. Ex vivo assessment of endothelial functions using aortic rings revealed impaired endothelium-dependent acetylcholine-induced relaxation in SNCA knockout (KO) mice. Furthermore, SNCA KO mice, especially those on a high-fat diet, displayed elevated blood pressure compared with wild-type mice; this could be eNOS dysfunction-dependent because of the lower difference caused by L-NAME administration. These results indicate that exogenous and endogenous SNCA in ECs might physiologically maintain vascular integrity, and age-related endothelial dysfunction might be partially ascribed to loss-of-function of SNCA in ECs.	[Takami, Yoichi; Wang, Cheng; Yamamoto, Koichi; Nozato, Yoichi; Imaizumi, Yuki; Nagasawa, Motonori; Takeshita, Hikari; Nakajima, Tsuneo; Takeya, Yasushi; Rakugi, Hiromi] Osaka Univ, Dept Geriatr & Gen Med, Grad Sch Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Nakagami, Hironori] Osaka Univ, Dept Hlth Dev & Med, Grad Sch Med, Osaka, Japan; [Takeda, Shuko] Osaka Univ, Dept Clin Gene Therapy, Grad Sch Med, Osaka, Japan; [Takeda, Shuko] Osaka Psychiat Med Ctr, Osaka Psychiat Res Ctr, Osaka, Japan; [Kaneda, Yasufumi] Osaka Univ, Dept Genome Biol, Div Gene Therapy Sci, Grad Sch Med, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Takami, Y (corresponding author), Osaka Univ, Dept Geriatr & Gen Med, Grad Sch Med, B6,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takami@geriat.med.osaka-u.ac.jp			Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI [24790756]; Osaka Heart Club	Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Osaka Heart Club	Japan Foundation for Applied Enzymology; Japan Geriatric Society; Japan Heart Foundation (JHF); JSPS KAKENHI, Grant/Award Number: 24790756; Osaka Heart Club	Anderson HDI, 2004, J BIOL CHEM, V279, P963, DOI 10.1074/jbc.M309552200; Austin SA, 2010, CIRC RES, V107, P1498, DOI 10.1161/CIRCRESAHA.110.233080; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bassil F, 2020, NEURON, V105, P260, DOI 10.1016/j.neuron.2019.10.010; Bobela W, 2015, BIOMOLECULES, V5, P2675, DOI 10.3390/biom5042675; Bozic M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15732-9; Burton DGA, 2018, BIOGERONTOLOGY, V19, P447, DOI 10.1007/s10522-018-9763-7; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cortes-Canteli M, 2020, J AM COLL CARDIOL, V75, P942, DOI 10.1016/j.jacc.2019.10.062; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Cui XP, 2012, BIOL PHARM BULL, V35, P2192, DOI 10.1248/bpb.b12-00598; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Donato AJ, 2009, AGING-US, V1, P678, DOI 10.18632/aging.100080; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fecchio C, 2018, MOLECULES, V23, DOI 10.3390/molecules23071531; Ghosh A, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0357-5; Gurnev PA, 2014, BIOPHYS J, V106, P556, DOI 10.1016/j.bpj.2013.12.028; Haque F, 2010, J PHYS CHEM B, V114, P4070, DOI 10.1021/jp1006704; Katusic ZS, 2016, CIRC J, V80, P1499, DOI 10.1253/circj.CJ-16-0423; Kayed R, 2020, J PARKINSON DIS, V10, P791, DOI 10.3233/JPD-201965; Kim KS, 2010, J BIOL CHEM, V285, P21416, DOI 10.1074/jbc.M110.103499; Kim TD, 2000, PROTEIN SCI, V9, P2489, DOI 10.1110/ps.9.12.2489; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kubota T, 2013, REV ENDOCR METAB DIS, V14, P207, DOI 10.1007/s11154-013-9242-z; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Loov C, 2016, CELL MOL NEUROBIOL, V36, P437, DOI 10.1007/s10571-015-0317-0; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Lucking CB, 2000, CELL MOL LIFE SCI, V57, P1894, DOI 10.1007/PL00000671; Man AWC, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01173; Marsh SE, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt109; McKeith I, 2004, LANCET NEUROL, V3, P19, DOI 10.1016/S1474-4422(03)00619-7; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Ota H, 2010, ARTERIOSCL THROM VAS, V30, P2205, DOI 10.1161/ATVBAHA.110.210500; Pak T, 2005, MED SCI MONITOR, V11, pBR357; Park SM, 2002, BLOOD, V100, P2506, DOI 10.1182/blood.V100.7.2506; Puschmann Andreas, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS24, DOI 10.1016/S1353-8020(11)70010-4; Rodriguez-Araujo G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12081; Rodriguez-Araujo G, 2013, CELL MOL LIFE SCI, V70, P1123, DOI 10.1007/s00018-012-1198-8; Schildknecht S, 2013, J NEUROCHEM, V125, P491, DOI 10.1111/jnc.12226; Sharma SK, 2017, CELL MOL LIFE SCI, V74, P617, DOI 10.1007/s00018-016-2340-9; Simonsen AH, 2016, BIOMARK MED, V10, P19, DOI 10.2217/BMM.14.105; Sung HJ, 2007, AM J PHYSIOL-CELL PH, V293, pC87, DOI 10.1152/ajpcell.00585.2006; Takami Y, 2007, ARTERIOSCL THROM VAS, V27, P2184, DOI 10.1161/ATVBAHA.107.142505; Tamo W, 2002, NEUROSCI LETT, V326, P5, DOI 10.1016/S0304-3940(02)00297-5; Toda N, 2012, PHARMACOL THERAPEUT, V133, P159, DOI 10.1016/j.pharmthera.2011.10.004; Xia N, 2013, NITRIC OXIDE-BIOL CH, V32, P29, DOI 10.1016/j.niox.2013.04.001; Xiao WB, 2014, IMMUNOBIOLOGY, V219, P836, DOI 10.1016/j.imbio.2014.07.014	51	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22555	10.1096/fj.202101621R	http://dx.doi.org/10.1096/fj.202101621R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1RR	36125010				2022-12-26	WOS:000857904200001
J	Leitgeb, U; Furtmueller, PG; Hofbauer, S; Brito, JA; Obinger, C; Pfanzagl, V				Leitgeb, Urban; Furtmueller, Paul G.; Hofbauer, Stefan; Brito, Jose A.; Obinger, Christian; Pfanzagl, Vera			The staphylococcal inhibitory protein SPIN binds to human myeloperoxidase with picomolar affinity but only dampens halide oxidation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-MECHANISMS; REDOX PROPERTIES; NEUTROPHILS; TARGET; THERMODYNAMICS; VISUALIZATION; REFINEMENT; SIMILARITY; AUTOPROC; CHLORIDE	The heme enzyme myeloperoxidase (MPO) is one of the key players in the neutrophil-mediated killing of invading patho-gens as part of the innate immune system. MPO generates antimicrobial oxidants, which indiscriminately and effectively kill phagocytosed pathogens. Staphylococcus aureus, however, is able to escape this fate, in part by secreting a small protein called SPIN (Staphylococcal Peroxidase Inhibitor), which spe-cifically targets and inhibits MPO in a structurally complex manner. Here, we present the first crystal structures of the complex of SPIN-aureus and a truncated version (SPIN-trun-cated) with mature dimeric leukocyte MPO. We unravel the contributions of the two domains to the kinetics and thermo-dynamics of SPIN-aureus binding to MPO by using a broad array of complementary biochemical and biophysical methods. The C-terminal "recognition" domain is shown to mediate specific binding to MPO, while interaction of the N-terminal "inhibitory" domain is guided mainly by hydrophobic effects and thus is less sequence dependent. We found that inhibition of MPO is achieved by reducing substrate migration, but SPIN-aureus cannot completely block MPO activity. Its' effectiveness is inversely related to substrate size, with no discernible dependence on other factors. Thus, SPIN-aureus is an extremely high-affinity inhibitor and highly efficient for sub-strates larger than halogens. As aberrant MPO activity is implicated in a number of chronic inflammatory diseases, SPIN-aureus is the first promising protein inhibitor for specific inhibition of human MPO.	[Leitgeb, Urban; Furtmueller, Paul G.; Hofbauer, Stefan; Obinger, Christian; Pfanzagl, Vera] Univ Nat Resources & Life Sci, Inst Biochem, Dept Chem, Vienna, Austria; [Brito, Jose A.] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal	University of Natural Resources & Life Sciences, Vienna; Universidade Nova de Lisboa	Pfanzagl, V (corresponding author), Univ Nat Resources & Life Sci, Inst Biochem, Dept Chem, Vienna, Austria.	vera.pfanzagl@boku.ac.at	; Hofbauer, Stefan/I-3889-2014	Brito, Jose A./0000-0002-8307-2282; Hofbauer, Stefan/0000-0003-3375-7715; Pfanzagl, Vera/0000-0002-9361-8365	FWF Project;  [P33997]	FWF Project(Austrian Science Fund (FWF)); 	The study was funded by the FWF Project P33997.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnhold J, 2003, REDOX REP, V8, P179, DOI 10.1179/135100003225002664; Arnhold J, 2006, EUR J INORG CHEM, P3801, DOI 10.1002/ejic.200600436; Banerjee S, 2011, BBA-PROTEINS PROTEOM, V1814, P375, DOI 10.1016/j.bbapap.2010.09.015; Battistuzzi G, 2006, BIOCHEMISTRY-US, V45, P12750, DOI 10.1021/bi061647k; Binz AK, 2003, BIOCHEMISTRY-US, V42, P4954, DOI 10.1021/bi034077m; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bricogne G., 2017, BUSTER VERSION 2 10; Burner U, 2000, J BIOL CHEM, V275, P20597, DOI 10.1074/jbc.M000181200; Carpena X, 2009, J BIOL CHEM, V284, P25929, DOI 10.1074/jbc.M109.002154; Chojnowski G, 2020, ACTA CRYSTALLOGR D, V76, P248, DOI 10.1107/S2059798320000455; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; de Jong NWM, 2018, J BIOL CHEM, V293, P2260, DOI 10.1074/jbc.RA117.000134; de Jong NWM, 2017, P NATL ACAD SCI USA, V114, P9439, DOI 10.1073/pnas.1707032114; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110085; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Furtmuller PG, 2006, ARCH BIOCHEM BIOPHYS, V445, P199, DOI 10.1016/j.abb.2005.09.017; Furtmuller PG, 2003, BIOCHEM BIOPH RES CO, V301, P551, DOI 10.1016/S0006-291X(02)03075-9; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Galijasevic S, 2019, BIOORG MED CHEM LETT, V29, P1, DOI 10.1016/j.bmcl.2018.11.031; Garai D, 2017, FREE RADICAL BIO MED, V113, P551, DOI 10.1016/j.freeradbiomed.2017.10.384; Gau J, 2016, FREE RADICAL BIO MED, V97, P307, DOI 10.1016/j.freeradbiomed.2016.06.026; GREEN NM, 1963, BIOCHEM J, V89, P599, DOI 10.1042/bj0890599; Grishkovskaya I, 2017, J BIOL CHEM, V292, P8244, DOI 10.1074/jbc.M117.775031; Ishigami I, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101799; JANIN J, 1995, BIOCHIMIE, V77, P497, DOI 10.1016/0300-9084(96)88166-1; Joosten RP, 2012, ACTA CRYSTALLOGR D, V68, P484, DOI 10.1107/S0907444911054515; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lazarevic-Pasti T, 2015, CURR DRUG METAB, V16, P168, DOI 10.2174/138920021603150812120640; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2014, NAT IMMUNOL, V15, P602, DOI 10.1038/ni.2921; Pace CN, 2011, J MOL BIOL, V408, P514, DOI 10.1016/j.jmb.2011.02.053; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfanzagl V, 2020, J BIOL CHEM, V295, P13488, DOI 10.1074/jbc.RA120.014087; Ploscariu NT, 2018, ARCH BIOCHEM BIOPHYS, V645, P1, DOI 10.1016/j.abb.2018.03.007; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Senthilmohan R, 2006, ARCH BIOCHEM BIOPHYS, V445, P235, DOI 10.1016/j.abb.2005.07.005; Smart O. S., 2021, GRADE VERSION 1 2 20; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Soubhye J, 2021, HANDB EXP PHARMACOL, V264, P261, DOI 10.1007/164_2020_388; Soubhye J, 2020, EXPERT OPIN THER PAT, V30, P595, DOI 10.1080/13543776.2020.1780210; Soubhye J, 2016, CURR MED CHEM, V23, P3975, DOI 10.2174/0929867323666160607111806; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Vagin A, 2015, ACTA CRYSTALLOGR A, V71, pS19, DOI 10.1107/S2053273315099672; Van Antwerpen P, 2010, J BIOL CHEM, V285, P16351, DOI 10.1074/jbc.M109.089748; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Vonrhein C, 2018, ACTA CRYSTALLOGR A, V74, pA360, DOI 10.1107/S010876731809640X; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442	68	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102514	10.1016/j.jbc.2022.102514	http://dx.doi.org/10.1016/j.jbc.2022.102514			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36150500	gold, Green Published			2022-12-26	WOS:000886086000010
J	Liu, CH; Zhang, W; Xu, GZ; Zhang, DL; Zhang, C; Qiao, S; Wang, ZM; Wang, HM				Liu, Chunhua; Zhang, Wei; Xu, Guozheng; Zhang, Daolai; Zhang, Cheng; Qiao, Sen; Wang, Zhimei; Wang, Hongmei			Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas' disease progression	FASEB JOURNAL			English	Article						gliomas; inflammation; lipid metabolism; menopause; neurotransmitters; ovariectomy	GLIOBLASTOMA; CELLS; PROLIFERATION; ACTIVATION; MANAGEMENT; PROGNOSIS; AUTOPHAGY; THERAPY; JNK	The risk of high-grade gliomas is lower in young females, however, its incidence enhances after menopause, suggesting potential protective roles of female sex hormones. Hormone oscillations after menopause have received attention as a possible risk factor. Little is known about risk factors for adult gliomas. We examined the association of the aging brain after menopause, determining the risk of gliomas with proteomics and the MALDI-MSI experiment. Menopause caused low neurotransmitter levels such as GABA and ACH, high inflammatory factor levels like il-1 beta, and increased lipid metabolism-related levels like triglycerides in the brain. Upregulated and downregulated proteins after menopause were correlated with differentially expressed glioma genes, such as ACTA2, CAMK2D, FNBPIL, ARL1, HEBP1, CAST, CLIC1, LPCAT4, MAST3, and DOCK9. Furthermore, differential gene expression analysis of monocytes showed that the downregulated gene LPCAT4 could be used as a marker to prevent menopausal gliomas in women. Our findings regarding the association of menopause with the risk of gliomas are consistent with several extensive cohort studies. In view of the available evidence, postmenopausal status is likely to represent a significant risk factor for gliomas.	[Liu, Chunhua; Xu, Guozheng] Shandong First Med Univ, Dept Physiol & Neurobiol, Jinan, Peoples R China; [Zhang, Wei; Wang, Hongmei] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China; [Zhang, Daolai; Zhang, Cheng; Wang, Hongmei] Binzhou Med Univ, Sch Pharm, Yantai, Peoples R China; [Qiao, Sen] Saarland Univ, Ctr Mol Signaling PZMS, Sch Med, Pharmacol & Toxicol, Homburg, Germany; [Wang, Zhimei] Southeast Univ, Jiangsu Prov Hi Tech Key Lab Biomed Res, Nanjing 211189, Peoples R China; [Wang, Zhimei] Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Southeast University - China; Binzhou Medical University; Universitatsklinikum des Saarlandes; Southeast University - China; Southeast University - China	Wang, HM (corresponding author), Southeast Univ, Sch Med, Nanjing 210009, Peoples R China.; Wang, ZM (corresponding author), Southeast Univ, Jiangsu Prov Hi Tech Key Lab Biomed Res, Nanjing 211189, Peoples R China.; Wang, ZM (corresponding author), Southeast Univ, Sch Chem & Chem Engn, Nanjing 211189, Peoples R China.	wangzm@seu.edu.cn; 101012573@seu.edu.cn	wang, hongmei/HGT-7374-2022	wang, hongmei/0000-0002-6975-9467	National Natural Science Foundation of China (NSFC) [81602327]; Shandong First Medical University (SFMU) [2019QL009]; zhishan scholars program [2242021R41070]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shandong First Medical University (SFMU); zhishan scholars program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81602327; Shandong First Medical University (SFMU), Grant/Award Number: 2019QL009; zhishan scholars program, Grant/Award Number: 2242021R41070	Ahmadzai P, 2018, NEUROLOGY, V90, pE1588, DOI 10.1212/WNL.0000000000005459; Belkhiri A, 2016, ONCOTARGET, V7, P17631, DOI 10.18632/oncotarget.7268; Blinkouskaya Y, 2021, MECH AGEING DEV, V200, DOI 10.1016/j.mad.2021.111575; Brinton RD, 2015, NAT REV ENDOCRINOL, V11, P393, DOI 10.1038/nrendo.2015.82; Castro MG, 2011, CURR GENE THER, V11, P155; Chen XR, 2020, THERANOSTICS, V10, P998, DOI 10.7150/thno.40076; de Pablos RM, 2019, PHARMACOL RES, V143, P58, DOI 10.1016/j.phrs.2019.03.005; Deli T, 2020, PATHOL ONCOL RES, V26, P63, DOI 10.1007/s12253-018-00569-x; Ding F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079977; Ding J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26310-y; Dono Antonio, 2020, CNS Oncol, V9, pCNS57, DOI 10.2217/cns-2020-0007; Edwards H, 2019, MENOPAUSE, V26, P45, DOI 10.1097/GME.0000000000001171; Elmaci I, 2019, CLIN NEUROL NEUROSUR, V177, P77, DOI 10.1016/j.clineuro.2018.12.022; Falkenstetter S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00155; Fang C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050756; Ferioli M, 2019, J CELL PHYSIOL, V234, P14852, DOI 10.1002/jcp.28304; Gava G, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100668; Gelosa P, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/3454212; Grebien F, 2015, NAT CHEM BIOL, V11, P571, DOI [10.1038/nchembio.1859, 10.1038/NCHEMBIO.1859]; Guo YJ, 2019, CELL RES, V29, P151, DOI 10.1038/s41422-018-0123-6; Hajj GNM, 2020, MOL ONCOL, V14, P159, DOI 10.1002/1878-0261.12595; Hamadi A, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-42; Hara Y, 2015, PHYSIOL REV, V95, P785, DOI 10.1152/physrev.00036.2014; He LM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.652512; Huang D, 2020, ONCOTARGETS THER, V13, P10525, DOI 10.2147/OTT.S234773; Jabeen S, 2020, J COMPUT ASSIST TOMO, V44, P692, DOI 10.1097/RCT.0000000000001080; Jia G, 2018, BIOMATERIALS, V178, P302, DOI 10.1016/j.biomaterials.2018.06.029; Katsushima K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13616; Khayum MA, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2020.104610; Kim YW, 2013, NEURO-ONCOLOGY, V15, P829, DOI 10.1093/neuonc/not024; Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113; Li MJ, 2012, CHEM-EUR J, V18, P8724, DOI 10.1002/chem.201103025; Liao JF, 2021, MOL NEUROBIOL, DOI 10.1007/s12035-021-02427-5; Liu W, 2020, ONCOTARGETS THER, V13, P2275, DOI 10.2147/OTT.S243953; Liu ZY, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20170168; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Maki PM, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.562275; Masui K, 2019, NEUROPATHOLOGY, V39, P3, DOI 10.1111/neup.12535; Mosconi L, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90084-y; Patil V, 2020, PEERJ, V8, DOI 10.7717/peerj.9755; Pei Z, 2020, BIOCHEM PHARMACOL, V176, DOI 10.1016/j.bcp.2020.113814; Phillips NA, 2021, MENOPAUSE, V28, P109, DOI 10.1097/GME.0000000000001714; Qu F, 2020, AUTOPHAGY, V16, P1413, DOI 10.1080/15548627.2019.1687210; Quinn MA, 2018, CELL REP, V22, P2690, DOI 10.1016/j.celrep.2018.02.041; Roldan-Valadez E, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150502; Romoli M, 2019, ANN CLIN TRANSL NEUR, V6, P2261, DOI 10.1002/acn3.50919; Santoro N, 2021, J CLIN ENDOCR METAB, V106, P1, DOI 10.1210/clinem/dgaa764; Than S, 2021, J CLIN ENDOCR METAB, V106, P410, DOI 10.1210/clinem/dgaa847; Wang Hao, 2018, Zhejiang Da Xue Xue Bao Yi Xue Ban, V47, P19; Watts NB, 2021, ENDOCR PRACT, V27, P379, DOI 10.1016/j.eprac.2021.02.001; Xian D, 2019, J CELL MOL MED, V23, P3808, DOI 10.1111/jcmm.14071; Xu SC, 2020, CANCER LETT, V476, P1, DOI 10.1016/j.canlet.2020.02.002; Zhang GQ, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003731; Zhang LD, 2019, MOL CANCER THER, V18, P173, DOI 10.1158/1535-7163.MCT-17-0782; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhu C, 2020, ONCOTARGETS THER, V13, P1129, DOI 10.2147/OTT.S237162; Zhu DS, 2019, LANCET PUBLIC HEALTH, V4, pE553, DOI 10.1016/S2468-2667(19)30155-0	57	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22570	10.1096/fj.202200427RR	http://dx.doi.org/10.1096/fj.202200427RR			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4X4ZW	36165217				2022-12-26	WOS:000860853200003
J	Zhang, SJ; Li, R; Ma, YR; Yan, Y; Ma, M; Zhang, KQ; Zhou, Y; Li, L; Pan, LL; Ying, H; Xue, Y				Zhang, Shengjie; Li, Ran; Ma, Yiruo; Yan, Ying; Ma, Mei; Zhang, Keqin; Zhou, Yun; Li, Ling; Pan, Lingling; Ying, Hao; Xue, Ying			Thyroid-stimulating hormone regulates cardiac function through modulating HCN2 via targeting microRNA-1a	FASEB JOURNAL			English	Article						cardiac dysfunction; hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2); hypothyroid heart disease; microRNA-1a; thyroid-stimulating hormone (TSH)	MESSENGER-RNA; SUBCLINICAL HYPOTHYROIDISM; HEART-DISEASE; I-F; EXPRESSION; CHANNELS; ALPHA; RATS	Previous studies have found microRNA-1 (miR-1) and hyperpolarization-activated cyclic nucleotide-gated channel 2 (HCN2) may be involved in the pathogenesis of thyroid hormone (TH) induced cardiac hypertrophy. However, little is known about the role of miR-1 and HCN2 in thyroid stimulation hormone (TSH)-induced cardiac dysfunction. In order to investigate the molecular mechanisms of TSH induced cardiac dysfunction and the role of miR-1/HCN2 in that process, we evaluated the expression of miR-1a/HCN2 in the ventricular myocardium of hypothyroid mice and in TSH-stimulated H9c2 cardiomyocytes. Our data revealed that hypothyroidism mice had smaller hearts, ventricular muscle atrophy, and cardiac contractile dysfunction compared with euthyroid controls. The upregulation of miR-1a and downregulation of HCN2 were found in ventricular myocardium of hypothyroid mice and TSH-stimulated H9c2 cardiomyocytes, indicating that miR-1a and HCN2 may be involved in TSH-induced cardiac dysfunction. We also found that the regulation of miR-1a and HCN2 expression and HCN2 channel activity by TSH requires TSHR, while the regulation of HCN2 expression and HCN2 channel function by TSH requires miR-1a. Thus, our data revealed the potential mechanism of TSH-induced cardiac dysfunction and might shed new light on the pathological role of miR-1a/HCN2 in hypothyroid heart disease.	[Zhang, Shengjie; Li, Ran; Zhang, Keqin; Zhou, Yun; Li, Ling; Pan, Lingling; Xue, Ying] Tongji Univ, Tongji Hosp, Dept Endocrinol & Metab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China; [Zhang, Shengjie; Ma, Yiruo; Yan, Ying; Ma, Mei; Ying, Hao] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Univ Chinese Acad Sci, Shanghai, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS	Xue, Y (corresponding author), Tongji Univ, Tongji Hosp, Dept Endocrinol & Metab, Sch Med, 389 Xincun Rd, Shanghai 200065, Peoples R China.	xy2007@alumni.sjtu.edu.cn			Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC) [81974105, 81670805, 81700743]; Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program [2019PJD050]	Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program(Shanghai Pujiang Program)	Cultivation project for National Natural Science Foundation of Shanghai Tongji Hospital; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81974105, 81670805 and 81700743; Novo Nordisk China Diabetes Young Scientific Talent Research Funding; Shanghai Pujiang Program, Grant/Award Number: 2019PJD050	Chen S, 2014, EUR J HEART FAIL, V16, P217, DOI 10.1002/ejhf.42; Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015; Diniz GP, 2017, J CELL PHYSIOL, V232, P3360, DOI 10.1002/jcp.25781; Diniz GP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0504-7; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Duan L, 2014, MOL BIOSYST, V10, P2775, DOI 10.1039/c4mb00338a; Fernandez-Ruocco J, 2019, THYROID, V29, P934, DOI 10.1089/thy.2018.0709; Fernandez-Velasco M, 2003, J PHYSIOL-LONDON, V553, P395, DOI 10.1113/jphysiol.2003.041954; Gassanov N, 2009, PFLUG ARCH EUR J PHY, V458, P1061, DOI 10.1007/s00424-009-0691-x; Gloss B, 2001, ENDOCRINOLOGY, V142, P544, DOI 10.1210/en.142.2.544; Gorski PA, 2015, CELL METAB, V21, P183, DOI 10.1016/j.cmet.2015.01.005; GREEN NK, 1989, J ENDOCRINOL, V122, P193, DOI 10.1677/joe.0.1220193; He W, 2016, EXP THER MED, V12, P433, DOI 10.3892/etm.2016.3290; Herrmann S, 2007, PFLUG ARCH EUR J PHY, V454, P517, DOI 10.1007/s00424-007-0224-4; Huang WQ, 2011, CARDIOVASC PATHOL, V20, P110, DOI 10.1016/j.carpath.2010.01.007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Jabbar A, 2017, NAT REV CARDIOL, V14, P39, DOI 10.1038/nrcardio.2016.174; Karakikes I, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000078; Klee GG, 1997, ENDOCRIN METAB CLIN, V26, P763, DOI 10.1016/S0889-8529(05)70281-4; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Kleinau G, 2013, ENDOCR REV, V34, P691, DOI 10.1210/er.2012-1072; Leone V, 2011, MOL ENDOCRINOL, V25, P1819, DOI 10.1210/me.2011-0014; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Lin HX, 2009, CELL PHYSIOL BIOCHEM, V23, P317, DOI 10.1159/000218178; Ludwig A, 1999, EMBO J, V18, P2323, DOI 10.1093/emboj/18.9.2323; Martinez-Quintana E, 2013, PEDIATR CARDIOL, V34, P912, DOI 10.1007/s00246-012-0571-6; Michels G, 2008, CARDIOVASC RES, V78, P466, DOI 10.1093/cvr/cvn032; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Pachucki J, 1999, CIRC RES, V85, P498, DOI 10.1161/01.RES.85.6.498; Riesen SC, 2013, SCHWEIZ ARCH TIERH, V155, P143, DOI 10.1024/0036-7281/a000431; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Song T, 2011, MOL MED REP, V4, P569, DOI 10.3892/mmr.2011.455; Suffredini S, 2012, BRIT J PHARMACOL, V165, P1457, DOI 10.1111/j.1476-5381.2011.01627.x; Taylor PN, 2018, NAT REV ENDOCRINOL, V14, P301, DOI 10.1038/nrendo.2018.18; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Wang F, 2017, ENDOCRINE, V57, P125, DOI 10.1007/s12020-017-1331-4; Xia S, 2010, BIOCHEM BIOPH RES CO, V395, P330, DOI 10.1016/j.bbrc.2010.04.003; Yao X, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-38; Yu X, 2004, P NATL ACAD SCI USA, V101, P1051, DOI 10.1073/pnas.0305167101; Yu X, 2007, AM J PHYSIOL-CELL PH, V292, pC1147, DOI 10.1152/ajpcell.00598.2005; Zicha S, 2005, CARDIOVASC RES, V66, P472, DOI 10.1016/j.cardiores.2005.02.011	42	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22561	10.1096/fj.202200574R	http://dx.doi.org/10.1096/fj.202200574R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T1SK	36125044				2022-12-26	WOS:000857906100001
J	Dai, L; Mugaanyi, J; Zhang, TY; Tong, JS; Cai, XC; Lu, CD; Lu, CJ				Dai, Lei; Mugaanyi, Joseph; Zhang, Tongyue; Tong, Jingshu; Cai, Xingchen; Lu, Caide; Lu, Changjiang			A pan-cancer bioinformatic analysis of the carcinogenic role of SMARCA1 in human carcinomas	PLOS ONE			English	Article							GENE-EXPRESSION; NETWORKS; PLATFORM; REVEALS; ATPASE; DOMAIN	SMARCA1is a mammalian imitation switch (ISWI) gene that encodes for SNF2L. SNF2L is involved in regulating cell transition from a committed progenitor state to a differentiated state. Although many papers have detailed the correlation between SMARCA1 and different cancers, no pan-cancer analysis has been conducted to date. We started by exploring the potential carcinogenic role of SMARCA1 across 33 carcinomas using the cancer genome atlas (TCGA) and the genotype-tissue expression (GTEx) databases. The expression of SMARCA1 was significantly elevated in some tumor types but not in others. There was a distinct relationship between SMARCA1 expression and patient prognosis. S116 phosphorylation levels were up-regulated in both lung adenocarcinoma and uterine corpus endometrial carcinoma. The expression level of SMARCA1 was positively correlated with cancerassociated fibroblasts infiltration in a number of tumors, such as colon adenocarcinoma, cervical squamous cell carcinoma and endocervical adenocarcinoma. It was also associated with CD8+ T-cell infiltration in head and neck squamous cell carcinoma and lung adenocarcinoma. Furthermore, SMARCA1 is involved in chromatin remodeling and protein processing-associated mechanisms. Our study presents an initial assessment and illustration of the carcinogenic role of SMARCA1 in different carcinomas.	[Dai, Lei; Mugaanyi, Joseph; Tong, Jingshu; Cai, Xingchen; Lu, Caide; Lu, Changjiang] Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Dept Hepatopancreatobiliary Surg, Ningbo, Zhejiang, Peoples R China; [Zhang, Tongyue] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China	Ningbo University; Huazhong University of Science & Technology	Lu, CD; Lu, CJ (corresponding author), Ningbo Univ, Lihuili Hosp, Ningbo Med Ctr, Dept Hepatopancreatobiliary Surg, Ningbo, Zhejiang, Peoples R China.	lucaide@nbu.edu.cn; yangtze21@sina.com	Mugaanyi, Joseph/HHZ-1402-2022; Dai, Lei/GXF-3979-2022	Mugaanyi, Joseph/0000-0003-1688-5475; Dai, Lei/0000-0001-5742-1963; /0000-0002-9374-7546	Ningbo Health Branding Subject Fund [PPXK2018-03]	Ningbo Health Branding Subject Fund	This study was supported by Ningbo Health Branding Subject Fund (PPXK2018-03).	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; [Anonymous], 2018, Am J Med Genet A, V176, P263, DOI 10.1002/ajmg.a.38426; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Blum A, 2018, CELL, V173, P530, DOI 10.1016/j.cell.2018.03.059; Bonneville R, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.17.00073; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chan BKC, 2018, ADV EXP MED BIOL, V1082, P47, DOI 10.1007/978-3-319-93791-5_2; Chan TA, 2019, ANN ONCOL, V30, P44, DOI 10.1093/annonc/mdy495; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chang LS, 2018, APPL IMMUNOHISTO M M, V26, pE15, DOI 10.1097/PAI.0000000000000575; Chen FJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13528-0; Chen XM, 2019, NAT REV DRUG DISCOV, V18, P99, DOI 10.1038/s41573-018-0004-1; Chetty R, 2020, J CLIN PATHOL, V73, P257, DOI 10.1136/jclinpath-2020-206451; Ding LX, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1006-2; Eberharter A, 2004, J CELL SCI, V117, P3707, DOI 10.1242/jcs.01175; Euskirchen G, 2012, J BIOL CHEM, V287, P30897, DOI 10.1074/jbc.R111.309302; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giles KA, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0258-9; Goodwin LR, 2018, MOL CELL NEUROSCI, V87, P55, DOI 10.1016/j.mcn.2017.10.008; Haeussler M, 2019, NUCLEIC ACIDS RES, V47, pD853, DOI 10.1093/nar/gky1095; Homann OR, 2016, MOL PSYCHIATR, V21, P1690, DOI 10.1038/mp.2016.24; Hota SK, 2013, NAT STRUCT MOL BIOL, V20, P222, DOI 10.1038/nsmb.2486; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2021, NUCLEIC ACIDS RES, V49, pD545, DOI 10.1093/nar/gkaa970; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kikuchi T, 2020, CANCER IMMUNOL IMMUN, V69, P23, DOI 10.1007/s00262-019-02433-6; Koch A, 2019, NUCLEIC ACIDS RES, V47, pW561, DOI 10.1093/nar/gkz445; Kwa MQ, 2019, CLIN EXP METASTAS, V36, P71, DOI 10.1007/s10585-019-09959-0; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li TW, 2020, NUCLEIC ACIDS RES, V48, pW509, DOI 10.1093/nar/gkaa407; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Liu TY, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0873-2; Lopes F, 2016, J MED GENET, V53, P190, DOI 10.1136/jmedgenet-2015-103568; Maurer A, 2020, VIRCHOWS ARCH, V477, P445, DOI 10.1007/s00428-020-02787-8; Metzakopian E, 2015, DEVELOPMENT, V142, P1315, DOI 10.1242/dev.115808; Miyai Y, 2020, CANCER SCI, V111, P1047, DOI 10.1111/cas.14346; Mueller-Planitz F, 2013, NAT STRUCT MOL BIOL, V20, P82, DOI 10.1038/nsmb.2457; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Neely KE, 2002, BBA-REV CANCER, V1603, P19, DOI 10.1016/S0304-419X(02)00067-7; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Patil Pallavi A, 2018, J Cytol Histol, V9, DOI 10.4172/2157-7099.1000524; Qiao ZW, 2017, ONCOTARGET, V8, P109587, DOI 10.18632/oncotarget.22730; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Shim S, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017047; Steven A, 2018, BREAST CARE, V13, P16, DOI 10.1159/000486585; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Unberath P, 2019, STUD HEALTH TECHNOL, V258, P46, DOI 10.3233/978-1-61499-959-1-46; Ye Y, 2009, MOL CANCER RES, V7, P1984, DOI 10.1158/1541-7786.MCR-09-0119; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Zhang Chao, 2017, F1000Res, V6, DOI 10.12688/f1000research.12168.1; Zhang Z, 2019, BRIEF BIOINFORM, V20, P1524, DOI 10.1093/bib/bby023; Zheng BX, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.876	60	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2022	17	9							e0274823	10.1371/journal.pone.0274823	http://dx.doi.org/10.1371/journal.pone.0274823			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6N4BG	36126083	Green Published, gold			2022-12-26	WOS:000889502800001
J	Gao, YF; Jiang, M; Guo, FQ; Liu, XJ; Zhang, Q; Yang, S; Yeung, YT; Yang, R; Wang, KK; Wu, Q; Zhang, DD; Zhang, CJ; Laster, KV; Ge, MM; Nie, WN; Liu, KD; Dong, ZG				Gao, Yunfeng; Jiang, Ming; Guo, Fangqin; Liu, Xuejiao; Zhang, Qi; Yang, Sen; Yeung, Yiu To; Yang, Ran; Wang, Keke; Wu, Qiong; Zhang, Dandan; Zhang, Chengjuan; Laster, Kyle Vaughn; Ge, Mengmeng; Nie, Wenna; Liu, Kangdong; Dong, Zigang			A novel lncRNA MTAR1 promotes cancer development through IGF2BPs mediated post-transcriptional regulation of c-MYC	ONCOGENE			English	Article							MESSENGER-RNA STABILITY; LIQUID PHASE-SEPARATION; LONG NONCODING RNA; ONCOGENE; CONTRIBUTES; GROWTH	Abnormal translation of the MYC proto-oncogene is a hallmark of the initiation and maintenance of tumorigenesis. However, the molecular mechanism underlying increased MYC protein levels in certain cancer types without a corresponding increase in MYC mRNA levels is unclear. Here, we identified a novel lncRNA, MTAR1, which is critical for post-transcriptional regulation of MYC-induced tumorigenesis. MTAR1 is essential for recruiting IGF2BPs into PABP1-mediated liquid-liquid phase separation (LLPS) complexes and facilitates IGF2BPs-mediated MYC mRNA translation. MTAR1 enhanced binding between IGF2BPs and PABP1, thereby promoting MYC mRNA stability and increased MYC mRNA translation. In summary, MTAR1 is a novel MYC-related lncRNA that contributes to tumor progression by enhancing MYC translation through mediating PABP1/IGF2BPs liquid-liquid phase separation.	[Gao, Yunfeng; Jiang, Ming; Guo, Fangqin; Liu, Xuejiao; Zhang, Qi; Yang, Sen; Yang, Ran; Wang, Keke; Wu, Qiong; Zhang, Dandan; Laster, Kyle Vaughn; Ge, Mengmeng; Nie, Wenna; Liu, Kangdong; Dong, Zigang] China US Henan Hormel Canc Inst, Zhengzhou 450000, Peoples R China; [Liu, Xuejiao; Wu, Qiong; Liu, Kangdong; Dong, Zigang] Zhengzhou Univ, Sch Basic Med Sci, Pathophysiol Dept, AMS, Zhengzhou 450000, Peoples R China; [Yeung, Yiu To] Univ Edinburgh, Ctr Reprod Hlth, Queens Med Res Inst, Med Res Council MRC, Edinburgh EH16 4TJ, Midlothian, Scotland; [Zhang, Chengjuan] Henan Canc Hosp, Dept Mol Pathol Cent Biorepository, Zhengzhou 450000, Peoples R China; [Liu, Kangdong; Dong, Zigang] Canc Chemoprevent Int Collaborat Lab, Zhengzhou 450000, Peoples R China; [Liu, Kangdong; Dong, Zigang] State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450000, Peoples R China	Zhengzhou University; University of Edinburgh; Zhengzhou University	Liu, KD; Dong, ZG (corresponding author), China US Henan Hormel Canc Inst, Zhengzhou 450000, Peoples R China.; Liu, KD; Dong, ZG (corresponding author), Zhengzhou Univ, Sch Basic Med Sci, Pathophysiol Dept, AMS, Zhengzhou 450000, Peoples R China.; Liu, KD; Dong, ZG (corresponding author), Canc Chemoprevent Int Collaborat Lab, Zhengzhou 450000, Peoples R China.; Liu, KD; Dong, ZG (corresponding author), State Key Lab Esophageal Canc Prevent & Treatment, Zhengzhou 450000, Peoples R China.	kdliu@hci-cn.org; zgdong@hci-cn.org	Jiang, Ming/GSE-4312-2022	Jiang, Ming/0000-0001-6794-3116	National Natural Science Foundations of China [81872335, 81802875, 81972639]; Project of Science and Technology of the Henan Province for Tackling Key Problems [182102310128]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of the Henan Province for Tackling Key Problems	This research is supported by the National Natural Science Foundations of China (No. 81802876), the Project of Science and Technology of the Henan Province for Tackling Key Problems (182102310128) and the National Natural Science Foundations of China (Nos. 81872335, 81802875, 81972639).	Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Bachireddy P, 2012, CLIN EXP IMMUNOL, V167, P188, DOI 10.1111/j.1365-2249.2011.04514.x; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Bolha L, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/7243968; Borzi C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2003-5; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Bridges MC, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202009045; Cai DF, 2019, NAT CELL BIOL, V21, P1578, DOI 10.1038/s41556-019-0433-z; Cao JG, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/4217259; Casey SC, 2018, BLOOD, V131, P2007, DOI 10.1182/blood-2017-11-742577; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Emst C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00168; Esposito M, 2021, NAT CELL BIOL, V23, P257, DOI 10.1038/s41556-021-00641-w; Fox AH, 2018, TRENDS BIOCHEM SCI, V43, P124, DOI 10.1016/j.tibs.2017.12.001; Gabay M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014241; Guo CJ, 2020, CELL, V181, P621, DOI 10.1016/j.cell.2020.03.006; Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z; Hunecke D, 2012, J PATHOL, V228, P520, DOI 10.1002/path.4059; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Lian Y, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317715804; Liu Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102621; Lu Y, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0485-0; Marderosian M, 2006, ONCOGENE, V25, P6277, DOI 10.1038/sj.onc.1209645; MEICHLE A, 1992, BIOCHIM BIOPHYS ACTA, V1114, P129, DOI 10.1016/0304-419X(92)90011-M; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sauvageau M, 2019, ADV EXP MED BIOL, V1203, P285, DOI 10.1007/978-3-030-31434-7_10; Tsang B, 2020, CELL, V183, P1742, DOI 10.1016/j.cell.2020.11.050; Wang JY, 2018, CANCER LETT, V419, P64, DOI 10.1016/j.canlet.2018.01.051; Yao RW, 2019, NAT CELL BIOL, V21, P542, DOI 10.1038/s41556-019-0311-8; Yu YF, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.2149; Zaslavsky BY, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9090473; Zhang H, 2020, SCI CHINA LIFE SCI, V63, P953, DOI 10.1007/s11427-020-1702-x; Zhang K, 2020, MOL CANCER RES, V18, P612, DOI 10.1158/1541-7786.MCR-19-0805; Zhou HX, 2018, TRENDS BIOCHEM SCI, V43, P499, DOI 10.1016/j.tibs.2018.03.007; Zhou W, 2021, MOL CELL, V81, P739, DOI 10.1016/j.molcel.2021.01.024; ZIMMERMAN K, 1990, Critical Reviews in Oncogenesis, V2, P75	46	0	0	6	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 14	2022	41	42					4736	4753		10.1038/s41388-022-02464-x	http://dx.doi.org/10.1038/s41388-022-02464-x		SEP 2022	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5I4GP	36109629				2022-12-26	WOS:000854052400001
J	Koizumi, M; Kama, Y; Hirano, KI; Endo, Y; Tanaka, T; Hozumi, K; Hosokawa, H				Koizumi, Maria; Kama, Yuichi; Hirano, Ken-ichi; Endo, Yusuke; Tanaka, Tomoaki; Hozumi, Katsuto; Hosokawa, Hiroyuki			Transcription factor Zbtb1 interacts with bridging factor Lmo2 and maintains the T-lineage differentiation capacity of lymphoid progenitor cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-LIKE 4; STEM-CELLS; SPECIFICATION; COMPLEX; FATE; COMMITMENT; IDENTIFICATION; PROLIFERATION; EXPRESSION; NETWORK	Hematopoietic stem and progenitor cells can differentiate into all types of blood cells. Regulatory mechanisms underlying pluripotency in progenitors, such as the ability of lymphoid progenitor cells to differentiate into T-lineage, remain unclear. We have previously reported that LIM domain only 2 (Lmo2), a bridging factor in large transcriptional complexes, is essential to retain the ability of lymphoid progenitors to differentiate into T-lineage. However, biochemical characterization of Lmo2 protein complexes in physiological hematopoietic progenitors remains obscure. Here, we identified approximately 600 Lmo2-interacting molecules in a lymphoid progenitor cell line by two-step affinity purification with LC-MS/MS analysis. Zinc finger and BTB domain containing 1 (Zbtb1) and CBFA2/RUNX1 partner transcriptional corepressor 3 (Cbfa2t3) were found to be the functionally important binding partners of Lmo2. We determined CRISPR/Cas9-mediated acute disruption of Zbtb1 or Cbfa2t3 in the lymphoid progenitor or bone marrow- derived primary hematopoietic progenitor cells causes signifi- cant defects in the initiation of T-cell development when Notch signaling is activated. Our transcriptome analysis of Zbtb1- or Cbfa2t3-deficient lymphoid progenitors revealed that Tcf7 was a common target for both factors. Additionally, ChIP-seq analysis showed that Lmo2, Zbtb1, and Cbfa2t3 cobind to the Tcf7 upstream enhancer region, which is occupied by the Notch intracellular domain/RBPJ transcriptional complex after Notch stimulation, in lymphoid progenitors. Moreover, trans-duction with Tcf7 restored the defect in the T-lineage potential of Zbtb1-deficient lymphoid progenitors. Thus, in lymphoid progenitors, the Lmo2/Zbtb1/Cbfa2t3 complex directly binds to the Tcf7 locus and maintains responsiveness to the Notch -mediated inductive signaling to facilitate T-lineage differentiation.	[Koizumi, Maria; Kama, Yuichi; Hirano, Ken-ichi; Hozumi, Katsuto; Hosokawa, Hiroyuki] Tokai Univ, Dept Immunol, Sch Med, Isehara, Kanagawa, Japan; [Endo, Yusuke] Kazusa DNA Res Inst, Lab Med Om Res, Chiba, Japan; [Endo, Yusuke] Chiba Univ, Dept Omics Med, Chiba, Japan; [Tanaka, Tomoaki; Hozumi, Katsuto] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan; [Hosokawa, Hiroyuki] Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan	Tokai University; Kazusa DNA Research Institute; Chiba University; Chiba University; Tokai University	Hosokawa, H (corresponding author), Tokai Univ, Dept Immunol, Sch Med, Isehara, Kanagawa, Japan.; Hosokawa, H (corresponding author), Tokai Univ, Inst Med Sci, Isehara, Kanagawa, Japan.	hosokawa.hiroyuki.g@tokai.ac.jp		Hirano, Ken-ich/0000-0003-3495-610X; Endo, Yusuke/0000-0002-7223-1938; Hosokawa, Hiroyuki/0000-0002-9592-2889; Tanaka, Tomoaki/0000-0002-9761-1750; Kama, Yuichi/0000-0002-9294-9429; MARIA, KOIZUMI/0000-0001-8275-5594; Hozumi, Katsuto/0000-0002-7685-6927	JSPS KAKENHI [JP19H03692, 16K08848, 17H05802, JP20K07330]; Tokai University Tokuda Memorial Cancer/Genome Basic Research Grant for Young Investigators; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation; Yasuda Medical Foundation; Daiichi Sankyo Foundation of Life Science; Research Grant of the Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research; Mitsubishi Foundatio; 2021 Tokai University School of Medicine Research Aid; Cooperative Research Project Program of the Medical Institute of Bioregulation Kyushu University; Research and Study Project of Tokai University General Research Organization	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tokai University Tokuda Memorial Cancer/Genome Basic Research Grant for Young Investigators; Tokyo Biochemical Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yasuda Medical Foundation; Daiichi Sankyo Foundation of Life Science; Research Grant of the Princess Takamatsu Cancer Research Fund; Foundation for Promotion of Cancer Research; Mitsubishi Foundatio; 2021 Tokai University School of Medicine Research Aid; Cooperative Research Project Program of the Medical Institute of Bioregulation Kyushu University; Research and Study Project of Tokai University General Research Organization	This work was supported by grants from the JSPS KAKENHI Grant Number JP19H03692, the Tokai University Tokuda Memorial Cancer/Genome Basic Research Grant for Young Investigators, the Tokyo Biochemical Research Foundation, The Uehara Memorial Foundation, The Naito Foundation, The Takeda Science Foundation, the Yasuda Medical Foundation, the Daiichi Sankyo Foundation of Life Science, the Research Grant of the Princess Takamatsu Cancer Research Fund, the Foundation for Promotion of Cancer Research, and The Mitsubishi Foundation (to H. H.), the 2021 Tokai University School of Medicine Research Aid (to M. K.), the JSPS KAKENHI Grant numbers 16K08848, 17H05802, and JP20K07330 (to K. H.), and the Cooperative Research Project Program of the Medical Institute of Bioregulation Kyushu University (to T. T.). This work was also partly supported by Research and Study Project of Tokai University General Research Organization to H. H.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Batta K, 2014, CELL REP, V9, P1871, DOI 10.1016/j.celrep.2014.11.002; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Cao X, 2016, J IMMUNOL, V197, P1199, DOI 10.4049/jimmunol.1600013; Cheng ZY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.713294; Cubedo E, 2012, BLOOD, V119, P5478, DOI 10.1182/blood-2012-01-403154; Engel ME, 2010, MOL CELL BIOL, V30, P1852, DOI 10.1128/MCB.01342-09; Germar K, 2011, P NATL ACAD SCI USA, V108, P20060, DOI 10.1073/pnas.1110230108; Goardon N, 2006, EMBO J, V25, P357, DOI 10.1038/sj.emboj.7600934; Hammond SM, 2005, LEUKEMIA RES, V29, P89, DOI 10.1016/j.leukres.2004.05.013; Harly C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00470; Harly C, 2019, NAT IMMUNOL, V20, P1150, DOI 10.1038/s41590-019-0445-7; Hirano KI, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.852427; Hirano KI, 2021, ELIFE, V10, DOI 10.7554/eLife.68227; Holmes Roxanne, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5156; Hosokawa H, 2021, J EXP MED, V218, DOI 10.1084/jem.20202648; Hosokawa H, 2021, BIOESSAYS, V43, DOI 10.1002/bies.202000345; Hosokawa H, 2021, NAT REV IMMUNOL, V21, P162, DOI 10.1038/s41577-020-00426-6; Hosokawa H, 2020, J EXP MED, V217, DOI 10.1084/jem.20190972; Hosokawa H, 2018, NAT IMMUNOL, V19, P1427, DOI 10.1038/s41590-018-0238-4; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hosokawa H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11289; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P18626, DOI 10.1073/pnas.1311100110; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Hozumi K, 2008, EUR J IMMUNOL, V38, P977, DOI 10.1002/eji.200737688; Hozumi K, 2020, DEV GROWTH DIFFER, V62, P49, DOI 10.1111/dgd.12641; Hunt A, 2011, MOL CELL BIOL, V31, P2544, DOI 10.1128/MCB.01458-10; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kim H, 2014, MOL CELL, V54, P107, DOI 10.1016/j.molcel.2014.02.017; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Layer JH, 2016, MOL CELL BIOL, V36, P488, DOI 10.1128/MCB.00901-15; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lu Y, 2017, ONCOTARGET, V8, P55877, DOI 10.18632/oncotarget.19645; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Punwani D, 2012, J IMMUNOL, V189, P1253, DOI 10.4049/jimmunol.1200623; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Romero-Wolf M, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202005093; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; Shin B, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019655118; Siggs OM, 2012, J EXP MED, V209, P19, DOI 10.1084/jem.20112084; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; Ungerback J, 2018, GENOME RES, V28, P1508, DOI 10.1101/gr.231423.117; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu Y, 2012, J EXP MED, V209, P2467, DOI 10.1084/jem.20121846; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008	60	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102506	10.1016/j.jbc.2022.102506	http://dx.doi.org/10.1016/j.jbc.2022.102506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36126774	gold, Green Published			2022-12-26	WOS:000882627400001
J	Mohapatra, P; Mohanty, S; Ansari, SA; Shriwas, O; Ghosh, A; Rath, R; Das Majumdar, SK; Swain, RK; Raghav, SK; Dash, R				Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Shriwas, Omprakash; Ghosh, Arup; Rath, Rachna; Das Majumdar, Saroj Kumar; Swain, Rajeeb K.; Raghav, Sunil K.; Dash, Rupesh			CMTM6 attenuates cisplatin-induced cell death in OSCC by regulating AKT/c-Myc-driven ribosome biogenesis	FASEB JOURNAL			English	Article						CMTM6; CX-5461; OSCC; ribosome biogenesis	RNA-POLYMERASE-I; C-MYC; TRANSCRIPTION; ACTIVATION; CARCINOMAS; EXPRESSION; TARGET; GENES; PD-L1	CMTM6, a type 3 transmembrane protein, is known to stabilize the expression of programmed cell death ligand 1 (PD-L1) and hence facilitates the immune evasion of tumor cells. Recently, we demonstrated that CMTM6 is a major driver of cisplatin resistance in oral squamous cell carcinomas (OSCC). However, the detailed mechanism of how CMTM6 rewires cisplatin resistance in OSCC is yet to be explored. RNA sequencing analysis of cisplatin-resistant OSCC lines stably expressing Nt shRNA and CMTM6 shRNA revealed that CMTM6 might be a potential regulator of the ribosome biogenesis network. Knocking down CMTM6 significantly inhibited transcription of 47S precursor rRNA and hindered the nucleolar structure, indicating reduced ribosome biogenesis. When CMTM6 was ectopically over-expressed in CMTM6KD cells, almost all ribosomal machinery components were rescued. Mechanistically, CMTM6 induced the expression of C-Myc, which promotes RNA polymerase I mediated rDNA transcription. In addition to this, CMTM6 was also found to regulate the AKT-mTORC1-dependent ribosome biogenesis and protein synthesis in cisplatin-resistant lines. The nude mice and zebrafish xenograft experiments indicate that blocking ribosome synthesis either by genetic inhibitor (CMTM6KD) or pharmacological inhibitor (CX-5461) significantly restores cisplatin-mediated cell death in chemoresistant OSCC. Overall, our study suggests that CMTM6 is a major regulator of the ribosome biogenesis network and targeting the ribosome biogenesis network is a viable target to overcome chemoresistance in OSCC. The novel combination of CX-5461 and cisplatin deserves further clinical investigation in advanced OSCC.	[Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Shriwas, Omprakash; Ghosh, Arup; Swain, Rajeeb K.; Raghav, Sunil K.; Dash, Rupesh] Inst Life Sci, Canc Biol Unit, Bhubaneswar, India; [Mohapatra, Pallavi; Mohanty, Sibasish; Ansari, Shamima Azma; Raghav, Sunil K.] Reg Ctr Biotechnol, Faridabad, India; [Rath, Rachna] Sriram Chandra Bhanj Dent Coll & Hosp, Cuttack, India; [Das Majumdar, Saroj Kumar] All India Inst Med Sci, Dept Radiotherapy, Bhubaneswar, India; [Raghav, Sunil K.] Manipal Acad Higher Educ, Manipal, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Srirama Chandra Bhanja Medical College & Hospital; All India Institute of Medical Sciences (AIIMS) Bhubaneswar; Manipal Academy of Higher Education (MAHE)	Dash, R (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India.	rupeshdash@ils.res.in			ICMR [5/13/9/2019-NCD-III]; DBT [BT/INF/22/SP28293/2018]	ICMR(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India)	This work is supported by ICMR (5/13/9/2019-NCD-III), Institute of Life Sciences, Bhubaneswar intramural support, and DBT BT/INF/22/SP28293/2018 (for imaging facility).	Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Bywater MJ, 2012, CANCER CELL, V22, P51, DOI 10.1016/j.ccr.2012.05.019; Chaturvedi A, 2020, HEAD NECK PATHOL, V14, P616, DOI 10.1007/s12105-019-01082-6; Cisterna B, 2010, INT REV CEL MOL BIO, V284, P67, DOI 10.1016/S1937-6448(10)84002-X; Cornelison R, 2017, CLIN CANCER RES, V23, P6529, DOI 10.1158/1078-0432.CCR-17-0282; Dai MS, 2008, J CELL BIOCHEM, V105, P670, DOI 10.1002/jcb.21895; DERENZINI M, 1991, VIRCHOWS ARCH B, V61, P1; Devlin JR, 2016, CANCER DISCOV, V6, P59, DOI 10.1158/2159-8290.CD-14-0673; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8; Gomez-Roman N, 2003, NATURE, V421, P290, DOI 10.1038/nature01327; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Huang SH, 2013, MED ORAL PATOL ORAL, V18, pE233, DOI 10.4317/medoral.18772; John LSS, 2000, CANCER GENE THER, V7, P749, DOI 10.1038/sj.cgt.7700166; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Leroy B, 2014, HUM MUTAT, V35, P756, DOI 10.1002/humu.22556; Maji S, 2019, CARCINOGENESIS, V40, P173, DOI 10.1093/carcin/bgy135; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Maji S, 2015, ONCOTARGET, V6, P16623, DOI 10.18632/oncotarget.3932; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mohapatra P, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.143643; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Penzo M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010055; Saeboe-Larssen S, 1998, GENETICS, V148, P1215; Sanderson RJ, 2002, BMJ-BRIT MED J, V325, P822, DOI 10.1136/bmj.325.7368.822; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shriwas O, 2021, BRIT J CANCER, V124, P2004, DOI 10.1038/s41416-021-01336-7; Shriwas O, 2020, APOPTOSIS, V25, P233, DOI 10.1007/s10495-020-01591-8; Teng FY, 2021, CELL MOL LIFE SCI, V78, P6557, DOI 10.1007/s00018-021-03921-8; Vo BT, 2016, CANCER CELL, V29, P5, DOI 10.1016/j.ccell.2015.12.003; YEUDALL WA, 1995, ORAL ONCOL, V31B, P136, DOI 10.1016/0964-1955(94)00030-8; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	36	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22566	10.1096/fj.202200808RR	http://dx.doi.org/10.1096/fj.202200808RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W0NA	36165231				2022-12-26	WOS:000859863200001
J	Soysa, HSM; Kumsaoad, S; Amornloetwattana, R; Watanabe, T; Suginta, W				Soysa, H. Sasimali M.; Kumsaoad, Sawitree; Amornloetwattana, Rawiporn; Watanabe, Takeshi; Suginta, Wipa			Single-channel characterization of the chitooligosaccharide transporter chitoporin (SmChiP) from the opportunistic pathogen Serratia marcescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHITINASE PRODUCTION; SYSTEM; PURIFICATION; (GLCNAC)(2); INFECTIONS; EXPRESSION; BIOFILM; PROTEIN; GENES	Serratia marcescens is an opportunistic pathogen that can utilize chitin as a carbon source, through its ability to produce chitin-degrading enzymes to digest chitin and membrane transporters to transport the degradation products (chitooli-gosaccharides) into the cells. Further characterization of these proteins is important to understand details of chitin meta-bolism. Here, we investigate the properties and function of the S. marcescens chitoporin, namely SmChiP, a chitooligo-saccharide transporter. We show that SmChiP is a monomeric porin that forms a stable channel in artificial phospholipid membranes, with an average single-channel conductance of 0.5 +/- 0.02 nS in 1 M KCl electrolyte. Additionally, we demonstrated that SmChiP allowed the passage of small mol-ecules with a size exclusion limit of <300 Da and exhibited substrate specificity toward chitooligosaccharides, both in membrane and detergent-solubilized forms. We found that SmChiP interacted strongly with chitopentaose (Kd = 23 +/- 2.0 mu M) and chitohexaose (Kd = 17 +/- 0.6 mu M) but did not recognize nonchitose oligosaccharides (maltohexaose and cel-lohexaose). Given that S. marcescens can use chitin as a primary energy source, SmChiP may serve as a target for further development of nutrient-based antimicrobial therapies directed against multidrug antibiotic-resistant S. marcescens infections.	[Soysa, H. Sasimali M.] Suranaree Univ Technol, Inst Sci, Sch Chem, Nakhon Ratchasima, Thailand; [Kumsaoad, Sawitree; Amornloetwattana, Rawiporn; Suginta, Wipa] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand; [Watanabe, Takeshi] Niigata Agrofood Univ, Fac Agrofood Sci, Dept Agrofood Sci, Niigata, Japan; [Soysa, H. Sasimali M.] Sabaragamuwa Univ Sri Lanka, Fac Appl Sci, Dept Phys Sci & Technol, Belihuloya 70140, Sri Lanka	Suranaree University of Technology; Vidyasirimedhi Institute of Science & Technology; Sabaragamuwa University of Sri Lanka	Suginta, W (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand.	wipa.s@vistec.ac.th			Thailand Science Research and Innovation (TSRI); Vidyasir-imedhi Institute of Science and Technology (VISTEC) [BRG610008]; Suranaree University of Technology (SUT) through an OGRG grant	Thailand Science Research and Innovation (TSRI); Vidyasir-imedhi Institute of Science and Technology (VISTEC); Suranaree University of Technology (SUT) through an OGRG grant	This research was funded by Thailand Science Research and Innovation (TSRI) and Vidyasir-imedhi Institute of Science and Technology (VISTEC) (BRG610008) . H. S. M. S. received PhD funding from Suranaree University of Technology (SUT) through an OGRG grant.	Amornloetwattana R, 2020, ACTA CRYSTALLOGR F, V76, P536, DOI [10.1107/S2053230X20013874, 10.1017/S2053230X20013874]; Arakawa Y, 2020, MICROBIOL IMMUNOL, V64, P231, DOI 10.1111/1348-0421.12781; Aronson JD, 1943, J BACTERIOL, V46, P261, DOI 10.1128/JB.46.3.261-267.1943; Aunkham A, 2021, BIOPHYS J, V120, P2124, DOI 10.1016/j.bpj.2021.03.034; Aunkham A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02523-y; Begic S, 2006, MICROBIOL-SGM, V152, P485, DOI 10.1099/mic.0.28428-0; Bes T, 2021, ANN CLIN MICROB ANTI, V20, DOI 10.1186/s12941-021-00464-5; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; COOKSEY RC, 1976, ANTIMICROB AGENTS CH, V10, P123, DOI 10.1128/AAC.10.1.123; Eren E, 2013, J BIOL CHEM, V288, P12042, DOI 10.1074/jbc.M113.463570; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris PNA, 2012, INT J ANTIMICROB AG, V40, P297, DOI 10.1016/j.ijantimicag.2012.06.004; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kawecki D, 2011, TRANSPL P, V43, P2991, DOI 10.1016/j.transproceed.2011.09.002; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; LUCKEY M, 1980, P NATL ACAD SCI-BIOL, V77, P167, DOI 10.1073/pnas.77.1.167; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; MONREAL J, 1969, CAN J MICROBIOL, V15, P689, DOI 10.1139/m69-122; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; NIKAIDO H, 1989, ANTIMICROB AGENTS CH, V33, P1831, DOI 10.1128/AAC.33.11.1831; RABINOWITZ K, 1952, Acta Med Orient, V11, P181; Ray C, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0192-2; Sanchez Laura, 1997, Microbiologia (Madrid), V13, P315; Satpathy S, 2016, BIOCATAL AGR BIOTECH, V7, P56, DOI 10.1016/j.bcab.2016.05.002; Shirshikova TV, 2021, MSPHERE, V6, DOI 10.1128/mSphere.00033-21; Soysa HSM, 2018, PHYS REV E, V97, DOI 10.1103/PhysRevE.97.052417; Soysa HSM, 2017, J BIOL CHEM, V292, P19328, DOI 10.1074/jbc.M117.812321; Soysa HSM, 2020, J BIOL CHEM, V295, P9421, DOI 10.1074/jbc.RA120.012921; Srinivasan R, 2016, J ETHNOPHARMACOL, V193, P592, DOI 10.1016/j.jep.2016.10.017; Stock I, 2003, INT J ANTIMICROB AG, V22, P35, DOI 10.1016/S0924-8579(02)00163-2; Suginta W, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101350; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suzuki K, 2002, BIOSCI BIOTECH BIOCH, V66, P1075, DOI 10.1271/bbb.66.1075; Suzuki K, 1998, BIOSCI BIOTECH BIOCH, V62, P128, DOI 10.1271/bbb.62.128; Suzuki K, 2016, BIOSCI BIOTECH BIOCH, V80, P376, DOI 10.1080/09168451.2015.1083399; Synstad B, 2008, BIOSCI BIOTECH BIOCH, V72, P715, DOI 10.1271/bbb.70594; SZEWZYK U, 1993, J CLIN MICROBIOL, V31, P1826, DOI 10.1128/JCM.31.7.1826-1830.1993; Takanao S, 2014, BIOSCI BIOTECH BIOCH, V78, P524, DOI 10.1080/09168451.2014.882755; TAYYAB S, 1991, BIOCHEM EDUC, V19, P149, DOI 10.1016/0307-4412(91)90060-L; Toratani T, 2008, MICROBIOL-SGM, V154, P1326, DOI 10.1099/mic.0.2007/016246-0; Toratani T, 2012, BIOSCI BIOTECH BIOCH, V76, P1920, DOI 10.1271/bbb.120403; Uchiyama T, 2003, J BACTERIOL, V185, P1776, DOI 10.1128/JB.185.6.1776-1782.2003; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; van der Vorm ER, 2002, J HOSP INFECT, V52, P263, DOI 10.1053/jhin.2002.1313; Voelz A, 2010, INT J HYG ENVIR HEAL, V213, P79, DOI 10.1016/j.ijheh.2009.09.003; Watanabe T, 1997, J BACTERIOL, V179, P7111, DOI 10.1128/jb.179.22.7111-7117.1997; Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237; Yoon HJ, 2005, AM J INFECT CONTROL, V33, P595, DOI 10.1016/j.ajic.2005.01.010	51	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102487	10.1016/j.jbc.2022.102487	http://dx.doi.org/10.1016/j.jbc.2022.102487			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36113582	Green Published, gold			2022-12-26	WOS:000875415100004
J	Xu, J; Chen, P; Yu, CQ; Shi, QQ; Wei, SS; Li, YX; Qi, HZ; Cao, QL; Guo, CL; Wu, XG; Di, GH				Xu, Jing; Chen, Peng; Yu, Chaoqun; Shi, Qiangqiang; Wei, Susu; Li, Yaxin; Qi, Hongzhao; Cao, Qilong; Guo, Chuanlong; Wu, Xianggen; Di, Guohu			Hypoxic bone marrow mesenchymal stromal cells-derived exosomal miR-182-5p promotes liver regeneration via FOXO1-mediated macrophage polarization	FASEB JOURNAL			English	Article						exosomes; hypoxia; liver regeneration; mesenchymal stromal cells; miR-182-5p	EXTRACELLULAR VESICLES; NONPARENCHYMAL CELLS; CARTILAGE REPAIR; PROLIFERATION; INTERLEUKIN-6	Mesenchymal stromal cells (MSCs) are attractive candidates for treating hepatic disorders given their potential to enhance liver regeneration and function. The paracrine paradigm may be involved in the mechanism of MSC-based therapy, and exosomes (Exo) play an important role in this paracrine activity. Hypoxia significantly improves the effectiveness of MSC transplantation. However, whether hypoxia preconditioned MSCs (Hp-MSCs) can enhance liver regeneration, and whether this enhancement is mediated by Exo, are unknown. In this study, mouse bone marrow-derived MSCs (BM-MSCs) and secreted Exo were injected through the tail vein. We report that Hp-MSCs promote liver regeneration after partial hepatectomy in mice through their secreted exosomes. Interestingly, MSC-Exo were concentrated in liver 6 h after administration and mainly taken up by macrophages, but not hepatocytes. Compared with normoxic MSC-Exo (N-Exo), hypoxic MSC-Exo (Hp-Exo) enhanced M2 macrophage polarization both in vivo and in vitro. Microarray analysis revealed significant enrichment of microRNA (miR)-182-5p in Hp-Exo compared with that in N-Exo. In addition, miR-182-5p knockdown partially abolished the beneficial effect of Hp-Exo. Finally, Hp-MSC-derived exosomal miR-182-5p inhibited theprotein expression of forkhead box transcription factor 1 (FOXO1) in macrophages, which inhibited toll-like receptor 4 (TLR4) expression and subsequently induced an anti-inflammatory response. These results highlight the therapeutic potential of Hp-Exo in liver regeneration and suggest that miR-182-5p from Hp-Exo facilitates macrophage polarization during liver regeneration by modulating the FOXO1/TLR4 signaling pathway.	[Xu, Jing; Chen, Peng; Yu, Chaoqun; Shi, Qiangqiang; Wei, Susu; Li, Yaxin; Di, Guohu] Qingdao Univ, Coll Med, Sch Basic Med, 308 Ningxia Rd, Qingdao 266071, Peoples R China; [Qi, Hongzhao] Qingdao Univ, Inst Translat Med, Qingdao, Peoples R China; [Cao, Qilong] Qingdao Haier Biotech Co Ltd, Qingdao, Peoples R China; [Guo, Chuanlong; Wu, Xianggen] Qingdao Univ Sci & Technol, Coll Chem Engn, Qingdao, Peoples R China; [Di, Guohu] Qingdao Univ, Sch Basic Med, Inst Stem Cell & Regenerat Med, Qingdao, Peoples R China	Qingdao University; Qingdao University; Qingdao University of Science & Technology; Qingdao University	Di, GH (corresponding author), Qingdao Univ, Coll Med, Sch Basic Med, 308 Ningxia Rd, Qingdao 266071, Peoples R China.	diguohu@qdu.edu.cn		Di, Guohu/0000-0001-9940-730X	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research) [2018YFA0109800]; China Postdoctoral Science Foundation [2019M652328]	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	National Key Research and Development Program of China Stem Cell and Translational Research (Stem Cell and Translational Research), Grant/Award Number: 2018YFA0109800; China Postdoctoral Science Foundation, Grant/Award Number: 2019M652328	Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Behnke K, 2018, HEPATOLOGY, V68, P2348, DOI 10.1002/hep.30088; Chen L, 2020, THERANOSTICS, V10, P9425, DOI 10.7150/thno.43315; Chen X, 2018, CANCER LETT, V435, P80, DOI 10.1016/j.canlet.2018.08.001; Cheng H, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01737-0; Couzin J, 2005, SCIENCE, V308, P1862, DOI 10.1126/science.308.5730.1862; Dai YX, 2020, J MOL CELL CARDIOL, V142, P65, DOI 10.1016/j.yjmcc.2020.02.007; Di GH, 2017, INVEST OPHTH VIS SCI, V58, P4344, DOI 10.1167/iovs.17-21506; Ding HR, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00412; Du LM, 2019, CELL METAB, V29, P1363, DOI 10.1016/j.cmet.2019.01.006; Ezquer F, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0469-y; Fan WQ, 2010, EMBO J, V29, P4223, DOI 10.1038/emboj.2010.268; Fang SB, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1723260; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Feng R, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1783869; Ferreira JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02837; Forbes SJ, 2016, NAT REV GASTRO HEPAT, V13, P473, DOI 10.1038/nrgastro.2016.97; Goikoetxea-Usandizaga N, 2022, HEPATOLOGY, V75, P550, DOI 10.1002/hep.32149; Haider KH, 2012, PROG MOL BIOL TRANSL, V111, P323, DOI 10.1016/B978-0-12-398459-3.00015-0; Heidari N, 2021, J CELL PHYSIOL, V236, P5906, DOI 10.1002/jcp.30275; Heymann F, 2015, HEPATOLOGY, V62, P279, DOI 10.1002/hep.27793; Hu CX, 2018, J CELL MOL MED, V22, P1428, DOI 10.1111/jcmm.13492; Hu YQ, 2019, CELL BIOCHEM FUNCT, V37, P504, DOI 10.1002/cbf.3423; Hu ZM, 2020, HEPATOLOGY, V71, P1421, DOI 10.1002/hep.30919; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; Izumi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07747-0; Kaido T, 2004, HEPATO-GASTROENTEROL, V51, P1667; Kan C, 2021, WORLD J CLIN CASES, V9, P10616, DOI [10.12998/wjcc.v9.i34.10616, 10.1299841/wjcc/v.i31.10616]; Kang Liang-I, 2012, Cells, V1, P1261, DOI 10.3390/cells1041261; Kang XW, 2021, EXP CELL RES, V405, DOI 10.1016/j.yexcr.2021.112635; Kim H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010028; Lee KS, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12152; Leung WKC, 2015, CANCER LETT, V362, P97, DOI 10.1016/j.canlet.2015.03.023; Lewis PS, 2020, J HEPATOL, V73, P349, DOI 10.1016/j.jhep.2020.02.031; Li XG, 2017, GUT, V66, P157, DOI 10.1136/gutjnl-2015-310514; Liu W, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1726-7; Liu W, 2020, ACTA BIOMATER, V103, P196, DOI 10.1016/j.actbio.2019.12.020; Liu YN, 2021, AM J PATHOL, V191, P1974, DOI 10.1016/j.ajpath.2021.07.010; Lu QJ, 2021, MOLECULES, V26, DOI 10.3390/molecules26082231; Luo ZC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1410-y; Malik R, 2002, SEMIN CELL DEV BIOL, V13, P425, DOI 10.1016/S1084952102001301; Maroto R, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1359478; Michalopoulos GK, 2021, NAT REV GASTRO HEPAT, V18, P40, DOI 10.1038/s41575-020-0342-4; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774; Oh SH, 2018, J HEPATOL, V69, P359, DOI 10.1016/j.jhep.2018.05.008; Penas-Martinez J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041926; Prado N, 2008, J IMMUNOL, V181, P1519, DOI 10.4049/jimmunol.181.2.1519; Rai RM, 1997, HEPATOLOGY, V25, P889, DOI 10.1002/hep.510250417; Rong YL, 2021, ACTA BIOMATER, V122, P325, DOI 10.1016/j.actbio.2020.12.034; Shin HS, 2018, STEM CELLS, V36, P1020, DOI 10.1002/stem.2818; Song XJ, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118821; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; Tanei T, 2016, CANCER RES, V76, P429, DOI 10.1158/0008-5472.CAN-15-1576; Tang SZ, 2021, EXP EYE RES, V205, DOI 10.1016/j.exer.2021.108485; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Uetsuka K, 2005, EXP MOL PATHOL, V79, P51, DOI 10.1016/j.yexmp.2005.02.002; Xie K, 2019, IUBMB LIFE, V71, P2020, DOI 10.1002/iub.2147; Yu CQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71337-8; Zhang DX, 2015, DIGEST DIS SCI, V60, P2718, DOI 10.1007/s10620-015-3676-y; Zhang SP, 2018, BIOMATERIALS, V156, P16, DOI 10.1016/j.biomaterials.2017.11.028; Zhao JX, 2019, CARDIOVASC RES, V115, P1205, DOI 10.1093/cvr/cvz040; Zheng J, 2020, ADV SCI, V7, DOI 10.1002/advs.201903746; Zhu CH, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-021-02625-x; Zhu LP, 2018, THERANOSTICS, V8, P6163, DOI 10.7150/thno.28021	67	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22553	10.1096/fj.202101868RRR	http://dx.doi.org/10.1096/fj.202101868RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N7UN	36111980				2022-12-26	WOS:000854221800001
J	Wang, Q; Wu, LH; Cao, RX; Gao, J; Chai, DM; Qin, YZ; Ma, L; Wu, SW; Tao, YS; Ma, J; Wang, ZW				Wang, Qi; Wu, Linhui; Cao, Ruoxue; Gao, Jing; Chai, Damin; Qin, Yanzi; Ma, Li; Wu, Shiwu; Tao, Yisheng; Ma, Jia; Wang, Zhi-wei			Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation	ONCOGENE			English	Article							F-BOX PROTEINS; TUMOR-SUPPRESSOR; LIGASE COMPLEX; MESENCHYMAL TRANSITION; PROLIFERATION; EXPRESSION; INVASION; SYSTEM; GROWTH; ROLES	Esophageal squamous cell carcinoma (ESCC) is one of the most common and deadly cancers. Fbxo45, a substrate recognition subunit of E3 ligase, is critically involved in tumorigenesis and tumor progression. However, the function of Fbxo45 and the underlying mechanisms have not been elucidated in ESCC. We used cellular and molecular methods to explore the molecular basis of Fbxo45-mediated ESCC development. We found that ectopic overexpression of Fbxo45 promoted the growth of Kyse-150, Kyse30 and ECA-109 cells and inhibited the apoptosis. Moreover, overexpression of Fbxo45 promoted the migration and invasion of ESCC cells. Consistently, knockdown of Fbxo45 exhibited the opposite effects on ESCC cells. Mechanistically, we observed that Fbxo45 binds to GGNBP2 via its SPRY domain and targets GGNBP2 for ubiquitination and degradation. GGNBP2 overexpression exhibited anticancer activity in ESCC cells. Furthermore, Fbxo45 exerted its functions by regulating GGNBP2 stability in ESCC cells. Notably, overexpression of Fbxo45 facilitated tumor growth in mice. Strikingly, Fbxo45 was highly expressed in ESCC tissues, and GGNBP2 had a lower expression in ESCC specimens. High expression of Fbxo45 and low expression of GGNBP2 were associated with poor prognosis in ESCC patients. Fbxo45 was negatively correlated with GGNBP2 expression in ESCC tissues. Therefore, Fbxo45 serves as an oncoprotein to promote ESCC tumorigenesis by targeting the stability of the tumor suppressor GGNBP2 in ESCC.	[Wang, Qi; Gao, Jing; Chai, Damin; Qin, Yanzi; Ma, Li; Wu, Shiwu; Tao, Yisheng] Bengbu Med Coll, Dept Pathol, Affiliated Hosp 1, Bengbu 233030, Anhui, Peoples R China; [Wang, Qi; Gao, Jing; Chai, Damin; Qin, Yanzi; Ma, Li; Wu, Shiwu; Tao, Yisheng] Bengbu Med Coll, Dept Pathol, Bengbu 233030, Anhui, Peoples R China; [Wu, Linhui; Cao, Ruoxue; Ma, Jia; Wang, Zhi-wei] Bengbu Med Coll, Sch Lab Med, Dept Biochem & Mol Biol, Key Lab Canc Res & Clin Lab Diag, Bengbu 233030, Anhui, Peoples R China; [Wang, Zhi-wei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou 325027, Zhejiang, Peoples R China	Bengbu Medical College; Bengbu Medical College; Bengbu Medical College; Wenzhou Medical University	Tao, YS (corresponding author), Bengbu Med Coll, Dept Pathol, Affiliated Hosp 1, Bengbu 233030, Anhui, Peoples R China.; Tao, YS (corresponding author), Bengbu Med Coll, Dept Pathol, Bengbu 233030, Anhui, Peoples R China.; Ma, J; Wang, ZW (corresponding author), Bengbu Med Coll, Sch Lab Med, Dept Biochem & Mol Biol, Key Lab Canc Res & Clin Lab Diag, Bengbu 233030, Anhui, Peoples R China.; Wang, ZW (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou 325027, Zhejiang, Peoples R China.	taoyishengbbyxy@163.com; majiamj10@126.com; zhiweichina@126.com						Abshire CF, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.55; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen X, 2014, CELL DEATH DIFFER, V21, P1535, DOI 10.1038/cdd.2014.92; Cheng LL, 2020, DIAGN PATHOL, V15, DOI 10.1186/s13000-020-00929-9; Ciechanover A, 2017, BEST PRACT RES CL HA, V30, P341, DOI 10.1016/j.beha.2017.09.001; Cino EA, 2016, J PHYS CHEM B, V120, P1060, DOI 10.1021/acs.jpcb.5b11565; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Glynn RW, 2010, CANCER TREAT REV, V36, P224, DOI 10.1016/j.ctrv.2009.12.007; Gong J, 2016, INT J ONCOL, V48, P886, DOI 10.3892/ijo.2016.3325; Gong J, 2015, INT J ONCOL, V47, P43, DOI 10.3892/ijo.2015.2983; Gong J, 2014, INT J ONCOL, V45, P2199, DOI 10.3892/ijo.2014.2684; Guan R, 2012, MOL CELL BIOCHEM, V365, P211, DOI 10.1007/s11010-012-1262-6; Hershko DD, 2008, CANCER-AM CANCER SOC, V112, P1415, DOI 10.1002/cncr.23317; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Kim HY, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03757-x; Kogure N, 2017, ANTICANCER RES, V37, P191, DOI 10.21873/anticanres.11305; Lan ZJ, 2016, BREAST CANCER RES TR, V158, P263, DOI 10.1007/s10549-016-3880-2; Levin AM, 2008, CANCER RES, V68, P6492, DOI 10.1158/0008-5472.CAN-08-0348; Li SQ, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.136358; Lin M, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0291-2; Lin M, 2019, CANCER LETT, V466, P61, DOI 10.1016/j.canlet.2019.09.008; Liu JJ, 2019, BREAST CANCER RES TR, V174, P65, DOI 10.1007/s10549-018-5052-z; MacGurn JA, 2012, ANNU REV BIOCHEM, V81, P231, DOI 10.1146/annurev-biochem-060210-093619; Malhotra GK, 2017, J SURG ONCOL, V115, P564, DOI 10.1002/jso.24592; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Pickens A, 2003, ANN THORAC SURG, V76, pS1367, DOI 10.1016/S0003-4975(03)01202-5; Plummer SJ, 1997, GENE CHROMOSOME CANC, V20, P354; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Richter KT, 2020, CELL DEATH DIFFER, V27, P758, DOI 10.1038/s41418-019-0385-7; Saiga T, 2009, MOL CELL BIOL, V29, P3529, DOI 10.1128/MCB.00364-09; Salat D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130288; Tada H, 2010, J BIOL CHEM, V285, P3840, DOI 10.1074/jbc.M109.046284; Tang XF, 2019, GENET TEST MOL BIOMA, V23, P791, DOI 10.1089/gtmb.2019.0129; Wang K, 2018, J CANCER RES CLIN, V144, P1509, DOI 10.1007/s00432-018-2653-1; Wang ZW, 2014, NAT REV CANCER, V14, P233, DOI 10.1038/nrc3700; Wu LH, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04675-2; Wu YM, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1014-2; Xia J, 2014, CURR PHARM DESIGN, V20, P5348, DOI 10.2174/1381612820666140128215756; Xia J, 2012, CURR DRUG TARGETS, V13, P1750, DOI 10.2174/138945012804545597; Xu M, 2015, ONCOTARGET, V6, P979, DOI 10.18632/oncotarget.2825; Xu YC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00689-5; Yang Q, 2014, BRIT J CANCER, V110, P1958, DOI 10.1038/bjc.2014.136; Yin FQ, 2014, ONCOL REP, V32, P362, DOI 10.3892/or.2014.3175; Yoshida K, 2005, ONCOL REP, V14, P531; Zhan A, 2017, ONCOL RES, V25, P831, DOI 10.3727/096504016X14816726393937; Zheng NN, 2016, BBA-REV CANCER, V1866, P12, DOI 10.1016/j.bbcan.2016.05.001; Zhu ZH, 2017, GYNECOL ONCOL, V147, P418, DOI 10.1016/j.ygyno.2017.08.025	49	0	0	4	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 21	2022	41	43					4795	4807		10.1038/s41388-022-02468-7	http://dx.doi.org/10.1038/s41388-022-02468-7		SEP 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5M4RI	36127399				2022-12-26	WOS:000855639800001
J	Srivastava, T; Garola, RE; Zhou, JP; Boinpelly, VC; Priya, L; Ali, MF; Rezaiekhaligh, MH; Heruth, DP; Novak, J; Alon, US; Joshi, T; Jiang, YX; McCarthy, ET; Savin, VJ; Johnson, ML; Sharma, R; Sharma, M				Srivastava, Tarak; Garola, Robert E.; Zhou, Jianping; Boinpelly, Varun C.; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Heruth, Daniel P.; Novak, Jan; Alon, Uri S.; Joshi, Trupti; Jiang, Yuexu; McCarthy, Ellen T.; Savin, Virginia J.; Johnson, Mark L.; Sharma, Ram; Sharma, Mukut			Prostanoid receptors in hyperfiltration-mediated glomerular injury: Novel agonists and antagonists reveal opposing roles for EP2 and EP4 receptors	FASEB JOURNAL			English	Article						fluid-flow shear stress; glomerular filtration barrier; glomerular hemodynamics; hyperfiltration; podocytes	PROSTAGLANDIN-E RECEPTORS; FLOW SHEAR-STRESS; STAGE RENAL-DISEASE; CYCLOOXYGENASE-2 EXPRESSION; BIOMECHANICAL FORCES; BETA-CATENIN; URINARY PROSTAGLANDIN-E2; CONGENITAL-ANOMALIES; NEPHROTIC SYNDROME; POTENTIAL ROLE	Increased fluid-flow shear stress (FFSS) contributes to hyperfiltration-induced podocyte and glomerular injury resulting in progression of chronic kidney disease (CKD). We reported that increased FFSS in vitro and in vivo upregulates PGE2 receptor EP2 (but not EP4 expression), COX2-PGE(2)-EP2 axis, and EP2-linked Akt-GSK3 beta-beta-catenin signaling pathway in podocytes. To understand and use the disparities between PGE2 receptors, specific agonists, and antagonists of EP2 and EP4 were used to assess phosphorylation of Akt, GSK3 beta and beta-catenin in podocytes using Western blotting, glomerular filtration barrier function using in vitro albumin permeability (P-alb) assay, and mitigation of hyperfiltration-induced injury in unilaterally nephrectomized (UNX) mice at 1 and 6 months. Results show an increase in P-alb by PGE(2), EP2 agonist (EP2(AGO)) and EP4 antagonist (EP4(ANT)), but not by EP2 antagonist (EP2(ANT)) or EP4 agonist (EP4(AGO)). Pretreatment with EP2(ANT) blocked the effect of PGE(2) or EP2(AGO) on P-alb. Modulation of EP2 and EP4 also induced opposite effects on phosphorylation of Akt and beta-Catenin. Individual agonists or antagonists of EP2 or EP4 did not induce significant improvement in albuminuria in UNX mice. However, treatment with a combination EP2(ANT) + EP4(AGO) for 1 or 6 months caused a robust decrease in albuminuria. EP2(ANT) + EP4(AGO) combination did not impact adaptive hypertrophy or increased serum creatinine. Observed differences between expression of EP2 and EP4 on the glomerular barrier highlight these receptors as potential targets for intervention. Safe and effective mitigating effect of EP2(ANT) + EP4(AGO) presents a novel opportunity to delay the progression of hyperfiltration-associated CKD as seen in transplant donors.	[Srivastava, Tarak; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Alon, Uri S.] Childrens Mercy Hosp, Sect Nephrol, Kansas City, MO 64128 USA; [Srivastava, Tarak; Garola, Robert E.; Priya, Lakshmi; Ali, Mohammed Farhan; Rezaiekhaligh, Mohammad H.; Heruth, Daniel P.; Alon, Uri S.] Univ Missouri, Kansas City, MO 64110 USA; [Srivastava, Tarak; Zhou, Jianping; Boinpelly, Varun C.; Sharma, Mukut] Midwest Vet Biomed Res Fdn MVBRF, Kansas City, MO USA; [Srivastava, Tarak; Johnson, Mark L.] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Garola, Robert E.] Childrens Mercy Hosp, Dept Pathol & Lab Med, Kansas City, MO 64128 USA; [Zhou, Jianping; Boinpelly, Varun C.; Savin, Virginia J.; Sharma, Ram; Sharma, Mukut] Kansas City VA Med Ctr, Renal Res Lab, Kansas City, MO USA; [Heruth, Daniel P.] Childrens Mercy Hosp, Childrens Mercy Res Inst, Kansas City, MO 64128 USA; [Novak, Jan] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Joshi, Trupti] Univ Missouri, Dept Hlth Management & Informat, Columbia, MO USA; [Joshi, Trupti; Jiang, Yuexu] Univ Missouri, Dept Elect Engn & Comp Sci, Columbia, MO USA; [Joshi, Trupti; Jiang, Yuexu] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO USA; [Joshi, Trupti] Univ Missouri, MU Inst Data Sci & Informat, Columbia, MO USA; [McCarthy, Ellen T.; Savin, Virginia J.; Sharma, Mukut] Univ Kansas, Med Ctr, Dept Internal Med, Jared Grantham Kidney Inst, Kansas City, KS 66103 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; Children's Mercy Hospital; Children's Mercy Hospital; University of Alabama System; University of Alabama Birmingham; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Kansas; University of Kansas Medical Center	Srivastava, T (corresponding author), Childrens Mercy Hosp, Sect Nephrol, Pediat, 2401 Gillham Rd, Kansas City, MO 64128 USA.	tsrivastava@cmh.edu		Srivastava, Tarak/0000-0002-8654-0627	HHS \ NIH \ NIDDK \ Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM) [R01DK107490]; U.S. Department of Veterans Affairs (VA) [VA BX001037]	HHS \ NIH \ NIDDK \ Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM); U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs)	HHS vertical bar NIH vertical bar NIDDK vertical bar Division of Diabetes, Endocrinology, and Metabolic Diseases (DEM), Grant/Award Number: R01DK107490; U.S. Department of Veterans Affairs (VA), Grant/Award Number: VA BX001037	ARGUESO LR, 1992, PEDIATR NEPHROL, V6, P412, DOI 10.1007/BF00873996; Aringer I, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040832; BLUM M, 1981, CLIN NEPHROL, V15, P87; Breyer MD, 2000, AM J PHYSIOL-RENAL, V279, pF12, DOI 10.1152/ajprenal.2000.279.1.F12; Carrisoza-Gaytan R, 2014, AM J PHYSIOL-RENAL, V307, pF195, DOI 10.1152/ajprenal.00634.2013; Chen X., 2016, J CLIN EXP NEPHROL, V1, P18, DOI DOI 10.21967/JBB.V1I1.37; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng HF, 2007, J AM SOC NEPHROL, V18, P551, DOI 10.1681/ASN.2006090990; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Chun KS, 2010, J BIOL CHEM, V285, P39672, DOI 10.1074/jbc.M110.117689; Chun KS, 2009, CARCINOGENESIS, V30, P1620, DOI 10.1093/carcin/bgp168; Dahly-Vernon AJ, 2005, HYPERTENSION, V45, P643, DOI 10.1161/01.HYP.0000153791.89776.43; DasGupta R, 1999, DEVELOPMENT, V126, P4557; DESANTO NG, 1994, NEPHRON, V66, P45, DOI 10.1159/000187764; Endlich N, 2001, J AM SOC NEPHROL, V12, P413, DOI 10.1681/ASN.V123413; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Friedrich C, 2006, AM J PHYSIOL-RENAL, V291, pF856, DOI 10.1152/ajprenal.00196.2005; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; Fujino H, 2002, J BIOL CHEM, V277, P2614, DOI 10.1074/jbc.M109440200; Fujino H, 2003, J BIOL CHEM, V278, P12151, DOI 10.1074/jbc.M212665200; Fukushima K, 2022, FEBS OPEN BIO, V12, P775, DOI 10.1002/2211-5463.13378; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ganesh T, 2014, J MED CHEM, V57, P4454, DOI 10.1021/jm401431x; GOMEZMARTINO JR, 1994, NEPHROL DIAL TRANSPL, V9, P251; Grams ME, 2016, NEW ENGL J MED, V374, P411, DOI 10.1056/NEJMoa1510491; Griffin Karen A., 1992, American Journal of Physiology, V263, pF1057; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Horiba N, 2002, NEPHRON, V91, P134, DOI 10.1159/000057615; Ibrahim HN, 2016, J AM SOC NEPHROL, V27, P2885, DOI 10.1681/ASN.2015091018; Ikegami R, 2001, J IMMUNOL, V166, P4689, DOI 10.4049/jimmunol.166.7.4689; Imig JD, 2002, AM J PHYSIOL-RENAL, V283, pF415, DOI 10.1152/ajprenal.00351.2001; Jiang JX, 2013, TRENDS PHARMACOL SCI, V34, P413, DOI 10.1016/j.tips.2013.05.003; Katsuyama M, 1998, BIOCHEM BIOPH RES CO, V251, P727, DOI 10.1006/bbrc.1998.9540; Kitase Y, 2010, J BONE MINER RES, V25, P2381, DOI 10.1002/jbmr.168; Komers R, 2007, CLIN EXP PHARMACOL P, V34, P36, DOI 10.1111/j.1440-1681.2007.04534.x; Kriz W, 2017, KIDNEY INT, V91, P1283, DOI 10.1016/j.kint.2017.02.032; Kriz W, 2015, J AM SOC NEPHROL, V26, P258, DOI 10.1681/ASN.2014030278; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Martineau LC, 2004, AM J PHYSIOL-RENAL, V286, pF693, DOI 10.1152/ajprenal.00331.2003; Massie AB, 2017, J AM SOC NEPHROL, V28, P2749, DOI 10.1681/ASN.2016101084; Matas AJ, 2018, AM J TRANSPLANT, V18, P1140, DOI 10.1111/ajt.14671; MATHIESEN ER, 1988, DIABETIC MED, V5, P145, DOI 10.1111/j.1464-5491.1988.tb00961.x; McCarthy ET, 2002, KIDNEY INT, V61, P534, DOI 10.1046/j.1523-1755.2002.00172.x; Miyamoto M, 2003, OSTEOARTHR CARTILAGE, V11, P644, DOI 10.1016/S1063-4584(03)00118-3; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NATH KA, 1987, AM J PHYSIOL, V252, pF829, DOI 10.1152/ajprenal.1987.252.5.F829; Nishigaki N, 1996, MOL PHARMACOL, V50, P1031; Nusing RM, 2005, J AM SOC NEPHROL, V16, P2354, DOI 10.1681/ASN.2004070556; O'Keeffe LM, 2018, ANN INTERN MED, V168, P276, DOI [10.7326/M17-1235, 10.7326/L18-0341]; Pai R, 2003, FASEB J, V17, P1640, DOI 10.1096/fj.02-1011com; Powell WS, 2021, CLIN SCI, V135, P1945, DOI 10.1042/CS20190657; Pozzi A, 2004, J BIOL CHEM, V279, P29797, DOI 10.1074/jbc.M313989200; Rangel-Filho A, 2005, J AM SOC NEPHROL, V16, P852, DOI 10.1681/ASN.2005010029; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Rosenberg M E, 1988, Contrib Nephrol, V68, P157; ROSENBERG M E, 1987, American Journal of Physiology, V253, pF1083; Sanchez PL, 1999, HYPERTENSION, V34, P848, DOI 10.1161/01.HYP.34.4.848; Sanna-Cherchi S, 2009, KIDNEY INT, V76, P528, DOI 10.1038/ki.2009.220; SAVIN VJ, 1992, J AM SOC NEPHROL, V3, P1260; Savin VJ, 1996, NEW ENGL J MED, V334, P878, DOI 10.1056/NEJM199604043341402; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Sharma M, 2006, EXP BIOL MED, V231, P99; Sharma M, 2004, EXP BIOL MED, V229, P85, DOI 10.1177/153537020422900111; Sharma M, 2017, PROSTAG OTH LIPID M, V132, P59, DOI 10.1016/j.prostaglandins.2017.01.003; Sharma R, 2006, FRONT BIOSCI-LANDMRK, V11, P968, DOI 10.2741/1853; Sluter MN, 2021, J MED CHEM, V64, P11816, DOI 10.1021/acs.jmedchem.1c00816; Srivastava T, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10051253; Srivastava T, 2020, PROSTAG OTH LIPID M, V146, DOI 10.1016/j.prostaglandins.2019.106403; Srivastava T, 2018, TRANSPLANTATION, V102, P1624, DOI 10.1097/TP.0000000000002304; Srivastava T, 2018, AM J PHYSIOL-RENAL, V314, pF22, DOI 10.1152/ajprenal.00325.2017; Srivastava T, 2017, NEPHROL DIAL TRANSPL, V32, P759, DOI 10.1093/ndt/gfw430; Srivastava T, 2014, AM J PHYSIOL-RENAL, V307, pF1323, DOI 10.1152/ajprenal.00335.2014; Srivastava T, 2014, NEPHROL DIAL TRANSPL, V29, P65, DOI 10.1093/ndt/gft387; Srivastava T, 2013, PROSTAG OTH LIPID M, V104, P49, DOI 10.1016/j.prostaglandins.2012.11.001; Srivastava T, 2010, J CELL COMMUN SIGNAL, V4, P79, DOI 10.1007/s12079-010-0088-9; STAHL RAK, 1986, NEPHRON, V42, P252, DOI 10.1159/000183676; Stitt-Cavanagh EM, 2010, J AM SOC NEPHROL, V21, P1678, DOI 10.1681/ASN.2009121234; Sugimoto Y, 2000, PROG LIPID RES, V39, P289, DOI 10.1016/S0163-7827(00)00008-4; SUZUKI S, 1980, PROSTAG LEUKOTR ESS, V4, P377, DOI 10.1016/0161-4630(80)90011-7; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VELOSA JA, 1985, MAYO CLIN PROC, V60, P586, DOI 10.1016/S0025-6196(12)60980-X; Vleeshouwers W, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613286; VRIESENDORP R, 1986, AM J MED, V81, P84, DOI 10.1016/0002-9343(86)90910-1; VRIESENDORP R, 1986, CLIN NEPHROL, V25, P105; Vukicevic S, 2006, KIDNEY INT, V70, P1099, DOI 10.1038/sj.ki.5001715; Wang JL, 1998, AM J PHYSIOL-RENAL, V275, pF613, DOI 10.1152/ajprenal.1998.275.4.F613; Westland R, 2013, NEPHROL DIAL TRANSPL, V28, P1844, DOI 10.1093/ndt/gft012; Westland R, 2013, PEDIATRICS, V131, pE478, DOI 10.1542/peds.2012-2088; Yao B, 2006, AM J PHYSIOL-RENAL, V291, pF368, DOI 10.1152/ajprenal.00500.2005; Young Sarah, 2007, Curr Protoc Hum Genet, VChapter 17, DOI 10.1002/0471142905.hg1703s54	95	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22559	10.1096/fj.202200875R	http://dx.doi.org/10.1096/fj.202200875R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4P3PA	36125047				2022-12-26	WOS:000855307500001
J	Gayen, M; Benoit, MR; Fan, QY; Hudobenko, J; Yan, RQ				Gayen, Manoshi; Benoit, Marc R.; Fan, Qingyuan; Hudobenko, Jacob; Yan, Riqiang			The CX3CL1 intracellular domain exhibits neuroprotection via insulin receptor/insulin-like growth factor receptor signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; PHOSPHATIDYLINOSITOL 3-KINASE; ALZHEIMERS-DISEASE; FOXO; NEURODEGENERATION; PHOSPHORYLATION; FRACTALKINE; MECHANISMS; RESISTANCE; MIGRATION	CX3CL1, also known as fractalkine, is best known for its signaling activity through interactions with its cognate receptor CX3CR1. However, its intrinsic function that is independent of interaction with CX3CR1 remains to be fully understood. We demonstrate that the intracellular domain of CX3CL1 (CX3CL1-ICD), generated upon sequential cleavages by alpha-/beta secretase and gamma-secretase, initiates a back signaling activity, which mediates direct signal transmission to gene expression in the nucleus. To study this, we fused a synthetic peptide derived from CX3CL1-ICD, named Tet34, with a 13-amino acid tetanus sequence at the N terminus to facilitate translocation into neuronal cells. We show that treatment of mouse neuroblastoma Neuro-2A cells with Tet34, but not its scrambled control (Tet34s), induced cell proliferation, as manifested by changes in protein levels of transcription factors and progrowth molecules cyclin D1, PCNA, Sox5, and Cdk2. Further biochemical assays reveal elevation of phosphorylated insulin receptor beta subunit, insulin-like growth factor-1 receptor beta subunit, and insulin receptor substrates as well as activation of proliferation-linked kinase AKT. In addition, transgenic mice overexpressing membrane-anchored C-terminal CX3CL1 also exhibited activation of insulin/insulin-like growth factor-1 receptor signaling. Remarkably, we found that this Tet34 peptide, but not Tet34s, protected against endoplasmic reticulum stress and cellular apoptosis when Neuro-2A cells were challenged with toxic oligomers of beta-amyloid peptide or hydrogen peroxide. Taken together, our results suggest that CX3CL1ICD may have translational potential for neuroprotection in Alzheimer's disease and for disorders resulting from insulin resistance.	[Gayen, Manoshi; Benoit, Marc R.; Fan, Qingyuan; Hudobenko, Jacob; Yan, Riqiang] Univ Connecticut Hlth, Dept Neurosci, Farmington, CT 06030 USA; [Fan, Qingyuan] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland Hts, OH 44195 USA	University of Connecticut; Cleveland Clinic Foundation	Yan, RQ (corresponding author), Univ Connecticut Hlth, Dept Neurosci, Farmington, CT 06030 USA.	riyan@uchc.edu		Benoit, Marc/0000-0001-6777-8472; Hudobenko, Jacob/0000-0001-9064-4149				Akhtar A, 2020, NEUROCHEM INT, V135, DOI 10.1016/j.neuint.2020.104707; Amador-Arjona A, 2015, P NATL ACAD SCI USA, V112, pE1936, DOI 10.1073/pnas.1421480112; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Benoit MR, 2019, AGING-US, V11, P10783, DOI 10.18632/aging.102504; Bunk EC, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.13; Calissi G, 2021, NAT REV DRUG DISCOV, V20, P21, DOI 10.1038/s41573-020-0088-2; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; de la Monte SM, 2017, DRUGS, V77, P47, DOI 10.1007/s40265-016-0674-0; de Mollo NP, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00491; Diep CH, 2016, MOL CANCER RES, V14, P141, DOI 10.1158/1541-7786.MCR-15-0431; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fan QY, 2020, J NEUROSCI, V40, P1133, DOI 10.1523/JNEUROSCI.1333-19.2019; Fan QY, 2019, J EXP MED, V216, P1891, DOI 10.1084/jem.20182238; Finneran DJ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1412-9; Fricker M, 2018, PHYSIOL REV, V98, P813, DOI 10.1152/physrev.00011.2017; Fu HJ, 2018, NAT NEUROSCI, V21, P1350, DOI 10.1038/s41593-018-0221-2; Guven A, 2020, ELIFE, V9, DOI 10.7554/eLife.49808; Guo TT, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00391-7; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; Holscher C, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00088; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Iatrou A, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00489-6; Iida Mari, 2013, Cancer Biol Ther, V14, P481, DOI 10.4161/cbt.24342; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kellar D, 2020, LANCET NEUROL, V19, P758, DOI 10.1016/S1474-4422(20)30231-3; Kennedy LM, 2013, CELL REP, V4, P996, DOI 10.1016/j.celrep.2013.07.045; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lees SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC1238, DOI 10.1152/ajpcell.00349.2008; Lei H, 2009, MOL CANCER RES, V7, P1294, DOI 10.1158/1541-7786.MCR-08-0531; Limatola C, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00229; Link W, 2019, METHODS MOL BIOL, V1890, P1, DOI 10.1007/978-1-4939-8900-3_1; Liu JK, 2005, NEUROBIOL DIS, V19, P407, DOI 10.1016/j.nbd.2005.01.022; Lu HR, 2011, CURR DRUG TARGETS, V12, P1235, DOI 10.2174/138945011796150280; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Manzoni C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024909; Martinez-Morales PL, 2010, EMBO REP, V11, P466, DOI 10.1038/embor.2010.61; Monsalve M, 2011, CURR DRUG TARGETS, V12, P1322, DOI 10.2174/138945011796150307; Nieto-Estevez V, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00052; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Parrizas M, 1997, J BIOL CHEM, V272, P154; Pfisterer U, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.64; Querfurth H, 2021, MOL NEURODEGENER, V16, DOI 10.1186/s13024-021-00428-5; Ro SH, 2013, ARCH BIOCHEM BIOPHYS, V534, P55, DOI 10.1016/j.abb.2012.07.017; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Saltiel AR, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI142241; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Soto M, 2019, P NATL ACAD SCI USA, V116, P6379, DOI 10.1073/pnas.1817391116; Spinelli M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00788; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Webb AE, 2014, TRENDS BIOCHEM SCI, V39, P159, DOI 10.1016/j.tibs.2014.02.003; Yoshiyama Y, 2012, NEUROBIOL DIS, V45, P329, DOI 10.1016/j.nbd.2011.08.017; Zanella F, 2010, CURR CANCER DRUG TAR, V10, P135, DOI 10.2174/156800910791054158	57	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102532	10.1016/j.jbc.2022.102532	http://dx.doi.org/10.1016/j.jbc.2022.102532			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36162508	gold, Green Published			2022-12-26	WOS:000882199400011
J	Teshima, T; Funai, R; Nakazawa, T; Ito, J; Utsumi, T; Kakumyan, P; Mukai, H; Yoshiga, T; Murakami, R; Nakagawa, K; Honda, Y; Matsui, K				Teshima, Takuya; Funai, Risa; Nakazawa, Takehito; Ito, Junya; Utsumi, Toshihiko; Kakumyan, Pattana; Mukai, Hiromi; Yoshiga, Toyoshi; Murakami, Ryutaro; Nakagawa, Kiyotaka; Honda, Yoichi; Matsui, Kenji			Coprinopsis cinerea dioxygenase is an oxygenase forming 10(S)-hydroperoxide of linoleic acid, essential for mushroom alcohol, 1-octen-3-ol, synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN LEAF VOLATILES; HYDROPEROXIDE LYASE; 10-HYDROPEROXIDE ISOMER; ASPERGILLUS-NIDULANS; FUSION PROTEIN; LIPOXYGENASE; FUNGI; GENE; IDENTIFICATION; MUTAGENESIS	1-Octen-3-ol is a volatile oxylipin found ubiquitously in Basidiomycota and Ascomycota. The biosynthetic pathway forming 1-octen-3-ol from linoleic acid via the linoleic acid 10(S)-hydroperoxide was characterized 40 years ago in mush-rooms, yet the enzymes involved are not identified. The dioxy-genase 1 and 2 genes (Ccdox1 and Ccdox2) in the mushroom Coprinopsis cinerea contain an N-terminal cyclooxygenase-like heme peroxidase domain and a C-terminal cytochrome P450 -related domain. Herein, we show that recombinant CcDOX1 is responsible for dioxygenation of linoleic acid to form the 10(S)-hydroperoxide, the first step in 1-octen-3-ol synthesis, whereas CcDOX2 conceivably forms linoleic acid 8-hydroperoxide. We demonstrate that KO of the Ccdox1 gene suppressed 1-octen-3-ol synthesis, although added linoleic acid 10(S)-hydroperoxide was still efficiently converted. The P450 -related domain of CcDOX1 lacks the characteristic Cys heme ligand and the evidence indicates that a second uncharacterized enzyme converts the 10(S)-hydroperoxide to 1-octen-3-ol. Additionally, we determined the gene KO strain (Delta Ccdox1) was less attractive to fruit fly larvae, while the feeding behavior of fungus gnats on Delta Ccdox1 mycelia showed little difference from that on the mycelia of the WT strain. The proliferation of fun-givorous nematodes on Delta Ccdox1 mycelia was similar to or slightly worse than that on WT mycelia. Thus, 1-octen-3-ol seems to be an attractive compound involved in emitter- receiver ecological communication in mushrooms.	[Teshima, Takuya; Funai, Risa; Utsumi, Toshihiko; Murakami, Ryutaro; Matsui, Kenji] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan; [Nakazawa, Takehito; Honda, Yoichi] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Ito, Junya; Nakagawa, Kiyotaka] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi, Japan; [Kakumyan, Pattana] Mae Fah Luang Univ, Sch Sci, Chiang Rai, Thailand; [Mukai, Hiromi] Forestry & Forest Prod Res Inst, Dept Forest Entomol, Tsukuba, Japan; [Yoshiga, Toyoshi] Saga Univ, Fac Agr, Dept Appl Biol Sci, Saga, Japan	Yamaguchi University; Kyoto University; Tohoku University; Mae Fah Luang University; Forestry & Forest Products Research Institute - Japan; Saga University	Matsui, K (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Yamaguchi, Japan.	matsui@yamaguchi-u.ac.jp		Ito, Junya/0000-0001-9190-4969	Japan Society for the Promotion of Science KAKENHI [19H02887];  [21J14407]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	This work was supported in part by grant-in-aid for scientific research by the Japan Society for the Promotion of Science KAKENHI (Grant number: 19H02887) to K. M. and by grant-in-aid for JSPS Fellows (Grant number 21J14407) to T. T.	Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; BOWERS WS, 1986, SCIENCE, V232, P105, DOI 10.1126/science.232.4746.105; Brash AR, 2014, J BIOL CHEM, V289, P13101, DOI 10.1074/jbc.M114.555904; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Brodhun F, 2010, BIOCHEM J, V425, P553, DOI 10.1042/BJ20091096; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; Cevallos JA, 2017, J CHEM ECOL, V43, P362, DOI 10.1007/s10886-017-0834-z; Combet Emilie, 2006, Mycoscience, V47, P317, DOI 10.1007/s10267-006-0318-4; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Ferrari R, 2018, BBA-GEN SUBJECTS, V1862, P2174, DOI 10.1016/j.bbagen.2018.07.012; Fisher AJ, 2003, PHYTOCHEMISTRY, V62, P159, DOI 10.1016/S0031-9422(02)00521-6; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; GOKTE N, 1989, PHYTOPARASITICA, V17, P263, DOI 10.1007/BF02980755; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Haraguchi S, 2020, BIOL CONTROL, V143, DOI 10.1016/j.biocontrol.2020.104203; Hornsten L, 2002, EUR J BIOCHEM, V269, P2690, DOI 10.1046/j.1432-1033.2002.02936.x; Huber SMFE, 2002, MOL GENET GENOMICS, V267, P757, DOI 10.1007/s00438-002-0717-y; Inamdar AA, 2020, ANNU REV MICROBIOL, V74, P101, DOI 10.1146/annurev-micro-012420-080428; Ito J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43645-1; Ito J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10536-2; Ito J, 2015, ANAL CHEM, V87, P4980, DOI 10.1021/acs.analchem.5b00851; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kataoka R, 2020, J BIOSCI BIOENG, V129, P192, DOI 10.1016/j.jbiosc.2019.08.010; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Matsui K, 2006, CURR OPIN PLANT BIOL, V9, P274, DOI 10.1016/j.pbi.2006.03.002; Mochizuki S, 2016, FEBS LETT, V590, P1017, DOI 10.1002/1873-3468.12133; Mukai H, 2021, J APPL ENTOMOL, V145, P348, DOI 10.1111/jen.12843; Nakazawa T, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv123; Nakazawa T, 2010, CURR GENET, V56, P361, DOI 10.1007/s00294-010-0307-1; Oliw EH, 2021, FUNGAL GENET BIOL, V157, DOI 10.1016/j.fgb.2021.103623; Oliw EH, 2018, LIPIDS, V53, P527, DOI 10.1002/lipd.12051; Oliw EH, 2016, J LIPID RES, V57, P1518, DOI 10.1194/jlr.M068981; Potter CJ, 2014, CELL, V156, P878, DOI 10.1016/j.cell.2014.02.003; Senger T, 2005, J BIOL CHEM, V280, P7588, DOI 10.1074/jbc.M411738200; Shen JY, 2014, J EXP BOT, V65, P419, DOI 10.1093/jxb/ert382; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Sueyoshi M, 2014, ZOOTAXA, V3790, P139, DOI 10.11646/zootaxa.3790.1.6; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P25, DOI 10.1016/0005-2760(84)90293-5; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V795, P163, DOI 10.1016/0005-2760(84)90117-6; WURZENBERGER M, 1982, Z LEBENSM UNTERS FOR, V175, P186, DOI 10.1007/BF01139769	49	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102507	10.1016/j.jbc.2022.102507	http://dx.doi.org/10.1016/j.jbc.2022.102507			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36122804	Green Published, gold			2022-12-26	WOS:000884698500007
J	Liston, SD; Ovchinnikova, OG; Kimber, MS; Whitfield, C				Liston, S. D.; Ovchinnikova, O. G.; Kimber, M. S.; Whitfield, C.			A dedicated C-6?-hydroxyacyltransferase required for biosynthesis of the glycolipid anchor for Vi antigen capsule in typhoidal Salmonella	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ESCHERICHIA-COLI; STRUCTURAL BASIS; ACYLTRANSFERASE; HYALURONAN; CATALYSIS; SYNTHASE; ACYLATION; MECHANISM; SEQUENCE	Vi antigen is an extracellular polysaccharide produced by Salmonella enterica Typhi, Citrobacter freundii, and some soil bacteria belonging to the Burkholderiales. In Salmonella Typhi, Vi-antigen capsule protects the bacterium against host defenses, and the glycan is used in a current glycoconjugate vaccine to protect against typhoid. Vi antigen is a glycolipid assembled in the cytoplasm and translocated to the cell surface by an export complex driven by an ABC transporter. In Salmonella Typhi, efficient export and cell-surface retention of the capsule layer depend on a reducing terminal acylated-HexNAc moiety. Although the precise structure and biosynthesis of the acylated terminus has not been resolved, it distinguishes Vi antigen from other known glycolipid substrates for bacterial ABC transporters. The genetic locus for Vi antigenbiosynthesis encodes a single acyltransferase candidate (VexE), which is implicated in the acylation process. Here, we determined the structure of the VexE in vitro reaction product by mass spectrometry and NMR spectroscopy to reveal that VexE catalyzes beta-hydroxyacyl-ACP dependent acylation of the activated sugar precursor, uridine-50-diphospho-GlcNAc, at C-6 to form UDP-6-O-[beta-hydroxymyristoyl]-alpha-D-GlcNAc. VexE belongs to the lysophosphatidyl acyltransferase family, and comparison of an Alphafold VexE model to solved lysophosphatidyl acyltransferase structures, together with modeling enzyme:substrate complexes, led us to predict an enzyme mechanism. This study provides new insight into Vi terminal structure, offers a new model substrate to investigate the mechanism of glycolipid ABC transporters, and adds biochemical understanding for a novel reaction used in the synthesis of an important bacterial virulence factor.	[Liston, S. D.; Ovchinnikova, O. G.; Kimber, M. S.; Whitfield, C.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Liston, S. D.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Guelph; University of Toronto	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	cwhitfie@uoguelph.ca		Liston, Sean/0000-0002-6218-2247	Foundation Grant from the Canadian Institutes of Health Research [FRN 2016-148364]; Natural Sciences and Engineering Research Council of Canada [RGPIN 2020-07113]; NSERC Canada Graduate Scholarship	Foundation Grant from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC Canada Graduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Foundation Grant from the Canadian Institutes of Health Research (FRN 2016-148364 to C. W.) and a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 2020-07113 to M. S. K.) . S. D. L. was a recipient of an NSERC Canada Graduate Scholarship and C. W. held a Canada Research Chair.	Albesa-Jove D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10906; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDERSON MS, 1987, J BIOL CHEM, V262, P5159; Anso I, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abj4565; Bainbridge BW, 2008, J BACTERIOL, V190, P4549, DOI 10.1128/JB.00234-08; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beld J, 2014, NAT PROD REP, V31, P61, DOI 10.1039/c3np70054b; Blackburn MR, 2018, GLYCOBIOLOGY, V28, P108, DOI 10.1093/glycob/cwx096; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Dovala D, 2016, P NATL ACAD SCI USA, V113, pE6064, DOI 10.1073/pnas.1610746113; Doyle L, 2019, NAT CHEM BIOL, V15, P632, DOI 10.1038/s41589-019-0276-8; Flugel RS, 2000, J BIOL CHEM, V275, P959, DOI 10.1074/jbc.275.2.959; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Guest RL, 2021, TRENDS MICROBIOL, V29, P334, DOI 10.1016/j.tim.2020.09.008; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HEYNS K., 1967, CARBOHYD RES, V3, P340, DOI 10.1016/S0008-6215(00)82210-7; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holt KE, 2020, ISME J, V14, P1713, DOI 10.1038/s41396-020-0628-0; HONE DM, 1991, VACCINE, V9, P810, DOI 10.1016/0264-410X(91)90218-U; Ishii T, 1999, CARBOHYD RES, V321, P257, DOI 10.1016/S0008-6215(99)00184-6; Jiang YF, 2006, BIOCHEMISTRY-US, V45, P10008, DOI 10.1021/bi060842w; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Keestra-Gounder AM, 2015, NAT REV MICROBIOL, V13, P206, DOI 10.1038/nrmicro3428; Kim DH, 2004, J MASS SPECTROM, V39, P743, DOI 10.1002/jms.645; KLUGMAN KP, 1987, LANCET, V2, P1165; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liston SD, 2018, P NATL ACAD SCI USA, V115, pE4870, DOI 10.1073/pnas.1801336115; Liston SD, 2016, P NATL ACAD SCI USA, V113, P6719, DOI 10.1073/pnas.1524665113; MacLennan CA, 2014, HUM VACC IMMUNOTHER, V10, P1478, DOI 10.4161/hv.29054; Maloney FP, 2022, NATURE, V604, P195, DOI 10.1038/s41586-022-04534-2; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Masoudi A, 2014, NATURE, V505, P422, DOI 10.1038/nature12679; Micoli F, 2012, VACCINE, V30, P853, DOI 10.1016/j.vaccine.2011.11.108; Micoli F, 2011, VACCINE, V29, P712, DOI 10.1016/j.vaccine.2010.11.022; Micoli F, 2020, P NATL ACAD SCI USA, V117, P24443, DOI 10.1073/pnas.2005857117; Mirdita Milot, 2021, Zenodo, DOI [10.1038/s41592-022-01488-1, 10.5281/ZENODO.5123297]; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; QADRI A, 1990, J IMMUNOASSAY, V11, P235, DOI 10.1080/01971529008053271; Robertson RM, 2017, NAT STRUCT MOL BIOL, V24, P666, DOI 10.1038/nsmb.3436; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; Sancho-Vaello E, 2017, BBA-MOL CELL BIOL L, V1862, P1355, DOI 10.1016/j.bbalip.2016.11.002; Sande Caitlin, 2021, EcoSal Plus, V9, peESP00332020, DOI 10.1128/ecosalplus.ESP-0033-2020; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SILLERUD LO, 1986, J BIOL CHEM, V261, P4380; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; Tersa M, 2018, ACS CHEM BIOL, V13, P131, DOI 10.1021/acschembio.7b00578; TULLOCH AP, 1976, LIPIDS, V11, P228, DOI 10.1007/BF02532862; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Wear SS, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2021.101486; Weigel PH, 2017, GLYCOBIOLOGY, V27, P536, DOI 10.1093/glycob/cwx012; Weigel PH, 2015, GLYCOBIOLOGY, V25, P632, DOI 10.1093/glycob/cwv006; Whitfield C, 2020, ANNU REV MICROBIOL, V74, P521, DOI 10.1146/annurev-micro-011420-075607; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Wilkins MR, 1999, METH MOL B, V112, P531; Williams AH, 2007, P NATL ACAD SCI USA, V104, P13543, DOI 10.1073/pnas.0705833104; Willis LM, 2013, P NATL ACAD SCI USA, V110, P7868, DOI 10.1073/pnas.1222317110; Yan LF, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111516	60	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102520	10.1016/j.jbc.2022.102520	http://dx.doi.org/10.1016/j.jbc.2022.102520			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36152747	gold			2022-12-26	WOS:000884698500003
J	Noguchi, M; Shimizu, M; Lu, P; Takahashi, Y; Yamauchi, Y; Sato, S; Kiyono, H; Kishino, S; Ogawa, J; Nagata, K; Sato, R				Noguchi, Makoto; Shimizu, Makoto; Lu, Peng; Takahashi, Yu; Yamauchi, Yoshio; Sato, Shintaro; Kiyono, Hiroshi; Kishino, Shigenobu; Ogawa, Jun; Nagata, Koji; Sato, Ryuichiro			Lactic acid bacteria-derived gamma-linolenic acid metabolites are PPAR delta ligands that reduce lipid accumulation in human intestinal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; POLYUNSATURATED FATTY-ACIDS; NUCLEAR RECEPTOR; EXPRESSION; HEALTH; MICROBIOTA; SYSTEM; ALPHA; EICOSANOIDS; PATTERNS	Gut microbiota regulate physiological functions in various hosts, such as energy metabolism and immunity. Lactic acid bacteria, including Lactobacillus plantarum, have a specific polyunsaturated fatty acid saturation metabolism that gener-ates multiple fatty acid species, such as hydroxy fatty acids, oxo fatty acids, conjugated fatty acids, and trans-fatty acids. How these bacterial metabolites impact host physiology is not fully understood. Here, we investigated the ligand activity of lactic acid bacteria-produced fatty acids in relation to nuclear hormone receptors expressed in the small intestine. Our re-porter assays revealed two bacterial metabolites of gamma-linolenic acid (GLA), 13-hydroxy-cis-6,cis-9-octadecadienoic acid (gamma HYD), and 13-oxo-cis-6,cis-9-octadecadienoic acid (gamma KetoD) activated peroxisome proliferator-activated receptor delta (PPARS) more potently than GLA. We demonstrate that both gamma HYD and gamma KetoD bound directly to the ligand-binding domain of human PPARS. A docking simulation indicated that four polar residues (T289, H323, H449, and Y473) of PPARS donate hydrogen bonds to these fatty acids. Interest-ingly, T289 does not donate a hydrogen bond to GLA, sug-gesting that bacterial modification of GLA introducing hydroxy and oxo group determines ligand selectivity. In hu-man intestinal organoids, we determined gamma HYD and gamma KetoD increased the expression of PPARS target genes, enhanced fatty acid II-oxidation, and reduced intracellular triglyceride accumulation. These findings suggest that gamma HYD and gamma KetoD, which gut lactic acid bacteria could generate, are naturally occurring PPARS ligands in the intestinal tract and may improve lipid metabolism in the human intestine.	[Noguchi, Makoto; Shimizu, Makoto; Yamauchi, Yoshio; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo, Japan; [Lu, Peng; Nagata, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biotechnol & Struct Biol Lab, Tokyo, Japan; [Takahashi, Yu; Yamauchi, Yoshio] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan; [Sato, Shintaro] Wakayama Med Univ, Sch Pharmaceut Sci, Dept Microbiol & Immunol, Wakayama, Japan; [Kiyono, Hiroshi] Chiba Univ, Inst Global Prominent Res, Mucosal Immunol & Allergy Therapeut, Future Med Educ & Res Org, Chiba, Japan; [Kishino, Shigenobu; Ogawa, Jun] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Kyoto, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Wakayama Medical University; Chiba University; Kyoto University	Shimizu, M; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutri Life Sci Lab, Tokyo, Japan.	amshimizu@g.ecc.u-tokyo.ac.jp; roysato@g.ecc.u-tokyo.ac.jp			JSPS KAKENHI [19H02906, 20H00408]; New Energy and Industrial Technology Development Or-ganization (NEDO) [P20011]; Ministry of Health and Welfare of Japan; Public/Private R&D Investment Strategic Expansion PrograM: PRISM; JST-Mirai Program [JPMJMI21C1]; Japan Agency for Medical Research and Development (AMED) [21ek0410062h0003]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); New Energy and Industrial Technology Development Or-ganization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Public/Private R&D Investment Strategic Expansion PrograM: PRISM; JST-Mirai Program; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (B) 19H02906 (to M. S.), Grant-in-Aid for Scientific Research (A) 20H00408 (to R. S.), the New Energy and Industrial Technology Development Organization (NEDO) P20011 (to J. O.), the Ministry of Health and Welfare of Japan and Public/Private R&D Investment Strategic Expansion PrograM: PRISM (to J. O.), JST-Mirai Program JPMJMI21C1 (to J. O.), and the Japan Agency for Medical Research and Development (AMED) 21ek0410062h0003 (to J. O.).	Auwerx J, 1999, CELL, V97, P161; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Bouchoux J, 2011, BIOL CELL, V103, P499, DOI 10.1042/BC20110024; Brunham LR, 2006, J CLIN INVEST, V116, P1052, DOI 10.1172/JCI27352; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chiarelli F, 2008, VASC HEALTH RISK MAN, V4, P297; D'Aquila T, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00180; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Doktorova M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00889-z; Drouin-Chartier JP, 2018, AM J CLIN NUTR, V107, P26, DOI 10.1093/ajcn/nqx013; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fernandez ML, 2005, J NUTR, V135, P2075, DOI 10.1093/jn/135.9.2075; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Fyffe SA, 2006, J MOL BIOL, V356, P1005, DOI 10.1016/j.jmb.2005.12.047; Gerritsen J, 2011, GENES NUTR, V6, P209, DOI 10.1007/s12263-011-0229-7; Giordano Attianese Greta M P, 2015, Nucl Recept Signal, V13, pe001, DOI 10.1621/nrs.13001; Girroir EE, 2008, BIOCHEM BIOPH RES CO, V371, P456, DOI 10.1016/j.bbrc.2008.04.086; Goto T, 2015, BIOCHEM BIOPH RES CO, V459, P597, DOI 10.1016/j.bbrc.2015.02.154; Hara T, 2014, BBA-MOL CELL BIOL L, V1841, P1292, DOI 10.1016/j.bbalip.2014.06.002; Hatae T, 2001, J BIOL CHEM, V276, P46260, DOI 10.1074/jbc.M107180200; Hira T, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800146; Hirata A, 2015, J LIPID RES, V56, P1340, DOI 10.1194/jlr.M059444; Kaczmarczyk MM, 2012, METABOLISM, V61, P1058, DOI 10.1016/j.metabol.2012.01.017; Kang ZF, 2020, FASEB J, V34, P8796, DOI 10.1096/fj.202000055RR; Keenan MJ, 2015, ADV NUTR, V6, P198, DOI 10.3945/an.114.007419; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Khuchua Z, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113464; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110; Klepsch V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01070; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lagakos WS, 2011, AM J PHYSIOL-GASTR L, V300, pG803, DOI 10.1152/ajpgi.00229.2010; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; Levi L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9794; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37589; Mathur SN, 2007, J LIPID RES, V48, P395, DOI 10.1194/jlr.M600325-JLR200; McCarville JL, 2020, ANNU REV IMMUNOL, V38, P147, DOI 10.1146/annurev-immunol-071219-125715; Miyamoto J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11978-0; Miyamoto J, 2015, J BIOL CHEM, V290, P2902, DOI 10.1074/jbc.M114.610733; Modica S, 2010, GASTROENTEROLOGY, V138, P636, DOI 10.1053/j.gastro.2009.09.060; Nagatake T, 2022, MUCOSAL IMMUNOL, V15, P289, DOI 10.1038/s41385-021-00477-5; Neels JG, 2014, PHYSIOL REV, V94, P795, DOI 10.1152/physrev.00027.2013; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Ohue-Kitano R, 2018, FASEB J, V32, P304, DOI 10.1096/fj.201700273R; Peters JM, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0098-x; Rossi G, 2018, NAT REV GENET, V19, P671, DOI 10.1038/s41576-018-0051-9; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Sasaki T, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016203; Schmidt DR, 2008, NUTR REV, V66, pS88, DOI 10.1111/j.1753-4887.2008.00092.x; Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846; Takahashi Y, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2022.104542; Takahashi Y, 2018, STEM CELL REP, V10, P314, DOI 10.1016/j.stemcr.2017.11.004; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uchinomiya S, 2020, CHEM COMMUN, V56, P3023, DOI 10.1039/c9cc09993j; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Vrins CLJ, 2009, J LIPID RES, V50, P2046, DOI 10.1194/jlr.M800579-JLR200; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xiao CT, 2019, CELL MOL GASTROENTER, V7, P487, DOI 10.1016/j.jcmgh.2018.10.015; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Zembroski AS, 2021, AM J PHYSIOL-GASTR L, V321, pG75, DOI 10.1152/ajpgi.00084.2021	73	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102534	10.1016/j.jbc.2022.102534	http://dx.doi.org/10.1016/j.jbc.2022.102534			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36162507	Green Published, gold			2022-12-26	WOS:000884698500008
J	Das, S; Panja, P; Chowdhury, G; Biswas, S; Dholey, Y; Adak, S				Das, Sumit; Panja, Puja; Chowdhury, Gaurab; Biswas, Saroj; Dholey, Yuthika; Adak, Subrata			The ChaC family of gamma-glutamyl cyclotransferases is required for Leishmania to switch to a slow growth state and for long- term survival of the parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOMA-BRUCEI; TRYPANOTHIONE BIOSYNTHESIS; REACTIVE OXYGEN; GLUTATHIONE; METABOLISM; GENOME; IDENTIFICATION; STRESS; ENZYME; CRUZI	The ChaC family of gamma-glutamyl cyclotransferases is conserved throughout all Kingdoms and catalyzes the degradation of GSH. So far, the ChaC family proteins in trypanosomal parasites are missing in the literature. Here, we report two members of the ChaC family of gamma-glutamyl cyclotransferases (LmChaC2a and LmChaC2b) in the unicellular pathogen Leishmania. Activity measurements suggest that these proteins catalyze degradation of GSH but no other gamma-glutamyl peptides. Recombinant LmChaC2a protein shows 17-fold lower catalytic efficiency (kcat 0.9 s-1) than LmChaC2b (kcat 15 s-1), although they showed comparable Km values ( 1.75 mM for LmChaC2a and 2.0 mM for LmChaC2b) toward GSH. qRT-PCR and Western blot analyses suggest that the LmChaC2a protein was found to be constitutively expressed, whereas LmChaC2b was regulated by sulfur stress. To investigate its precise physiological function in Leishmania, we generated overexpressed, knockout, and com-plement cell lines. Flow cytometric analyses show the presence of a higher intracellular GSH concentration and lower intra-cellular ROS level, indicative of a more reductive environment in null mutants. We found LmChaC2-expressing cells grow in GSH-containing sulfur-limited media, while the null mutants failed to grow, suggesting that LmChaC2 is crucial for cell growth with GSH as the only sulfur source. Null mutants, although reach the stationary phase rapidly, display impaired long-term survival, indicating that LmChaC2-mediated GSH degradation is necessary for prolonged survival. In vivo studies suggest that LmChaC2-dependent controlled GSH degradation promotes chronic infection by the parasite. Altogether, these data indicate that LmChaC2 plays an important role in GSH homeostasis in Leishmania.	[Das, Sumit; Panja, Puja; Chowdhury, Gaurab; Biswas, Saroj; Dholey, Yuthika; Adak, Subrata] CSIR Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), CSIR Indian Inst Chem Biol, Div Struct Biol & Bioinformat, Kolkata, India.	adaks@iicb.res.in			Council of Scientific and Industrial Research (CSIR) NCP Project [MLP-136]; Department of Science and Technology [CRG/2021/000421]; CSIR fellowships; UGC fellowships	Council of Scientific and Industrial Research (CSIR) NCP Project; Department of Science and Technology(Department of Science & Technology (India)); CSIR fellowships(Council of Scientific & Industrial Research (CSIR) - India); UGC fellowships	This work was supported by Council of Scientific and Industrial Research (CSIR) NCP Project MLP-136, Department of Science and Technology, (project no CRG/2021/000421), UGC fellowships (to S. D, P. P. and Y. D.) and CSIR fellowships (to S. B. and G. C.).	Abbott JJ, 2002, BIOCHEMISTRY-US, V41, P2741, DOI 10.1021/bi0159128; Adhikari A, 2019, BIOCHEM J, V476, P1303, DOI 10.1042/BCJ20190041; ARRICK BA, 1981, J EXP MED, V153, P720, DOI 10.1084/jem.153.3.720; Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; Bachhawat AK, 2018, IUBMB LIFE, V70, P585, DOI 10.1002/iub.1756; Baudouin-Cornu P, 2012, J BIOL CHEM, V287, P4552, DOI 10.1074/jbc.M111.315705; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biswas S, 2020, FEBS J, V287, P5183, DOI 10.1111/febs.15305; Crawford RR, 2015, J BIOL CHEM, V290, P15878, DOI 10.1074/jbc.M114.635144; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Das P, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101198; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; Dumas C, 1997, EMBO J, V16, P2590, DOI 10.1093/emboj/16.10.2590; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Franco R, 2009, CELL DEATH DIFFER, V16, P1303, DOI 10.1038/cdd.2009.107; Huynh TT, 2003, J BIOL CHEM, V278, P39794, DOI 10.1074/jbc.M306306200; Irigoin F, 2008, FREE RADICAL BIO MED, V45, P733, DOI 10.1016/j.freeradbiomed.2008.05.028; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kaur A, 2017, J BIOL CHEM, V292, P638, DOI 10.1074/jbc.M116.727479; Kloehn J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004683; Krauth-Siegel RL, 2008, BBA-GEN SUBJECTS, V1780, P1236, DOI 10.1016/j.bbagen.2008.03.006; Kumar A, 2012, EMBO REP, V13, P1095, DOI 10.1038/embor.2012.156; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Mavi PS, 2020, ANTIOXID REDOX SIGN, V32, P1348, DOI 10.1089/ars.2019.7867; McConville Malcolm J, 2015, F1000Res, V4, P938, DOI 10.12688/f1000research.6724.1; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mukherjee A, 2009, MOL MICROBIOL, V74, P914, DOI 10.1111/j.1365-2958.2009.06907.x; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nogoceke E, 1997, BIOL CHEM, V378, P827, DOI 10.1515/bchm.1997.378.8.827; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; Oakley AJ, 2010, J BIOL CHEM, V285, P9642, DOI 10.1074/jbc.M109.082099; ORLOWSKI M, 1970, P NATL ACAD SCI USA, V67, P1248, DOI 10.1073/pnas.67.3.1248; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; PENNINCKX MJ, 1993, ADV MICROB PHYSIOL, V34, P239, DOI 10.1016/S0065-2911(08)60031-4; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; SACKS DL, 1984, SCIENCE, V223, P1417, DOI 10.1126/science.6701528; Saunders EC, 2011, J BIOL CHEM, V286, P27706, DOI 10.1074/jbc.M110.213553; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Tetaud E, 1998, J BIOL CHEM, V273, P19383, DOI 10.1074/jbc.273.31.19383; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Venketaraman V, 2003, INFECT IMMUN, V71, P1864, DOI 10.1128/IAI.71.4.1864-1871.2003; Weldrick DP, 1999, FEMS MICROBIOL LETT, V173, P139, DOI 10.1111/j.1574-6968.1999.tb13495.x; Zhang HL, 2012, FASEB J, V26, P1442, DOI 10.1096/fj.11-199869	52	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102510	10.1016/j.jbc.2022.102510	http://dx.doi.org/10.1016/j.jbc.2022.102510			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36126772	Green Published, gold			2022-12-26	WOS:000882627400007
J	Du, H; Huang, ZX; Zhou, X; Kuang, XL; Long, CD; Tang, H; Zeng, JS; Huang, H; Liu, HJ; Zhu, BB; Fu, LC; Hu, K; Lin, SB; Wang, H; Zhang, QJ; Yan, JH; Shen, HX				Du, Han; Huang, Zixin; Zhou, Xin; Kuang, Xielan; Long, Chongde; Tang, Han; Zeng, Jingshu; Huang, Hao; Liu, Huijun; Zhu, Binbin; Fu, Licheng; Hu, Ke; Lin, ShuiBin; Wang, Hua; Zhang, Qingjiong; Yan, Jianhua; Shen, Huangxuan			Oxidative stress-induced lncRNA CYLD-AS1 promotes RPE inflammation via Nrf2/miR-134-5p/NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						AMD; inflammation; lncRNA; miRNA; oxidative stress; RPE	DAMAGE; DEGENERATION	Oxidative stress-induced damage to and dysfunction of retinal pigment epithelium (RPE) cells are important pathogenetic factors of age-related macular degeneration (AMD); however, the underlying molecular mechanism is not fully understood. Long noncoding RNAs (lncRNAs) have important roles in various biological processes. In this study, using an oxidative damage model in RPE cells, we identified a novel oxidation-related lncRNA named CYLD-AS1. We further revealed that the expression of CYLD-AS1 was increased in RPEs during oxidative stress. Depletion of CYLD-AS1 promoted cell proliferation and mitochondrial function and protected RPE cells against hydrogen peroxide (H2O2)-induced damage. Mechanistically, CYLD-AS1 also regulated the expression of NRF2, which is related to oxidative stress, and NF-kappa B signaling pathway members, which are related to inflammation. Remarkably, these two signaling pathways were mediated by the CYLD-AS1 interactor miR-134-5p. Moreover, exosomes secreted by CYLD-AS1 knockdown RPE cells had a lower proinflammatory effect than those secreted by control cells. In summary, our study revealed that CYLD-AS1 affects the oxidative stress-related and inflammatory functions of RPE cells by sponging miR-134-5p to mediate NRF2/NF-kappa B signaling pathway activity, suggesting that targeting CYLD-AS1 could be a promising strategy for the treatment of AMD and related diseases.	[Du, Han; Huang, Zixin; Zhou, Xin; Kuang, Xielan; Long, Chongde; Tang, Han; Zeng, Jingshu; Huang, Hao; Liu, Huijun; Zhu, Binbin; Fu, Licheng; Hu, Ke; Zhang, Qingjiong; Yan, Jianhua; Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlie Rd, Guangzhou 510060, Peoples R China; [Zhou, Xin] Univ Florida, Dept Mol Genet & Microbiol, Coll Med, Gainesville, FL USA; [Kuang, Xielan; Shen, Huangxuan] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Biobank Eye, Guangzhou, Peoples R China; [Huang, Hao] Guangzhou Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Liu, Huijun] Wuhan Univ Sci & Technol, Tianyou Hosp, Dept Ophthalmol, Wuhan, Peoples R China; [Lin, ShuiBin] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Precis Med Inst, Guangzhou, Peoples R China; [Wang, Hua] Southern Med Univ, Zhujiang Hosp, Dept Intens Care, Guangzhou, Peoples R China	Sun Yat Sen University; State University System of Florida; University of Florida; Sun Yat Sen University; Guangzhou Medical University; Wuhan University of Science & Technology; Sun Yat Sen University; Southern Medical University - China	Yan, JH; Shen, HX (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, 54 Xianlie Rd, Guangzhou 510060, Peoples R China.	yanjh2011@126.com; shenhx@mail.sysu.edu.cn			National Natural Science Foundation of China [81670874, 81670885]; Natural Science Foundation of Guangdong Province of China [2020A1515010144, 2021A1515010513, 2022A1515012442]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Open Research Funds of the State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds of the State Key Laboratory of Ophthalmology; Open Research Funds of the State Key Laboratory of Ophthalmology	The work was supported by the National Natural Science Foundation of China (81670874 and 81670885), Natural Science Foundation of Guangdong Province of China (Nos. 2020A1515010144, 2021A1515010513, and 2022A1515012442), and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (No. N/A) and the Open Research Funds of the State Key Laboratory of Ophthalmology (No. N/A).	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Biswas S, 2021, INVEST OPHTH VIS SCI, V62, DOI 10.1167/iovs.62.3.20; Bridges MC, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202009045; Brown EE, 2019, REDOX BIOL, V24, DOI 10.1016/j.redox.2019.101201; Chen X, 2020, MOL THER, V28, P929, DOI 10.1016/j.ymthe.2020.01.010; Cho MJ, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0327-y; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Du YY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/2684672; Eamegdool SS, 2020, FREE RADICAL BIO MED, V146, P357, DOI 10.1016/j.freeradbiomed.2019.11.018; Fan YT, 2018, ARCH BIOCHEM BIOPHYS, V650, P1, DOI 10.1016/j.abb.2018.05.008; Felszeghy S, 2019, REDOX BIOL, V20, P1, DOI 10.1016/j.redox.2018.09.011; Flores-Bellver M, 2021, J EXTRACELL VESICLES, V10, DOI 10.1002/jev2.12165; Gallenga CE, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10060848; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Golestaneh N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.453; Guo J, 2022, EUR J MED CHEM, V242, DOI 10.1016/j.ejmech.2022.114630; He J, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3681707; He Y, 2020, AM J PHYSIOL-ENDOC M, V320, pE598, DOI 10.1152/ajpendo.00089.2020; Huang H, 2021, CELL SIGNAL, V88, DOI 10.1016/j.cellsig.2021.110153; Jadeja RN, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101336; Jarrett SG, 2012, MOL ASPECTS MED, V33, P399, DOI 10.1016/j.mam.2012.03.009; Kaarniranta K, 2020, PROG RETIN EYE RES, V79, DOI 10.1016/j.preteyeres.2020.100858; Ke YF, 2020, J CELL BIOCHEM, V121, P4849, DOI 10.1002/jcb.29713; Liu LY, 2017, MOL MED REP, V16, P730, DOI 10.3892/mmr.2017.6625; Liva F, 2019, CURR DRUG TARGETS, V20, P903, DOI 10.2174/1389450120666190122114857; Long YC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2110; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Plafker SM, 2012, INT REV CEL MOL BIO, V298, P135, DOI 10.1016/B978-0-12-394309-5.00004-3; Postnikova OA, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030205; Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002; Rinn JL, 2020, ANNU REV BIOCHEM, V89, P283, DOI 10.1146/annurev-biochem-062917-012708; Sun QY, 2018, TRENDS GENET, V34, P142, DOI 10.1016/j.tig.2017.11.005; Tomida D, 2011, INVEST OPHTH VIS SCI, V52, P3193, DOI 10.1167/iovs.10-6737; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Uemura A, 2021, PROG RETIN EYE RES, V84, DOI 10.1016/j.preteyeres.2021.100954; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Wan PX, 2020, CELL DEATH DIFFER, V27, P176, DOI 10.1038/s41418-019-0351-4; Wang CY, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4586839; Zhang H, 2020, J CELL MOL MED, V24, P12368, DOI 10.1111/jcmm.15736; Zhang Y, 2020, THERANOSTICS, V10, P10823, DOI 10.7150/thno.47830; Zhao D, 2020, CLIN SCI, V134, P2419, DOI 10.1042/CS20200694; Zhao JW, 2022, CELL DEATH DISCOV, V8, DOI 10.1038/s41420-022-01146-7	44	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22577	10.1096/fj.202200887R	http://dx.doi.org/10.1096/fj.202200887R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1SF	36165267				2022-12-26	WOS:000859945000001
J	Tang, WM; Pei, MM; Li, JY; Xu, NZ; Xiao, WS; Yu, Z; Zhang, JM; Hong, LJ; Guo, Z; Lin, JJ; Dai, WY; Xiao, YZ; Wu, XS; Liu, GN; Zhi, FC; Li, GX; Xiong, J; Chen, Y; Zhang, H; Xiang, L; Li, AM; Liu, SD; Wang, JD				Tang, Weimei; Pei, Miaomiao; Li, Jiaying; Xu, Nanzhu; Xiao, Wushuang; Yu, Zhen; Zhang, Jieming; Hong, Linjie; Guo, Zheng; Lin, Jianjiao; Dai, Weiyu; Xiao, Yizhi; Wu, Xiaosheng; Liu, Guangnan; Zhi, Fachao; Li, Guoxin; Xiong, Jing; Chen, Ye; Zhang, Hui; Xiang, Li; Li, Aimin; Liu, Side; Wang, Jide			The miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop modulates the metastasis and invasion of gastric cancer cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; WNT SIGNALING PATHWAY; MOLECULAR-CLONING; TUMOR-METASTASIS; IN-VITRO; C-MYC; PROLIFERATION; FRAT1; EXPRESSION; REGULATOR	Although the abnormal expression of miRNAs in cancer cells is a widely accepted phenomenon, the molecular mechanisms underlying miR-3648 progression and metastasis in gastric cancer (GC) remain unclear. miR-3648 expression is downregulated and its ectopic expression in GC cells significantly suppressed cell proliferation and metastasis. Mechanistic analyses indicated that miR-3648 directly targets FRAT1 or FRAT2 and inhibits FRAT1- or FRAT2-mediated invasion and motility in vitro and in vivo. Moreover, FRAT1 physically interacted with FRAT2. Furthermore, FRAT1 overexpression promoted GC cell invasion, whereas siRNA-mediated repression of FRAT2 in FRAT1-overexpressing GC cells reversed its invasive potential. Besides, miR-3648 inactivated the Wnt/beta-catenin signalling pathway by downregulating FRAT1 and FRAT2 in GC. Interestingly, c-Myc, a downstream effector of Wnt/beta-catenin signalling, was also downregulated by miR-3648 overexpression. In turn, c-Myc negatively regulated miR-3648 expression by binding to the miR-3648 promoter. In addition, miR-3648 expression levels were negatively correlated with c-Myc, FRAT1, and FRAT2 expression in fresh gastric samples. Our studies suggest that miR-3648 acts as a tumour-suppressive miRNA and that the miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop could be a critical regulator of GC progression.	[Tang, Weimei; Pei, Miaomiao; Li, Jiaying; Xu, Nanzhu; Xiao, Wushuang; Yu, Zhen; Zhang, Jieming; Hong, Linjie; Dai, Weiyu; Xiao, Yizhi; Wu, Xiaosheng; Liu, Guangnan; Zhi, Fachao; Xiong, Jing; Li, Aimin; Liu, Side; Wang, Jide] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Peoples R China; [Guo, Zheng] Shenzhen Univ, Gen Hosp, Int Canc Ctr, Dept Hematol & Oncol, Xueyuan AVE 1098, Shenzhen 518000, Guangdong, Peoples R China; [Lin, Jianjiao; Zhi, Fachao; Xiang, Li; Liu, Side; Wang, Jide] Longgang Dist Peoples Hosp, Dept Gastroenterol, Shenzhen 518172, Peoples R China; [Li, Guoxin] Southern Med Univ, Nanfang Hosp, Dept Gen Surg, Guangzhou 510515, Peoples R China; [Chen, Ye] Southern Med Univ, Shenzhen Hosp, Clin Microecol Ctr, Shenzhen 518000, Peoples R China; [Zhang, Hui] Southern Med Univ, Hexian Mem Affiliated Hosp, Dept Gastroenterol, Guangzhou 511400, Peoples R China	Southern Medical University - China; Shenzhen University; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Li, AM; Liu, SD; Wang, JD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou 510515, Peoples R China.; Xiang, L; Liu, SD; Wang, JD (corresponding author), Longgang Dist Peoples Hosp, Dept Gastroenterol, Shenzhen 518172, Peoples R China.	shellyxiangli@163.com; lam0725@163.com; liuside2011@163.com; jidewang55@163.com			Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University; National Natural Science Foundation of China [81974448, 81772964, 82073066, 82103152]; GuangDong Basic and Applied Basic Research Foundation [2020A1515110059]; Guangdong Gastrointestinal Disease Research Center [2017B020209003]; Guangdong Medical Research Foundation [B2019126]; Shenzhen Science and Technology Innovation Commission [JCYJ20180306170328854]; Shenzhen Science and Technology Innovation Commission Fund [JCYJ20210324135005013]; Shenzhen Longgang District Science and Technology Innovation commission fund [LGKCYLWS 2021000012]	Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GuangDong Basic and Applied Basic Research Foundation; Guangdong Gastrointestinal Disease Research Center; Guangdong Medical Research Foundation; Shenzhen Science and Technology Innovation Commission; Shenzhen Science and Technology Innovation Commission Fund; Shenzhen Longgang District Science and Technology Innovation commission fund	We acknowledge the generous support of the Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University. This study was supported by grants from the National Natural Science Foundation of China (Nos. 81974448, 81772964, 82073066 and 82103152), GuangDong Basic and Applied Basic Research Foundation (No. 2020A1515110059), Guangdong Gastrointestinal Disease Research Center (No. 2017B020209003), Guangdong Medical Research Foundation (No. B2019126), Shenzhen Science and Technology Innovation Commission (No. JCYJ20180306170328854), Shenzhen Science and Technology Innovation Commission Fund (No. JCYJ20210324135005013) and Shenzhen Longgang District Science and Technology Innovation commission fund (No. LGKCYLWS 2021000012).	Ahadi A, 2020, IUBMB LIFE, V72, P884, DOI 10.1002/iub.2259; Codolo G, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02923; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Doumpas N, 2019, EMBO J, V38, DOI 10.15252/embj.201798873; Fan HY, 2018, BIOCHEM BIOPH RES CO, V503, P3100, DOI 10.1016/j.bbrc.2018.08.099; Folgueras AR, 2004, INT J DEV BIOL, V48, P411, DOI 10.1387/ijdb.041811af; Freemantle SJ, 2002, GENE, V291, P17, DOI 10.1016/S0378-1119(02)00594-2; Gu XF, 2014, NEURO-ONCOLOGY, V16, P217, DOI 10.1093/neuonc/not194; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Ibrahim HM, 2019, J GASTROINTEST CANC, V50, P370, DOI 10.1007/s12029-018-0079-2; Jiang JX, 2015, ONCOTARGET, V6, P2767, DOI 10.18632/oncotarget.3089; Karim RZ, 2004, PATHOLOGY, V36, P120, DOI 10.1080/00313020410001671957; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Katoh M, 2009, INT J ONCOL, V34, P1411, DOI 10.3892/ijo_00000269; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Li QW, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5683-4; Lin J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2474-4; Liu JJ, 2014, CANCER LETT, V347, P98, DOI 10.1016/j.canlet.2014.01.024; Liu LY, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109865; Liu Q, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1370-1; Lu J, 2020, J CELL PHYSIOL, V235, P6287, DOI 10.1002/jcp.29556; Lv YF, 2016, CANCER LETT, V373, P164, DOI 10.1016/j.canlet.2016.01.046; Lv ZB, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1357-7; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; Paclikova P, 2021, CELL SIGNAL, V85, DOI 10.1016/j.cellsig.2021.110058; Pang YM, 2018, J CELL MOL MED, V22, P6262, DOI 10.1111/jcmm.13916; Peng Y, 2017, CANCER LETT, V385, P117, DOI 10.1016/j.canlet.2016.10.035; Peng YP, 2019, ONCOL RES, V27, P65, DOI 10.3727/096504018X15191223015016; Ren LL, 2019, THERANOSTICS, V9, P449, DOI 10.7150/thno.29055; Ruan ZY, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106003; Saitoh T, 2002, INT J ONCOL, V20, P785; Saitoh T, 2001, INT J ONCOL, V19, P311; Saitoh T, 2001, BIOCHEM BIOPH RES CO, V281, P815, DOI 10.1006/bbrc.2001.4421; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sun WR, 2019, MOL THER-NUCL ACIDS, V16, P519, DOI 10.1016/j.omtn.2019.04.006; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tang WM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08225-3; Tian WJ, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-1139-9; van Amerongen R, 2010, ONCOGENE, V29, P93, DOI 10.1038/onc.2009.310; van der Wal T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227435; Wang B, 2014, HEPATOLOGY, V59, P555, DOI 10.1002/hep.26712; Werner TV, 2017, AGING-US, V9, P932, DOI 10.18632/aging.101201; Xing RW, 2019, J NANOSCI NANOTECHNO, V19, P7526, DOI 10.1166/jnn.2019.16413; Xu K, 2019, MOL THER, V27, P1810, DOI 10.1016/j.ymthe.2019.05.017; Yan GQ, 2021, LIFE SCI, V264, DOI 10.1016/j.lfs.2020.118726; Yang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep33078; Yang XZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0874-1; Yang ZC, 2018, EXP CELL RES, V368, P194, DOI 10.1016/j.yexcr.2018.04.030; Ye GT, 2017, THERANOSTICS, V7, P3338, DOI 10.7150/thno.20512; Zhang M, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1815-7; Zhang P, 2017, BRIT J CANCER, V117, P525, DOI 10.1038/bjc.2017.181; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094; Zhang Y, 2019, J GASTRIC CANCER, V19, P315, DOI 10.5230/jgc.2019.19.e28; Zhao CC, 2017, ONCOL REP, V38, P352, DOI 10.3892/or.2017.5673; Zhao MY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0103-7; Zheng KH, 2016, CANCER LETT, V376, P178, DOI 10.1016/j.canlet.2016.03.024; Zhou DH, 2021, EXP THER MED, V22, DOI 10.3892/etm.2021.10230; Zhou Y, 2020, J THORAC DIS, V12, P3478, DOI 10.21037/jtd-20-1557A	58	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 21	2022	41	43					4823	4838		10.1038/s41388-022-02451-2	http://dx.doi.org/10.1038/s41388-022-02451-2		SEP 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5M4RI	36153370	Green Published, hybrid			2022-12-26	WOS:000857812100002
J	Belachew, B; Gao, J; Byrd, AK; Raney, KD				Belachew, Binyam; Gao, Jun; Byrd, Alicia K.; Raney, Kevin D.			Hepatitis C virus nonstructural protein NS3 unfolds viral G-quadruplex RNA structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICASE ACTIVITY; DUPLEX DNA; REPLICATION; BINDING; UNWINDS; DOMAIN; LOOPS; TRANSLOCATION; DISPLACEMENT; MOLECULES	Hepatitis C virus (HCV) is a major cause of liver-related diseases and hepatocellular carcinoma. The helicase domain of one of the nonstructural proteins of HCV, NS3 (nonstruc-tural protein 3), is essential for viral replication; however, its specific biological role is still under investigation. Here, we set out to determine the interaction between a purified recombi-nant full length NS3 and synthetic guanine-rich substrates that represent the conserved G-quadruplex (G4)-forming sequences in the HCV-positive and HCV-negative strands. We performed fluorescence anisotropy binding, G4 reporter duplex unwind-ing, and G4RNA trapping assays to determine the binding and G4 unfolding activity of NS3. Our data suggest that NS3 can unfold the conserved G4 structures present within the genome and the negative strand of HCV. Additionally, we found the activity of NS3 on a G4RNA was reduced significantly in the presence of a G4 ligand. The ability of NS3 to unfold HCV G4RNA could imply a novel biological role of the viral helicase in replication.	[Belachew, Binyam; Gao, Jun; Byrd, Alicia K.; Raney, Kevin D.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Raney, KD (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.				National Institute of Health [R35GM122601]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Health Grant R35GM122601 (K. D. R) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.	Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Byrd AK, 2005, BIOCHEMISTRY-US, V44, P12990, DOI 10.1021/bi050703z; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Byrd AK, 2018, J BIOL CHEM, V293, P17792, DOI 10.1074/jbc.RA118.004499; Byrd AK, 2015, J BIOL CHEM, V290, P6482, DOI 10.1074/jbc.M114.630749; Byrd AK, 2012, FRONT BIOSCI-LANDMRK, V17, P2070, DOI 10.2741/4038; Caterino M, 2022, METHODS, V204, P110, DOI 10.1016/j.ymeth.2021.09.003; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; Cui HR, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.567317; del Villar-Guerra R, 2018, ANGEW CHEM INT EDIT, V57, P7171, DOI 10.1002/anie.201709184; Edwards AD, 2021, NUCLEIC ACIDS RES, V49, P416, DOI 10.1093/nar/gkaa1172; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gao J, 2019, CHEM COMMUN, V55, P4467, DOI 10.1039/c8cc10091h; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Griffin WC, 2017, J BIOL CHEM, V292, P9567, DOI 10.1074/jbc.M117.776211; Gwack Y, 1996, BIOCHEM BIOPH RES CO, V225, P654, DOI 10.1006/bbrc.1996.1225; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Jaubert C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26582-3; Kharel P, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1568; Kolykhalov AA, 2000, J VIROL, V74, P2046, DOI 10.1128/JVI.74.4.2046-2051.2000; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lavezzo E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006675; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Levin MK, 2002, J BIOL CHEM, V277, P29377, DOI 10.1074/jbc.M112315200; Liu HH, 2021, J AM CHEM SOC, V143, P7368, DOI 10.1021/jacs.1c00131; Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038; Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6; Marecki John C, 2021, Enzymes, V50, P335, DOI 10.1016/bs.enz.2021.09.005; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Oliver AW, 1999, BIOCHEM J, V339, P525, DOI 10.1042/0264-6021:3390525; Pandey S, 2013, J PHYS CHEM B, V117, P6896, DOI 10.1021/jp401739m; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Quinkert D, 2005, J VIROL, V79, P13594, DOI 10.1128/JVI.79.21.13594-13605.2005; Rajagopal V, 2008, J MOL BIOL, V376, P69, DOI 10.1016/j.jmb.2007.10.070; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Raney VM, 2012, BIOCHEMISTRY-US, V51, P7596, DOI 10.1021/bi300654v; Reynolds KA, 2015, BIOCHEMISTRY-US, V54, P4248, DOI 10.1021/acs.biochem.5b00214; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Sauer M, 2017, BIOCHEM SOC T, V45, P1173, DOI 10.1042/BST20170097; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Song JW, 2016, TRANSLATION, V4, DOI 10.1080/21690731.2016.1244031; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tippana R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09802-w; Varshney D, 2020, NAT REV MOL CELL BIO, V21, P459, DOI 10.1038/s41580-020-0236-x; Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535; Yangyuoru PM, 2018, J BIOL CHEM, V293, P1924, DOI 10.1074/jbc.M117.815076; Zhang C, 2005, J VIROL, V79, P8687, DOI 10.1128/JVI.79.14.8687-8697.2005; Zhou T, 2018, J VIROL, V92, DOI 10.1128/JVI.01253-17	59	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102486	10.1016/j.jbc.2022.102486	http://dx.doi.org/10.1016/j.jbc.2022.102486			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36108740	Green Published, gold			2022-12-26	WOS:000881802600008
J	Zhang, W; Ye, FH; Xiong, J; He, F; Yang, L; Yin, F; Peng, J; Wang, XL				Zhang, Wen; Ye, Fanghua; Xiong, Juan; He, Fang; Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole			Silencing of miR-132-3p protects against neuronal injury following status epilepticus by inhibiting IL-1 beta-induced reactive astrocyte (A1) polarization	FASEB JOURNAL			English	Article						astrocyte; epilepsy; microRNAs; neuronal damage	TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL MOSSY FIBERS; IMMATURE RAT MODEL; DOWN-REGULATION; EXPRESSION; MICRORNA-132; INTERLEUKIN-1-BETA; INFLAMMATION; ACTIVATION; MIR-146A	Mesial temporal lobe epilepsy (MTLE) is one of the most common refractory epilepsies and is usually accompanied by a range of brain pathological changes, such as neuronal injury and astrocytosis. Naive astrocytes are readily converted to cytotoxic reactive astrocytes (A1) in response to inflammatory stimulation, suppressing the polarization of A1 protects against neuronal death in early central nervous system injury. Our previous study found that pro-inflammatory cytokines and miR-132-3p (hereinafter referred to as "miR-132") expression were upregulated, but how miR-132 affected reactive astrocyte polarization and neuronal damage during epilepsy is not fully understood. Here, we aimed to explore the effect and mechanism of miR-132 on A1 polarization. Our results confirmed that A1 markers were significantly elevated in the hippocampus of MTLE rats and IL-1 beta-treated primary astrocytes. In vivo, knockdown of miR-132 by lateral ventricular injection reduced A1 astrocytes, neuronal loss, mossy fiber sprouting, and remitted the severity of status epilepticus and the recurrence of spontaneous recurrent seizures. In vitro, the neuronal cell viability and axon length were reduced by additional treatment with A1 astrocyte conditioned media (ACM), and downregulation of astrocyte miR-132 rescued the inhibition of cell activity by A1 ACM, while the length of axons was further inhibited. The regulation of miR-132 on A1 astrocytes may be related to its target gene expression. Our results show that interfering with astrocyte polarization may be a breakthrough in the treatment of refractory epilepsy, which may extend to the research of other astrocyte polarization-mediated brain injuries.	[Zhang, Wen; Ye, Fanghua; Xiong, Juan; He, Fang; Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole] Cent South Univ, Xiangya Hosp, Dept Pediat, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Yang, Li; Yin, Fei; Peng, Jing; Wang, Xiaole] Hunan Intellectual & Dev Disabil Res Ctr, Pediat, Changsha, Peoples R China	Central South University	Peng, J; Wang, XL (corresponding author), Cent South Univ, Xiangya Hosp, Dept Pediat, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	pengjing627@126.com; 1195663129@qq.com		Zhang, Wen/0000-0003-4391-8199	Central South University (CSU) [2019zzts347]; National Natural Science Foundation of China (NSFC) [81371434, 81771408, 81801297]	Central South University (CSU); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Central South University (CSU), Grant/Award Number: 2019zzts347; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81371434, 81771408 and 81801297	Althammer F, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01892-4; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Aten Sydney, 2016, RNA Dis, V3; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Batiuk MY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14198-8; Binder DK, 2001, TRENDS NEUROSCI, V24, P47, DOI 10.1016/S0166-2236(00)01682-9; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Chai G, 2015, INT J BIOCHEM CELL B, V64, P11, DOI 10.1016/j.biocel.2015.03.013; Damaye CA, 2011, INT J NEUROSCI, V121, P575, DOI 10.3109/00207454.2011.598979; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Diaz-Castro B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw8546; Dokalis N, 2019, SEMIN IMMUNOPATHOL, V41, P699, DOI 10.1007/s00281-019-00764-1; Escartin C, 2021, NAT NEUROSCI, V24, P312, DOI 10.1038/s41593-020-00783-4; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Funding AT, 2006, J INVEST DERMATOL, V126, P1784, DOI 10.1038/sj.jid.5700252; Gottipati MK, 2020, ACTA BIOMATER, V117, P273, DOI 10.1016/j.actbio.2020.09.057; Gross C, 2016, CELL REP, V17, P37, DOI 10.1016/j.celrep.2016.08.074; Guo MF, 2020, J NEUROIMMUNOL, V346, DOI 10.1016/j.jneuroim.2020.577284; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Haan N, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0327-3; Hayakawa K, 2014, STEM CELL RES, V12, P531, DOI 10.1016/j.scr.2013.12.008; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hinkle JT, 2019, MOVEMENT DISORD, V34, P959, DOI 10.1002/mds.27718; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Huang YY, 2014, INT J CLIN EXP MED, V7, P1639; Ikegaya Y, 1999, J NEUROSCI, V19, P802; Iori V, 2017, NEUROBIOL DIS, V99, P12, DOI 10.1016/j.nbd.2016.12.007; Itoh N, 2018, P NATL ACAD SCI USA, V115, pE302, DOI 10.1073/pnas.1716032115; Jimenez-Mateos EM, 2012, NAT MED, V18, P1087, DOI 10.1038/nm.2834; Jimenez-Mateos EM, 2011, AM J PATHOL, V179, P2519, DOI 10.1016/j.ajpath.2011.07.036; Jobst BC, 2015, JAMA-J AM MED ASSOC, V313, P285, DOI 10.1001/jama.2014.17426; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; King A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10080503; Kong HM, 2015, J MOL NEUROSCI, V57, P28, DOI 10.1007/s12031-015-0574-x; Korotkov A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11510-8; Korotkov A, 2020, GLIA, V68, P60, DOI 10.1002/glia.23700; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Koyama R, 2004, J NEUROSCI, V24, P7215, DOI 10.1523/JNEUROSCI.2045-04.2004; Lado FA, 2001, EPILEPSIA, V42, P458, DOI 10.1046/j.1528-1157.2001.30900.x; Li SY, 2018, BIOCHEM PHARMACOL, V151, P245, DOI 10.1016/j.bcp.2017.12.023; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu DSH, 2009, NEUROBIOL DIS, V35, P337, DOI 10.1016/j.nbd.2009.05.009; Liu M, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01946-7; del Rey NLG, 2022, NEUROPATH APPL NEURO, V48, DOI 10.1111/nan.12812; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Nakazawa T, 2003, MOL BIOL CELL, V14, P2921, DOI 10.1091/mbc.e02-09-0623; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Numakawa T, 2011, NEUROSCI LETT, V505, P242, DOI 10.1016/j.neulet.2011.10.025; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Omran A, 2012, EPILEPSIA, V53, P1215, DOI 10.1111/j.1528-1167.2012.03540.x; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Pohlen MS, 2017, EPILEPSY RES, V137, P56, DOI 10.1016/j.eplepsyres.2017.09.012; Rahimian P, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0716-2; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; REPRESA A, 1993, HIPPOCAMPUS, V3, P257, DOI 10.1002/hipo.450030303; Rothhammer V, 2015, SEMIN IMMUNOPATHOL, V37, P625, DOI 10.1007/s00281-015-0515-3; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salta E, 2014, DEV CELL, V30, P423, DOI 10.1016/j.devcel.2014.07.006; Sano F, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.135391; Schiweck J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00261; Sirko S, 2015, GLIA, V63, P2340, DOI 10.1002/glia.22898; Slack JL, 2000, J BIOL CHEM, V275, P4670, DOI 10.1074/jbc.275.7.4670; Sloviter RS, 2006, J COMP NEUROL, V494, P944, DOI 10.1002/cne.20850; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Song YJ, 2019, J CELL BIOCHEM, V120, P9147, DOI 10.1002/jcb.28190; Su YL, 2019, FASEB J, V33, P10859, DOI 10.1096/fj.201900743R; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; Vangoor VR, 2019, J NEUROSCI, V39, P5064, DOI 10.1523/JNEUROSCI.3014-18.2019; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang XL, 2018, EPILEPSY RES, V139, P14, DOI 10.1016/j.eplepsyres.2017.10.006; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xia L, 2017, ONCOTARGET, V8, P40668, DOI 10.18632/oncotarget.16541; Xiao ZH, 2015, J NEUROIMMUNOL, V282, P110, DOI 10.1016/j.jneuroim.2015.04.003; Xu B, 2017, CELL RES, V27, P882, DOI 10.1038/cr.2017.62; Yao CC, 2019, BRIT J PHARMACOL, V176, P337, DOI 10.1111/bph.14530; Yoshimura A, 2016, NEUROCHEM INT, V97, P26, DOI 10.1016/j.neuint.2016.04.013; Yuan JX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5108489; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhang LF, 2021, J NEUROCHEM, V158, P880, DOI 10.1111/jnc.15457; Zhang YN, 2021, INT J BIOL SCI, V17, P2795, DOI 10.7150/ijbs.60509; Zhu XJ, 2012, NEUROBIOL DIS, V45, P253, DOI 10.1016/j.nbd.2011.08.009; Zou HJ, 2021, FRONT NEUROSCI-SWITZ, V15, DOI 10.3389/fnins.2021.628917; Zou LH, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00429	88	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22554	10.1096/fj.202200110RR	http://dx.doi.org/10.1096/fj.202200110RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N7UO	36111973				2022-12-26	WOS:000854221900001
J	Wu, LY; Ahmadid, M; Qureshi, SA; Razaid, K; Khan, YA				Wu, Liyun; Ahmadid, Muneeb; Qureshi, Salman Ali; Razaid, Kashif; Khan, Yousaf Ali			An analysis of machine learning risk factors and risk parity portfolio optimization	PLOS ONE			English	Article							CROSS-SECTION; INTELLIGENCE; VOLATILITY; MODEL; CVAR	Many academics and experts focus on portfolio optimization and risk budgeting as a topic of study. Streamlining a portfolio using machine learning methods and elements is examined, as well as a strategy for portfolio expansion that relies on the decay of a portfolio's risk into risk factor commitments. There is a more vulnerable relationship between commonly used trademarked portfolios and neural organizations based on variables than famous dimensionality decrease strategies, as we have found. Machine learning methods also generate covariance and portfolio weight structures that are more difficult to assess. The least change portfolios outperform simpler benchmarks in minimizing risk. During periods of high instability, risk-adjusted returns are present, and these effects are amplified for investors with greater sensitivity to chance changes in returns R.	[Wu, Liyun] Shanghai Urban Construct Vocat Coll, Sch Trade & Econ, Shanghai, Peoples R China; [Ahmadid, Muneeb] Jiangxi Univ Finance & Econ, Sch Finance, Nanchang, Jiangxi, Peoples R China; [Qureshi, Salman Ali] Allama Iqbal Open Univ, Dept Business Adm, Islamabad, Pakistan; [Razaid, Kashif] Univ Educ Lahore, UE Business Sch, Div Management & Adm Sci, Lahore, Pakistan; [Khan, Yousaf Ali] Hazara Univ Mansehra, Dept Math & Stat, Mansehra, Pakistan	Jiangxi University of Finance & Economics; Hazara University	Ahmadid, M (corresponding author), Jiangxi Univ Finance & Econ, Sch Finance, Nanchang, Jiangxi, Peoples R China.	muneeb112@gmail.com						Bai X, 2016, QUANT FINANC, V16, P357, DOI 10.1080/14697688.2015.1031815; Bali TG, 2011, J FINANC ECON, V99, P427, DOI 10.1016/j.jfineco.2010.08.014; Banihashemi S, 2017, OPER RES PERSPECT, V4, P21, DOI 10.1016/j.orp.2017.02.001; Bank D., 2020, ARXIV, DOI DOI 10.48550/ARXIV.2003.05991; Bhansali V., 2014, TAIL RISK HEDGING CR; Bianchi D, 2021, REV FINANC STUD, V34, P1046, DOI 10.1093/rfs/hhaa062; Bruder B., 2012, MANAGING RISK EXPOSU; Choueifaty Y, 2008, J PORTFOLIO MANAGE, V35, P40, DOI 10.3905/JPM.2008.35.1.40; Clarke R, 2006, J PORTFOLIO MANAGE, V33, P10, DOI 10.3905/jpm.2006.661366; Conlon T., 2021, ARXIV; Costa G, 2020, J GLOBAL OPTIM, V78, P207, DOI 10.1007/s10898-020-00915-x; D'Hondt C, 2020, J EMPIR FINANC, V59, P278, DOI 10.1016/j.jempfin.2020.10.002; DeMiguel V., 2017, PORTFOLIO PERSPECTIV; Fabozzi FA, 2021, J PORTFOLIO MANAGE, V47, P41, DOI 10.3905/jpm.2021.1.228; Fama EF, 2015, J FINANC ECON, V116, P1, DOI 10.1016/j.jfineco.2014.10.010; Feng GH, 2020, J FINANC, V75, P1327, DOI 10.1111/jofi.12883; Feng YY, 2015, IEEE T SIGNAL PROCES, V63, P5285, DOI 10.1109/TSP.2015.2452219; Gambeta V, 2020, J RISK FINANC MANAG, V13, DOI 10.3390/jrfm13100237; Geetha R, 2021, ARCH COMPUT METHOD E, V28, P2861, DOI 10.1007/s11831-020-09478-2; Goncalves A. P., 2012, INT C IND ENG OPERAT; Gu SH, 2021, J ECONOMETRICS, V222, P429, DOI 10.1016/j.jeconom.2020.07.009; Haftor DM, 2021, J BUS RES, V131, P196, DOI 10.1016/j.jbusres.2021.04.015; Homescu C., 2014, ONE OPTIMAL PORTFOLI; Huang XB, 2022, J INT TRADE ECON DEV, V31, P375, DOI 10.1080/09638199.2021.1981983; Jacob Devlin, 2019, Arxiv, DOI arXiv:1810.04805; Ji R, 2018, ANN OPER RES, V262, P547, DOI 10.1007/s10479-015-2044-9; Kelly B. T., 2020, SSRN; Kolm PN, 2014, EUR J OPER RES, V234, P356, DOI 10.1016/j.ejor.2013.10.060; Kone N. G., 2020, MULTIPERIOD PORTFOLI; KONNO H, 1991, MANAGE SCI, V37, P519, DOI 10.1287/mnsc.37.5.519; Kozak S, 2020, J FINANC ECON, V135, P271, DOI 10.1016/j.jfineco.2019.06.008; Lettau M, 2020, REV FINANC STUD, V33, P2274, DOI 10.1093/rfs/hhaa020; Light N, 2017, REV FINANC STUD, V30, P1339, DOI 10.1093/rfs/hhw102; Lohre H, 2014, J RISK, V16, P53, DOI 10.21314/JOR.2014.284; Lopes PN, 2004, PERS SOC PSYCHOL B, V30, P1018, DOI 10.1177/0146167204264762; Maillard S, 2010, J PORTFOLIO MANAGE, V36, P60, DOI 10.3905/jpm.2010.36.4.060; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; Mausser H, 2018, QUANT FINANC, V18, P1927, DOI 10.1080/14697688.2018.1434317; Meucci A., 2009, RISK, P74; Meucci A., 2015, SSRN; Moreira A, 2017, J FINANC, V72, P1611, DOI 10.1111/jofi.12513; Morgan J. P., 1996, RISKMETRICS TECHNICA; Moura GV, 2020, J BANK FINANC, V118, DOI 10.1016/j.jbankfin.2020.105882; Olivares-Nadal AV, 2018, OPER RES, V66, P733, DOI 10.1287/opre.2017.1699; Perrin S., 2020, MACHINE LEARNING ASS, P261; Poddig T, 2012, FINANC MARK PORTFOLI, V26, P369, DOI 10.1007/s11408-012-0190-5; Qian E., 2005, RISK PARITY PORTFOLI; Ranjan C., 2019, BUILD RIGHT AUTOEN 2; Rapach DE, 2013, J FINANC, V68, P1633, DOI 10.1111/jofi.12041; Richard J. C., 2019, ARXIV; Rockafellar R. T., 2000, J RISK, V2, P21, DOI 10.21314/JOR.2000.038; SHARPE WF, 1963, MANAGE SCI, V9, P277, DOI 10.1287/mnsc.9.2.277; Strub MS, 2019, J ECON DYN CONTROL, V108, DOI 10.1016/j.jedc.2019.103751; Uryasev S., 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P49, DOI 10.1109/CIFER.2000.844598; Wang JY, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1900, DOI 10.1145/3292500.3330647; Young MR, 1998, MANAGE SCI, V44, P673, DOI 10.1287/mnsc.44.5.673	58	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2022	17	9							e0272521	10.1371/journal.pone.0272521	http://dx.doi.org/10.1371/journal.pone.0272521			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6V9BY	36156075	gold, Green Published			2022-12-26	WOS:000895334800001
J	Camy, C; Brioche, T; Senni, K; Bertaud, A; Genovesio, C; Lamy, E; Fovet, T; Chopard, A; Pithioux, M; Roffino, S				Camy, Claire; Brioche, Thomas; Senni, Karim; Bertaud, Alexandrine; Genovesio, Cecile; Lamy, Edouard; Fovet, Theo; Chopard, Angele; Pithioux, Martine; Roffino, Sandrine			Effects of hindlimb unloading and subsequent reloading on the structure and mechanical properties of Achilles tendon-to-bone attachment	FASEB JOURNAL			English	Article						Achilles tendon enthesis; collagen II; fibrocartilage; hindlimb suspension; mechanical properties; reloading	SIMULATED MICROGRAVITY; NUCLEUS PULPOSUS; TAIL SUSPENSION; ENTHESIS; STRAIN; COLLAGEN; MUSCLE; DISUSE; FIBROCARTILAGE; PROTEOGLYCANS	While muscle and bone adaptations to deconditioning have been widely described, few studies have focused on the tendon enthesis. Our study examined the effects of mechanical loading on the structure and mechanical properties of the Achilles tendon enthesis. We assessed the fibrocartilage surface area, the organization of collagen, the expression of collagen II, the presence of osteoclasts, and the tensile properties of the mouse enthesis both after 14 days of hindlimb suspension (HU) and after a subsequent 6 days of reloading. Although soleus atrophy was severe after HU, calcified fibrocartilage (CFc) was a little affected. In contrast, we observed a decrease in non-calcified fibrocartilage (UFc) surface area, collagen fiber disorganization, modification of morphological characteristics of the fibrocartilage cells, and altered collagen II distribution. Compared to the control group, restoring normal loads increased both UFc surface area and expression of collagen II, and led to a crimp pattern in collagen. Reloading induced an increase in CFc surface area, probably due to the mineralization front advancing toward the tendon. Functionally, unloading resulted in decreased enthesis stiffness and a shift in site of failure from the osteochondral interface to the bone, whereas 6 days of reloading restored the original elastic properties and site of failure. In the context of spaceflight, our results suggest that care must be taken when performing countermeasure exercises both during missions and during the return to Earth.	[Camy, Claire; Lamy, Edouard; Pithioux, Martine; Roffino, Sandrine] Aix Marseille Univ, Inst Movement Sci, ISM, CNRS, Marseille, France; [Brioche, Thomas; Fovet, Theo; Chopard, Angele] Montpellier Univ, INRAE, DMEM, UMR 866, Montpellier, France; [Senni, Karim] Ecole Biol Ind EBI, Lab EBInnov, Cergy, France; [Bertaud, Alexandrine] Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France; [Bertaud, Alexandrine; Genovesio, Cecile; Lamy, Edouard] Fac Pharm Marseille, Lab Biochim, Marseille, France; [Pithioux, Martine] Aix Marseille Univ, St Marguerite Hosp, AP HM, ISM,Inst Locomot,Dept Orthopaed & Traumatol,CNRS, Marseille, France; [Pithioux, Martine; Roffino, Sandrine] Aix Marseille Univ, AP HM, CNRS, Cent Marseille,ISM,Mecahio Platform,Anat Lab, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Universite de Montpellier; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Roffino, S (corresponding author), Inst Sci Mouvement, UMR 7287, Parc Sci & Technol Luminy 163,Ave Luminy, F-13288 Marseille 09, France.	sandrine.roffino@univ-amu.fr		CAMY, Claire/0000-0002-3691-8193	Centre National d'Etudes Spatiales (CNES) [4800000797]	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales)	Centre National d'Etudes Spatiales (CNES), Grant/Award Number: 4800000797	Abraham AC, 2022, J ORTHOP RES, V40, P977, DOI 10.1002/jor.25113; Almeida-Silveira MI, 2000, EUR J APPL PHYSIOL, V81, P252; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Basso N, 2005, BONE, V37, P370, DOI 10.1016/j.bone.2005.04.033; BENJAMIN M, 1992, J ANAT, V180, P327; BENJAMIN M, 1990, J ANAT, V171, P1; BEST TM, 1993, J ORTHOP RES, V11, P897, DOI 10.1002/jor.1100110617; Bloomfield SA, 2016, COMPR PHYSIOL, V6, P645, DOI 10.1002/cphy.c130027; Campbell TM, 2021, J TISSUE ENG REGEN M, V15, P567, DOI 10.1002/term.3195; Chen S, 2017, CELL TISSUE RES, V370, P53, DOI 10.1007/s00441-017-2613-0; Chimenti RL, 2017, J ORTHOP RES, V35, P910, DOI 10.1002/jor.23338; Chimenti RL, 2016, J BIOMECH, V49, P39, DOI 10.1016/j.jbiomech.2015.11.008; Cury DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153568; Deymier AC, 2020, BONE, V131, DOI 10.1016/j.bone.2019.115152; Deymier AC, 2019, ACTA BIOMATER, V83, P302, DOI 10.1016/j.actbio.2018.10.024; Eisner LE, 2022, J BIOMECH ENG-T ASME, V144, DOI 10.1115/1.4053086; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Franchi M, 2013, CONNECT TISSUE RES, V54, P267, DOI 10.3109/03008207.2013.807808; Friese N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155177; Frizziero A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-20; FROWEN P, 1995, J ANAT, V186, P417; Gao YF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00235; Genin GM, 2009, BIOPHYS J, V97, P976, DOI 10.1016/j.bpj.2009.05.043; Gerbaix M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00746; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Golman M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi5584; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Hutton WC, 2002, SPINE, V27, P1286, DOI 10.1097/00007632-200206150-00008; Iandolo D, 2021, CURR OSTEOPOROS REP, V19, P626, DOI 10.1007/s11914-021-00713-8; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jensen PT, 2018, J SHOULDER ELB SURG, V27, P739, DOI 10.1016/j.jse.2017.10.030; Juneja SC, 2013, ARTHRITIS, DOI 10.1155/2013/154812; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kannus P, 1996, J BONE MINER RES, V11, P79; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Knowles HJ, 2012, VIRCHOWS ARCH, V461, P205, DOI 10.1007/s00428-012-1274-3; Koike Y, 2005, J ORTHOP RES, V23, P1433, DOI 10.1016/j.orthres.2005.02.015; Krause AR, 2020, NPJ MICROGRAVITY, V6, DOI 10.1038/s41526-020-00126-4; Kubo K, 2000, EUR J APPL PHYSIOL, V83, P463, DOI 10.1007/s004210000309; Kwok AT, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90010-2; Lang T, 2017, NPJ MICROGRAVITY, V3, DOI 10.1038/s41526-017-0013-0; Leyden J, 2019, REGENERATIVE MEDICINE AND PLASTIC SURGERY: SKIN AND SOFT TISSUE, BONE, CARTILAGE, MUSCLE, TENDON AND NERVES, P355, DOI 10.1007/978-3-030-19962-3_25; Lyman J, 2004, AM J SPORT MED, V32, P457, DOI 10.1177/0095399703258621; Maffulli N, 2006, CLIN J SPORT MED, V16, P329, DOI 10.1097/00042752-200607000-00008; Maganaris CN, 2004, SPORTS MED, V34, P1005, DOI 10.2165/00007256-200434140-00005; Matsumoto F, 2003, ARCH PHYS MED REHAB, V84, P662, DOI 10.1016/S0003-9993(03)04834-7; MINNS RJ, 1973, J BIOMECH, V6, P153, DOI 10.1016/0021-9290(73)90084-5; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; Mutsuzaki H, 2015, KNEE, V22, P469, DOI 10.1016/j.knee.2015.03.004; NAKAGAWA Y, 1989, EUR J APPL PHYSIOL O, V59, P239, DOI 10.1007/BF02386194; Perrier A, 2017, COMPOS PART A-APPL S, V102, P18, DOI 10.1016/j.compositesa.2017.07.018; Potter R, 2014, J BIOMECH, V47, P2314, DOI 10.1016/j.jbiomech.2014.04.036; Reeves ND, 2005, J APPL PHYSIOL, V98, P2278, DOI 10.1152/japplphysiol.01266.2004; Rigozzi S, 2009, J BIOMECH, V42, P1547, DOI 10.1016/j.jbiomech.2009.03.031; Roffino S, 2021, LIFE SCI SPACE RES, V29, P46, DOI 10.1016/j.lssr.2021.03.001; RUFAI A, 1995, J ORTHOP RES, V13, P585, DOI 10.1002/jor.1100130414; Schwartz AG, 2013, BONE, V55, P44, DOI 10.1016/j.bone.2013.03.010; Schwartz AG, 2015, DEVELOPMENT, V142, P196, DOI 10.1242/dev.112714; Shackelford LC, 2004, J APPL PHYSIOL, V97, P119, DOI 10.1152/japplphysiol.00741.2003; Shaw HM, 2007, SCAND J MED SCI SPOR, V17, P303, DOI 10.1111/j.1600-0838.2007.00689.x; Shen H, 2017, FASEB J, V31, P5466, DOI 10.1096/fj.201700320R; Sone T, 1998, BONE, V22, p155S, DOI 10.1016/S8756-3282(98)00004-0; Spiesz EM, 2018, ACTA BIOMATER, V70, P281, DOI 10.1016/j.actbio.2018.01.034; Thomopoulos S, 2007, J ORTHOP RES, V25, P1154, DOI 10.1002/jor.20418; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; VAILAS AC, 1988, J APPL PHYSIOL, V65, P373, DOI 10.1152/jappl.1988.65.1.373; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Waggett AD, 1998, MATRIX BIOL, V16, P457, DOI 10.1016/S0945-053X(98)90017-8; Yasuoka H, 2007, SPINE, V32, pE734, DOI 10.1097/BRS.0b013e31815b7e51; Zheng PF, 2020, FUSION ENG DES, V161, DOI 10.1016/j.fusengdes.2020.112006	70	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22548	10.1096/fj.202200713R	http://dx.doi.org/10.1096/fj.202200713R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4T8QA	36121701	Green Submitted			2022-12-26	WOS:000858373100001
J	Yamaguchi, K; Itakura, M; Tsukamoto, M; Lim, SY; Uchida, K				Yamaguchi, Kosuke; Itakura, Masanori; Tsukamoto, Mona; Lim, Sei-Young; Uchida, Koji			Natural polyphenols convert proteins into histone-binding ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; PRODUCTS; (-)-EPIGALLOCATECHIN-3-GALLATE; DEGRADATION; RECEPTOR; H2B	Antioxidants are sensitive to oxidation and are immediately converted into their oxidized forms that can react with pro-teins. We have recently found that proteins incubated with oxidized vitamin C (dehydroascorbate) gain a new function as a histone-binding ligand. This finding led us to predict that an-tioxidants, through conversion to their oxidized forms, may generally have similar functions. In the present study, we identified several natural polyphenols as a source of histone ligands and characterized the mechanism for the interaction of protein-bound polyphenols with histone. Through screening of 25 plant-derived polyphenols by assessing their ability to convert bovine serum albumin into histone ligands, we iden-tified seven polyphenols, including (-)-epigallocatechin-3-O-gallate (EGCG). Additionally, we found that the histone tail domain, which is a highly charged and conformationally flex-ible region, is involved in the interaction with the polyphenol-modified proteins. Further mechanistic studies showed the involvement of a complex heterogeneous group of the polyphenol-derived compounds bound to proteins as histone-binding elements. We also determined that the interaction of polyphenol-modified proteins with histones formed aggregates and exerted a protective effect against histone-mediated cyto-toxicity toward endothelial cells. These findings demonstrated that histones are one of the major targets of polyphenol-modified proteins and provide important insights into the chemoprotective functions of dietary polyphenols.	[Yamaguchi, Kosuke; Itakura, Masanori; Tsukamoto, Mona; Lim, Sei-Young; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Uchida, Koji] CREST, Japan Agcy Med Res & Dev, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), CREST, Japan Agcy Med Res & Dev, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp			JSPS KAKENHI; AMED;  [JP17H06170];  [JP20K15467];  [JP19gm0910013h0003]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; ; ; 	Acknowledgments - We thank Ms Yuki Hondoh for her excellent editorial support. This work was supported by JSPS KAKENHI Grant Numbers JP17H06170, JP20K15467, and by AMED under Grant Number JP19gm0910013h0003.	BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Chikazawa M, 2013, J BIOL CHEM, V288, P13204, DOI 10.1074/jbc.M113.452177; Daigo K, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005522; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Furuhashi M, 2017, BIOCHEMISTRY-US, V56, P4701, DOI 10.1021/acs.biochem.7b00409; Gerszon J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190656; GONIAS SL, 1985, THROMB RES, V39, P97, DOI 10.1016/0049-3848(85)90125-2; Hatasa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153002; Herren T, 2006, BIOCHEMISTRY-US, V45, P9463, DOI 10.1021/bi060756w; Hong S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7457; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Itakura M, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-30626-8; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Ku MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28804; Kujirai T, 2016, NUCLEIC ACIDS RES, V44, P6127, DOI 10.1093/nar/gkw202; Kurinomaru T, 2017, INT J BIOL MACROMOL, V100, P11, DOI 10.1016/j.ijbiomac.2016.06.016; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Machida S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04863; Okubo K, 2018, NAT MED, V24, P232, DOI 10.1038/nm.4462; Pemberton AD, 2010, PROTEOMICS, V10, P1484, DOI 10.1002/pmic.200900818; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rhee SG, 2010, METHOD ENZYMOL, V474, P23, DOI 10.1016/S0076-6879(10)74002-7; Roginsky V, 2005, J AGR FOOD CHEM, V53, P4529, DOI 10.1021/jf040382i; Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Silvestre-Roig C, 2019, NATURE, V569, P236, DOI 10.1038/s41586-019-1167-6; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Ullmann U, 2003, J INT MED RES, V31, P88, DOI 10.1177/147323000303100205; Wei YQ, 2016, FOOD CHEM, V204, P218, DOI 10.1016/j.foodchem.2016.02.134; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamaguchi K, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101035	33	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102529	10.1016/j.jbc.2022.102529	http://dx.doi.org/10.1016/j.jbc.2022.102529			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36162500	Green Published, gold			2022-12-26	WOS:000886086000004
J	Linzer, RW; Guida, DL; Aminov, J; Snider, JM; Khalife, G; Buyukbayraktar, AB; Alhaddad, C; Resnick, AE; Wang, PL; Pan, CH; Allopenna, JJ; Clarke, CJ				Linzer, Ryan W.; Guida, Danielle L.; Aminov, Jonathan; Snider, Justin M.; Khalife, Gabrielle; Buyukbayraktar, A. Burak; Alhaddad, Charbel; Resnick, Andrew E.; Wang, Pule; Pan, Chun-Hao; Allopenna, Janet J.; Clarke, Christopher J.			Dihydroceramide desaturase 1 (DES1) promotes anchorage-independent survival downstream of HER2-driven glucose uptake and metabolism	FASEB JOURNAL			English	Article						breast cancer; cell survival; metastasis; oncogene; sphingolipid	CANCER-CELL RESISTANCE; SPHINGOLIPID METABOLISM; MOLECULAR-MECHANISMS; ANOIKIS RESISTANCE; INDUCED APOPTOSIS; UP-REGULATION; CERAMIDE; SPHINGOSINE; DEATH; IDENTIFICATION	Oncogenic reprogramming of cellular metabolism is a hallmark of many cancers, but our mechanistic understanding of how such dysregulation is linked to tumor behavior remains poor. In this study, we have identified dihydroceramide desaturase (DES1)-which catalyzes the last step in de novo sphingolipid synthesis-as necessary for the acquisition of anchorage-independent survival (AIS), a key cancer enabling biology, and establish DES1 as a downstream effector of HER2-driven glucose uptake and metabolism. We further show that DES1 is sufficient to drive AIS and in vitro tumorigenicity and that increased DES1 levels-found in a third of HER2+ breast cancers-are associated with worse survival outcomes. Taken together, our findings reveal a novel pro-tumor role for DES1 as a transducer of HER2-driven glucose metabolic signals and provide evidence that targeting DES1 is an effective approach for overcoming AIS. Results further suggest that DES1 may have utility as a biomarker of aggressive and metastasis-prone HER2+ breast cancer.	[Clarke, Christopher J.] SUNY Stony Brook, Dept Med, 100 Nicolls Rd, Stony Brook, NY 11776 USA; [Clarke, Christopher J.] SUNY Stony Brook, Ctr Canc, 100 Nicolls Rd, Stony Brook, NY 11776 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Clarke, CJ (corresponding author), SUNY Stony Brook, Dept Med, 100 Nicolls Rd, Stony Brook, NY 11776 USA.; Clarke, CJ (corresponding author), SUNY Stony Brook, Ctr Canc, 100 Nicolls Rd, Stony Brook, NY 11776 USA.	christopher.clarke@stonybrookmedicine.edu		Pan, Chun-Hao/0000-0002-0776-9408	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH) [R01 CA248014]; Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Carol M. Baldwin Breast Cancer Research Fund (Carol M. Baldwin Breast Cancer Research Fund, Inc.); HHS | National Institutes of Health (NIH), Grant/Award Number: R01 CA248014; Sass Foundation; SUNY | Stony Brook University (SBU); Ward Melville Heritage Organization Walk for Beauty	Alsanafi M, 2021, CELL BIOCHEM BIOPHYS, V79, P461, DOI 10.1007/s12013-021-00990-1; Alsanafi M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00222-18; Apraiz A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-477; Avivar-Valderas A, 2013, ONCOGENE, V32, P4932, DOI 10.1038/onc.2012.512; Becker KA, 2020, J NEUROCHEM, V154, P662, DOI 10.1111/jnc.14985; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Boppana NB, 2017, ANTICANCER RES, V37, P455, DOI 10.21873/anticanres.11337; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Cai Q, 2015, ONCOGENE, V34, P3315, DOI 10.1038/onc.2014.264; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Chipuk JE, 2012, CELL, V148, P988, DOI 10.1016/j.cell.2012.01.038; Cingolani F, 2014, J LIPID RES, V55, P1711, DOI 10.1194/jlr.M049759; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Cuvillier O, 2001, CELL DEATH DIFFER, V8, P162, DOI 10.1038/sj.cdd.4400793; Czubowicz K, 2014, MOL NEUROBIOL, V50, P26, DOI 10.1007/s12035-013-8606-4; da Silva G, 2021, CANCER BIOMARK, V32, P49, DOI 10.3233/CBM-203100; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derouet M, 2007, NEOPLASIA, V9, P536, DOI 10.1593/neo.07217; Ecker J, 2021, GASTROENTEROLOGY, V161, P910, DOI 10.1053/j.gastro.2021.05.009; Foley JM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0466-4; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Geeraert L, 1997, BIOCHEM J, V327, P125, DOI 10.1042/bj3270125; Guenther GG, 2014, ONCOGENE, V33, P1776, DOI 10.1038/onc.2013.139; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Guillermet-Guibert J, 2009, MOL CANCER THER, V8, P809, DOI 10.1158/1535-7163.MCT-08-1096; Haakenson JK, 2015, J BIOL CHEM, V290, P8632, DOI 10.1074/jbc.M114.609677; HAIMOVITZFRIEDMAN A, 1994, J EXP MED, V180, P525, DOI 10.1084/jem.180.2.525; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hartfield PJ, 1997, FEBS LETT, V401, P148, DOI 10.1016/S0014-5793(96)01460-3; Hawk MA, 2018, NAT CELL BIOL, V20, P272, DOI 10.1038/s41556-018-0034-2; Hernandez-Tiedra S, 2016, AUTOPHAGY, V12, P2213, DOI 10.1080/15548627.2016.1213927; Herr I, 1997, EMBO J, V16, P6200, DOI 10.1093/emboj/16.20.6200; Holliday MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074768; Hu W, 2005, MOL BIOL CELL, V16, P1555, DOI 10.1091/mbc.E04-07-0594; Illuzzi G, 2010, J BIOL CHEM, V285, P18594, DOI 10.1074/jbc.M109.072801; Ingram LM, 2021, LIPIDS HEALTH DIS, V20, DOI 10.1186/s12944-021-01437-5; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Jiang YX, 2013, BIOMOLECULES, V3, P435, DOI 10.3390/biom3030435; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Lee WJ, 2004, EXP MOL MED, V36, P420, DOI 10.1038/emm.2004.54; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Luberto C, 2002, J BIOL CHEM, V277, P41128, DOI 10.1074/jbc.M206747200; Mason JA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108821; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Nagahashi M, 2016, J SURG RES, V204, P435, DOI 10.1016/j.jss.2016.05.022; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Rahmaniyan M, 2011, J BIOL CHEM, V286, P24754, DOI 10.1074/jbc.M111.250779; Reckzeh ES, 2019, CELL CHEM BIOL, V26, P1214, DOI 10.1016/j.chembiol.2019.06.005; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ryland LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084648; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sawada M, 2004, CELL DEATH DIFFER, V11, P997, DOI 10.1038/sj.cdd.4401438; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Schmelzle T, 2007, P NATL ACAD SCI USA, V104, P3787, DOI 10.1073/pnas.0700115104; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shamseddine AA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.268; Siebeneicher H, 2016, CHEMMEDCHEM, V11, P2261, DOI 10.1002/cmdc.201600276; Snider AJ, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10101393; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Snider JM, 2018, J LIPID RES, V59, P1046, DOI 10.1194/jlr.D081646; Spassieva SD, 2012, J LIPID RES, V53, P918, DOI 10.1194/jlr.M019075; Stover T, 2003, J PHARMACOL EXP THER, V307, P468, DOI 10.1124/jpet.103.054056; Sundaram K, 2016, BIOCHEM J, V473, P743, DOI 10.1042/BJ20150586; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tam AB, 2018, DEV CELL, V46, P327, DOI 10.1016/j.devcel.2018.04.023; Vitolo MI, 2009, CANCER RES, V69, P8275, DOI 10.1158/0008-5472.CAN-09-1067; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wang XZ, 1999, CANCER RES, V59, P5842; Widau RC, 2010, J BIOL CHEM, V285, P13827, DOI 10.1074/jbc.M109.085076; Yu M, 2017, ONCOTARGET, V8, P43356, DOI 10.18632/oncotarget.17445	77	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22558	10.1096/fj.202200748R	http://dx.doi.org/10.1096/fj.202200748R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1HU	36165222				2022-12-26	WOS:000859917400001
J	Wang, MX; Yan, L; Chen, J; Zhao, JM; Zhu, J; Yu, SH				Wang, Meng-Xi; Yan, Li; Chen, Juan; Zhao, Jun-Mei; Zhu, Jiang; Yu, Shan-He			Reinforced erythroid differentiation inhibits leukemogenic potential of t(8;21) leukemia	FASEB JOURNAL			English	Article						AML1-ETO; c-Kit; CD43; erythroid differentiation; Ldb1; leukemia	ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; AML1-ETO; PROTEIN; BETA; EXPRESSION; PROMOTES; KIT; PROGENITOR; COMPLEXES	Oncoprotein AML1-ETO (AE) derived from t(8;21)(q22;q22) translocation is typically present in a portion of French-American-British-M2 subtype of acute myeloid leukemia (AML). Although these patients have relatively favorable prognoses, substantial numbers of them would relapse after conventional therapy. Here, we explored whether reinforcing the endogenous differentiation potential of t(8;21) AML cells would diminish the associated malignancy. In doing so, we noticed an expansion of immature erythroid blasts featured in both AML1-ETO9a (AE9a) and AE plus c-KIT (N822K) (AK) murine leukemic models. Interestingly, in the AE9a murine model, a spontaneous step-wise erythroid differentiation path, as characterized by the differential expression of CD43/c-Kit and the upregulation of several key erythroid transcription factors (TFs), accompanied the decline or loss of leukemia-initiating potential. Notably, overexpression of one of the key erythroid TFs, Ldb1, potently disrupted the repopulation of AE9a leukemic cells in vivo, suggesting a new promising intervention strategy of t(8;21) AML through enforcing their erythroid differentiation.	[Wang, Meng-Xi; Chen, Juan; Zhu, Jiang; Yu, Shan-He] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol,Sch Med, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai, Peoples R China; [Yan, Li; Zhao, Jun-Mei] Wuhan Univ, Dept Hematol, Renmin Hosp, Wuhan, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Zhu, Jiang] Shanghai Jiao Tong Univ, Collaborat Innovat Ctr Hematol, Ruijin & Lospital, Sch Med, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Wuhan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhu, J; Yu, SH (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Hematol,Sch Med, State Key Lab Med Genom,Natl Res Ctr Translat Med, Shanghai, Peoples R China.	zhujiang@shsmu.edu.cn; yushanhe@shsmu.edu.cn		Yu, Shanhe/0000-0002-0268-7374	National Key Research and Development Program of China [2018YFA0107802]; National Major Scientific and Technological Special Project [2018ZX09101001]; National Natural Science Foundation of China (NSFC) [81430002, 81770206, 81800099, 81900148, 81900168, 82000109, 82100188, 82270154]; Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research [2019CXJQ01]; Shanghai Rising-Star Program [20QC1400100]	National Key Research and Development Program of China; National Major Scientific and Technological Special Project; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research; Shanghai Rising-Star Program	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0107802; National Major Scientific and Technological Special Project, Grant/Award Number: 2018ZX09101001; National Natural Science Foundation of China (NSFC), Grant/Award Number: 81430002, 81770206, 81800099, 81900148, 81900168, 82000109, 82100188 and 82270154; Novo Nordisk Hemophilia Research Fund in China; Samuel Waxman Cancer Research Foundation (SWCRF); Shanghai Collaborative Innovation Program on Regenerative Medicine and Stem Cell Research, Grant/Award Number: 2019CXJQ01; Shanghai Rising-Star Program, Grant/Award Number: 20QC1400100	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Harbi S, 2020, BLOOD ADV, V4, P229, DOI 10.1182/bloodadvances.2019000168; Bagger FO, 2019, NUCLEIC ACIDS RES, V47, pD881, DOI 10.1093/nar/gky1076; Baliakas P, 2014, AM J HEMATOL, V89, P249, DOI 10.1002/ajh.23618; BETTAIEB A, 1988, BLOOD, V71, P1226; Byun HM, 2017, OPEN MED-WARSAW, V12, P76, DOI 10.1515/med-2017-0014; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; Choi YJ, 2006, CANCER RES, V66, P2990, DOI 10.1158/0008-5472.CAN-05-2944; Choi YJ, 2005, CRIT REV EUKAR GENE, V15, P207, DOI 10.1615/CritRevEukarGeneExpr.v15.i3.30; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; de The H, 2018, NAT REV CANCER, V18, P117, DOI 10.1038/nrc.2017.103; Desai R, 2020, LEUKEMIA, V34, P1706, DOI 10.1038/s41375-019-0657-8; Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Elliott S, 2014, ANN HEMATOL, V93, P181, DOI 10.1007/s00277-013-1947-2; Foster BM, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010031; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Grisolano JL, 2003, P NATL ACAD SCI USA, V100, P9506, DOI 10.1073/pnas.1531730100; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Jimi E, 2005, INT IMMUNOL, V17, P815, DOI 10.1093/intimm/dxh263; Li LQ, 2013, BLOOD, V121, P4575, DOI 10.1182/blood-2013-01-479451; Long J, 2017, LEUKEMIA, V31, P2761, DOI 10.1038/leu.2017.130; Love PE, 2014, TRENDS GENET, V30, P1, DOI 10.1016/j.tig.2013.10.001; Man N, 2017, BLOOD, V129, P2782, DOI 10.1182/blood-2016-10-745034; Marneth AE, 2018, HAEMATOLOGICA, V103, pE395, DOI 10.3324/haematol.2017.180844; Marschalek R, 2015, ARCH PHARM, V348, P221, DOI 10.1002/ardp.201400449; Mei SL, 2017, NUCLEIC ACIDS RES, V45, pD658, DOI 10.1093/nar/gkw983; MOORE T, 1994, J IMMUNOL, V153, P4978; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Pikman Y, 2018, BLOOD, V132, P1241, DOI 10.1182/blood-2018-04-784157; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; SCHMID I, 1992, CYTOMETRY, V13, P204, DOI 10.1002/cyto.990130216; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Steffen B, 2011, BLOOD, V117, P4328, DOI 10.1182/blood-2009-09-242545; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Tan Y, 2021, BLOOD, V137, P1503, DOI 10.1182/blood.2020005698; Terszowski G, 2005, BLOOD, V105, P1937, DOI 10.1182/blood-2004-09-3459; Thiel VN, 2017, LEUKEMIA, V31, P2491, DOI 10.1038/leu.2017.105; Tonks A, 2007, LEUKEMIA, V21, P2495, DOI 10.1038/sj.leu.2404961; Tonks A, 2003, BLOOD, V101, P624, DOI 10.1182/blood-2002-06-1732; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YY, 2011, P NATL ACAD SCI USA, V108, P2450, DOI 10.1073/pnas.1019625108; Wang YY, 2005, P NATL ACAD SCI USA, V102, P1104, DOI 10.1073/pnas.0408831102; YAMASAKI H, 1995, LEUKEMIA, V9, P1147; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Zhu SH, 2020, LEUKEMIA, V34, P2484, DOI 10.1038/s41375-020-0768-2	50	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22562	10.1096/fj.202200026RR	http://dx.doi.org/10.1096/fj.202200026RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4P4DJ	36125067				2022-12-26	WOS:000855344900001
J	Shukla, PK; Sinha, D; Leng, AM; Bissell, JE; Thatipamula, S; Ganguly, R; Radmall, KS; Skalicky, JJ; Shrieve, DC; Chandrasekharan, MB				Shukla, Prakash K.; Sinha, Dhiraj; Leng, Andrew M.; Bissell, Jesse E.; Thatipamula, Shravya; Ganguly, Rajarshi; Radmall, Kaitlin S.; Skalicky, Jack J.; Shrieve, Dennis C.; Chandrasekharan, Mahesh B.			Mutations of Rad6 E2 ubiquitin-conjugating enzymes at alanine-126 in helix-3 affect ubiquitination activity and decrease enzyme stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B MONOUBIQUITINATION; N-END RULE; YEAST RAD6; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; DNA-DAMAGE; PROTEIN; DYNAMICS; COMPLEX; INSIGHTS	Rad6, an E2 ubiquitin-conjugating enzyme conserved from yeast to humans, functions in transcription, genome mainte-nance, and proteostasis. The contributions of many conserved secondary structures of Rad6 and its human homologs UBE2A and UBE2B to their biological functions are not understood. A mutant RAD6 allele with a missense substitution at alanine-126 (A126) of helix-3 that causes defects in telomeric gene silencing, DNA repair, and protein degradation was reported over 2 decades ago. Here, using a combination of genetics, biochemical, biophysical, and computational approaches, we discovered that helix-3 A126 mutations compromise the ability of Rad6 to ubiquitinate target proteins without disrupting in-teractions with partner E3 ubiquitin-ligases that are required for their various biological functions in vivo. Explaining the defective in vitro or in vivo ubiquitination activities, molecular dynamics simulations and NMR showed that helix-3 A126 mutations cause local disorder of the catalytic pocket of Rad6 in addition to disorganizing the global structure of the protein to decrease its stability in vivo. We also show that helix-3 A126 mutations deform the structures of UBE2A and UBE2B, the human Rad6 homologs, and compromise the in vitro ubiq-uitination activity and folding of UBE2B. Providing insights into their ubiquitination defects, we determined helix-3 A126 mutations impair the initial ubiquitin charging and the fnal discharging steps during substrate ubiquitination by Rad6. In summary, our studies reveal that the conserved helix-3 is a crucial structural constituent that controls the organization of catalytic pockets, enzymatic activities, and biological functions of the Rad6-family E2 ubiquitin-conjugating enzymes.	[Shukla, Prakash K.; Leng, Andrew M.; Bissell, Jesse E.; Thatipamula, Shravya; Ganguly, Rajarshi; Radmall, Kaitlin S.; Shrieve, Dennis C.; Chandrasekharan, Mahesh B.] Univ Utah, Sch Med, Dept Radiat Oncol, Salt Lake City, UT 84112 USA; [Shukla, Prakash K.; Leng, Andrew M.; Bissell, Jesse E.; Thatipamula, Shravya; Ganguly, Rajarshi; Radmall, Kaitlin S.; Shrieve, Dennis C.; Chandrasekharan, Mahesh B.] Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT 84112 USA; [Sinha, Dhiraj] Aix Marseille Univ, IHU, Marseille, France; [Skalicky, Jack J.] Univ Utah, Dept Biochem, Sch Med, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Aix-Marseille Universite; Utah System of Higher Education; University of Utah	Chandrasekharan, MB (corresponding author), Univ Utah, Sch Med, Dept Radiat Oncol, Salt Lake City, UT 84112 USA.; Chandrasekharan, MB (corresponding author), Univ Utah, Huntsman Canc Inst, Sch Med, Salt Lake City, UT 84112 USA.	mahesh.chandrasekharan@hci.utah.edu		Bissell, Jesse/0000-0001-7971-4046; Shrieve, Dennis/0000-0002-9212-7249; Chandrasekharan, Mahesh/0000-0002-9956-8354; shukla, prakash/0000-0001-5152-3715	Department of Radiation Oncology, Huntsman Cancer Institute, CCSG Nuclear Control seed grant [P30CA042014];  [NIGMS-5R01GM127783-02]	Department of Radiation Oncology, Huntsman Cancer Institute, CCSG Nuclear Control seed grant; 	This work was supported by funds provided by the Department of Radiation Oncology, Huntsman Cancer Institute, CCSG Nuclear Control seed grant (P30CA042014) and NIGMS-5R01GM127783-02 to M. B. C.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Akiyoshi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003216; Andreson BL, 2010, NUCLEIC ACIDS RES, V38, P6490, DOI 10.1093/nar/gkq552; Atkin G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00063; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Berndsen CE, 2013, NAT CHEM BIOL, V9, P154, DOI [10.1038/NCHEMBIO.1159, 10.1038/nchembio.1159]; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Borg NA, 2017, ANNU REV CANC BIOL, V1, P59, DOI 10.1146/annurev-cancerbio-040716-075607; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chandrasekharan MB, 2011, METHODS, V54, P304, DOI 10.1016/j.ymeth.2011.02.010; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; Collins GA, 2010, YEAST, V27, P965, DOI 10.1002/yea.1805; Cook BW, 2012, BIOCHEM J, V445, P167, DOI 10.1042/BJ20120504; Damgaard RB, 2021, CELL DEATH DIFFER, V28, P423, DOI 10.1038/s41418-020-00703-w; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; de Oliveira JF, 2019, NAT CHEM BIOL, V15, P62, DOI 10.1038/s41589-018-0177-2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Freiberg G, 2000, CURR GENET, V37, P221, DOI 10.1007/s002940050523; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; GARCIA AE, 1992, PHYS REV LETT, V68, P2696, DOI 10.1103/PhysRevLett.68.2696; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Goddard D., 2008, SPARKY 3; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hibbert RG, 2011, P NATL ACAD SCI USA, V108, P5590, DOI 10.1073/pnas.1017516108; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hollingsworth SA, 2018, NEURON, V99, P1129, DOI 10.1016/j.neuron.2018.08.011; Hormaechea-Agulla D, 2018, MOL CELLS, V41, P168, DOI 10.14348/molcells.2018.0008; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Hyberts SG, 2012, TOP CURR CHEM, V316, P125, DOI 10.1007/128_2011_187; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Ju DH, 2008, MOL CELL BIOL, V28, P1404, DOI 10.1128/MCB.01787-07; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Khan FI, 2016, INT J BIOL MACROMOL, V85, P48, DOI 10.1016/j.ijbiomac.2015.12.072; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; Kliza K, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00021; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kumar P, 2015, NUCLEIC ACIDS RES, V43, P9039, DOI 10.1093/nar/gkv845; Kumar P, 2015, PROTEINS, V83, P1185, DOI 10.1002/prot.24812; Li Mamie Z, 2012, Methods Mol Biol, V852, P51, DOI 10.1007/978-1-61779-564-0_5; Lv ZY, 2017, MOL CELL, V65, P699, DOI 10.1016/j.molcel.2017.01.008; Maguid S, 2006, J MOL EVOL, V63, P448, DOI 10.1007/s00239-005-0209-x; Markin CJ, 2010, J AM CHEM SOC, V132, P17775, DOI 10.1021/ja105267w; Middleton AJ, 2017, J MOL BIOL, V429, P3430, DOI 10.1016/j.jmb.2017.06.008; MORRISON A, 1988, MOL CELL BIOL, V8, P1179, DOI 10.1128/MCB.8.3.1179; Nakanishi S, 2009, J CELL BIOL, V186, P371, DOI 10.1083/jcb.200906005; Olsen SK, 2013, MOL CELL, V49, P884, DOI 10.1016/j.molcel.2013.01.013; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Pan M, 2021, NATURE, V600, P334, DOI 10.1038/s41586-021-04097-8; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichler A, 2005, NAT STRUCT MOL BIOL, V12, P264, DOI 10.1038/nsmb903; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Ptak C, 2001, MOL CELL BIOL, V21, P6537, DOI 10.1128/MCB.21.19.6537-6548.2001; RABOY B, 1994, EUR J BIOCHEM, V221, P247, DOI 10.1111/j.1432-1033.1994.tb18735.x; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Rodrigues CHM, 2018, NUCLEIC ACIDS RES, V46, pW350, DOI 10.1093/nar/gky300; Rout MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25476-8; Rout MK, 2014, J AM CHEM SOC, V136, P17446, DOI 10.1021/ja505440b; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Samant RS, 2019, METHOD ENZYMOL, V619, P27, DOI 10.1016/bs.mie.2018.12.039; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sarcevic B, 2002, EMBO J, V21, P2009, DOI 10.1093/emboj/21.8.2009; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Sewduth RN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093036; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; SIKORSKI RS, 1989, GENETICS, V122, P19; Sinha D, 2018, J MOL MODEL, V24, DOI 10.1007/s00894-018-3722-8; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; SUNG P, 1990, P NATL ACAD SCI USA, V87, P2695, DOI 10.1073/pnas.87.7.2695; Turco E, 2015, J BIOL CHEM, V290, P5298, DOI 10.1074/jbc.M114.626788; Valimberti I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14849; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Williams KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11061-8; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Worthylake DR, 1998, J BIOL CHEM, V273, P6271, DOI 10.1074/jbc.273.11.6271; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124377; Zhen YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101663; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	114	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	28	11							102524	10.1016/j.jbc.2022.102524	http://dx.doi.org/10.1016/j.jbc.2022.102524			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6I4GS	36162503	gold, Green Published			2022-12-26	WOS:000886086000001
J	Chen, HW; Li, PW; Chen, JM; Wang, YF; Yu, Q; Wu, YH; Chen, Y; Cai, JT				Chen, Hanwen; Li, Peiwei; Chen, Jiamin; Wang, Yufang; Yu, Qiao; Wu, Yihua; Chen, Yan; Cai, Jianting			Peripheral blood mononuclear cell microRNAs are novel biomarkers for diagnosing and monitoring Crohn's disease	FASEB JOURNAL			English	Article						biomarker; Crohn's disease; diagnosis; miRNA; peripheral blood mononuclear cell; prognosis	INFLAMMATORY-BOWEL-DISEASE; FECAL CALPROTECTIN; ULCERATIVE-COLITIS; EXPRESSION; RISK; TUMORIGENESIS; CONTRIBUTES; APOPTOSIS; PROFILES; PLAYERS	Crohn's disease is a recurrent, progressive, immune-mediated inflammatory disease and merely manifests non-specific symptoms at early stage. In this study, we isolated peripheral blood mononuclear cells (PBMCs) to determine whether PBMC miRNAs are reliable biomarkers for Crohn's disease diagnosing and monitoring. 5 Crohn's disease patients and 5 healthy controls were recruited to find differentially expressed miRNAs by next generation sequencing. Candidate PBMC miRNAs were further validated by qRT-PCR in another cohort consisting of 86 Crohn's disease patients and 39 healthy controls. We found PBMC miR-582-5p could diagnose Crohn's disease with the area under receiver operating characteristic curve (AUROC) of 0.701(95%CI 0.606-0.796, p < .001). While PBMC miR-96-5p was significantly higher in active Crohn's disease and correlated with both clinical (rho =0.376, p < .001) and endoscopic activity (rho =0.512, p = .015). Furthermore, PBMC miR-96-5p had a better performance in recognizing active Crohn's disease with AUROC of 0.727 (95%CI 0.609-0.844, p = .001) than C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and fecal calprotectin. In conclusion, PBMC miR-582-5p may be further utilized as a diagnostic biomarker, while miR-96-5p may be a novel and valuable biomarker in monitoring disease activity.	[Chen, Hanwen; Li, Peiwei; Chen, Jiamin; Yu, Qiao; Chen, Yan; Cai, Jianting] Zhejiang Univ, Sch Med, Ctr Inflammatory Bowel Dis, Dept Gastroenterol,Affiliated Hosp 2, Hangzhou, Peoples R China; [Wang, Yufang] Third Peoples Hosp Hangzhou, Dept Gastroenterol, Hangzhou, Peoples R China; [Wu, Yihua] Zhejiang Univ, Sch Publ Hlth, Dept Toxicol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University	Chen, Y; Cai, JT (corresponding author), Zhejiang Univ, Sch Med, Affiliate Hosp 2, Dept Gastroenterol, 88 Jiefang Rd, Hangzhou, Peoples R China.	chenyan72_72@zju.edu.cn; jtcai6757@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81802881]; Zhejiang Provincial Natural Science Foundation of China [LQ22H160042]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81802881; Zhejiang Provincial Natural Science Foundation of China, Grant/Award Number: LQ22H160042	Bai JA, 2015, WORLD J GASTROENTERO, V21, P6180, DOI 10.3748/wjg.v21.i20.6180; Biasci D, 2019, GUT, V68, P1386, DOI 10.1136/gutjnl-2019-318343; Brain O, 2013, IMMUNITY, V39, P521, DOI 10.1016/j.immuni.2013.08.035; Burczynski ME, 2006, J MOL DIAGN, V8, P51, DOI 10.2353/jmoldx.2006.050079; Chen P, 2019, ALIMENT PHARM THER, V49, P733, DOI 10.1111/apt.15159; Chen XL, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201267; Chen Y, 2013, BIOCHEM BIOPH RES CO, V438, P133, DOI 10.1016/j.bbrc.2013.07.040; Ghorpade DS, 2013, J BIOL CHEM, V288, P33037, DOI 10.1074/jbc.M113.492496; Gong XR, 2022, HUM GENE THER, V00, P1, DOI 10.1089/hum.2022.078; He C, 2016, GUT, V65, P1938, DOI 10.1136/gutjnl-2015-309389; Huang L, 2022, BIOENGINEERED, V13, P12, DOI 10.1080/21655979.2021.1976894; Huang S, 2019, MOL THER-NUCL ACIDS, V16, P91, DOI 10.1016/j.omtn.2019.01.004; Iborra M, 2013, CLIN EXP IMMUNOL, V173, P250, DOI 10.1111/cei.12104; Ji YH, 2018, BIOCHEM BIOPH RES CO, V503, P2443, DOI 10.1016/j.bbrc.2018.06.174; Kalla R, 2015, GUT, V64, P504, DOI 10.1136/gutjnl-2014-307891; Lasson A, 2015, J CROHNS COLITIS, V9, P26, DOI 10.1016/j.crohns.2014.06.002; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Li PZ, 2022, CELL DEATH DIS, V13, DOI 10.1038/s41419-022-04525-1; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Liu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078381; Long X, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.4; Lugering A, 2001, GASTROENTEROLOGY, V121, P1145, DOI 10.1053/gast.2001.28702; Martinez-Hernandez R, 2018, J CLIN ENDOCR METAB, V103, P1139, DOI 10.1210/jc.2017-02318; Mendoza JL, 2009, GASTROEN CLIN BIOL, V33, pS158, DOI 10.1016/S0399-8320(09)73151-3; Mohammadi A, 2019, J CROHNS COLITIS, V13, P1459, DOI 10.1093/ecco-jcc/jjz076; Mohammadi A, 2018, J CROHNS COLITIS, V12, P568, DOI 10.1093/ecco-jcc/jjy010; Netz U, 2018, INFLAMM BOWEL DIS, V24, P159, DOI 10.1093/ibd/izx009; Ormseth MJ, 2020, J RHEUMATOL, V47, P188, DOI 10.3899/jrheum.181029; Palone F, 2016, INFLAMM BOWEL DIS, V22, P2886, DOI 10.1097/MIB.0000000000000938; Pan TL, 2021, CYTOTECHNOLOGY, V73, P473, DOI 10.1007/s10616-021-00471-6; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schonauen K, 2018, INFLAMM BOWEL DIS, V24, P1547, DOI 10.1093/ibd/izy046; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Vavricka SR, 2012, INFLAMM BOWEL DIS, V18, P496, DOI 10.1002/ibd.21719; Verstockt S, 2019, J CROHNS COLITIS, V13, P916, DOI 10.1093/ecco-jcc/jjz007; Wang W, 2020, BIOMED PHARMACOTHER, V121, DOI 10.1016/j.biopha.2019.109411; Wu F, 2011, INFLAMM BOWEL DIS, V17, P241, DOI 10.1002/ibd.21450; Yu KK, 2018, J MOL MED, V96, P65, DOI 10.1007/s00109-017-1593-6; Zhou J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10176-2	42	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22549	10.1096/fj.202200452R	http://dx.doi.org/10.1096/fj.202200452R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1QE	36165177				2022-12-26	WOS:000859939500001
J	Singh, G; Senapati, S; Satpathi, S; Behera, PK; Das, B; Nayak, B				Singh, Garima; Senapati, Shantibhusan; Satpathi, Sanghamitra; Behera, Prativa Kumari; Das, Biswajit; Nayak, Bismita			Establishment of decellularized extracellular matrix scaffold derived from caprine pancreas as a novel alternative template over porcine pancreatic scaffold for prospective biomedical application	FASEB JOURNAL			English	Article						bioartificial endocrine pancreas scaffold; biomimetic material; caprine pancreas; decellularization; diabetes; tissue engineering	ENDOGENOUS RETROVIRUS; ENDOTHELIAL-CELLS; HEPARAN-SULFATE; ISLET ISOLATION; CORE PROTEIN; HEART-VALVE; LIVER; COLLAGEN; GROWTH; INFECTION	In this study, the caprine pancreas has been presented as an alternative to the porcine organ for pancreatic xenotransplantation with lesser risk factors. The obtained caprine pancreas underwent a systematic cycle of detergent perfusion for decellularization. It was perfused using anionic (0.5% w/v sodium dodecyl sulfate) as well as non-ionic (0.1% v/v triton X-100, t-octyl phenoxy polyethoxy ethanol) detergents and washed intermittently with 1XPBS supplemented with 0.1% v/v antibiotic and nucleases in a gravitation-driven set-up. After 48 h, a white decellularized pancreas was obtained, and its extracellular matrix (ECM) content was examined for scaffold-like properties. The ECM content was assessed for removal of cellular content, and nuclear material was evaluated with temporal H&E staining. Quantified DNA was found to be present in a negligible amount in the resultant decellularized pancreas tissue (DPT), thus prohibiting it from triggering any immunogenicity. Collagen and fibronectin were confirmed to be preserved upon trichrome and immunohistochemical staining, respectively. SEM and AFM images reveal interconnected collagen fibril networks in the DPT, confirming that collagen was unaffected. sGAG was visualized using Prussian blue staining and quantified with DMMB assay, where DPT has effectively retained this ECM component. Uniaxial tensile analysis revealed that DPT possesses better elasticity than NPT (native pancreatic tissue). Physical parameters like tensile strength, stiffness, biodegradation, and swelling index were retained in the DPT with negligible loss. The cytocompatibility analysis of DPT has shown no cytotoxic effect for up to 72 h on normal insulin-producing cells (MIN-6) and cancerous glioblastoma (LN229) cells in vitro. The scaffold was recellularized using isolated mouse islets, which have established in vitro cell proliferation for up to 9 days. The scaffold received at the end of the decellularization cycle was found to be non-toxic to the cells, retained biological and physical properties of the native ECM, suitable for recellularization, and can be used as a safer and better alternative as a transplantable organ from a xenogeneic source.	[Singh, Garima; Nayak, Bismita] Natl Inst Technol, Dept Life Sci, Immunol & Mol Med Lab, Rourkela 769008, Odisha, India; [Senapati, Shantibhusan; Das, Biswajit] Inst Life Sci, Tumor Microenvironm & Anim Models Lab, Bhubaneswar, India; [Satpathi, Sanghamitra] Hi Tech Med Coll & Hosp, Dept Pathol, Rourkela, India; [Behera, Prativa Kumari] Ispat Gen Hosp, Dept Histopathol, Rourkela, India	National Institute of Technology (NIT System); National Institute of Technology Rourkela; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Nayak, B (corresponding author), Natl Inst Technol, Dept Life Sci, Immunol & Mol Med Lab, Rourkela 769008, Odisha, India.	nayakb@nitrkl.ac.in		DAS, BISWAJIT/0000-0002-5657-5626; Senapati, Shantibhusan/0000-0001-7108-8255				Agarwal T, 2018, J TISSUE ENG REGEN M, V12, pE1678, DOI 10.1002/term.2594; ATALA A, 1993, J UROLOGY, V150, P608, DOI 10.1016/S0022-5347(17)35561-1; Atala A, 2009, CURR OPIN BIOTECH, V20, P575, DOI 10.1016/j.copbio.2009.10.003; Banerjee I, 2012, J BIOMAT SCI-POLYM E, V23, P355, DOI 10.1163/092050610X551943; Bhuyan J., 2016, J EVID BASED MED HEA, V3, P4001; Bi HJ, 2020, BIOMATERIALS, V233, DOI 10.1016/j.biomaterials.2019.119673; Bittmann I, 2012, VIROLOGY, V433, P329, DOI 10.1016/j.virol.2012.08.030; Buehler MJ, 2006, P NATL ACAD SCI USA, V103, P12285, DOI 10.1073/pnas.0603216103; Butler AE, 2016, J CLIN ENDOCR METAB, V101, P523, DOI 10.1210/jc.2015-3566; Choong FJ, 2015, AM J TRANSPLANT, V15, P2851, DOI 10.1111/ajt.13366; Cissell DD, 2017, TISSUE ENG PART C-ME, V23, P243, DOI 10.1089/ten.tec.2017.0018; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Cross SE, 2017, AM J TRANSPLANT, V17, P451, DOI 10.1111/ajt.13975; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Damania A, 2018, ACS APPL MATER INTER, V10, P114, DOI 10.1021/acsami.7b13727; Das Piyali, 2021, Cartilage, V13, p1292S, DOI 10.1177/1947603519855769; Denner J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080215; Denner J, 2012, CLIN MICROBIOL REV, V25, P318, DOI 10.1128/CMR.05011-11; Divya P, 2009, J TISSUE ENG REGEN M, V3, P377, DOI 10.1002/term.174; Duisit J, 2018, ACTA BIOMATER, V73, P339, DOI 10.1016/j.actbio.2018.04.009; Duisit J, 2017, ANN SURG, V266, P754, DOI 10.1097/SLA.0000000000002396; Dunne LW, 2014, BIOMATERIALS, V35, P4940, DOI 10.1016/j.biomaterials.2014.03.003; Eltom A, 2019, ADV MATER SCI ENG, V2019, DOI 10.1155/2019/3429527; Figaro S, 2015, IRBM, V36, P101, DOI 10.1016/j.irbm.2015.01.010; Fischer K., 2016, SCI REP-UK, V6, P1, DOI DOI 10.1038/S41598-016-0001-8; Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015; Fruhauf NR, 2004, SURGERY, V136, P47, DOI 10.1016/j.surg.2003.12.017; Fu RH, 2014, CELL TRANSPLANT, V23, P621, DOI 10.3727/096368914X678382; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; Gaetani R, 2018, TISSUE ENG PART C-ME, V24, P697, DOI [10.1089/ten.tec.2018.0180, 10.1089/ten.TEC.2018.0180]; Gerli MFM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191497; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilpin A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9831534; Gola J, 2014, REPROD BIOL, V14, P68, DOI 10.1016/j.repbio.2014.01.006; Gupta S.K., 2017, BIOL ENG MED, V2, P1, DOI DOI 10.15761/BEM.1000112; Hashemi J, 2018, CELLS TISSUES ORGANS, V205, P72, DOI 10.1159/000487230; He M, 2013, TISSUE ENG PART B-RE, V19, P194, DOI [10.1089/ten.teb.2012.0340, 10.1089/ten.TEB.2012.0340]; Hou YT, 2020, J BIOSCI BIOENG, V129, P741, DOI 10.1016/j.jbiosc.2019.12.012; Hou YT, 2012, BIOCHEM ENG J, V69, P172, DOI 10.1016/j.bej.2012.09.007; Hussein KH, 2016, MAT SCI ENG C-MATER, V67, P766, DOI 10.1016/j.msec.2016.05.068; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Hwang JM, 2017, ACTA BIOMATER, V53, P268, DOI 10.1016/j.actbio.2017.01.079; Iacovacci V, 2016, BIOCHEM PHARMACOL, V100, P12, DOI 10.1016/j.bcp.2015.08.107; International Diabetes Federation, 2019, IDF DIABETES ATLAS, V9th ed, P168; Jiang YS, 2021, INT J MOL MED, V47, P463, DOI 10.3892/ijmm.2020.4818; Joszko K, 2019, ACTA BIOENG BIOMECH, V21, P87, DOI 10.5277/ABB-01382-2019-02; Kadota Y, 2014, ORGANOGENESIS, V10, P268, DOI 10.4161/org.27879; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Katsuki Y, 2016, PANCREATOLOGY, V16, P922, DOI 10.1016/j.pan.2016.06.007; Kawasaki E, 2004, DIABETES RES CLIN PR, V66, pS27, DOI 10.1016/j.diabres.2003.09.015; Kim MJ, 2014, MACROMOL RES, V22, P575, DOI 10.1007/s13233-014-2097-7; Kim N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165156; Kobayashi M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246221; Kular JK., 2014, J TISSUE ENG, V5, P1; Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003; Labriola L, 2007, MOL CELL ENDOCRINOL, V263, P120, DOI 10.1016/j.mce.2006.09.011; Lee PF, 2017, ACTA BIOMATER, V49, P181, DOI 10.1016/j.actbio.2016.11.047; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liao J, 2020, J MATER CHEM B, V8, P10023, DOI 10.1039/d0tb01534b; Lopera HM, 2020, ACTA BIOMATER, V107, P115, DOI 10.1016/j.actbio.2020.03.003; Lozoya OA, 2011, BIOMATERIALS, V32, P7389, DOI 10.1016/j.biomaterials.2011.06.042; Ma FF, 2019, J PROTEOME RES, V18, P3156, DOI 10.1021/acs.jproteome.9b00241; Maghsoudlou P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155324; Mang R, 2001, J GEN VIROL, V82, P1829, DOI 10.1099/0022-1317-82-8-1829; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mendibil U, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155447; Mendoza-Novelo B, 2011, ACTA BIOMATER, V7, P1241, DOI 10.1016/j.actbio.2010.11.017; MERTENS G, 1992, J BIOL CHEM, V267, P20435; Mirmalek-Sani SH, 2013, BIOMATERIALS, V34, P5488, DOI 10.1016/j.biomaterials.2013.03.054; Mullen LM, 2010, TISSUE ENG PART C-ME, V16, P1439, DOI [10.1089/ten.tec.2009.0806, 10.1089/ten.TEC.2009.0806]; Naderi H, 2011, J BIOMATER APPL, V26, P383, DOI 10.1177/0885328211408946; Nakamura T, 2018, CELL MOL GASTROENTER, V5, P51, DOI 10.1016/j.jcmgh.2017.10.006; Napierala H, 2017, SCI REP-UK, V7, DOI 10.1038/srep41777; Orlando G, 2013, BIOMATERIALS, V34, P5915, DOI 10.1016/j.biomaterials.2013.04.033; Peloso A, 2016, ANN SURG, V264, P169, DOI 10.1097/SLA.0000000000001364; PUELACHER WC, 1994, INT J ORAL MAX SURG, V23, P49, DOI 10.1016/S0901-5027(05)80328-5; Reing JE, 2010, BIOMATERIALS, V31, P8626, DOI 10.1016/j.biomaterials.2010.07.083; Ren HZ, 2013, LIVER INT, V33, P448, DOI 10.1111/liv.12088; Rickels MR, 2019, ENDOCR REV, V40, P631, DOI 10.1210/er.2018-00154; Sackett SD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28857-1; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Shojaie S, 2015, STEM CELL REP, V4, P419, DOI 10.1016/j.stemcr.2015.01.004; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Spang MT, 2018, ACTA BIOMATER, V68, P1, DOI 10.1016/j.actbio.2017.12.019; Specke V, 2001, VIROLOGY, V285, P177, DOI 10.1006/viro.2001.0934; Tacke SJ, 2000, VIROLOGY, V268, P87, DOI 10.1006/viro.1999.0149; Tacke SJ, 2003, INTERVIROLOGY, V46, P17, DOI 10.1159/000068120; Tardalkar K, 2017, TISSUE ENG REGEN MED, V14, P755, DOI 10.1007/s13770-017-0070-1; Townsend SE, 2019, ENDOCRINOLOGY, V160, P1885, DOI 10.1210/en.2019-00206; Tremmel DM, 2018, ORGANOGENESIS, V14, P163, DOI 10.1080/15476278.2018.1517509; Chandrika KU, 2021, TISSUE ENG REGEN MED, V18, P99, DOI 10.1007/s13770-020-00296-y; Vaccari G, 2009, VET RES, V40, DOI 10.1051/vetres/2009031; Valdoz JC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms222312690; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Venkatasubramanian RT, 2006, ANN BIOMED ENG, V34, P823, DOI 10.1007/s10439-005-9044-x; Venkatasubramanian RT, 2010, ANN BIOMED ENG, V38, P694, DOI 10.1007/s10439-010-9921-9; Walters NJ, 2015, ACTA BIOMATER, V11, P3, DOI 10.1016/j.actbio.2014.09.038; Wang YJ, 2015, XENOTRANSPLANTATION, V22, P48, DOI 10.1111/xen.12141; White LJ, 2017, ACTA BIOMATER, V50, P207, DOI 10.1016/j.actbio.2016.12.033; White SA, 2009, LANCET, V373, P1808, DOI 10.1016/S0140-6736(09)60609-7; Yagi H, 2013, CELL TRANSPLANT, V22, P231, DOI 10.3727/096368912X654939; Zanardo TEC., 2020, FRONT BIOENG BIOTECH, V8, P1; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhou HY, 2018, ANN SURG, V267, P590, DOI 10.1097/SLA.0000000000002129; Zhou JY, 2010, BIOMATERIALS, V31, P2549, DOI 10.1016/j.biomaterials.2009.11.088	106	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22574	10.1096/fj.202200807R	http://dx.doi.org/10.1096/fj.202200807R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4X4ZW	36165227				2022-12-26	WOS:000860853200001
J	Chang, C; Ma, G; Cheung, E; Hutchins, AP				Chang, Chen; Ma, Gang; Cheung, Edwin; Hutchins, Andrew P.			A programmable system to methylate and demethylate N6-methyladenosine (m6A) on specific RNA transcripts in mammalian cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-CHROMOSOME INACTIVATION; MESSENGER-RNA; CRISPR SYSTEMS; M(6)A; GENE; TRANSLATION; ALKBH5; METTL3; N-6-METHYLADENOSINE; DISCOVERY	RNA N6-methyladenosine (m6A) is the most abundant in-ternal mRNA modification and forms part of an epitran-scriptomic system that modulates RNA function. m6A is reversibly catalyzed by specific enzymes, and those modifica-tions can be recognized by RNA-binding proteins that in turn regulate biological processes. Although there are many re-ports demonstrating m6A participation in critical biological functions, this exploration has mainly been conducted through the global KO or knockdown of the writers, erasers, or readers of m6A. Consequently, there is a lack of informa-tion about the role of m6A on single transcripts in biological processes, posing a challenge in understanding the biological functions of m6A. Here, we demonstrate a CRISPR/dCas13a-based RNA m6A editors, which can target RNAs using a sin-gle or multiple CRISPR RNA array to methylate or demeth-ylate m6A in human 293T cells and mouse embryonic stem cells. We systematically assay its capabilities to enable the targeted rewriting of m6A dynamics, including modulation of circular RNA translation and transcript half-life. Finally, we use the system to specifically modulate m6A levels on the noncoding JUST (X-inactive specific transcript) to modulate X chromosome silencing and activation. The editors described here can be used to explore the roles of m6A in biological processes.	[Chang, Chen; Ma, Gang; Hutchins, Andrew P.] Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Peoples R China; [Chang, Chen; Cheung, Edwin] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Peoples R China; [Ma, Gang; Hutchins, Andrew P.] Southern Univ Sci & Technol, Sch Life Sci, Shenzhen Key Lab Gene Regulat & Syst Biol, Shenzhen, Peoples R China	Southern University of Science & Technology; University of Macau; Southern University of Science & Technology	Hutchins, AP (corresponding author), Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Peoples R China.; Cheung, E (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Peoples R China.; Hutchins, AP (corresponding author), Southern Univ Sci & Technol, Sch Life Sci, Shenzhen Key Lab Gene Regulat & Syst Biol, Shenzhen, Peoples R China.	echeung@um.edu.mo; andrewh@sustech.edu.cn	Hutchins, Andrew/O-5708-2018	Hutchins, Andrew/0000-0001-7784-2255	National Natural Science Foundation of China [31970589, 32150710521]; Shenzhen Innovation Committee of Science and Technology [ZDSYS20200811144002008]; Stable Support Plan Program of Shenzhen Natural Science Fund [20200925153035002]; University of Macau [MYRG2020-00100-FHS]; Macau Science and Technology Development Fund [0011/2019/AKP]; Center for Computational Science and Engineering of Southern University of Science and Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Innovation Committee of Science and Technology; Stable Support Plan Program of Shenzhen Natural Science Fund; University of Macau; Macau Science and Technology Development Fund; Center for Computational Science and Engineering of Southern University of Science and Technology	We thank Jacob Hanna for the kind gift of the Mettl3 KO mESCs. This work was supported by the National Natural Science Foundation of China (grant nos.: 31970589 and 32150710521) , the Shenzhen Innovation Committee of Science and Technology (grant no.: ZDSYS20200811144002008) , the Stable Support Plan Program of Shenzhen Natural Science Fund (grant no.: 20200925153035002) , the University of Macau (grant no.: MYRG2020-00100-FHS) , and the Macau Science and Technology Development Fund (grant no.: 0011/2019/AKP) . This work was supported by the Center for Computational Science and Engineering of Southern University of Science and Technology.	Abakir A, 2020, NAT GENET, V52, P48, DOI 10.1038/s41588-019-0549-x; Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049; Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chen XN, 2021, ADV SCI, V8, DOI 10.1002/advs.202003902; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Coker H, 2019, BBA-GENE REGUL MECH, V1862, P310, DOI 10.1016/j.bbagrm.2018.12.002; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Engel M, 2018, NEURON, V99, P389, DOI 10.1016/j.neuron.2018.07.009; Engreitz JM, 2016, NAT REV MOL CELL BIO, V17, P756, DOI 10.1038/nrm.2016.126; Feng C, 2014, J BIOL CHEM, V289, P11571, DOI 10.1074/jbc.M113.546168; Fu Y, 2020, NAT CHEM BIOL, V16, P955, DOI 10.1038/s41589-020-0524-y; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Goell JH, 2021, TRENDS BIOTECHNOL, V39, P678, DOI 10.1016/j.tibtech.2020.10.012; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Huang J, 2019, PROTEIN CELL, V10, P272, DOI 10.1007/s13238-018-0518-7; Huisman B, 2017, TRENDS BIOCHEM SCI, V42, P85, DOI 10.1016/j.tibs.2016.12.004; Ji PF, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/3256524; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jones AN, 2022, NUCLEIC ACIDS RES, V50, P2350, DOI 10.1093/nar/gkac080; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Konermann S, 2018, CELL, V173, P665, DOI 10.1016/j.cell.2018.02.033; Koonin EV, 2017, CURR OPIN MICROBIOL, V37, P67, DOI 10.1016/j.mib.2017.05.008; Li JX, 2020, NUCLEIC ACIDS RES, V48, P5684, DOI 10.1093/nar/gkaa269; Li L, 2020, MOL CELL, V80, P525, DOI 10.1016/j.molcel.2020.09.022; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Li ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16306-5; Liang DM, 2014, GENE DEV, V28, P2233, DOI 10.1101/gad.251926.114; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]; Liu JD, 2021, NATURE, V591, P322, DOI 10.1038/s41586-021-03313-9; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Liu L, 2017, CELL, V168, P121, DOI 10.1016/j.cell.2016.12.031; Liu XM, 2019, NAT CHEM BIOL, V15, P865, DOI 10.1038/s41589-019-0327-1; Makarova KS, 2017, CELL, V168, P946, DOI [10.1016/j.cell.2016.12.038, 10.1016/j.cell.2017.02.018]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mo J, 2020, ADV SCI, V7, DOI 10.1002/advs.202001402; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Petropoulos S, 2016, CELL, V167, P285, DOI [10.1016/j.cell.2016.03.023, 10.1016/j.cell.2016.08.009]; Roignant JY, 2017, TRENDS GENET, V33, P380, DOI 10.1016/j.tig.2017.04.003; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Smargon AA, 2020, NAT CELL BIOL, V22, P143, DOI 10.1038/s41556-019-0454-7; Sun L, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.637309; Sun X, 2022, METHODS, V203, P56, DOI 10.1016/j.ymeth.2022.03.006; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2015, RNA, V21, P172, DOI 10.1261/rna.048272.114; Wang Y, 2020, NAT CHEM BIOL, V16, P896, DOI 10.1038/s41589-020-0525-x; Wei JB, 2021, CURR OPIN CELL BIOL, V70, P109, DOI 10.1016/j.ceb.2020.11.005; Wilson C, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0572-6; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Xia Z, 2021, NUCLEIC ACIDS RES, V49, P7361, DOI 10.1093/nar/gkab517; Xiang JF, 2018, MOL CELL, V69, P126, DOI 10.1016/j.molcel.2017.12.006; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xiao Y, 2018, ANGEW CHEM INT EDIT, V57, P15995, DOI 10.1002/anie.201807942; Xu C, 2014, J BIOL CHEM, V289, P17299, DOI 10.1074/jbc.M114.550350; Xu WQ, 2021, NATURE, V591, P317, DOI 10.1038/s41586-021-03210-1; Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yu J, 2018, NUCLEIC ACIDS RES, V46, P1412, DOI 10.1093/nar/gkx1182; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116; Zhang ZY, 2018, CELL RES, V28, P1050, DOI 10.1038/s41422-018-0092-9; Zhao J, 2020, SMALL, V16, DOI 10.1002/smll.201907301; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	90	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102525	10.1016/j.jbc.2022.102525	http://dx.doi.org/10.1016/j.jbc.2022.102525			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6D3XI	36162509	Green Published, gold			2022-12-26	WOS:000882627400009
J	Kuhlmann, FM; Key, PN; Hickerson, SM; Turk, J; Hsu, FF; Beverley, SM				Kuhlmann, F. Matthew; Key, Phillip N.; Hickerson, Suzanne M.; Turk, John; Hsu, Fong-Fu; Beverley, Stephen M.			Inositol phosphorylceramide synthase null Leishmania are viable and virulent in animal infections where salvage of host sphingomyelin predominates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; DE-NOVO SYNTHESIS; GLYCOINOSITOL PHOSPHOLIPIDS; STABLE TRANSFECTION; TRYPANOSOMA-CRUZI; SPHINGOLIPIDS; CERAMIDE; DIFFERENTIATION; MACROPHAGES; RESISTANCE	Many pathogens synthesize inositol phosphorylceramide (IPC) as the major sphingolipid (SL), differing from the mammalian host where sphingomyelin (SM) or more complex SLs predominate. The divergence between IPC synthase and mammalian SL synthases has prompted interest as a potential drug target. However, in the trypanosomatid protozoan Leishmania, cultured insect stage promastigotes lack de novo SL synthesis (Aspt2-) and SLs survive and remain virulent, as infective amastigotes salvage host SLs and continue to produce IPC. To further understand the role of IPC, we generated null IPCS mutants in Leishmania major (Aipcs-). Unexpectedly and unlike fungi where IPCS is essential, Aipcs- was remarkably normal in culture and highly virulent in mouse infections. Both IPCS activity and IPC were absent in Aipcs- promastigotes and amastigotes, arguing against an alternative route of IPC syn-thesis. Notably, salvaged mammalian SM was highly abundant in purified amastigotes from both WT and Aipcs-, and salvaged SLs could be further metabolized into IPC. SM was about 7-fold more abundant than IPC in WT amastigotes, estab-lishing that SM is the dominant amastigote SL, thereby rendering IPC partially redundant. These data suggest that SM salvage likely plays key roles in the survival and virulence of both WT and Aipcs- parasites in the infected host, confirma-tion of which will require the development of methods or mutants deficient in host SL/SM uptake in the future. Our findings call into question the suitability of IPCS as a target for chemotherapy, instead suggesting that approaches targeting SM/SL uptake or catabolism may warrant further emphasis.	[Kuhlmann, F. Matthew; Key, Phillip N.; Hickerson, Suzanne M.; Beverley, Stephen M.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Kuhlmann, F. Matthew; Turk, John; Hsu, Fong-Fu] Washington Univ, Dept Internal Med, Sch Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Beverley, SM (corresponding author), Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA.	stephen.beverley@wustl.edu		Beverley, Stephen/0000-0001-5319-0811; Key, Phillip/0000-0002-7886-8008; Kuhlmann, Frederick/0000-0003-1085-0589				Akopyants NS, 2004, MOL BIOCHEM PARASIT, V136, P71, DOI 10.1016/j.molbiopara.2004.03.002; Ali HZ, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/691363; Alqaisi AQI, 2018, PARASITOLOGY, V145, P156, DOI 10.1017/S0031182017000877; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Banuls AL, 2011, CLIN MICROBIOL INFEC, V17, P1451, DOI 10.1111/j.1469-0691.2011.03640.x; Bin Mannan S, 2021, PARASITOL INT, V81, DOI 10.1016/j.parint.2020.102229; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; CURRIE LA, 1995, PURE APPL CHEM, V67, P1699, DOI 10.1351/pac199567101699; da Silva LM, 2010, P NATL ACAD SCI USA, V107, P11965, DOI 10.1073/pnas.1004599107; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Dennis EA, 2010, J BIOL CHEM, V285, P39976, DOI 10.1074/jbc.M110.182915; Denny PW, 2006, J BIOL CHEM, V281, P28200, DOI 10.1074/jbc.M600796200; Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Figueiredo JM, 2005, BIOCHEM J, V387, P519, DOI 10.1042/BJ20041842; Ghosh S, 2001, MOL CELL BIOCHEM, V223, P47, DOI 10.1023/A:1017996609928; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Goyard S, 2000, MOL BIOCHEM PARASIT, V108, P249, DOI 10.1016/S0166-6851(00)00210-3; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; Guan XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13931-x; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Harrison PJ, 2018, NAT PROD REP, V35, P921, DOI 10.1039/c8np00019k; Heidler SA, 2000, BBA-MOL BASIS DIS, V1500, P147, DOI 10.1016/S0925-4439(99)00097-6; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P437, DOI 10.1016/S1044-0305(99)00150-6; Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0; Hsu FF, 2007, J AM SOC MASS SPECTR, V18, P1591, DOI 10.1016/j.jasms.2007.05.017; KANESHIRO ES, 1986, J LIPID RES, V27, P1294; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Koeller Carolina Macedo, 2011, Enzyme Res, V2011, P648159, DOI 10.4061/2011/648159; Luberto C, 2001, GENE DEV, V15, P201, DOI 10.1101/gad.856001; Matmati N, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00340-19; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; Megyeri M, 2016, J MOL BIOL, V428, P4765, DOI 10.1016/j.jmb.2016.09.010; Mina JG, 2011, ORG BIOMOL CHEM, V9, P1823, DOI 10.1039/c0ob00871k; Mina JG, 2010, INT J BIOCHEM CELL B, V42, P1553, DOI 10.1016/j.biocel.2010.06.008; Mina JGM, 2018, PARASITOLOGY, V145, P134, DOI 10.1017/S0031182017001081; Norcliffe JL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22063-9; Oskouian B, 2010, ADV EXP MED BIOL, V688, P185; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Pillai AB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001944; Pinneh EC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217087; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Salto ML, 2003, EUKARYOT CELL, V2, P756, DOI 10.1128/EC.2.4.756-768.2003; Sangshetti JN, 2015, RSC ADV, V5, P32376, DOI 10.1039/c5ra02669e; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; SCHNEIDER P, 1993, BIOCHEM J, V295, P555, DOI 10.1042/bj2950555; Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662; Singh OP, 2014, CLIN INFECT DIS, V58, P1424, DOI 10.1093/cid/ciu102; Smith R. M., 2004, UNDERSTANDING MASS S; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Spincemaille P, 2014, BBA-GEN SUBJECTS, V1840, P3131, DOI 10.1016/j.bbagen.2014.06.015; Subramanya S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008538; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Suzuki E, 2008, BBA-GEN SUBJECTS, V1780, P362, DOI 10.1016/j.bbagen.2007.09.009; Tanaka AK, 2007, J ANTIMICROB CHEMOTH, V59, P487, DOI 10.1093/jac/dkl518; TITUS RG, 1985, PARASITE IMMUNOL, V7, P545, DOI 10.1111/j.1365-3024.1985.tb00098.x; WHO, 2010, WHO TECH REP SER, V949, P1; WINTER G, 1994, J CELL SCI, V107, P2471; Xu W, 2011, INFECT IMMUN, V79, P3377, DOI 10.1128/IAI.00037-11; Zhang K, 2005, MOL MICROBIOL, V55, P1566, DOI 10.1111/j.1365-2958.2005.04493.x; Zhang K, 2003, EMBO J, V22, P6016, DOI 10.1093/emboj/cdg584; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565; Zhang K, 2021, CURR OPIN MICROBIOL, V63, P98, DOI 10.1016/j.mib.2021.07.004; Zhang K, 2010, ADV EXP MED BIOL, V688, P238; Zhang K, 2010, MOL BIOCHEM PARASIT, V170, P55, DOI 10.1016/j.molbiopara.2009.12.004; Zhang O, 2013, MOL MICROBIOL, V90, P489, DOI 10.1111/mmi.12378; Zhang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031059; Zhang O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000692	73	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102522	10.1016/j.jbc.2022.102522	http://dx.doi.org/10.1016/j.jbc.2022.102522			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6G4BI	36162499	Green Submitted, gold, Green Published			2022-12-26	WOS:000884698500005
J	Maruta, Y; Fukuda, M				Maruta, Yuto; Fukuda, Mitsunori			Large Rab GTPase Rab44 regulates microtubule-dependent retrograde melanosome transport in melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-VA; COAT-COLOR; MEMBRANE; IDENTIFICATION; BINDING; MODEL; SLAC2-A/MELANOPHILIN; MELANOREGULIN; MELANOPHORES; DEGRADATION	Melanosomes are melanin-containing organelles in mela-nocytes, and they are responsible for skin and hair pigmenta-tion in mammals. The intracellular distribution of melanosomes is mainly determined by the balance between their anterograde transport on actin filaments and retrograde transport on microtubules. Although we have shown previously that melanoregulin and Rab36 serve as cargo receptors on melanosomes for retrograde transport, their knockdown does not completely inhibit retrograde melanosome transport, sug-gesting the existence of an additional cargo receptor(s) in melanocytes. In this study, we investigated the possible involvement of an atypical large Rab, Rab44, which also con-tains EF-hand domains and a coiled-coil domain, in retrograde melanosome transport in mouse melanocytes (Rab27A-defi- cient melan-ash cells). Our results showed that Rab44 localizes on mature melanosomes through lipidation of its C-terminal Rab-like GTPase domain, and that its knockdown results in suppression of retrograde melanosome transport. In addition, our biochemical analysis indicated that Rab44 interacts with the dynein-dynactin motor complex via its coiled-coil domain-containing middle region. Since simultaneous deple-tion of Rab44, melanoregulin, and Rab36 resulted in almost complete inhibition of retrograde melanosome transport, we propose that Rab44 is the third cargo receptor. We also showed that the N-terminal region of Rab44, which contains EF-hand domains, is required for both retrograde melanosome trans-port and its Ca2+-modulated activities. Our findings indicated that Rab44 is a third melanosomal cargo receptor, and that, unlike other cargo receptors previously described, its transport function is regulated by Ca2+.	[Maruta, Yuto; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Lab Membrane Trafficking Mech, Sendai, Miyagi, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Integrat Life Sci, Lab Membrane Trafficking Mech, Sendai, Miyagi, Japan.	nori@tohoku.ac.jp	Fukuda, Mitsunori/I-1511-2015	Fukuda, Mitsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22H02613]; Japan Science and Technology Agency (JST) CREST [JPMJCR17H4]; JST; estab-lishment of university fellowships towards the creation of science technology innovation [JPMJFS2102]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); estab-lishment of university fellowships towards the creation of science technology innovation	This work was supported in part by Grant-in-Aid for Scientific Research (B) 22H02613 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to M. F.) , Japan Science and Technology Agency (JST) CREST grant JPMJCR17H4 (to M. F.) , and JST, the estab-lishment of university fellowships towards the creation of science technology innovation, grant JPMJFS2102 (to Y. M.) .	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bers DM, 2010, METHOD CELL BIOL, V99, P1, DOI [10.1016/S0091-679X(10)99001-8, 10.1016/B978-0-12-374841-6.00001-3]; Bowman SL, 2019, TRAFFIC, V20, P404, DOI 10.1111/tra.12646; Canty JT, 2020, TRENDS BIOCHEM SCI, V45, P440, DOI 10.1016/j.tibs.2020.02.002; Delevoye C, 2019, CURR OPIN CELL BIOL, V59, P147, DOI 10.1016/j.ceb.2019.05.003; Evans RD, 2014, CURR BIOL, V24, P1743, DOI 10.1016/j.cub.2014.06.019; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Homma Y, 2021, FEBS J, V288, P36, DOI 10.1111/febs.15453; Homma Y, 2019, J CELL BIOL, V218, P2035, DOI 10.1083/jcb.201810134; Hume AN, 2011, BIOCHEM SOC T, V39, P1191, DOI 10.1042/BST0391191; Ishida M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08238; Kadowaki T, 2021, FEBS OPEN BIO, V11, P1165, DOI 10.1002/2211-5463.13133; Kadowaki T, 2020, CELL MOL IMMUNOL, V17, P1287, DOI 10.1038/s41423-020-0413-z; Kobayashi H, 2014, BIOL OPEN, V3, P803, DOI 10.1242/bio.20148771; KOTZ KJ, 1994, J CELL BIOL, V124, P463, DOI 10.1083/jcb.124.4.463; Kuroda TS, 2005, METHOD ENZYMOL, V403, P431, DOI 10.1016/S0076-6879(05)03038-7; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Leung KF, 2006, J LIPID RES, V47, P467, DOI 10.1194/jlr.R500017-JLR200; Longe Cyril, 2022, J Allergy Clin Immunol, V150, P676, DOI 10.1016/j.jaci.2022.04.009; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Marubashi S, 2020, CELL STRUCT FUNCT, V45, P45, DOI 10.1247/csf.19039; Matsui T, 2013, EMBO REP, V14, P450, DOI 10.1038/embor.2013.32; Matsui T, 2012, J BIOL CHEM, V287, P28619, DOI 10.1074/jbc.M112.370544; MOORE KJ, 1988, GENETICS, V119, P933; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nascimento AA, 2003, ANNU REV CELL DEV BI, V19, P469, DOI 10.1146/annurev.cellbio.19.111401.092937; Noguchi S, 2014, J INVEST DERMATOL, V134, P461, DOI 10.1038/jid.2013.310; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Ohbayashi Norihiko, 2020, F1000Res, V9, DOI 10.12688/f1000research.24625.1; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reck-Peterson SL, 2018, NAT REV MOL CELL BIO, V19, P382, DOI 10.1038/s41580-018-0004-3; Rodionov V, 2003, CURR BIOL, V13, P1837, DOI 10.1016/j.cub.2003.10.027; Saitoh T, 2003, J BIOL CHEM, V278, P36005, DOI 10.1074/jbc.M304266200; SAMMAK PJ, 1992, J CELL BIOL, V117, P57, DOI 10.1083/jcb.117.1.57; Sheets L, 2007, CURR BIOL, V17, P1721, DOI 10.1016/j.cub.2007.09.028; Srikanth Sonal, 2017, Small GTPases, V8, P43, DOI 10.1080/21541248.2016.1192921; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tokuhisa M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67638-7; Tsukuba T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147691; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wang YX, 2019, J CELL BIOL, V218, P1619, DOI 10.1083/jcb.201806097; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 1998, J CELL BIOL, V143, P1899, DOI 10.1083/jcb.143.7.1899; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Wu XF, 2014, CURR OPIN CELL BIOL, V29, P1, DOI 10.1016/j.ceb.2014.02.003; Wu XS, 2012, BIOCHEM BIOPH RES CO, V426, P209, DOI 10.1016/j.bbrc.2012.08.064; Y. J. Subramaniam, 2021, bioRxiv, DOI 10.1101/2021.03.11.434917	50	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102508	10.1016/j.jbc.2022.102508	http://dx.doi.org/10.1016/j.jbc.2022.102508			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36126775	Green Published, gold			2022-12-26	WOS:000881802600010
J	Bhakt, P; Raney, M; Kaur, R				Bhakt, Priyanka; Raney, Mayur; Kaur, Rupinder			The SET-domain protein CgSet4 negatively regulates antifungal drug resistance via the ergosterol biosynthesis transcriptional regulator CgUpc2a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDA-GLABRATA; TRANSPORTER GENE; AZOLE; SUSCEPTIBILITY; ECHINOCANDIN; EXPRESSION; CHROMATIN; AGENTS; IDENTIFICATION; CASPOFUNGIN	Invasive fungal infections, which pose a serious threat to human health, are increasingly associated with a high mor-tality rate and elevated health care costs, owing to rising resistance to current antifungals and emergence of multidrug-resistant fungal species. Candida glabrata is the second to fourth common cause of Candida bloodstream infections. Its high propensity to acquire resistance toward two mainstream drugs, azoles (inhibit ergosterol biosynthesis) and echino-candins (target cell wall), in clinical settings, and its inherent low azole susceptibility render antifungal therapy unsuccessful in many cases. Here, we demonstrate a pivotal role for the SET {suppressor of variegation 3 to 9 [Su(var)3-9], enhancer of zeste [E(z)], and trithorax (Trx)} domain-containing protein, CgSet4, in azole and echinocandin resistance via negative regulation of multidrug transporter-encoding and ergosterol biosynthesis (ERG) genes through the master transcriptional factors CgPdr1 and CgUpc2A, respectively. RNA-Seq analysis revealed that C. glabrata responds to caspofungin (CSP; echinocandin antifungal) stress by downregulation and upre-gulation of ERG and cell wall organization genes, respectively. Although CgSet4 acts as a repressor of the ergosterol biosynthesis pathway via CgUPC2A transcriptional down -regulation, the CSP-induced ERG gene repression is not dependent on CgSet4, as CgSet4 showed diminished abun-dance on the CgUPC2A promoter in CSP-treated cells. Furthermore, we show a role for the last three enzymes of the ergosterol biosynthesis pathway, CgErg3, CgErg5, and CgErg4, in antifungal susceptibility and virulence in C. glabrata. Altogether, our results unveil the link between ergosterol biosynthesis and echinocandin resistance and have implica-tions for combination antifungal therapy.	[Bhakt, Priyanka; Raney, Mayur; Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Lab Fungal Pathogenesis, Hyderabad, India; [Raney, Mayur] Manipal Acad Higher Educ, Grad Studies, Manipal, Karnataka, India; [Kaur, Rupinder] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE); Drexel University	Kaur, R (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	rkaur@cdfd.org.in			Department of Biotechnology/Wellcome Trust India Alliance Senior Fellowship [IA/S/15/1/501831]; Department of Biotechnology [BT/PR42015/MED/29/1561/2021, BT/PR40336/BRB/10/1921/2020]; Science and Engineering Research Board, Department of Science and Technology, Government of India [CRG/2021/000530]; Department of Biotechnology, Government of India	Department of Biotechnology/Wellcome Trust India Alliance Senior Fellowship; Department of Biotechnology; Science and Engineering Research Board, Department of Science and Technology, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology/Wellcome Trust India Alliance Senior Fellowship to R. K. (grant no.: IA/S/15/1/501831; www.indiaalliance.org/) and grants from the Department of Biotechnology (grant nos.: BT/PR42015/MED/29/1561/2021 and BT/PR40336/BRB/10/1921/2020; www.dbtindia.gov.in/), and Science and Engineering Research Board, Department of Science and Technology (grant no.: CRG/2021/000530; www.serb.gov.in/), Government of India. M. R. is a recipient of Junior Research Fellowship sponsored by the Department of Biotechnology, Government of India.	Agarwal AK, 2003, J BIOL CHEM, V278, P34998, DOI 10.1074/jbc.M306291200; Arendrup MC, 2017, J INFECT DIS, V216, pS445, DOI 10.1093/infdis/jix131; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Astvad KMT, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01564-17; Bairwa G, 2014, BIOCHEM J, V458, P323, DOI 10.1042/BJ20130757; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bhakt P, 2018, MOL MICROBIOL, V110, P425, DOI 10.1111/mmi.14110; Bhattacharya S, 2018, MBIO, V9, DOI 10.1128/mBio.01291-18; Bongomin F, 2017, J FUNGI, V3, DOI 10.3390/jof3040057; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Cavalheiro M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00995-18; Chakrabarti A, 2015, INTENS CARE MED, V41, P285, DOI 10.1007/s00134-014-3603-2; Choudhary DK, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00886-19; Cirigliano A, 2019, BBA-MOL CELL BIOL L, V1864, P290, DOI 10.1016/j.bbalip.2018.12.002; Cormack BP, 1999, GENETICS, V151, P979; Cota JM, 2008, ANTIMICROB AGENTS CH, V52, P1144, DOI 10.1128/AAC.01542-07; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Ferrari S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000268; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; Freitag M, 2017, ANNU REV MICROBIOL, V71, P413, DOI 10.1146/annurev-micro-102215-095757; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Galocha M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092345; Garcia-Rubio R, 2021, MBIO, V12, DOI 10.1128/mBio.01959-21; Garcia-Rubio R, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.702779; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Healey KR, 2018, J FUNGI, V4, DOI 10.3390/jof4030105; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Izumikawa K, 2003, YEAST, V20, P249, DOI 10.1002/yea.962; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Jethmalani Y, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202101126; Jimenez-Ortigosa C, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01277-17, 10.1128/aac.01277-17]; Johnson MD, 2010, CURR FUNGAL INFECT R, V4, P87, DOI 10.1007/s12281-010-0018-6; Jorda T, 2020, GENES-BASEL, V11, DOI 10.3390/genes11070795; Baker KM, 2021, bioRxiv, DOI 10.1101/2021.11.17.469015; Katiyar SK, 2012, ANTIMICROB AGENTS CH, V56, P6304, DOI 10.1128/AAC.00813-12; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; Kodedova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139306; Ksiezopolska E, 2021, CURR BIOL, V31, P5314, DOI 10.1016/j.cub.2021.09.084; Kumar K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7020039; Lewis RE, 2011, MAYO CLIN PROC, V86, P805, DOI 10.4065/mcp.2011.0247; Li QQ, 2018, MOL MED REP, V17, P6585, DOI 10.3892/mmr.2018.8716; Liu TT, 2005, ANTIMICROB AGENTS CH, V49, P2226, DOI 10.1128/AAC.49.6.2226-2236.2005; Miyazaki T, 2010, ANTIMICROB AGENTS CH, V54, P1639, DOI 10.1128/AAC.01364-09; Moirangthem R, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02415-20; Nagi M, 2011, GENES CELLS, V16, P80, DOI 10.1111/j.1365-2443.2010.01470.x; OLLINGER TL, 2021, MSPHERE, V0006; Pais P, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00554-20; Perlin DS, 2017, LANCET INFECT DIS, V17, pE383, DOI 10.1016/S1473-3099(17)30316-X; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P1199, DOI 10.1128/JCM.06112-11; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; Pfaller MA, 2019, OPEN FORUM INFECT DI, V6, pS79, DOI 10.1093/ofid/ofy358; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Puig S, 2005, CELL, V120, P99, DOI 10.1016/j.cell.2004.11.032; Reinoso-Martin C, 2003, EUKARYOT CELL, V2, P1200, DOI 10.1128/EC.2.6.1200-1210.2003; Rosenwald AG, 2016, G3-GENES GENOM GENET, V6, P2893, DOI 10.1534/g3.116.032490; Sanglard D, 1999, ANTIMICROB AGENTS CH, V43, P2753, DOI 10.1128/AAC.43.11.2753; Schwarzmuller T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004211; Serratore ND, 2018, GENETICS, V208, P1037, DOI 10.1534/genetics.117.300554; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Tran K, 2018, J BIOL CHEM, V293, P14429, DOI 10.1074/jbc.RA118.003078; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Valachovic M, 2004, LIPIDS, V39, P747, DOI 10.1007/s11745-004-1291-6; Vallabhaneni Snigdha, 2015, Open Forum Infect Dis, V2, pofv163, DOI 10.1093/ofid/ofv163; Vermitsky JP, 2004, ANTIMICROB AGENTS CH, V48, P3773, DOI 10.1128/AAC.48.10.3773-3781.2004; Vu BG, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009582; Vu BG, 2019, MBIO, V10, DOI 10.1128/mBio.00934-19; Whaley SG, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0554-5; Whaley SG, 2014, ANTIMICROB AGENTS CH, V58, P4543, DOI 10.1128/AAC.02217-13	71	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102485	10.1016/j.jbc.2022.102485	http://dx.doi.org/10.1016/j.jbc.2022.102485			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36108742	Green Published, gold			2022-12-26	WOS:000875415100003
J	Chu, YJ; Zuo, JX; Zhang, Y; Gao, GQ; Hu, XY; Han, RD; Liu, C; Zhou, HS; Li, M; Peng, W; Wang, Y				Chu, Yijing; Zuo, Jianxin; Zhang, Yan; Gao, Guoqiang; Hu, Xiaoyu; Han, Rendong; Liu, Chong; Zhou, Huansheng; Li, Min; Peng, Wei; Wang, Yan			Co-culture with chorionic villous mesenchymal stem cells promotes endothelial cell proliferation and angiogenesis via ABCA9-AKT pathway	FASEB JOURNAL			English	Article						ABCA9; AKT; CV-MSCs; HUVEC; preeclampsia	AKT; MARKERS; TRANSPLANTATION; INFLAMMATION	Human chorionic villous mesenchymal stem cells (CV-MSCs) are a promising and effective therapeutic option for tissue injury. Vascular dysfunction during pregnancies is significantly involved in the pathogenesis of preeclampsia (PE). This work aims to investigate how CV-MSCs regulate the function of vascular endothelial cells. In this study, RNA-seq analysis was used to examine the changes in HUVECs treated with CV-MSC conditioned medium (CM). We examined the levels of ABCA9 and AKT signaling in human umbilical vein endothelial cells (HUVECs) by immunohistochemistry, western blotting, and qRT-PCR assays. CCK-8, colony formation, and tube formation assays were used to understand the role of ABCA9 in HUVEC proliferation and angiogenesis mediated by CV-MSCs. The CV-MSC treatment significantly enhanced the HUVEC proliferation and angiogenesis. Furthermore, a significant increase in the ABCA9 expression and AKT pathway activation was observed in CV-MSCs -treated HUVECs. Consistent with these findings, ABCA9 overexpression exhibited the same proliferation-and angiogenesis-promoting effect in HUVECs as induced by CV-MSC CM, also accompanied the AKT signaling activation. In addition, inhibition of ABCA9 inactivated the AKT signaling in HUVECs and reduced the HUVEC proliferation and angiogenesis. Importantly, the elevation of proliferation and angiogenesis induced by ABCA9 overexpression in HUVECs could be reversed by AKT pathway inhibition. Our results suggest that ABCA9-dependent AKT signaling activation mediated by CV-MSCs could promote HUVEC proliferation and angiogenesis.	[Chu, Yijing; Zuo, Jianxin; Zhang, Yan; Gao, Guoqiang; Hu, Xiaoyu; Han, Rendong; Liu, Chong; Zhou, Huansheng; Li, Min; Peng, Wei] Qingdao Univ, Affiliated Hosp, Dept Obstet, 16 Jiangsu Rd, Qingdao 266000, Peoples R China; [Wang, Yan] Qingdao Univ, Affiliated Hosp, Dept Spinal Surg, Haier 59, Qingdao 266071, Peoples R China	Qingdao University; Qingdao University	Peng, W (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Obstet, 16 Jiangsu Rd, Qingdao 266000, Peoples R China.; Wang, Y (corresponding author), Qingdao Univ, Affiliated Hosp, Dept Spinal Surg, Haier 59, Qingdao 266071, Peoples R China.	82791819@163.com; sanwang1986@163.com			Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University	Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University	This study was supported by the Clinical Medicine+X Project of the Affiliated Hospital of Qingdao University.	Abumaree MH, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1153-9; Al-ofi EA, 2017, J REPROD IMMUNOL, V121, P26, DOI 10.1016/j.jri.2017.05.002; Amaral LM, 2015, VASC HEALTH RISK MAN, V11, P403, DOI 10.2147/VHRM.S64798; Anasiz Y, 2017, STEM CELL REV REP, V13, P587, DOI 10.1007/s12015-017-9757-x; Babajani A, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00748; Basmaeil YS, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0984-0; Brown D, 2020, MED HYPOTHESES, V140, DOI 10.1016/j.mehy.2020.109669; Ceserani V, 2016, VASC CELL, V8, DOI 10.1186/s13221-016-0037-3; Chen Y, 2017, ONCOGENE, V36, P2879, DOI 10.1038/onc.2016.442; Chu YJ, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00681-7; Chu YJ, 2020, CELL SIGNAL, V69, DOI 10.1016/j.cellsig.2020.109549; Cunningham CJ, 2018, J CEREBR BLOOD F MET, V38, P1276, DOI 10.1177/0271678X18776802; Ding DC, 2011, CELL TRANSPLANT, V20, P5, DOI 10.3727/096368910X; Ding HF, 2017, CELL MOL IMMUNOL, V14, P693, DOI 10.1038/cmi.2015.99; Du WJ, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0297-0; Evangelista M, 2008, CYTOTECHNOLOGY, V58, P33, DOI 10.1007/s10616-008-9162-z; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Gao QQ, 2016, J HYPERTENS, V34, P1380, DOI 10.1097/HJH.0000000000000944; Gentile MT, 2019, JOVE-J VIS EXP, DOI 10.3791/58591; Heo SH, 2014, INT J BIOL SCI, V10, P438, DOI 10.7150/ijbs.8095; Hsuan YCY, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.526; Imperio GE, 2019, J CELL MOL MED, V23, P610, DOI 10.1111/jcmm.13966; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Karatza AA, 2020, CURR PEDIATR REV, V16, P194, DOI 10.2174/1573396316666191224092405; Keshtkar S, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0791-7; Kim YH, 2012, YONSEI MED J, V53, P1036, DOI 10.3349/ymj.2012.53.5.1036; Konukoglu D, 2017, ADV EXP MED BIOL, V956, P511, DOI 10.1007/5584_2016_90; Li M, 2020, HYPERTENS PREGNANCY, V39, P126, DOI 10.1080/10641955.2020.1744000; Lip SV, 2020, AM J OBSTET GYNECOL, V222, DOI 10.1016/j.ajog.2019.11.1286; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Ma J, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-018-1104-x; MacDonald ES, 2020, FRONT VET SCI, V6, DOI 10.3389/fvets.2019.00507; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Pecher SJ, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082604; Rempel S, 2019, ANNU REV BIOCHEM, V88, P551, DOI 10.1146/annurev-biochem-013118-111705; Rodriguez-Fuentes DE, 2021, ARCH MED RES, V52, P93, DOI 10.1016/j.arcmed.2020.08.006; Saleh M, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00433-z; Samsonraj RM, 2017, STEM CELL TRANSL MED, V6, P2173, DOI 10.1002/sctm.17-0129; SandvoSS Mareike, 2017, Reprod Sci, V24, P568, DOI 10.1177/1933719116667216; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Silva-Carvalho AE, 2019, CYTOKINE GROWTH F R, V47, P32, DOI 10.1016/j.cytogfr.2019.05.006; Song M, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00595-w; Tachikawa M, 2008, MICROVASC RES, V75, P68, DOI 10.1016/j.mvr.2007.05.002; Tachikawa M, 2018, ANAT SCI INT, V93, P456, DOI 10.1007/s12565-018-0435-0; van Rijn BB, 2016, HYPERTENSION, V67, P404, DOI 10.1161/HYPERTENSIONAHA.115.06455; Wang ZG, 2017, J CELL MOL MED, V21, P2432, DOI 10.1111/jcmm.13165; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Yetik-Anacak G, 2006, VASC PHARMACOL, V45, P268, DOI 10.1016/j.vph.2006.08.002; Yu HX, 2015, VASC PHARMACOL, V71, P57, DOI 10.1016/j.vph.2015.03.003; Zhang XF, 2017, ACTA BIOMATER, V59, P317, DOI 10.1016/j.actbio.2017.07.001	51	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22568	10.1096/fj.202101316RR	http://dx.doi.org/10.1096/fj.202101316RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4W1MV	36165221				2022-12-26	WOS:000859930700001
J	Klau, LJ; Podell, S; Creamer, KE; Demko, AM; Singh, HW; Allen, EE; Moore, BS; Ziemert, N; Letzel, AC; Jensen, PR				Klau, Leesa J.; Podell, Sheila; Creamer, Kaitlin E.; Demko, Alyssa M.; Singh, Hans W.; Allen, Eric E.; Moore, Bradley S.; Ziemert, Nadine; Letzel, Anne Catrin; Jensen, Paul R.			The Natural Product Domain Seeker version 2 (NaPDoS2) webtool relates ketosynthase phylogeny to biosynthetic function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYKETIDE SYNTHASES; NONRIBOSOMAL PEPTIDE; DIVERSITY; DISCOVERY; EVOLUTION; PATHWAY; GENES; TOOL; BIOINFORMATICS; SUPERFAMILY	The Natural Product Domain Seeker (NaPDoS) webtool detects and classifies ketosynthase (KS) and condensation domains from genomic, metagenomic, and amplicon sequence data. Unlike other tools, a phylogeny-based clas-sification scheme is used to make broader predictions about the polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) genes in which these domains are found. NaPDoS is particularly useful for the analysis of incomplete biosynthetic genes or gene clusters, as are often observed in poorly assembled genomes and metagenomes, or when loci are not clustered, as in eukaryotic genomes. To help support the growing interest in sequence-based analyses of natural product biosynthetic diversity, here we intro-duce version 2 of the webtool, NaPDoS2, available at http://napdos.ucsd.edu/napdos2. This update includes the addition of 1417 KS sequences, representing a major expansion of the taxonomic and functional diversity repre-sented in the webtool database. The phylogeny-based KS classification scheme now recognizes 41 class and subclass assignments, including new type II PKS subclasses. Work-flow modifications accelerate run times, allowing larger datasets to be analyzed. In addition, default parameters were established using statistical validation tests to maximize KS detection and classification accuracy while minimizing false positives. We further demonstrate the applications of NaPDoS2 to assess PKS biosynthetic po-tential using genomic, metagenomic, and PCR amplicon datasets. These examples illustrate how NaPDoS2 can be used to predict biosynthetic potential and detect genes involved in the biosynthesis of specific structure classes or new biosynthetic mechanisms.	[Klau, Leesa J.; Podell, Sheila; Creamer, Kaitlin E.; Demko, Alyssa M.; Singh, Hans W.; Allen, Eric E.; Moore, Bradley S.; Ziemert, Nadine; Letzel, Anne Catrin; Jensen, Paul R.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Klau, Leesa J.] Norwegian Univ Sci & Technol NTNU, Dept Biotechnol & Food Sci, Trondheim, Norway; [Allen, Eric E.] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA; [Demko, Alyssa M.] Smithsonian Marine Stn, Ft Pierce, FL 34949 USA; [Ziemert, Nadine] Univ Tubingen, Interfac Inst Microbiol & Infect Med, Inst Bioinformat & Med Infor matics IBMI, Morgenstelle 28,72, Tubingen, Germany; [Ziemert, Nadine] German Ctr Infect Res DZ, Partner Site Tubingen, Tubingen, Germany	University of California System; University of California San Diego; Scripps Institution of Oceanography; Norwegian University of Science & Technology (NTNU); University of California System; University of California San Diego; University of California System; University of California San Diego; Smithsonian Institution; Smithsonian National Museum of Natural History; Eberhard Karls University of Tubingen	Jensen, PR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.			Podell, Sheila/0000-0001-7073-5190; Creamer, Kaitlin/0000-0002-0666-2107; Klau, Leesa/0000-0003-2482-3880	National Institutes of Health; National Science Foundation Graduate Research Fellowship Program; National Science Foundation Division of Molecular and Cellular Biosciences;  [5R01GM085770];  [DGE-1650112];  [DGE-2038238];  [MCB-1149552]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); ; ; ; 	Funding and additional information-This research was supported by the National Institutes of Health (grant no. 5R01GM085770 to P. R. J. and B. S. M.) , the National Science Foundation Graduate Research Fellowship Program (grant no. DGE-1650112 to K. E. C. and A. M. D.; grant no. DGE-2038238 to H. W. S.) , and the National Science Foundation Division of Molecular and Cellular Biosciences (grant MCB-1149552 to E. E. A.) . The content is solely the re-sponsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Almeida H, 2019, IEEE INT C BIOINFORM, P1280, DOI 10.1109/BIBM47256.2019.8983041; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bauman KD, 2022, NAT CHEM BIOL, V18, P538, DOI 10.1038/s41589-022-00993-w; Beedessee G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2195-8; Blin K, 2021, NUCLEIC ACIDS RES, V49, pW29, DOI 10.1093/nar/gkab335; Borsetto C, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0692-8; Bretschneider T, 2013, NATURE, V502, P124, DOI 10.1038/nature12588; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Cai HM, 2019, SCI DATA, V6, DOI 10.1038/sdata.2019.22; Cao SG, 2010, ORG LETT, V12, P4652, DOI 10.1021/ol1020064; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen AC, 2018, NAT PROD REP, V35, DOI 10.1039/c8np00040a; Chen HT, 2016, APPL MICROBIOL BIOT, V100, P541, DOI 10.1007/s00253-015-7093-0; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chooi YH, 2012, J ORG CHEM, V77, P9933, DOI 10.1021/jo301592k; Cimermancic P, 2014, CELL, V158, P412, DOI 10.1016/j.cell.2014.06.034; Coates RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085140; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Du DY, 2020, NAT CHEM BIOL, V16, P776, DOI 10.1038/s41589-020-0530-0; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Elfeki M, 2018, ACS CHEM BIOL, V13, P2074, DOI 10.1021/acschembio.8b00254; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feng LK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24682-9; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gallo A, 2013, TOXINS, V5, P717, DOI 10.3390/toxins5040717; Goksuluk D, 2016, R J, V8, P213; Grammbitter GLC, 2019, J AM CHEM SOC, V141, P16615, DOI 10.1021/jacs.8b10776; Gumerov VM, 2020, NUCLEIC ACIDS RES, V48, pW72, DOI 10.1093/nar/gkaa243; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Helfrich EJN, 2019, NAT CHEM BIOL, V15, P813, DOI 10.1038/s41589-019-0313-7; Herbst DA, 2018, NAT PROD REP, V35, P1046, DOI 10.1039/c8np00039e; Hertweck C, 2015, TRENDS BIOCHEM SCI, V40, P189, DOI 10.1016/j.tibs.2015.02.001; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hillenmeyer ME, 2015, P NATL ACAD SCI USA, V112, P13952, DOI 10.1073/pnas.1511688112; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jiang CG, 2008, MOL PHYLOGENET EVOL, V49, P691, DOI 10.1016/j.ympev.2008.09.002; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kautsar SA, 2020, NUCLEIC ACIDS RES, V48, pD454, DOI 10.1093/nar/gkz882; Kim J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-169; Komaki H., 2006, ACTINOMYCETOLOGICA, V20, P42, DOI DOI 10.3209/SAJ.20.42; Kwon HJ, 2002, SCIENCE, V297, P1327, DOI 10.1126/science.1073175; Lee WC, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95890-y; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Lemoine F, 2018, NATURE, V556, P452, DOI 10.1038/s41586-018-0043-0; Lemoine F, 2019, NUCLEIC ACIDS RES, V47, pW260, DOI 10.1093/nar/gkz303; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Lohman JR, 2015, P NATL ACAD SCI USA, V112, P12693, DOI 10.1073/pnas.1515460112; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Medema MH, 2021, NAT REV GENET, V22, P553, DOI 10.1038/s41576-021-00363-7; Medema MH, 2021, NAT PROD REP, V38, P301, DOI 10.1039/d0np00090f; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Metz JG, 2001, SCIENCE, V293, P290, DOI 10.1126/science.1059593; Millan-Aguinaga N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02845-3; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Moffitt MC, 2003, J MOL EVOL, V56, P446, DOI 10.1007/s00239-002-2415-0; Mungan MD, 2020, NUCLEIC ACIDS RES, V48, pW546, DOI 10.1093/nar/gkaa374; Nakamura H, 2012, J AM CHEM SOC, V134, P18518, DOI 10.1021/ja308318p; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Oliver A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95106-3; Owen JG, 2013, P NATL ACAD SCI USA, V110, P11797, DOI 10.1073/pnas.1222159110; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rebets Y, 2015, ANGEW CHEM INT EDIT, V54, P2280, DOI 10.1002/anie.201408901; Reddy BVB, 2014, CHEM BIOL, V21, P1023, DOI 10.1016/j.chembiol.2014.06.007; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Schoner TA, 2016, CHEMBIOCHEM, V17, P247, DOI 10.1002/cbic.201500474; Schorn MA, 2021, NAT CHEM BIOL, V17, P363, DOI 10.1038/s41589-020-00724-z; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Sigrist R, 2020, ACS CHEM BIOL, V15, P1067, DOI 10.1021/acschembio.0c00081; Skinnider MA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19986-1; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Torres JP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16376-5; Villebro R, 2019, J IND MICROBIOL BIOT, V46, P469, DOI 10.1007/s10295-018-02131-9; Walczak RJ, 2000, FEMS MICROBIOL LETT, V183, P171, DOI 10.1111/j.1574-6968.2000.tb08953.x; Walker PD, 2021, NAT PROD REP, V38, P723, DOI 10.1039/d0np00045k; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P2232, DOI 10.1128/AEM.71.5.2232-2238.2005; Wietz M, 2013, J CHEM ECOL, V39, P879, DOI 10.1007/s10886-013-0316-x; Zhang GT, 2016, CURR TOP MED CHEM, V16, P1727, DOI 10.2174/1568026616666151012112818; Ziemert N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034064	85	0	0	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102480	10.1016/j.jbc.2022.102480	http://dx.doi.org/10.1016/j.jbc.2022.102480			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36108739	Green Published, gold			2022-12-26	WOS:000875415100007
J	Britton, BM; London, JA; Martin-Lopez, J; Jones, ND; Liu, JQ; Lee, JB; Fishel, R				Britton, Brooke M.; London, James A.; Martin-Lopez, Juana; Jones, Nathan D.; Liu, Jiaquan; Lee, Jong -Bong; Fishel, Richard			Exploiting the distinctive properties of the bacterial and human MutS homolog sliding clamps on mismatched DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MSH2-MSH6; ESCHERICHIA-COLI MUTS; ATPASE ACTIVITY; STATISTICAL PARAMETER; HMUTS-ALPHA; REPAIR; BINDING; HMSH2; MSH6; RECOGNITION	MutS homologs (MSHs) are highly conserved core components of DNA mismatch repair. Mismatch recognition provokes ATP-binding by MSH proteins that drives a conformational transition from a short-lived lesion-searching clamp to an extremely stable sliding clamp on the DNA. Here, we have expanded on previous bulk biochemical studies to examine the stability, lifetime, and kinetics of bacterial and human MSH sliding clamps on mismatched DNA using surface plasmon resonance and single-molecule analysis of fluo-rescently labeled proteins. We found that ATP-bound MSH complexes bound to blocked-end or very long mismatched DNAs were extremely stable over a range of ionic conditions. These observations underpinned the development of a high-throughput Forster resonance energy transfer system that specifically detects the formation of MSH sliding clamps on mismatched DNA. The Forster resonance energy transfer system is capable of distinguishing between HsMSH2-HsMSH3 and HsMSH2-HsMSH6 and appears suitable for chemical inhibitor screens. Taken together, our results provide additional insight into MSH sliding clamps as well as methods to distinguish their functions in mismatch repair.	[Britton, Brooke M.; London, James A.; Martin-Lopez, Juana; Jones, Nathan D.; Liu, Jiaquan; Fishel, Richard] Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA; [Lee, Jong -Bong] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, South Korea; [Lee, Jong -Bong] POSTECH, Interdisciplinary Biosci & Bioengn, Pohang, South Korea	University System of Ohio; Ohio State University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Fishel, R (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA.	fishel.7@osu.edu		Britton, Brooke/0000-0003-1606-0991; MARTIN-LOPEZ, JUANA VICTORIA/0000-0003-2777-2740; LIU, JIAQUAN/0000-0001-6206-3742	National Institutes of Health [GM129764, CA067007]; NRF of Korea - Ministry of Science and ICT [2017K1A1A2013241]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRF of Korea - Ministry of Science and ICT(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by National Institutes of Health grants CA067007 and GM129764 (R. F.) and the Global Research Lab Program through the NRF of Korea funded by the Ministry of Science and ICT 2017K1A1A2013241 (J.-B. L.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Balakin KV, 2006, CURR MED CHEM, V13, P223, DOI 10.2174/092986706775197917; Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 2001, J BIOL CHEM, V276, P34339, DOI 10.1074/jbc.M104256200; Blackwell LJ, 1998, J BIOL CHEM, V273, P32055, DOI 10.1074/jbc.273.48.32055; Bowen N, 2017, P NATL ACAD SCI USA, V114, P3607, DOI 10.1073/pnas.1701753114; Charbonneau N, 2009, CANCER BIOL THER, V8, P1411, DOI 10.4161/cbt.8.14.8886; Cho WK, 2012, STRUCTURE, V20, P1264, DOI 10.1016/j.str.2012.04.017; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Dowen JM, 2010, MOL CELL BIOL, V30, P3321, DOI 10.1128/MCB.01558-09; DRUMMOND JT, 1995, SCIENCE, V268, P1909, DOI 10.1126/science.7604264; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fernandez-Leiro R, 2021, NAT STRUCT MOL BIOL, V28, P373, DOI 10.1038/s41594-021-00577-7; FISHEL RA, 1986, J MOL BIOL, V188, P147, DOI 10.1016/0022-2836(86)90300-1; Fishel R, 2016, P NATL ACAD SCI USA, V113, P3918, DOI 10.1073/pnas.1602650113; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Gorman J, 2012, P NATL ACAD SCI USA, V109, pE3074, DOI 10.1073/pnas.1211364109; Gradia S, 2000, J BIOL CHEM, V275, P3922, DOI 10.1074/jbc.275.6.3922; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; Graham WJ, 2018, J BIOL CHEM, V293, P18055, DOI 10.1074/jbc.RA118.005439; Groothuizen FS, 2015, ELIFE, V4, DOI 10.7554/eLife.06744; Hanne J, 2018, J BIOL CHEM, V293, P14285, DOI 10.1074/jbc.RA118.002264; Hargreaves VV, 2012, J BIOL CHEM, V287, P41232, DOI 10.1074/jbc.M112.402495; Hargreaves VV, 2010, J BIOL CHEM, V285, P9301, DOI 10.1074/jbc.M109.096388; Harrington JA, 2007, MOL CELL BIOL, V27, P6546, DOI 10.1128/MCB.00855-07; Heinen CD, 2002, CANCER CELL, V1, P469, DOI 10.1016/S1535-6108(02)00073-9; Heinen CD, 2011, J BIOL CHEM, V286, P40287, DOI 10.1074/jbc.M111.297523; Hermans N, 2016, NUCLEIC ACIDS RES, V44, P6770, DOI 10.1093/nar/gkw411; Huang JQ, 2001, CANCER RES, V61, P1619; Iaccarino I, 1998, EMBO J, V17, P2677, DOI 10.1093/emboj/17.9.2677; Ilouga PE, 2007, J BIOMOL SCREEN, V12, P21, DOI 10.1177/1087057106295507; Jeong C, 2011, NAT STRUCT MOL BIOL, V18, P379, DOI 10.1038/nsmb.2009; Jiang JJ, 2005, MOL CELL, V20, P771, DOI 10.1016/j.molcel.2005.10.014; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Jones L, 2017, LANCET NEUROL, V16, P88, DOI 10.1016/S1474-4422(16)30350-7; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kolodner RD, 2000, NATURE, V407, P687, DOI 10.1038/35037701; KOLODNER RD, 1995, TRENDS BIOCHEM SCI, V20, P397, DOI 10.1016/S0968-0004(00)89087-8; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kolodner RD, 2007, P NATL ACAD SCI USA, V104, P12953, DOI 10.1073/pnas.0705698104; Kolodner RD, 2016, DNA REPAIR, V38, P3, DOI 10.1016/j.dnarep.2015.11.009; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Liu JQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13191-5; Liu JQ, 2016, NATURE, V539, P583, DOI 10.1038/nature20562; Liu JQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16883; London J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019215118; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Lynch Henry T., 1993, Current Opinion in Oncology, V5, P687, DOI 10.1097/00001622-199307000-00013; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Mardenborough YSN, 2019, NUCLEIC ACIDS RES, V47, P11667, DOI 10.1093/nar/gkz834; Marra G, 1998, P NATL ACAD SCI USA, V95, P8568, DOI 10.1073/pnas.95.15.8568; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Martinez JS, 2016, P NATL ACAD SCI USA, V113, P3515, DOI 10.1073/pnas.1601691113; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mazurek A, 2009, P NATL ACAD SCI USA, V106, P4177, DOI 10.1073/pnas.0808572106; MELHUISH WH, 1972, J RES NBS C ENG INST, VA 76, P547, DOI 10.6028/jres.076A.049; Mendillo ML, 2007, J BIOL CHEM, V282, P16345, DOI 10.1074/jbc.M700858200; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Modrich P, 1997, J BIOL CHEM, V272, P24727, DOI 10.1074/jbc.272.40.24727; Ortega J, 2021, CELL RES, V31, P542, DOI 10.1038/s41422-021-00468-y; Palombo F, 1996, CURR BIOL, V6, P1181, DOI 10.1016/S0960-9822(02)70685-4; Popp Maximilian Wei-Lin, 2009, Curr Protoc Protein Sci, VChapter 15, DOI 10.1002/0471140864.ps1503s56; Qiu RY, 2015, P NATL ACAD SCI USA, V112, P10914, DOI 10.1073/pnas.1505655112; Rath A, 2019, HUM MUTAT, V40, P2044, DOI 10.1002/humu.23848; Senavirathne G, 2018, ANAL BIOCHEM, V556, P78, DOI 10.1016/j.ab.2018.06.016; Senavirathne G, 2015, NAT METHODS, V12, P901, DOI 10.1038/nmeth.3588; Smith CE, 2015, J BIOL CHEM, V290, P21580, DOI 10.1074/jbc.M115.662189; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Spies M, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a022657; Srivatsan A, 2014, J BIOL CHEM, V289, P9352, DOI 10.1074/jbc.M114.552190; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Sui YX, 2007, J BIOMOL SCREEN, V12, P229, DOI 10.1177/1087057106296498; Thompson BA, 2014, NAT GENET, V46, P107, DOI 10.1038/ng.2854; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Watanabe T, 1996, CANCER, V77, P627, DOI 10.1002/(SICI)1097-0142(19960215)77:4<627::AID-CNCR7>3.0.CO;2-D; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	84	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102505	10.1016/j.jbc.2022.102505	http://dx.doi.org/10.1016/j.jbc.2022.102505			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36126773	Green Published, gold			2022-12-26	WOS:000881802600006
J	Pal, A; Paripati, AK; Deolal, P; Chatterjee, A; Prasad, PR; Adla, P; Sepuri, NBV				Pal, Amita; Paripati, Arun Kumar; Deolal, Pallavi; Chatterjee, Arpan; Prasad, Pushpa Rani; Adla, Priyanka; Sepuri, Naresh Babu V.			Eisosome protein Pil1 regulates mitochondrial morphology, mitophagy, and cell death in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED GTPASE; PLASMA-MEMBRANE; FISSION MACHINERY; ROS PRODUCTION; YEAST; FUSION; DNM1P; STRESS; PHOSPHORYLATION; DEGRADATION	Mitochondrial morphology and dynamics maintain mito-chondrial integrity by regulating its size, shape, distribution, and connectivity, thereby modulating various cellular pro-cesses. Several studies have established a functional link be-tween mitochondrial dynamics, mitophagy, and cell death, but further investigation is needed to identify specific proteins involved in mitochondrial dynamics. Any alteration in the integrity of mitochondria has severe ramifications that include disorders like cancer and neurodegeneration. In this study, we used budding yeast as a model organism and found that Pil1, the major component of the eisosome complex, also localizes to the periphery of mitochondria. Interestingly, the absence of Pil1 causes the branched tubular morphology of mitochondria to be abnormally fused or aggregated, whereas its over -expression leads to mitochondrial fragmentation. Most importantly, pil1 Delta cells are defective in mitophagy and bulk autophagy, resulting in elevated levels of reactive oxygen spe-cies and protein aggregates. In addition, we show that pil1 Delta cells are more prone to cell death. Yeast two-hybrid analysis and co-immunoprecipitations show the interaction of Pil1 with two major proteins in mitochondrial fission, Fis1 and Dnm1. Additionally, our data suggest that the role of Pil1 in main-taining mitochondrial shape is dependent on Fis1 and Dnm1, but it functions independently in mitophagy and cell death pathways. Together, our data suggest that Pil1, an eisosome protein, is a novel regulator of mitochondrial morphology, mitophagy, and cell death.	[Pal, Amita; Paripati, Arun Kumar; Deolal, Pallavi; Chatterjee, Arpan; Prasad, Pushpa Rani; Adla, Priyanka; Sepuri, Naresh Babu V.] Univ Hyderabad, Dept Biochem, Hyderabad, Telangana, India	University of Hyderabad	Sepuri, NBV (corresponding author), Univ Hyderabad, Dept Biochem, Hyderabad, Telangana, India.	nareshuohyd@gmail.com		Deolal, Pallavi/0000-0003-1909-0707	Department of Biotechnology [BUILDER-DBT-BT/INF/22/SP41176/2020]; Council of Scientific and Industrial Research (CSIR) , India; Institute of Eminence, University of Hyderabad [BUILDER-DBT-BT/INF/22/SP41176/2020];  [UoH-IoE-RC3-21-010]	Department of Biotechnology; Council of Scientific and Industrial Research (CSIR) , India(Council of Scientific & Industrial Research (CSIR) - India); Institute of Eminence, University of Hyderabad; 	This work was supported by funding from Department of Biotechnology (BUILDER-DBT-BT/INF/22/SP41176/2020) , and Institute of Eminence, University of Hyderabad (UoH-IoE-RC3-21-010) to N. B. V. S. Lab. A. P., A. K. P., P. D., A. C., and P. A. acknowledge the Senior Research Fellowship (SRF) & Junior Research Fellowship (JRF) from Council of Scientific and Industrial Research (CSIR) , India.	Abeliovich H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3789; Allu PK, 2015, MOL BIOL CELL, V26, P406, DOI 10.1091/mbc.E14-09-1371; Amen T, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz6339; Bernhardt D, 2015, SCI REP-UK, V5, DOI 10.1038/srep07885; Bhatti JS, 2017, BBA-MOL BASIS DIS, V1863, P1066, DOI 10.1016/j.bbadis.2016.11.010; Blackstone C, 2011, NAT CELL BIOL, V13, P521, DOI 10.1038/ncb0511-521; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Bockler S, 2017, J CELL BIOL, V216, P2481, DOI 10.1083/jcb.201611197; Bosl B, 2006, J STRUCT BIOL, V156, P139, DOI 10.1016/j.jsb.2006.02.004; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Burman JL, 2017, J CELL BIOL, V216, P3231, DOI 10.1083/jcb.201612106; Cerveny KL, 2007, DEV CELL, V12, P363, DOI 10.1016/j.devcel.2007.01.017; Chen YC, 2019, ISCIENCE, V11, P305, DOI 10.1016/j.isci.2018.12.021; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Douglas LM, 2014, ANNU REV MICROBIOL, V68, P377, DOI 10.1146/annurev-micro-091313-103507; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Gournas C, 2018, P NATL ACAD SCI USA, V115, pE3145, DOI 10.1073/pnas.1719462115; Graef M, 2016, J CELL BIOL, V215, P599, DOI 10.1083/jcb.201611079; Griffin EE, 2005, J CELL BIOL, V170, P237, DOI 10.1083/jcb.200503148; Grossmann G, 2007, EMBO J, V26, P1, DOI 10.1038/sj.emboj.7601466; Grousl T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122770; Hammermeister M, 2010, MOL BIOL CELL, V21, P2443, DOI 10.1091/mbc.E10-02-0096; Hawthorne D C, 1974, Curr Top Microbiol Immunol, V64, P1; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Kabeche R, 2015, J CELL SCI, V128, P4057, DOI 10.1242/jcs.176867; Kanki T, 2015, BBA-MOL CELL RES, V1853, P2756, DOI 10.1016/j.bbamcr.2015.01.005; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lacy MM, 2017, MOL BIOL CELL, V28, P2251, DOI 10.1091/mbc.E17-04-0238; Leadsham JE, 2013, CELL METAB, V18, P279, DOI 10.1016/j.cmet.2013.07.005; Lee JH, 2015, EUKARYOT CELL, V14, P1017, DOI 10.1128/EC.00106-15; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Liu L, 2014, CELL RES, V24, P787, DOI 10.1038/cr.2014.75; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Malinska K, 2004, J CELL SCI, V117, P6031, DOI 10.1242/jcs.01493; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Malinsky J, 2010, YEAST, V27, P473, DOI 10.1002/yea.1772; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mascaraque V, 2013, MOL CELL PROTEOMICS, V12, P557, DOI 10.1074/mcp.M112.020438; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Moharir A, 2018, MOL BIOL CELL, V29, P2113, DOI 10.1091/mbc.E17-11-0691; MOOR H, 1963, J CELL BIOL, V17, P609, DOI 10.1083/jcb.17.3.609; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Moreira KE, 2012, J CELL BIOL, V198, P405, DOI 10.1083/jcb.201202097; Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Murphy MP, 2013, CELL METAB, V18, P145, DOI 10.1016/j.cmet.2013.07.006; Nagashima S, 2020, SCIENCE, V367, P1366, DOI 10.1126/science.aax6089; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nillegoda NB, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00057; Ohlmeier S, 2010, ELECTROPHORESIS, V31, P2869, DOI 10.1002/elps.200900759; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Olivera-Couto A, 2011, MOL BIOL CELL, V22, P2360, DOI 10.1091/mbc.E10-12-1021; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Sepuri NBV, 2007, FEBS J, V274, P4615, DOI 10.1111/j.1742-4658.2007.05990.x; Sepuri NBV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035321; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; Song J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004539; Stradalova V, 2009, J CELL SCI, V122, P2887, DOI 10.1242/jcs.051227; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tieu Q, 2000, J CELL BIOL, V151, P353, DOI 10.1083/jcb.151.2.353; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472; Walther TC, 2007, EMBO J, V26, P4946, DOI 10.1038/sj.emboj.7601933; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060; Ziolkowska NE, 2012, TRENDS CELL BIOL, V22, P151, DOI 10.1016/j.tcb.2011.12.002; Zorov DB, 2014, PHYSIOL REV, V94, P909, DOI 10.1152/physrev.00026.2013	95	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102533	10.1016/j.jbc.2022.102533	http://dx.doi.org/10.1016/j.jbc.2022.102533			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36162502	Green Published, gold			2022-12-26	WOS:000881802600009
